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Abstract 
 
(+)-Salvianolic acid C alike to other members of the polyphenolic family is composed of 
three caffeic acid units including (R)-Danshensu.  Its retrosynthetic analysis presents two key 
fragments, a 2-arylbenzo[b]furan core and the (R)-Danshensu side chain. These two synthons 
were the initial synthetic targets and the final steps were to join these fragments and 
deprotection.   
 
In chapter two, the synthesis of the 2-arylbenzo[b]furan core is discussed, which overall, was 
made in a total of four linear steps with an overall yield of 22%.  In chapter three, an 
asymmetric route to a protected derivative of (R)-Danshensu was developed utilizing the 
Darzens condensation reaction en route to afford racemic trimethyldanshensu in 85% yield. 
The racemic mixture was separated by a lipase-mediated kinetic resolution to afford (R) and 
(S)-danshensu derivatives, with overall yields of 20% and 14%, respectively. Both danshensu 
derivatives were 10% higher in optical purity compared to previous resolutions of this type.   
 
In chapter four, a lengthy investigation into the esterification of the two key building blocks 
was undertaken followed by deprotection to afford (+)-pentamethylsalvianolic acid C in 71% 
yield. The demethylation of all five methyl ether groups was challenging. The only reagent 
compatible with the electron rich substrate that deprotected 80% [four out of five methyl 
ethers] was boron tribromide. Unfortunately the low product yield did not allow for 
unambiguous characterization. The research outcomes provided two methylated derivatives 
of (+)-Salvianolic acid C: methyl (+)-pentamethylsalvianolate C and (+)-
pentamethylsalvianolic acid C prepared in overall yields of 15% and 11%, respectively.   
To explore the development of novel, Danshen derived drug candidates in chapter five, a 
chalcone-salvianolic acid C hybrid compound was prepared with a low overall yield of 2%. 
Chapter five also discusses an attempt to elaborate a new synthetic pathway to the diacid core 
of (+)-Salvianolic acid D.  
 
Samples of the methylated derivatives of (+)-Salvianolic acid C and the chalcone building 
block were sent for biological testing (chapter 6). It was found that two compounds possess 
Abstract 
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antifungal activity against Candida alblicans. The same compounds were also tested as β-
amyloid peptide (Aβ42) inhibitors in a yeast spot assay. Preliminary studies indicated all three 
compounds improved the survival rate of the yeast cells compared to the control. These 
findings indicate that there is potential for these methylated derivatives of (+)-Salvianolic 
acid C to serve as potential drug candidates. 
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1. Introduction 
 
1.1 Danshen Review 
 
1.1.1 Background  
 
Danshen, the dried root and rhizome of Salvia miltiorrhiza Bunge, of the Lamiacea family 
(formerly Labiacea) is one of the most popular Traditional Chinese Medicines (TCM) and 
has been used globally to promote circulation and improve blood flow. With a history of at 
least 2000 years Danshen has been used in China for decades (since 1970) to provide 
therapeutic relief from coronary heart disease, cerebrovascular disease, hepatitis, 
hepatocirrhosis, chronic renal failure, dysmenorrhea, arthritis and neuroasthenic insomnia.
1,2
 
Other medicinal properties of this herb include antiviral, antioxidant and antitumour 
activities.
3
 
 
S. miltiorrhiza is an annual sage native to China and Japan. It is also known to grow in 
Mongolia and Korea. In China it can be found in the hilly areas of the west, southwest and 
southeast. Today Danshen products are readily available from herbal shops in the US, Europe 
and Australia. As the Chinese have possessed the knowledge of Danshen for years, it has 
developed a renowned appreciation among the Chinese community (in 2002 sales totaled at 
US$120 million) and naturally there have been several pharmaceutical forms established.
4
 
 
Danshen is readily available in many commercially obtainable forms. These include tablets, 
capsules, granules, injectables, oral liquids, sprays and dripping pills. The „dripping pill‟ is 
made by blending the herbal extract with excipients (a pharmacologically inactive substance 
to act as a carrier) over heat followed by dripping the mixture into a cold solution to allow for 
solidification of the droplets. These prescriptions can consist of either Danshen or Fufang 
Danshen. Fufang in Chinese herbal medicine is a formula comprising multiple herbs.
5
 
 
There are numerous forms of Fufang Danshen for the improvement of specific bodily 
functions. The Fufang Danshen tablet and dripping pill are the two most common products in 
China. The Fufang Danshen dripping pill has been registered as a drug in several countries 
including Vietnam, Russia, Cuba, the Korean Republic and Saudi Arabia. The Fufang 
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Danshen dripping pill was the first TCM approved for phase II and III clinical trials by the 
Food and Drug Administration (FDA) in 1997.
4
 
 
There are three families of compounds present in Danshen. A hydrophobic, lipid soluble, 
diterpene family named the Tanshinones, a hydrophilic, polyphenolic combination of 
compounds consisting mainly of depsides or Salvianolic acids and a select group of flavones. 
The polyphenolic acids are given this name as they are unique to the Salvia genus.
2
 
Biological activity studies had mainly focused on the hydrophobic tanshinones before 1990. 
Recently researchers have focused on the hydrophilic constituents of Danshen since it was 
discovered that Chinese practitioners were prescribing a water decoction (a method of 
extraction by boiling in water) injection agent of Danshen for the treatment of cerebral and 
coronary vascular disease.
3
 
 
Before 1990 the unique bioactivity of Danshen was presumed to be due to the tanshinones 
and the dried root of S. miltiorrhiza was initially named „Tanshen‟. But after the discovery of 
the Salvianolic acids and their unprecedented activity the name was changed to „Danshen‟ to 
represent both families of active metabolites. This revelation led to the isolation and 
characterisation of the caffeic acid derived metabolites. 
 
1.1.2 Hydrophilic Constituents of Salvia miltiorrhiza (Danshen) 
 
Caffeic acid oligomers (depsides) are the predominant species of water soluble components 
in Danshen and to date twenty-six derivatives have been isolated and their structures 
elucidated via chemical and spectroscopic experiments.
6
 Another five hydrophilic 
compounds, including polyphenolic glycosides have been identifed.
7
 
 
The caffeic acid derivatives in Danshen can be categorised into four main groups: monomers, 
dimers, trimers and tetramers and are termed depsides or Salvianolic acids in the scientific 
literature. 
 
Caffeic acid (1, Figure 1) plays a fundamental role in the biochemistry of Lamiacea and 
occurs predominantly in the dimer form as Rosmarinic acid (5, Figure 2).
2
 The trimers and 
tetramers of caffeic acid are the depsides which contribute the majority of therapeutic effects 
exhibited by the aqueous extracts of Danshen. 
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Nearly all of the caffeic acid depsides are potent antioxidants due to their polyphenolic 
structure. It is said by Zhao et al.
8
 that the structural requirements of a compound to possess 
high antioxidant activity are the presence of multiple 3,4-dihydroxyphenyl moieties and 
electron donating groups. This family of compounds clearly falls into this category with all of 
the depsides being classified as hydroxyl-cinnamic acids. 
 
1.1.2.1 Caffeic acid monomers 
 
 
Figure 1 Caffeic acid monomers within Danshen (Salvia miltiorrhiza) 
 
Danshensu (3) was first isolated from S. miltiorrhiza (Danshen) in 1981.
2
 It was later 
identified to be a coronary vasodilator with the ability to scavenge free oxygen radicals 
generated during ischemia-reperfusion injury more efficiently than superoxide dismutase 
(SOD).
2
 The amide form of Danshensu (4) has been reported to exceed its carboxylic acid 
partner in therapeutic action after being reported to possess an antioxidant activity greater 
than that of ascorbic acid.
2
 
 
1.1.2.2 Caffeic acid dimers 
 
Rosmarinic acid (5) is one of the most abundant depsides present in Danshen and has been 
reported to possess high antioxidant activity. It was first isolated from Rosmarinis officinalis 
in 1958 and was named accordingly.
3
 Salvianolic acid F (9) is an 8a-decarboxylated dimer 
bearing a trans-stilbenoid skeleton, whose structure was confirmed by total synthesis.
3
 
Salvianic acid C (7) was isolated from an injection agent of Danshen and the structure was 
elucidated via mass spectrometry.
3
 Salvianolic acid G (11) is a caffeic acid dimer consisting 
of a dibenzooxepin skeleton and was the first of its kind found in the Salvia genus.
2
 
Prolithospermic acid (10) was first isolated from S. prezwalski and given the name 
Prezwalskinic acid A and it is still referred to by this name in some articles found in Chinese 
literature.
2
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All depsides apart from 5, Salvianolic acids A and B (12, Figure 3 and 23, Figure 4) and 
Lithospermic acid (19, Figure 3) are generally present in minute quantities (≤ 0.01%) within 
the annual sage (Danshen) but still contribute to the synergistic therapeutic effect of 
Danshen.
7
 
 
 
Figure 2 Caffeic acid dimers within Danshen (Salvia miltiorrhiza) 
 
1.1.2.3 Caffeic acid trimers 
 
Trimers are the most diverse and abundant form of caffeic acid oligomers present in 
Danshen. Dimethyl lithospermate (21) has an antioxidant power similar to that of the amide 
form of Danshensu (4, Figure 1), displaying stronger radical scavenging activity than 
ascorbic acid.
2
 Salvianolic acid A (12) is a stilbenoid trimer that possesses strong antioxidant 
properties. Its structure is similar to Salvianolic acid F (9, Figure 2), retaining the stilbenoid 
skeleton with a Danshensu chain esterified with the carboxylic acid. During its isolation, 
Salvianolic acid A (12, Figure 3) was found to be rather unstable. When Salvianolic acid A is 
run on a TLC plate deactivated with 2% formic acid, only Salvianolic acid C (13, Figure 3) 
is detected and is thought to result from Brønsted acid promoted cyclisation of Salvianolic 
acid A.
9
 Salvianolic acid C (13) is therefore suggested to be an artifact.
3
  Isosalvianolic acid 
C (18, Figure 3) was originally only known to solely exist within S. chinensis, until recently 
when it was discovered in Danshen.
7
 Isosalvianolic acid C (18) possesses the same 
dibenzooxepin skeleton as Salvianolic acid G (11, Figure 2), which is thought to be unique to 
S miltiorrhiza.  
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Figure 3 Caffeic acid trimers present within Danshen (Salvia miltiorrhiza) 
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1.1.2.4 Caffeic acid tetramers 
 
 
Figure 4 Caffeic acid tetramers present within Danshen (Salvia miltiorrhiza) 
 
As caffeic acid predominantly exists as its dimer form (Rosmarinic acid), caffeic acid 
tetramers are considered to be essentially dimerised Rosmarinic depsides. Salvianolic acid B 
(23) is the most abundant depside in Danshen. This has been proven beyond reasonable doubt 
by multiple researchers using High Performance Liquid-Chromatography (HPLC) 
techniques.
6,7,10,11
 Salvianolic acid B (23), since its discovery in 1988, has been the subject of 
hundreds of pharmacological studies and is thought to be responsible for most of the 
therapeutic effects exhibited by aqueous extracts of Danshen simply due to its natural 
abundance, which can vary between 1 – 7 % (w/w of dry plant material).9,12  Salvianolic acid 
B exists mainly in salt form with counterions magnesium (Mg
2+
, 25), ammonium (NH4
+
) and 
potassium (K
+
, 26). These ionic forms of 23 are found in many species of Salvia.
2
  The 
abundance of Salvianolic acid E, a precursor to Salvianolic acid B, is surprisingly more 
restricted having only being reported in Danshen.
3
 It is suggested that Ethyl Salvianoate B 
(24) is produced during the extraction and isolation process, therefore could be considered an 
artifact.
3
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Initial investigations into the hydrophilic constituents revealed that there were two major 
components Salvianolic acid B (23) and Lithospermic acid B. These two polyphenols were 
thought to be diastereomers of each other as the α,β positions of the dihydrobenzofuran core 
were assigned with (R,R) and (S,S)-configuration respectively. Recently, it was proved by 
Watzke et al.
13
 that these two secondary metabolites are in fact the same compound by 
chemical correlation. Watzke et al. proposed that one of the configurational assignments was 
incorrect as it seemed suspicious that both compounds could be isolated with very similar 
procedures. Fortunately Watzke et al. recently completed the first total asymmetric synthesis 
of Lithospermic acid (19, Figure 3) and had a sample of a permethylated synthetic precursor 
whose absolute configuration was confirmed by X-ray analysis of a bromo-substituted late 
stage-synthetic intermediate. The methylated precursor was subjected to methanolysis to 
afford the methylated, optically pure dihydrobenzofuran core of Lithospermic acid. 
Commercial Salvianolic acid B (23) was first permethylated and then degraded under the 
same conditions to afford the dihydrobenzofuran core. The specific rotation of both samples 
was then measured and both samples had the same positive rotation and relative magnitude 
for the rotation. To confirm this finding, Circular Dichroism (CD) experiments were also 
performed on both samples and the CD spectra were identical. These results clearly show that 
previous absolute configurations, respectively assigned to the dihydrobenzofuran 
stereocentres of Salvianolic acid B (23) were incorrect and indicate that Salvianolic acid B 
and Lithospermic acid B are the same compound. Unfortunately Salvianolic acid B is still 
referred to as Lithopermic acid B in the Chinese literature and by other authors, but one 
should be aware that the same compound is being discussed and any new biological 
properties are due to the latter.  
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1.1.2.5 Other hydrophilic compounds 
 
 
Figure 5 Miscellaneous polyphenols from Danshen (Salvia miltiorrhiza) 
 
Other hydrophilic compounds with comparable bioactivity to the Salvianolic acids include 
XH-14 (27) and 1-hydroxypinoresinol-1-O-β-D-glucoside (30), a bisepoxylignan. 
Protocatechuic acid (28) and Protocatechuic aldehyde (29) are also present, but limited 
pharmacological studies have been carried out on these two constituents. XH-14 (27) is 
known to be a novel adenosine A1 receptor ligand bearing the same benzofuran skeleton as 
Prolithospermic acid, but a different substitution pattern. What makes XH-14 (27) unique is 
that the core skeleton does not contain any nitrogen atoms providing a new structural motif 
capable of possessing high A1 receptor antagonist activity and is water soluble. XH-14 has 
been synthesised multiple times and therefore been studied extensively. The bisepoxylignan 
(30) is unique to Danshen and has displayed phenomenal antioxidant activity.
3
  
 
Higher order caffeic acid oligomers (up to six caffeic acid units) are present within the Salvia 
genus, but to this date have not been identified within the S. miltiorrhiza species.
2
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1.1.3 Salvia taxonomy 
 
The Salvia genus consists of approximately 900 species of sage in the Lamiacea (mint) 
family of herbs.
2
 Approximately 78 species are native to China.
3
 Caffeic acid metabolites 
found in Danshen are known to exist within other species of the Salvia genus. 
 
Table 1 Salvia species containng Danshen caffeic acid monomers 
Caffeic acid monomers Salvia species 
Caffeic acid 
Miltiorrhiza 
Albimaculata 
Bowleyana 
Calycina 
Chinesis 
Horminum 
Limbata 
Officinalis 
Plebeia 
Sonchifolia 
Triloba 
Isoferulic acid Miltiorrhiza 
Danshensu 
Miltiorrhiza 
Chinesis 
Prionitis 
Sonchifolia 
(R)-(+)-3-(3,4-
dihydroxyphenyl)lactamide  
Miltiorrhiza 
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Table 2 Salvia species containing Danshen caffeic acid dimers 
Caffeic acid dimers Salvia species 
Rosmarinic acid 
Miltiorrhiza 
Bowleyana 
Cavaleriei 
Chinesis 
Flava 
Lavandulifolia 
Officinalis 
Prionitis 
Sonchifolia 
Yunnanensis 
Methyl rosmarinate 
Miltiorrhiza 
Bowleyana 
Prionitis 
Sonchifolia 
Prolithospermic acid 
Miltiorrhiza 
Prezwalskii 
Salvianolic acid G Miltiorrhiza 
Salvianolic acid F Miltiorrhiza 
Salvianolic acid D 
Miltiorrhiza 
Chinesis 
Salvianic acid C Miltiorrhiza 
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Table 3 Salvia species containing Danshen caffeic acid trimers 
Caffeic acid trimers Salvia species 
Salvianolic acid H 
Miltiorrhiza 
Cavaleriei 
Salvianolic acid I 
Miltiorrhiza 
Cavaleriei 
Officinalis 
Salvianolic acid J 
Miltiorrhiza 
Flava 
Salvianolic acid K 
Miltiorrhiza 
Deserta 
Salvianolic acid A 
Miltiorrhiza 
Cavaleriei 
Flava 
Prionitis 
Salvianolic acid C 
Miltiorrhiza 
Bowleyana 
Cavaleriei 
Prionitis 
Isosalvianolic acid C 
Miltiorrhiza 
Cavaleriei 
Chinesis 
Prionitis 
Lithospermic acid 
Cavaleriei 
Chinesis 
Sonchifolia 
Methyl lithospermate Miltiorrhiza 
Dimethyl lithopermate Miltiorrhiza 
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Table 4 Salvia species that contain Danshen caffeic acid tetramers 
Caffeic acid Tetramers Salvia species 
Salvianolic acid B 
Miltiorrhiza 
Bowleyana 
Cavaleriei 
Chinesis 
Flava 
Prionitis 
Sonchifolia 
Yunnanensis 
Salvianolic acid E Miltiorrhiza 
Ethyl Salvianoate B Miltiorrhiza 
Mg
2+
 Salvianoate B Miltiorrhiza 
NH
4+
-K
+
-Salvianoate B Miltiorrhiza 
 
As the tables above indicate, almost all of the depsides found in Danshen are known to exist 
within other species of Salvia. For example, Salvianolic acid B (23) is most abundant in S. 
bowleyana and can be isolated with an overall yield 7.04 % (w/w of dry plant material).
3
 
Although, the relative abundance of Salvianolic acid B (23) can vary between 1 – 7 % in 
other species of Salvia depending on geographical source and harvest season.
12
 
 
Caffeic acid (1) itself is a common building block for other hydrophilic metabolites and 
therefore is found in many other genera and families. Rosmarinic acid (5) has been found in 
several families including Boaginaceae and Blechnaceae. (+)-Lithopsermic acid (19) is 
known to be present within Lithospermum ruderale and Tournefortia sarmentosa of the 
Boraginaceae family. Thus, Caffeic acid (1) cannot be used as a chemotaxonomical marker to 
differentiate between other genera, species and families.
3
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1.1.4 Pharmacology 
 
1.1.4.1 Acute ischemic Stroke 
 
There is an extensive collection of herbal remedies (TCM) for the treatment of high blood 
pressure or coronary artery disease. Bearing this is mind, in China the first method of 
treatment for blood flow related diseases is to prescribe a Danshen decoction presumably due 
to its well documented medicinal properties and low toxicity.
14
 
 
One deleterious overall effect of coronary artery disease is stroke. Thus, clinical studies and 
trials of Danshen, Danshen formulations and products have focused on Danshen‟s effect on 
relieving the major causes of stroke including thrombosis, astherosclerosis, oxidative damage 
and cerebral ischemia-reperfusion. 
 
The exact mechanism of action for Danshen‟s protection against stroke and its causes is 
unknown. However, it has been suggested that Danshen formulations could inhibit the 
Angiotensin Converting Enzyme (ACE) as Danshen has been reported to decrease 
Angiotensin II levels. ACE inhibitors‟ are known to decrease the likelihood of having a 
stroke as they have been thoroughly studied in cardiovascular disease and have been shown 
to decrease the risk of suffering a primary or secondary stroke. ACE inhibitors‟ primary 
functions are to lower blood pressure, dilate arteries and to decrease blood clotting. With 
regard to stroke, angiotensin has several threatening effects including hypertension, 
increasing noradrenergic nerve activity and blocking norepinephrine reuptake in the brain. 
Cerebral ischemia-reperfusion during stroke can also contribute to an increase in 
norepinephrine levels. Excess of these neurotransmitters can be damaging to the brain by 
inducing excitotoxicity and other mechanisms. Danshen has been shown to decrease the 
release of norepinephrine, dopamine, and serotonin during brain ischemia. Another possible 
mechanism could be decreasing clot formation by decreasing cardiac fibrillation.
5
 
 
Specific clinical trials of Danshen and its hydrophilic constituents have demonstrated that 
Salvianolic acids (SA) from Danshen can increase regional cerebral blood flow (rCBF) after 
ischemia.
3
  In a study of total Salvianolic acids effect on rCBF in ischemic rats it was found 
that 30 mins after middle cerebral artery occlusion (MCAO) intravenous injection of total 
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Salvianolic acids improved the rCBF of ischemic rats significantly (Table 5, where RVrCBF 
stands for Relative Value of regional Cerebral Blood Flow).
15
 
 
Table 5 Effect of Salvianolic acid (SA) administration on the RVrCBF of rats (M ± SD, P < 0.05) 
Group 
Animal 
number (n) 
Dose (mg/kg) 
RVrCBF (%) 
After 15 min After 30 min 
Ischemia rats 8 NS 47.9 ± 12.1 44.2 ± 10.6 
SA + ischemia 8 6 67.1 ± 14.7 66.8 ± 16.9 
SA + ischemia 8 10 63.7 ± 10.0 61.5 ± 14.4 
 
Other trials provide evidence to suggest that Salvianolic acid B is an ACE inhibitor and 
increases NO (nitric oxide, a vasorelaxant) production by endothelial cells.
5
 Salvianolic acid 
B has also been reported to possess antihypertensive properties and is protective against 
cerebral ischemia-reperfusion.
5
 Aqueous extract of Danshen alleviates hypertension in the 
two-kidney/one-clip (2K1C) Goldblatt renovascular hypertensive rats model and reduced the 
activity of serum ACE and the levels of aldosterone.
16
 A combination of Rosmarinic acid 
with Salvianolic acids from Danshen can inhibit thrombosis, thromboxane B2 formation and 
platlet aggregation.
5
  
 
Further, Salvianolic acid B and aqueous ethanol extracts of Danshen have been reported to 
possess anti-inflammatory properties as these therapeutics can inhibit TNF-α-induced 
(Tumour Necrosis Factor) expression of VCAM-1 (Vascular Adhesion Molecule-1) and 
TNF-α-induced activation of NF-κB (Nuclear Factor) in human aortic endothelial cells. TNF-
α is a pro-inflammatory cytokine and is regulated by NF-κB while VCAM-1 regulates the 
migration of leukocytes into the vessel wall.
16
  
 
A recent review discusses the potential for Mg
2+
 Salvianoate B (MSB) (referred to as 
Magnesium Lithospermate B (MLB) in the article) to be used as a treatment for ischemic 
stroke.
1
 The article justifies this therapeutic action by arguing that MSB can reversibly inhibit 
the Na
+
/K
+
-ATPase active transport system and therefore provides a neuroprotective effect in 
ischemia-reperfusion through ATP conservation and modulating intracellular Ca
2+
 levels just 
as cardiac glycosides do. Unfortunately, severe side effects and narrow therapeutic index of 
cardiac glycosides have limited their clinical application. MSB has a similar 3D structure to 
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Ouabain, a naturally derived cardiac glycoside. The authors conducted molecular modeling 
experiments of MSB‟s interaction with Na+/K+-ATPase and it is discovered that MSB binds 
with the ion pump in a similar fashion to Ouabain with the four aromatic rings of MSB 
forming a strong hydrophobic interaction with hydrophobic residues around the binding 
pocket (the primary binding site for many pharmacological agents) of Na
+
/K
+
-ATPase. It is 
then proposed that MSB, with its low toxicity combined with other drugs, as it is currently 
used in many Fufang formulations, would serve as an efficient treatment for cardiovascular 
diseases and ischemic stroke due to the chemical and pharmacological similarities between 
MSB and Ouabain. This mechanism could explain the efficacy Danshen displays in relieving 
stroke symptoms.    
 
1.1.4.2 Thrombosis 
 
The literal meaning of Thrombosis is to form a blood clot (thrombus) inside the blood vessel 
thereby obstructing blood flow. If a blood vessel is broken, the body uses platelets 
(thrombocytes) and fibrin to form a blood clot and thus prevent blood loss.
17
 
 
Thrombosis is a major cause of stroke. Small blood clots (or thrombi) lodge in small arteries 
of the brain, especially middle cerebral artery (MCA) and cause ischemia. The use of total 
Salvianolic acids can inhibit the formation of thrombosis, decrease the plasma endothelin 
content and reduce the high level of thromboxane B2 (TXB2) after cerebral ischemia. 
Rosmarinic acid has been reported to exhibit mild antithrombotic effects (Table 6).
3,5
 
 
Table 6 Antithrombotic effect of Rosmarinic acid 
Danshen hydrophilic Inhibitory activity Dose (mg/kg) % Inhibition 
Rosmarinic acid 
 
Venous thrombosis 
50 41.9 
100 54.8 
Blood platelet 
aggregation 
50 30.4 
100 46.4 
   
A recent manuscript discuses the ability of Salvianolic acid B to act as an antithrombotic by 
inhibiting platelet deposition onto collagen under physiological flow conditions as a result of 
an interaction of Salvianolic acid B with the platelet collagen receptor α2β1.18 This 
bioactivity is described as being specific for the collagen receptor α2β1 by preventing 
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receptor binding to platelets and immobolised collagen. It is suggested that the observed 
bioactivity could contribute to Danshen‟s antithrombotic properties. It is noteworthy that to 
the author‟s knowledge, this is the first report of a component having been extracted from a 
plant to display inhibitory activity toward the α2β1 collagen receptor. Unfortunately, high 
concentrations of Salvianolic acid B (up to 1000 μg/mL) in vitro were needed to inhibit 
platelet deposition; therefore further studies are required to determine the physiological 
relevance of these findings.  
 
Other reports of Danshen‟s efficacy toward the inhibition of platelet aggregation include a 
study on the effect of total Salvianolic acids‟ against platelet aggregation (in vitro and in 
vivo) following cerebral ischemia in MCAo rats.
15
 Total Salvianolic acids‟ inhibited platelet 
aggregation induced by collagen, ADP (adenosine diphosphate), and AA (amino acid) in a 
concentration-dependant manner, in vitro (Table 7).  
 
Table 7 Effect of total Salvianolic acids (SA) on Platelet aggregation in vitro 
Danshen hydrophilic 
Aggregation 
promoter 
IC50 value (10^3 mg/L) 
Total salvianolic acids 
Collagen 0.197 
ADP 2.22 
AA 3.29 
 
Total salvianolic acids‟ (SA) proved more potent towards collagen generated platelet 
aggregation.
15
 This agrees with the previous statement regarding the bioactivity of Danshen 
as an antithrombotic. The potency of total salvianolic acids‟ for platelet aggregation 
generated by collagen could be explained by the ability of Salvianolic acid B to bind to the 
collagen receptor α2β1. Total salvianolic acids‟ also inhibited platelet aggregation in the in 
vivo studies but generally required a higher concentration to have a significant effect (Table 
8). However a similar efficacy for collagen-induced platelet aggregation was observed.  
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Table 8 Effect of total Salvianolic acids‟ (SA) on rat platelet aggregation induced by collagen and ADP in vivo (M ± SD, P 
< 0.01)15 
Group 
Dose 
(mg/kg) 
Platelet aggregation (%) 
Collagen ADP 
Vehicle NS 57.8 ± 5.0 63.2 ± 5.1 
SA 3 56.1 ± 3.1 60.6 ± 5.7 
SA 6 13.0 ± 3.5 60.6 ± 5.7 
SA 10 5.4 ± 2.2 47.4 ± 5.9 
 
1.1.4.3 Angina pectoris 
 
Angina pectoris is a form of coronary artery disease. Common symptoms include chest pain 
due to ischemia (a lack of blood, thus a lack of oxygen supply and waste removal) of the 
heart muscle generally directly related to obstruction or spasm of the coronary arteries. 
 
Danshen has been reported to protect the body from hypocalcemia.
14
  Acidic metabolites 
from a Danshen decoction have been observed to exert a protective action on myocardinal 
cells by acting as a calcium (Ca
2+
) antagonist. The activity of Danshen against forms of 
coronary artery disease, such as angina pectoris could be explained by this activity. A recent 
study was carried out in an effort to deduce the mechanism of action through which 
salvianolic acid causes relaxation of isolated coronary artery rings precontracted with 1 μM 
5-hydroxytyrptamine (5-HT).
19
 It was determined that both aqueous extracts of Danshen and 
Salvianolic acid B possess dose-dependent vasorelaxant properties in rat coronary arteries. It 
was observed that the aqueous extract of Danshen was 6.3 times less potent than Salvianolic 
acid B (Table 9).  
 
Table 9 Danshen aqueous extract and Salvianolic acid B-induced relaxation of 5-HT-precontracted tone in isolated rat 
coronary arteries (P < 0.001) 
Danshen hydrophilic 
IC50 value (μg/mL) 
mean ± S.E.M. 
Aqueous extract 930.3 ± 133.5 
Salvianolic acid B 147.9 ± 17.4 
 
A series of experiments were then conducted to determine the mechanism of action. It was 
found that the dilatory action, as described above was produced primarily by inhibition of 
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Ca
2+
 (calcium) channels in the vascular smooth muscles cells (Table 10). A minor 
component was mediated by the opening of K
+
 channels. This supports the idea of Danshen 
decoctions acting as Ca
2+
 antagonists.
19
 
 
Table 10 Effects of Danshen aqueous extract, Salvianolic acid B and Nifedipine on CaCl2-induced contraction in isolated rat 
coronary arteries incubated in Ca2+-free buffer primed with 5-HT (P < 0.001) 
Group Dose 
Vasodilatory response 
(g, mean ± S.E.M.) 
Result 
CaCl2 NA 0.453 ± 0.039 NA 
Nifedipine (control) 35 ng/mL 0.010 ± 0.014 98% reduction 
Danshen aqueous extract 2 mg/mL 0.002 ± 0.012 100% reduction 
Salvianolic acid B 0.72 mg/mL 0.030 ± 0.022 93% reduction 
 
1.1.4.4 Myocardial infarction 
 
Myocardial infarction (heart attack) is caused by an interruption of blood flow to the heart. 
Danshen is a critical TCM that has been used for the treatment of acute myocardial infarction. 
Danshen has been reported to improve the opening and formation of coronary collateral 
circulation and therefore protect the myocardium in experimental myocardial infarction in 
both dogs and rats. The cardioprotective effects of Danshen are comparable to Captopril (the 
first ACE inhibitor invented) and Ramipril, both ACE inhibitors‟ which have a long history 
of being used to treat patients with various cardiovascular diseases.
14
   
 
1.1.4.5 Antiviral 
 
Water extracts of Danshen have displayed significant potent effect against HIV-1 integrase 
activity in vitro. In a study performed by Abd-Elazem et al.
20
 an extensive purification 
scheme was developed where bioassay guided isolation was used to assist in the separation 
and isolation of two of the major polyphenols from Danshen; Lithospermic acid (19, Figure 
3) and Lithospermic acid B (correct name Salvianolic acid B 23, Figure 4) which were 
isolated in high purity (> 99.5 %). The inhibitory effect of both polyphenols against HIV 
replication was then investigated and it was found that both compounds showed similar IC50 
values for the suppression of HIV replication in H9 cells when compared to two diketo acids 
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(L-731,988 and L-708,906) that were listed as exceptionally promising integrase inhibiting 
drugs in 2000 (Table 11).
20
 
 
Table 11 Inhibition of HIV-1 replication in H9 cells infected with HIV-1IIIBA17 virus 
HIV-1 Integrase Inhibitor IC50 (µM) 
Diketo acid 1 – 2  
Lithospermic acid (19) 2.0 
Salvianolic acid B (23) 6.9 
 
The cytotoxicity of both compounds in H9 cells was then examined and by an MTT assay. It 
was determined that after a culture period of eight days the cells remained viable even at the 
highest concentrations tested (297 µM for Lithospermic acid and 223 µM for Salvianolic acid 
B). Therefore both Lithospermic acid and Salvianolic acid B are non-toxic to H9 cells in 
culture.   
 
Another measurement of a compounds efficacy for inhibition of HIV-1 integrase is to 
observe the ability of the drug candidate to prevent the integrase (IN) enzyme catalysing the 
integration of viral double-stranded DNA (dsDNA) into the host chromosome via removing 
the last two nucleotides (GT) leaving two recessed 3´-OH ends. Consequently a 3´-end 
processing assay was conducted and the IC50 values were determined (Table 12).
20
 
 
Table 12 Inhibition of 3´-end processing of HIV-1 integrase by Lithospeermic and Salvianolic acid B 
HIV-1 Integrase Inhibitor IC50 (µM) 
Diketo acid 6.0 
Lithospermic acid (19) 0.83 
Salvianolic acid B (23) 0.45 
 
From the tables above it can be seen that polyphenols 19 and 23 are highly potent inhibitors 
of HIV-1 integrase as their IC50 values are remarkably lower than that of the known integrase 
inhibitor. At these higher concentrations the diketo acids have been observed to exert some 
cellular toxicity. This is favorable towards polyphenols 19 and 23 as new HIV integrase 
inhibitors and exemplifies their particular activity.   
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In an attempt to display how unique these HIV integrase inhibitors are Abd-Elazem et al.
20
 
proceeded to investigate the effect of polyphenols 19 and 23 on the inhibition of strand 
transfer, the second function of the virus. Strand transfer (3´-joining) involves joining the 
recessed 3´-end to the 5´-end of an integrase induced break in another identical 
oligonucleotide, as a target DNA.  
 
The results show (Table 13) that both polyphenols strongly inhibited strand transfer, even 
more so than another recently discovered HIV-1 integrase inhibitor, Isocomplestatin, a far 
more complex natural product bearing a heavily strained macrocycle. 
 
Table 13 Inhibition of strand transfer (3´-end joining) of HIV-1 integrase activity 
HIV-1 Integrase Inhibitor IC50 (µM) 
Isocomplestatin 5.9 
Lithospermic acid (19) 0.48 
Salvianolic acid B (23) 0.37 
 
Kinetic and mechanistic studies of the inhibitory action of Lithospermic acid (19, Figure 3) 
suggest that the polyphenol is binding to the enzyme HIV-1 integrase and preventing any 
enzymatic reaction at a fast rate. Overall this study shows that Danshen polyphenols 
Lithospermic acid (19) and Salvianolic acid B (23) are selective and potent inhibitors of HIV-
1 integrase. Coupled with their absence of cytotoxicity they have potential to be used as novel 
therapeutic agents for AIDS. 
 
1.1.4.6 Anticancer 
 
Salvianolic acid B (Sal-B) has been reported to inhibit the growth of human head and neck 
squamous cell carcinoma (HNSCC) cells both in vitro and in vivo through inhibition of 
cyclooxygenase-2 (COX-2) expression and induction of apoptosis.
12
 The cytotoxic effects of 
Sal-B were investigated in vitro and the resulting IC50 values are displayed in the table below 
(Table 14). 
 
The mechanism of action was investigated and it was deduced that the anticancer effects of 
Sal-B are exhibited through a COX-2 – dependent pathway to inhibit PGE2-synthesis 
(Prostaglandin two) as well as a COX-2 – independent pathway to regulate apoptosis of 
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HNSCC. Numerous studies have indicated that overexpression of COX-2 occurs in many 
cancers including HNSCC.  
 
Table 14 Salvianolic acid B inhibits cell viability in HNSCC cell lines (P < 0.05) 
HNSCC cell line IC50 value (μM) 
JHU-022 ~18 
JHU-013 50 
 
Further studies indicated that Sal-B displayed a higher efficacy for the suppression of 
HNSCC tumour growth compared with celecoxid, a commercial COX-2 inhibitor. Celecoxid 
has been reported to increase the risk of cardiovascular events (from 2.3 % to 3.4 %) when 
patients receive 200 mg to 400 mg of celecoxid twice daily. This report clearly indicates that 
Sal-B as a single agent is capable of selectively suppressing COX-2 expression. 
 
1.1.4.7 Antioxidant (Hyperlipidemia) 
 
As caffeic acid oligomers are the predominant hydrophilic species present in Danshen they 
are suspected of being responsible for the TCM‟s antioxidant activity. The antioxidant effects 
of caffeic acid metabolites include anti-lipid-peroxidation, radical scavenging and 
antioxidation of low density lipoprotein (LDL).
3
 
 
Oxidative damage is primarily caused by reactive oxygen species (ROS) including hydroxyl 
radical (OH
∙-
), hydrogen peroxide (H2O2
∙-
) and superoxide (O2
∙-
) radical attacking lipids in 
cell membranes, proteins and DNA to cause membrane injury, protein and DNA 
modification.
3
 Research suggests that an accumulation of ROS in a biological system is 
directly responsible for tissue damage that affects cellular integrity and functions. Oxidative 
damage initiated by ROS is frequently linked to the onset of various diseases and long term 
health problems including aging, arthritis, cancer, inflammation, diabetes and heart disease.
21
 
 
The protective effect of Caffeic acid, Danshensu, Rosmarinic acid, Salvianolic acid‟s A and 
B, Prolithospermic acid and Protocatechuic aldehyde against peroxidative damage to live 
microsomes, hepatocytes and erythrocytes of rats was examined. All seven compounds 
exhibited inhibitory activity against the lipid peroxidation induced by iron/cysteine and the 
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erythocytes hemolysis induced by hydrogen peroxide. Out of the seven compounds, 
Salvianolic acid A displayed the highest efficacy.
3
  
 
In regard to caffeic acid oligomers possessing radical scavenging activity it has been reported 
that Rosmarinic acid and Salvianolic acids‟ A, B, and C can lower the production of 
superoxide radical in the xanthine oxidase system.
3
 Xanthine oxidase converts oxygen (O2) 
into superoxide radical (O2∙), which in turn dismutates into H2O2 and generates hydroxyl 
radicals (OH∙) through the Fenton reaction, ultimately resulting in cell damage.21   The same 
compounds, except for Salvianolic acid A, have also been reported to act as hydroxyl radical 
scavengers as they dose-dependently inhibit the hydroxylation of salicylic acid in both 
EDTA-H2O2-Fe
2+
 and Vitamin C-H2O2-Fe
2+
 systems.
3
 
 
Oxidised low density lipoprotein (LDL) contributes towards the onset of coronary 
atherosclerosis. The medical term atherosclerosis refers to hardening of the arteries and is due 
to cholesterol build-up around the walls of arteries caused by an influx of cholesterol through 
oxidised LDL. The oxidation is primarily caused by free radicals. The radical scavenging 
activity of Salvianolic acid‟s A and B can inhibit LDL oxidation resulting in a decrease of 
LDL reuptake by the macrophages.
14
 Other Danshen hydrophilics have been tested for anti-
lipid-peroxidative activity and Rosmarinic acid and Lithospermic acid exhibited more potent 
activity than Probucol, a cholesterol lowering agent.
3
  
 
In an attempt to develop an understanding into the mechanism of action for the therapeutic 
antioxidant effect of Danshen an in vitro study was conducted to determine the magnitude 
and efficacy for DPPH (1,1-diphenyl-2-picrylhydrazyl) free radical scavenging, hydroxyl and 
hydrogen peroxide radical scavenging activities, metal chelating activity and reducing 
power.
21
 The antioxidant properties of aqueous extract from Salvia militorrhiza (ESM) and 
Panax notoginseng (EPN), another Traditional Chinese Medicine (TCM) were compared 
(Table 15).  
 
Generally ESM displayed a higher potency for radical scavenging compared to EPN; the 
activity was predominantly dose dependant. The scavenging activity for OH∙ was comparable 
between both extracts, but ESM still prevailed with a slightly higher efficacy. Even though 
H2O2 is not very active, the ease with which it penetrates the cellular membrane leads to OH∙ 
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formation when it reacts with Fe
2+
 or O2∙ in the cell. In this case, EPN produced a higher 
efficacy for H2O2 activity. ESM did not display any Fe
2+
 chelating properties and EPN again 
proved superior. The low levels of activity here for ESM could be explained by the structural 
complexity of the polyphenolic compounds in the extract. However, ESM exhibited strong 
reducing properties for the reduction of Fe
3+
 to Fe
2+
 in a dose dependant manner. An Electron 
Spin Resonace (ESR) study showed that ROS participate in myocardinal (heart) reperfusion. 
The evidence presented in this study contributes towards an understanding of Danshen‟s 
known activity against various forms of heart disease. It is then stated that this study indicates 
that the antioxidant properties of ESM and EPN are distinct and complementary and provides 
insight into the synergistic effects of fufang pharmaceuticals.  
 
Table 15 IC50 values for ESM and EPN potency for antioxidant properties (P < 0.05) 
Oxidant 
IC50 (mg/mL) 
ESM EPN 
O2∙ 1.76 − 
DPPH∙ 0.024 3.09 
OH∙ 1.12 1.74 
H2O2 − 0.58 
Fe
2+
 − 1.2 
Fe
3+
 → Fe2+ 0.35 − 
 
There have been multiple reports of Danshen hydrophilics, in particular Salvianolic acid B 
(Sal B) and Danshensu (DSS) possessing antioxidant activity but until recently their chemical 
mechanisms remained poorly understood. A study has recently been carried out investigating 
these antioxidant activities at the molecular level, comparing the potency of Sal B and DSS 
for lipid peroxidation, metal chelating (Fe
2+
) and reactive oxygen species (ROS) scavenging 
(Table 16).
8
 Iron, present as Fe
2+
 is thought to catalyse lipid peroxidation by generating 
hydroxyl radicals (OH∙) via the Fenton reaction and thereby accelerating lipid peroxidation. 
The total antioxidant capacity of Sal B and DSS, determined by ABTS (2,2‟-azino-di-3-
ethylbenzthiazoline sulphonate) and DPPH radical scavenging was compared to the same 
dose of Vitamin C (Vit C) and expressed numerically as Vitamin C Equivalent Antioxidant 
Capacity (VCEAC) (Table 17).  
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Table 16 Antioxidant activity of Salvianolic acid B (Sal B) and Danshensu (DSS) (n = 5, P < 0.05) 
Oxidant 
[Dose] 
(mg/mL) 
Inhibition (%) IC50 (μg/mL) 
Vit C Sal B DSS Vit C Sal B DSS 
Fe
2+
 1.0 15 7.5 2.8 − − − 
HOO
∙−
 0.10 > 90 30 20 − − − 
OH∙− Dependant − − − 534 94 102 
O2∙
−
 Dependant − − − 820 160 560 
 
It was determined that both Sal B and DSS are weak Fe
2+
 chelators. It is known that 
polyphenols such as Quercetin, a flavonol possess metal chelating activity. The same 
phenomenon was observed in the previous study for an aqueous Danshen extract. Both Sal B 
and DSS exhibited a weaker scavenging activity for HOO
∙−
 than Vitamin C. However, both 
Sal B and DSS proved superior in their ability to inhibit OH
∙−
 and O2
∙−
 radicals compared to 
Vitamin C. 
 
Table 17 Vitamin C equivalent capacity by ABTS and DPPH assay (Mean ± SD, n = 5, P < 0.05) 
Radical 
VCEAC (mg/100mL) 
Sal B DSS 
ABTS 18.59 ± 0.25 12.89 ± 0.16 
DPPH 13.02 ± 0.21 11.02 ± 0.10 
 
VCEAC values of Sal B and DSS displayed a linear relationship with concentration. The 
results indicated that both Sal B and DSS are potent free radical scavengers, with Sal B 
displaying a slightly greater efficacy for the inhibition of ABTS and DPPH radicals. It is clear 
then from this study that the oxidative protective effects administered by Sal B and DSS are 
due to their radical scavenging activity.  
 
A structure-activity study was then conducted to determine the chemical requirements for a 
successful antioxidant. It was discovered that the number of phenolic hydroxyls is 
proportional to antioxidant activity as they are electron donating. This explains why Sal B 
and DSS exhibited greater antioxidant activity compared to Vitamin C. The β-OH present in 
DSS is electron withdrawing, resulting in lower antioxidant activity. The same reasoning 
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explains why other Danshen polyphenols (other Salvianolic acids‟ and the glucosides) exhibit 
extraordinary antioxidant activity.  
 
1.1.4.8 Side Effects and Toxicity  
 
The two most commonly used forms of Danshen are the Fufang Danshen Dripping Pill and 
the Fufang Danshen Tablet. As discussed previously, this is primarily due to these particular 
forms being readily available across the world and their efficacy for the treatment of 
numerous biological disorders due to the synergistic effects displayed by the herbal mixtures.  
 
Over the past four decades several studies and trials, conducted in China have revealed a 
small group of side effects (Tables 18 and 19).
4
 The typical dose was ten pills, three times a 
day and was administered sublingually. The tablet was taken orally; three tablets, three times 
daily. These trials appear to have been conducted with humans but no exact specification was 
given. 
 
Table 18 Observed side effects following the administration of Fufang Danshen Dripping Pill 
Group size 
Number of adversely 
effected patients 
Side effect 
100 3 Thirst 
40 1 
Mild gastrointestinal 
reaction 
160 2 
142 3 
56 2 Headache 
 
Table 19 Oberserved side effects following the administration of Fufang Danshen Tablet 
Group size 
Number of adversely 
effected patients 
Side effect 
34 2 
Upper abdominal 
discomfort 
34 3 Bad appetite 
 
Out of these studies only a small percentage of patients (1 – 9 %) exhibited adverse effects 
after being administered with either the Fufang Danshen Dripping Pill or Tablet.
4
 The side 
effects are generally mild and could be considered common or expected among clinical trials 
of approved pharmaceuticals with large sample groups. 
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The acute toxicity (LD50) of crude aqueous Danshen extract has been measured by two 
groups. In 1998 it was calculated to be 25.807 g/kg in mice and then in 2007 it was 
determined to be approximately 27g/kg/day in mice.
4,12
 The mean value of these two LD50 
values is equivalent to approximately 4000 times the intended clinical human dosage (6.56 
mg of Danshen extract/kg). It can therefore be said that Danshen extracts are nontoxic, but 
the same cannot be said for Danshen fufang pharmaceuticals due to the presence of other 
herbal medicines.  
 
The nontoxic nature of Danshen has been exemplified through a series of toxicity studies. 
When an oral dose of 2500 mg/kg of Danshen extract was administered over a period of 90 
days to rats it was found to be nontoxic.
4
 A long term toxicity study of Danshen revealed that 
S. miltiorrhiza glucose can induce reversible hepatomegaly (an enlarged liver) in rats (4/22) 
when administered via intraperitineal route at a dose of 5 g/kg/day.
12
 The hepatomegaly could 
be resolved by discontinuing the S. miltiorrhiza glucose. 
 
1.1.4.9 Herb-Drug interactions 
 
It has been reported that co-administration of a single dose of racemic Warfarin (2 mg/kg) 
with Danshen extract (5 g/kg twice daily, for three days) prolongs prothrombin time.
22
 The 
same publication suggests that the hydrophilic components of Danshen possess an inhibitory 
effect on the activity of CYP2C9, an isoform of cytochrome P450. Three possible cases of 
over anti-coagulation and bleeding were reported as result of receiving Danshen medication 
with warfarin therapy.
4
 
 
Recent discoveries have shed light on this potentially life threatening synergy. A new study 
outlines a potential mechanism by which herb-drug interactions could inhibit or alter the 
intended therapeutic response of an in vitro system.
22
 Four major hydrophilics of Danshen 
(Table 20) were tested for their ability to inhibit the catalytic activity of a series of P450 
isoforms commonly involved in drug-metabolised reactions. The degree of inhibition was 
characterized by examining the activities of marker reactions in Human Liver Microsomes 
(HMLs) via HPLC-MS (High Pressure Liquid Chromatography – Mass Spectometry). 
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Table 20 The IC50 values for the inhibition of Danshen components on CYP enzymes activities (a = with Testosterone 
marker, b = Midazolam marker, P ≤ 0.05) 
Danshen hydrophilic 
IC50 value (μM) 
CYP1A2 CYP2C9 CYP2D6 CYP3A4
a
 CYP3A4
b
 
Protocatechuic acid > 200 > 200 > 200 > 200 > 200 
Protocatechuic aldehyde > 200 > 200 > 200 130 160 
Danshensu 110 50 > 200 > 200 > 200 
Salvianolic acid B 105 > 200 > 200 > 200 > 200 
  
It was found that the majority of Danshen hydrophilics tested displayed no inhibitory activity 
towards the isoforms. However, Salvianolic acid B and Danshensu were found to exhibit 
mild, time-dependant inhibitory effects on CYP1A2. Danshensu was found to inhibit 
competitively against CYP2C9 activity in HLMs with a Ki of 35 μM. A major finding was 
that protocatechuic aldehyde moderately inhibited isoform CYP3A4 (Table 20). This is 
highly significant as CYP3A4 is the most abundant isoenzyme in the human liver and is 
responsible for the metabolism of a majority of drugs. Overall, this data suggests that 
Danshen therapeutics can be used safely and effectively when combined with other 
pharmaceuticals but it is necessary to study the interactions between drugs and TCMs, 
especially in the case of warfarin.  
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1.1.5 Pharmacokinetics 
 
Of the Danshen hydrophillics, pharmacokinetic studies have only been performed on 
Salvianolic acid B (23, Figure 4 incorrectly named Lithospermic acid B), the salts thereof 
(predominantly the Mg
2+
 salt 25, Figure 4) and Rosmarinic acid (5, Figure 2). This is due to 
the commercial availability of 5 and the common belief that the majority of therapeutic action 
exhibited by Danshen is due to 23 because of its natural abundace. There are more records of 
other studies having taken place but the results are very unreliable with critical data points 
and pharmacokinetic parameters being omitted (group size, type of administration, dose etc.). 
 
The first pharmacokinetic study on Salvianolic acid B (23, Figure 4) was carried out by 
Zhang et al.
23
 In this study the in vivo bioavailability of 23 was assessed in rats after 
intravenous and oral administration. Salvianolic acid B was administered as the Mg
2+
 salt 
(25, Figure 4) as this is the most abundant form of the polyphenol in Danshen decoctions. 
The instrument used was an HPLC-ECD with a dectection limit of 13.5 nM. The 
pharmacokinetic parameters obtained using a two-compartment model after intravenous 
administration are displayed in Table 21 and those for oral administration in Table 22. 
Comparison of the AUC (Area Under Calibration curve, proportional to the total amount of 
unaltered drug in the rats blood) value obtained after intravenous administration (20 mg/kg, 
1130 ± 329 µg·min/mL) with that found after oral administration (100 mg/kg, 1.26 ± 0.36 
µg·min/mL) indicates an extremely low systemic bioavailability which was calculated to be 
0.022% from the intravenous (20 mg/kg) AUC value. 
 
Magnesium salvianolate B (25) was initially orally administered at 20 mg/kg but no plasma 
Savianolic acid B (23) could be detected. When 25 was administered at 100 mg/kg only trace 
quantities of 23 could be detected (Cmax = 0.041 ± 0.007 µg/mL). Zhang et al.
23
 rationalised 
this phenomenon by studying the absorption of 25 in the gastrointestinal (GI) tract of rats. It 
was observed that when 25 was orally administered at a dose of 100 mg/kg the majority of 
the dose (65%) was detected in the GI tract, 4 hours after the administration. Half of the dose 
(50%) travelled to the lower parts of the intestine indicating poor absorption through the rat 
small intestine. This observation was confirmed by a jejunal loop experiment where the 
concentration of 23 in the loop increased from 113 ± 10.6 µM at 10 min to 126 ± 16.9 µM at 
20 min. Zhang et al.
23
 explains that the reason for the polyphenols poor absorption via the GI 
tract is primarily due to their high molecular weight (23 718.61 g/mol, 25 740.90 g/mol) as 
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flavonoid polymers with molecular weights of 578 g/mol are simply not absorbed but similar, 
smaller polyphenols like caffeic acid are. 
 
Table 21 Pharmacokinetic parameters of Salvianolic acid B (23) after intravenous administration of Mg2+ salvianolate B (25, 
Figure 4) to rats (Mean ± SD, n = 5, P < 0.05) 
Parameter 
Dose (mg/Kg) 
4 20 
A (µg/mL) 1.50 ± 0.25 19.5 ± 7.41 
α (min-1) 0.063 ± 0.001 0.035 ± 0.007 
t½α (min) 12.3 ± 2.14 22.7 ± 4.29 
B (µg/mL) 0.34 ± 0.05 2.74 ± 4.29 
β (min-1) 0.0076 ± 0.0004 0.0062 ± 0.0009 
t½β (min) 128 ± 4.68 176 ± 30.4 
AUC (µg·min/mL) 87.8 ± 10.9 1130 ± 329 
Vss (L/kg) 7.60 ± 1.03 3.61 ± 1.16 
MRT (min) 137 ± 3.71 141 ± 23.4 
CLtot (mL/min/kg) 55.5 ± 7.1 23.5 ± 6.0 
 
The total clearance time (CLtot) for Salvianolic acid B (23) when intravenously administered 
as the Mg
2+
 salt 25 at a dose of 4 mg/kg was 55.5 ± 7.1 mL/min/kg (Table 21). This value is 
larger than 25 mL/min/kg of kidney plasma flow and the 32 mL/min/kg of hepatic plasma 
flow in the rat. Renal clearance (CLR) and biliary clearance (CLB) parameters were also 
calculated and were found to be 0.38 and 2.68 mL/min/kg which are significantly lower than 
the CLtot value. In addition, the distribution volume at steady state (Vss) for the same dose was 
7.60 ± 1.03 L/kg which is significantly greater than the total volume of body fluid in the rat 
(0.6 L/kg). These observations are consistent with either rapid distribution (including 
penetration or uptake into tissue) or metabolism of Salvianolic acid B (23) in the tissue. The 
values for parameters CLtot and Vss (Table 21) at the higher dose of 20 mg/kg are 23.5 ± 
6.0 mL/min/kg and 3.61 ± 1.16 L/kg respectively which are significantly smaller than that at 
the low dose. This observation paired with the high AUC value at the higher dose (1130 ± 
329 µg·min/mL) suggest a non-linear relationship and this is consistent with the hypothesis 
that 23 could be widely distributed or metabolised at the high dose. The conclusions of 
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extensive distribution and metabolism rationalise the observed low systemic bioavailability of 
Salvianolic acid B (23). 
 
Table 22 Pharmacokinetic properties of Salvianolic acid B (23) after oral adminisation of Mg2+ salvianolate B (25, Figure 
4) to rats (Mean ± SD, n = 5, P < 0.05) 
Parameter 
Dose (mg/kg) 
100 
AUC0-90min (µg·min/mL) 1.26 ± 0.36 
Cmax (µg/mL) 0.041 ± 0.007 
Tmax (min) 20 ± 5.47 
 
Later in 2004 a second publication appeared in the literature by Li et al.
24
 describing the in 
vivo pharmacokinetic activity of Salvianolic acid B (23, Figure 4) in beagle dogs. Li et al. 
developed a specific liquid chromatography – tandem mass spectrometry (LC/MS/MS) 
method for the detection of blood serum concentrations of 23 with a limit of detection of 
1.5 µg/L (or 2.09 nM) which up to six times more sensitive than the HPLC-ECD method 
used by Zhang et al.
23
 earlier in 2004. As in the earlier study 23 was administered 
intravenously as Mg
2+
 salt 25 (Figure 4) and the pharmacokinetic properties were obtained 
using a two-compartment model (Table 23).  
 
The low values of t½α and t½β and high values for k12 across all doses suggest that Salvianolic 
acid B (23) readily leaves the central compartment and is distributed quickly into the tissue. 
Li et al.
24
 propose that low values of t½α and t½β could suggest polyphenol 23 has a high 
affinity for tissues and organs. Large values for CL and V were obtained for each dose and 
support the statement that 23 is rapidly distributed amongst tissue and suggest extensive 
metabolism. Variance between the increase of AUC values at the high dose of 12 mg/kg 
compared to proportional increase of AUC values at the low dose of 3 mg/kg and the 
considerable difference between CL and V values at the two extremes of the dosing scale 
(109 ± 24 mg·min/L at 3 mg/kg compared with 582 ± 84 mg·min/L at 12 mg/kg) suggest 
saturated distribution and metabolism might occur at the high dose. All of these observations 
are consistent with the findings of Zhang et al.
23
 and suggest that Salvianolic acid B behaves 
similarly in beagle dogs as it does in rats after intravenous administration.  
 
Chapter 1   
Page | 45  
 
Table 23 Pharmacokinetic properties of Salvianolic acid B (23) and intravenous administration of Mg2+ salvianoate B (25) 
to beagle dogs (Mean ± SD, n = 6) 
Parameter 
Dose (mg/kg) 
3 6 12 
Co (mg/L) 24 ± 4 47 ± 12 107 ± 15 
AUC0-tn (mg·min/L) 109 ± 24 248 ± 55 582 ± 84 
AUC0-∞ (mg·min/L) 109 ± 24 248 ± 55 583 ± 84 
MRT0-∞ (min) 16.3 ± 3.8 14.8 ± 2.9 14.0 ± 0.8 
k10 (h
-1
) 13.2 ± 2.1 11.6 ± 1.5 11.2 ± 13 
k12 (h
-1
) 5.2 ± 1.6 3.9 ± 2.2 3.1 ± 0.5 
k21 (h
-1
) 1.5 ± 0.5 1.4 ± 0.4 1.4 ± 0.3 
V (L/kg) 1.7 ± 0.5 1.6 ± 0.6 1.3 ± 0.3 
t½α (min) 2.2 ± 0.2 2.7 ± 0.5 2.9 ± 0.3 
t½β (min) 43 ± 9 42 ± 7 42 ±10 
CL (mL/min/kg) 28 ± 5 26 ± 7 21 ± 3 
 
Later in 2004 Zhang et al.
25
 published a second paper describing an investigation into the 
metabolites of Salvianolic acid B (23, Figure 4) following their previous pharmacokinetic 
study where it was observed that when 23, administered intravenously and orally in rats as 
the Mg
2+
 salt (25, Figure 4) is rapidly distributed and extensively metabolised. Zhang et al.
25
 
hypothesise that the metabolic products of 23 may possess some biological activity and 
contribute towards the efficacy of 23 and Danshen decoctions in vivo. 
 
From their previous work, Zhang et al.
25
 knew that when 25 was administered orally or 
intravenously to rats it would accumulate in stomach bile (GI tract) due to poor absorption. 
Therefore samples of stomach bile after intravenous injection at a dose of 4 mg/kg or oral 
administration at a dose of 100 mg/kg were analysed via HPLC-UV and four new peaks 
labeled M1 through to M4 were detected. The bile from sixteen rats after bolus intravenous 
injection at a dose of 25 mg/kg were combined and applied to a Diaion HP-20 column 
followed by repeated Wakogel C18 column chromatography to isolate metabolites M1 
(80 mg), M2 (40 mg), M3 (11 mg) and M4 (2 mg) in purities of 97, 98, 90 and 90% based on 
HPLC-UV analyses. The chemical structure of each metabolite was then elucidated via 
comprehensive NMR analyses (1D and 2D NMR) and FAB-LRMS (fast atom bombardment-
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low resolution mass spectroscopy) spectroscopy. From these experiments the metabolites 
were characterised as four meta-O-methylated derivatives of 23, namely 3-O-monomethyl 
(M1), 3,3ʹʹ-O-dimethyl (M2), 3,3ʹʹ,3ʹʹʹ-O-trimethyl (M3), and 3,3ʹʹʹ-O-dimethylsalvianolic 
acid B (M4) (see Figure 6).  
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Figure 6 Proposed metabolic pathway of Salvianolic acid B (23) 
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To determine how and where 23 was being metabolised the excretion of the metabolites was 
studied.  After a 4 mg/kg intravenous dose of Mg
2+
 salt 25 (Figure 4), approximately 90% of 
the dose was excreted into the bile as metabolites M1 through to M4 only 2 hours after the 
injection. This data is consistent with rapid uptake of 23 into hepatic cells and where the 
polyphenol is metabolised via methylation. Only a small percentage of 23 (0.70 ± 0.26%) and 
trace quantities of the metabolites were excreted into urine. 
 
Following this discovery, an in vitro metabolism study was carried out where each of the 
metabolites (M1 to M4) and 23 incubated separately with rat liver cytosol in the presence of 
SAM (S-adenosyl-L-methionine) and the products were analysed via HPLC-UV. Only one 
product from each metabolite and 23 was detected. This result revealed the metabolic 
pathway (see Figure 6) where methylation occurs first at the C-3 meta-hydroxyl to afford 
M1, which is then methylated primarily at C-3'' and rarely at C-3''' to yield M2 and M4 
respectively. Both M2 and M4 are then methylated at C-3''' and C-3'' respectively to form 
M4. With the methylation being selective for meta-hydroxyls and the requirement of SAM in 
the in vitro studies suggests that the enzyme responsible for catalyzing the methylation is 
catechol O-methyltransferase (COMT).  
 
As Salvianolic acid B (23) and other Danshen polyphenols are known to be potent 
antioxidants the antioxidant activity of the three major metabolites (M1, M2 and M3) was 
measured by calculating the second-order rate constant (k2) for DPPH˙ (1,1-diphenyl-2-
picrylhydrazyl) radical scavenging (Table 24). Although all the metabolites had a weaker 
antioxidant activity than Salvianolic acid B (23) they still displayed potent DPPH radical 
scavenging activity. M1 showed the most potent activity and was stronger than α-tocopherol 
and caffeic acid. M2 and M3 were slightly less potent but still stronger antioxidants than 
ferulic acid and BHT. 
 
Zhang et al.
25
 conclude the study by stating that, since Salvianolic acid B can enter liver cells 
and be metabolised via methylation, there is a possibility that the methylated metabolites (M1 
to M4) could exert some pharmacological action either in the liver itself via enterohepatic 
circulation or, as they are excreted in the bile and are less polar, be more readily absorbed via 
the GI tract and travel into the host and exert their unknown action elsewhere. 
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Table 24 Antioxidant activity of the metabolites of Salvianolic acid B (23) compared to antioxidant standards 
Compound k2 (µM
-1
s
-1
 × 10
-4
) 
Salvianolic acid B (23) 33 
M1 2.24 
M2 0.573 
M3 0.182 
Caffeic acid 1.52 
Ferulic acid 0.12 
α-Tocopherol 1.94 
BHT 0.018 
 
Recently the metabolic pathway of Salvianolic acid B (23) was confirmed by Cui et al.
26
 
during a pharmacokinetic study. The in vivo metabolism of 23 in rats and in vitro metabolism 
in rat liver cytosol were studied using a new technique HPLC-Ion trap-MS which has the 
benefit of providing full scan mass spectra while still offering high sensitivity. In this 
particular study the limit of detection (LOD) was 0.01 µg/mL (10 µg/L) which is ten times 
less sensitive then the LC/MS method developed by Li et al.
24
 in their pharmacokinetic study 
of Salvianolic acid B in beagle dogs (LOD 1.5 µg/L or 0.0015 µg/mL). This is due to Li et 
al.
24
 using a triple-quadrupole MS, a more sensitive mass spectrometer.  
 
For the in vivo study, three male SD rats were administered an intravenous dose of 20 mg/kg 
and periodic blood samples were withdrawn, the plasma was separated and analysed via 
LC/MS. The data obtained from the three rats was averaged and is displayed in Table 25. 
The results obtained by Cui et al.
26
 are consistent with those published by Zhang et al. in the 
first pharmacokinetic study of Salvianolic acid B (23) with large values for Vd (8.93 L/kg) 
and CL (2.01 L/h/kg) indicating rapid distribution and metabolism of 23 in tissues and 
organs. 
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Table 25 Pharmacokinetic parameters of Salvianolic acid B (23) after intravenous administration (20 mg/kg) to three rats 
(mean ± SD) 
Parameter Value 
t½ (h) 3.07 ± 0.42 
ke (h
-1
) 0.23 ± 0.03 
AUC0-t (µg·h/mL) 9.94 ± 0.36 
AUC0-∞ (µg·h/mL) 11.82 ± 0.74 
MRT (h) 2.36 ± 0.34 
Vd (L/kg) 8.93 ± 0.87 
CL (L/h/kg) 2.01 ± 0.07 
 
To identify the metabolites present in vivo, the bile of three rats was collected after a single 
intravenous dose (8 mg/kg) of Salvianolic acid B (23) and prepared for analysis via LC/MS. 
The same four metabolites of 23 (M1 to M4, Figure 6) were detected in the bile by 
comparing the molecular ion obtained for 23 to that of the metabolites. Detailed MS/MS 
analyses were also performed to confirm the detection. The four metabolites and unchanged 
23 were also detected in rat feces after an intravenous dose of 8 mg/kg. No metabolites or 23 
were found in the urine. No glucuronide or sulfate conjugates of 23 were detected in rat bile, 
feces, urine and plasma samples under the conditions developed. The in vitro study 
performed by Cui et al.
26
 gave the same results as that reported by Zhang et al.
25
 where 23 
disappeared quickly when incubated with rat liver cytosol and the same metabolites (M1 to 
M4, Figure 6) were detected via LC/MS. Overall the results from this study suggest that 
methylation is the major metabolic pathway of Salvianolic acid B (23) in rats. 
 
In a related publication, Zhang et al.
27
 reported that methylated polyphenols (Rosmarinic acid 
5, Figure 2; Lithospemic acid 19, Figure 3; Salvianolic acid B 23, Figure 4) from Danshen 
can alkylate cellular GSH (glutathione) thereby inducing NQO1 (quinone oxidoreductase1) 
activity, a potent phase II detoxifying enzyme to protect mammalian cells against toxic 
quinones. It was discovered that while the free polyphenols of 5, 19 and 23 could form GSH 
conjugates in vitro they did not react with cellular GSH in vivo and therefore did not possess 
NQO1-inducing activity, due to the hydrophilic nature of these compounds preventing their 
absorption into the cells. Having realised this, Zhang et al.
27
 decided to improve the 
liposolubility of the polyphenolic acids by conducting a global methylation of all free phenols 
and carboxylic acid moieties and found that methylated Lithospermic acid (19) and 
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Rosmarinic acid (5) could readily form GSH conjugates. However only a small percentage of 
methylated Salvianolic acid B (23) was alkylated by GSH. The methylated GSH conjugates 
were then tested and conjugates from methylated 5 and 19 were found to possess high 
NQO1-inducing activity with CD values of 17.86 ± 2.34 µg/mL and 11.97 ± 0.60 µg/mL 
respectively. Interestingly, the NQO1-inducing activity of 23 and its methylated analogue 
were almost the same.  
 
The metabolic pathway for Rosmarinic acid (5, Figure 2) is quite different to that of 
Salvianolic acid B (23, Figure 4). The metabolism of 5 was determined by Nakazawa et al.
28
 
when 5 was administered orally at a dose of 200 mg/kg to rats and seven metabolites (RA-
M1 – RA-M6, see Figure 7), including unchanged 5 were detected in urine samples 
collected 24 h after the administration via HPLC-UV. Four of the seven metabolites were 
also detected in the blood plasma 12 h after oral administration. The seven metabolites were 
then isolated from rat urine via Sephadex LH-20 chromatography followed by preparative 
HPLC to yield RA-M1 (14 mg), RA-M2 (30 mg), RA-M3 (10 mg), RA-M4 (4 mg), RA-M5 
(30 mg), RA-M6 (8 mg) as well as unchanged 5. 
 
Metabolites RA-M1 – RA-M3 were then characterised via enzymatic hydrolysis of the 
sulfate moiety with arylsulfatase followed by comparison of their spectroscopic (
13
C NMR, 
IR and FAB-MS) and chemical data. Metabolites RA-M4 – RA-M6 were identified by 
comparison with authentic samples. The total cumulative amounts of 5 and the six 
metabolites 48 h after the oral administration (200 mg/kg) corresponded to 31.836 ± 6.512% 
(mean ± S.E., n = 5) of the dose. The major metabolites were RA-M2 (12.137 ± 2.805%) and 
RA-M5 (18.357 ± 3.499%). The other metabolites each had a relative abundance of less than 
1%. Overall, Nakazawa et al.
28
 determined that when Rosmarinic acid (5) is administered 
orally to rats and excreted in urine the predominant metabolic pathways consist of cleavage 
of the ester bond, selective para-dehydroxylation, methylation and sulfate-conjugation.   
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Figure 7 The six metabolites of Rosmarinic acid (5) found in rat urine after oral adminisatration 
 
In 2005, Konishi et al.
29
 published a detailed pharmacokinetic study on the metabolism of 
Rosmarinic acid (5) and Caffeic acid (1, Figure 1) in rats. The primary focus was to study the 
absorption characteristics of both compounds and their sulfate conjugates to determine which 
one was more lipophilic and elucidate where the polyphenols are being metabolised. Male 
Wistar rats were administered with 100µmol/kg of either 5 or 1 via gastric intubation (orally) 
and blood was withdrawn from the portal vein and abdominal artery periodically. The serum 
was separated and analysed via HPLC-ECD before and after incubation with sulfatase type 
H-5 to allow for simple calculation of the concentration of the respective sulfate and 
glucuronide conjugates. The results were then interpreted using noncompartmental 
pharmacokinetic analysis and are displayed in Tables 26 to 28.  
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Table 26 Pharmacokinetic Parameters of Caffeic acid (1) and Rosmarinic acid (5) in the Portal Vein after administration of a 
single oral dose (100 µmol/kg) (Cmax = mean ± SEM, n = 3) 
Parameter 1 5 
Cmax (µmol/L) 11.24 ± 2.29 1.36 ± 0.08 
tmax (min) 10 10 
t½ (min) 34.8 56.9 
AUC0-1.5 h (µmol·min/L) 585.0 60.4 
Relative absorption efficiency 9.7 
 
Analysis of the samples withdrawn from the portal vein reveal that both 1 and 5 were 
absorbed quickly into the GI tract, with small tmax (time to reach Cmax) values of only 10 min. 
Comparison of the AUC values reveal that the absorption efficiency of 1 into the GI tract is 
estimated to be 9.7-fold greater than that of 5. Polyphenols 1 and 5 were also eliminated 
quickly, presumably via stomach bile with half-lives (t½) of 34.8 and 56.9 min respectively. 
 
Table 27 Pharmacokinetic parameters of Caffeic acid (1) and Rosmarinic acid (5) in the Abdominal Artery after 
administration of a single oral dose (100 µmol/kg) (Cmax = mean ± SEM, n = 3) 
Parameter 1 5 
Cmax (µmol/L) 2.27 ± 0.16 0.46 ± 0.07 
tmax (min) 10 5 
t½ (min) 34.3 63.9 
AUC0-1.5 h (µmol·min/L) 109.7 16.6 
Relative absorption efficiency 6.6 
 
Similar properties were observed in the abdominal artery where 1 and 5 were absorbed 
quickly and reached their Cmax (maximum serum concentration) in 10 and 5 min (tmax), 
respectively.  The concentration of 1 and 5 then dissipated quickly via elimination from the 
liver with t½ of 34.3 and 63.9 min respectively. The same trend for absorption efficiency is 
also observed where comparison of the AUC values suggests that 1 was absorbed more 
readily than 5.  
 
The large differences in absorption efficiency can be attributed to the affinity of 1 and 5 for 
MCTs (medium-chain triglycerides), which assist in the transportation of drugs from the GI 
tract to the portal system. The structural criteria for MCT substrates are a monoanionic 
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carboxyl group and non-polar side chain or an aromatic hydrophobic motif. Esterified 
phenolic acids, such as 5 are likely to prevent molecular recognition of the monocarboxylic 
anion and will have no affinity for MCTs. Therefore 1 has a greater affinity for MCTs over 5 
which provides some insight into the absorption mechanism for these two compounds. 
 
Table 28 Pharmacokineitic parameters of conjugated Caffeic acid (1) and Rosmarinic acid (5) in the Portal Vein and 
Abdominal Aretery after administration of a single oral dose (100 µmol/kg) (Cmax = mean ± SEM, n = 3) 
Parameter 1 5 
Portal vein   
Cmax (µmol/L) 31.23 ± 1.69 0.86 ± 0.22 
tmax (min) 20 30 
AUC0-1.5 h (µmol·min/L) 1673.4 65.2 
Abdominal artery   
Cmax (µmol/L) 30.39 ± 2.48 0.96 ± 0.09 
tmax (min) 20 30 
AUC0-1.5 h (µmol·min/L) 1614.4 69.5 
 
Konishi et al.
29
 suggests that as the concentration profiles of conjugated 1 and 5 are almost 
identical, with AUC values being almost the same for two regions (Table 28) it is possible 
that 1 and 5 are primarily conjugated (metabolised) during the absorption process and that 
further conjugation had not occurred in the liver. Comparison of the AUC values obtained 
from the portal vein (Table 26) and abdominal artery (Table 27) suggest that 1 and 5 are 
predominantly eliminated from the liver. The ratio of AUC values across the two sampling 
regions, 0.19 for 1 and 0.27 for 5 suggest that 1 is more susceptible to hepatic elimination 
than 5.  
 
Overall Konishi et al.
29
 demonstrated that Caffeic acid (1) has a higher efficiency for 
intestinal absorption than Rosmarinic acid (5) and provided new evidence that these two 
polyphenols could form conjugates during the absorption mechanism which could contribute 
towards an understanding of the metabolic pathway of 1 and 5. Coincidently, the absorption 
characteristics found for 5 by Konishi et al.
29
 are strikingly similar to those of Salvianolic 
acid B (23, Figure 4) observed by Zhang et al.
25
 and Li et al.
24
 Clearly there is a structural 
relationship for the absorption pathway of these two compounds and the reasons presented 
here for their poor absorption could be applied to either polyphenol.   
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1.2 Total Syntheses of Danshen hydrophilics completed 
 
1.2.1 (±)-Danshensu 
 
Danshensu was the first of the Danshen hydrophilics to be synthesised. The first total 
synthesis of Danshensu was achieved by Fen et al.
30
 in 1983 via the Erlenmeyer synthesis of 
4-benzylideneoxazol-5(4H)-ones (33) obtained from the condensation reaction between 
Protocatechualdehyde (29) and N-acetylglycine (32) in the presence of refluxing acetic 
anhydride and sodium acetate (Scheme 1). Upon boiling azlactone 33 in a H2O/Acetone 
solvent mixture, α-(acetylamino)cinnamic acid 34 was obtained and subjected to hydrolysis 
in boiling 1M HCl yielding 3-(3,4-dihydroxyphenyl)-2-oxopropanoic acid 35. No keto-enol 
tautomerism of the α-keto product was reported. This product was then reduced via the 
Clemmensen reduction, using a zinc-mercury amalgam to yield (±)-3-(3,4-dihydroxyphenyl)-
2-hydroxypropanoic acid (36), which was isolated as sodium salt 37 in 37 % overall yield. 
 
 
Scheme 1 First synthesis of (±)-Danshensu by Xue et al. 
 
This preparation of (±)-Danshensu was used in the first synthesis of racemic Rosmarinic acid 
in 1989, where Protocatechualdehyde (29) was substituted for Piperonal 38 and only the enol 
form of the 2-oxopropanoic acid was isolated (Scheme 2).
31
 The α-hydroxycinnamic acid 
(41) was then reduced to α-hydroxypropanoic acid 42 via palladium on carbon (Pd/C) 
mediated hydrogenation with hydrogen gas (H2). 
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Scheme 2 Erlenmeyer synthesis of a piperonal analogue of (±)-Danshensu 
 
Almost two decades after the original synthesis (1992), another publication appeared in 
Synthesis claiming that the initial synthesis of racemic Danshensu was flawed. It was claimed 
by Wong et al.
32
 that when they tried to replicate this synthesis of Danshensu several 
challenges were encountered. It was found that in the second step of the synthesis catalytic 
amounts of sodium acetate (NaOAc) remarkably increased the yield of the hydrolysis to form 
α-(acetylamino)cinnamic acid 34 (Scheme 1). A similar isolated yield of 34 could be 
accomplished by substituting the Ac2O/NaOAc for 0.2 M HCl (Scheme 3). Either process 
could be used as it has a negligible effect on the overall yield. 
 
In the next reaction, a higher concentration of HCl (3 M) was used and the enol product 43 
(Scheme 3), instead of the keto was isolated as a single isomer and confirmed by 
1
H NMR 
analysis. This was the major difference from the preceding publication where no evidence of 
keto-enol tautomerism was reported. However, even with enol product 43 in hand, the 
Clemmenson reduction still occurred under the same conditions except with toluene as a co-
solvent. After the final step (±)-Danshensu was obtained in 25% overall yield. This yield is 
over 10% less than in the original synthesis, however higher overall yields were obtained for 
analogues. This could be due to a number of reasons, the most likely being that one yield is 
more accurate than the other due to only the overall yield being given in the original synthesis 
without any stepwise yields. As it seems very unlikely that the α-keto acid 35 (Scheme 1) 
could be obtained after acidic hydrolysis of the α-(acetylamino)cinnamic acid 34 (Scheme 1) 
one cannot rule out the possibility of other mistakes having taken place during either the 
preparation of the initial manuscript or experimental work.  
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Scheme 3 Improved Erlenmeyer synthesis of (±)-Danshensu by Wong et al. 
 
The synthesis was then shortened to two steps by combining the acidic ring opening and 
substitution with the Clemmensen reduction in a „one-pot‟ procedure thereby circumventing 
the inherent instability of the α-hydroxycinnamic acid intermediate in an attempt to improve 
the overall yield (Scheme 4). The 4-benzylideneoxazol-5(4H)-one 33 was refluxed with 3M 
HCl until complete conversion to α-hydroxycinnamic acid 43 was detected via TLC and the 
zinc-mercury amalgam was added. As suspected this led to reduction of the olefinic bond in 
43 and α-hydroxyacid 36 was formed with an overall yield of 35%. This is 10% greater than 
the stepwise approach showing the effect of reducing the number of steps and simplifying the 
procedure. Also, this yield is quite similar to the overall yield stated in the original synthesis 
so possibly this was the original synthetic route. 
 
 
Scheme 4 'One-pot' Erlenmeyer synthesis of Danshensu by Wong et al. 
 
The scope of this procedure was then examined and it was discovered that it could be applied 
to synthesis of N-benzoylamino acids (Scheme 5). Using the same Clemmensen reduction 
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conditions, α-(benzoylamino)cinnamic acids (44) could be reduced to N-
benzoylaminopropanoic acids (45) with a yield of 76 – 91%. 
 
 
Scheme 5 Adaption of the Erlenmeyer synthesis to the preparation of N-benzoylamino acids 
 
An alternative pathway to α-hydroxyesters or acids is via Darzens condensation where 
glycidic esters are prepared by the reaction of an aldehyde or ketone with an α-halo ester in 
the presence of a strong base such as sodium ethoxide (NaOEt), sodamide (NaNH2), or 
potassium t-butoxide (t-BuOK) which can then be in-turn converted to the desired compound 
via hydrogenation or nucleophilic attack.
33
 Recently, Ju et al.
34
 took advantage of this 
methodology and prepared a library of racemic Danshensu derivatives (Scheme 6). For (±)-
Danshensu, benzylated protocatechualdehyde 46 was condensed with ethyl chloroacetate (47) 
in the presence of sodium methoxide (NaOMe) to obtain methyl glycidic ester 48 in 43% 
yield when isolated by column chromatography. Glycidic ester 48 was then reduced using 
mild hydrogenation conditions (10% Pd/C, H2 (1 atm)) to form α-hydroxyester 49 in 62% 
yield. The methyl ester of 49 was then saponified with NaOH to form (±)-Danshensu (36) in 
58% making the overall yield 15%.  
 
 
Scheme 6 Preparation of (±)-Danshensu via Darzens glycidic ester synthesis 
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The Darzens approach to the preparation of Danshensu provides a simpler route eliminating 
the need for high temperatures and reducing the number of steps to three but the overall yield 
of (±)-Danshensu is reduced by more than 50%. Clearly further experimentation and 
optimisation of this pathway is required.    
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1.2.2 (R)-(+)-Danshensu 
 
In completing the first non-enzymatic synthesis of optically active (R)-(+)-Rosmarinic acid, 
Eicher et al.
35
 were the first group to prepare enantiomerically pure (R)-(+)-Danshensu via 
traditional linear synthesis. The strategy of Eicher et al.
35
 was to use the optimised 
Erlenmeyer synthesis of Wong et al.
32
 for α-hydroxycinnamic acid 50 and then conduct an 
asymmetric hydrogenation of the latter in the presence of a chiral catalyst. However this 
approach was unsuccessful, even after variation of protecting groups (Scheme 7). Other 
failed attempts included enantioselective reduction of α-hydroxycinnamic acid derivatives by 
chiral boranate reagent K-Glucoride, but these experiments were also unsuccessful.  
 
 
Scheme 7 Experimental asymmetric reductions of α-hydroxycinnamic acid 50 by Eicher et al. 
 
These failed attempts encouraged Eicher et al.
35
 to examine lipase mediated resolution of α-
hydroxyester 53 as a practical route to the optically active (R)-(+)-Danshensu moiety 54 
(Scheme 8). For this procedure 50 was first reduced to racemic α-hydroxyacid 51 via 
catalytic hydrogenation. Then, 51 was protected as diallylether 52 which could then be 
converted to allylester 53 by reaction with N,N‟-diisopropy-O-allyl isourea (56). After 
experimenting with various enzymes and lipases it was discovered that Pseudomonas sp. 
Lipase (PS, Amano) could effectively resolve racemate 53 to the corresponding (R)-α-
hydroxyester 54 and (S)-α-acetyloxyester 55 with a high enantiomeric excess (ee; ee > 99%) 
for the (R)-enantiomer. The ee was confirmed via 
1
H NMR analysis of the (–)-Camphanic 
acid diastersomers thereby completing this stage of the synthesis having successfully formed 
the (R)-(+)-Danshensu moiety of (+)-Rosmarinic acid in a total of four steps, with an overall 
yield of 52% from α-hydroxycinnamic acid 50. 
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Scheme 8 First chemical synthesis of (R)-(+)-Danshensu by Eicher et al. 
 
Since the publication of these novel syntheses of racemic and chiral Danshensu, many other 
research groups have used this chemistry as a means of obtaining Danshensu derivatives for 
pharmacological studies. In 2009 Dong et al.
36
 required a library of Danshensu derivatives to 
investigate their chemical stability and lipid solubility, as these characteristics of authentic 
(+)-Danshensu are known to diminish the overall bioactivity. The purpose was to determine 
if they could be applied as potent antioxidants for the treatment of myocardinal infarction, a 
common therapeutic property of aqueous Danshen extract. Dong et al. used a modified 
version of the Erlenmeyer synthesis optimised by Wong et al.
32
 for the synthesis of α-
hydoxycinnamic acid 50 by avoiding azlactone formation by conducting the first step at 
140
o
C instead of 120
o
C (Scheme 9). Next Dong et al.
36
 had envisioned conducting a 
stereoselective reduction of the latter to prepare optically active (+)-Danshensu analogues. 
Chapter 1   
Page | 62  
 
 
Scheme 9 Synthesis of (R)-Danshensu analogues by Dong et al. including first asymmetric reduction of α-hydroxycinnmate 
of type 57 
 
The plan was to reduce the double bond asymmetrically via catalytic hydrogenation and 
obtain the (R)-enantiomer of Danshensu selectively. The first strategy was to attempt the 
hydrogenation in the presence of a Pd/C catalyst with cinchonidine as the chiral auxiliary, 
similar to that attempted by Eicher et al.
35
 Unfortunately, this proved unsuccessful with an ee 
of 16%, consistent with that observed by Eicher et al.
35
 The second strategy was to use a 
Rhodium derived catalyst ([Rh(cod)2]BF4) combined with a monodentate phosphoramidite 
chiral ligand (60, Scheme 9). To improve catalyst compatibility, and the overall lipid 
solubility of the final product all hydroxyls and carboxylic functionalities of 50 were 
protected as the acetyl and methyl esters, respectively to afford compound 57. Cinnamate 57 
was then subjected to the asymmetric reduction and (R)-Danshensu analogue (58) could be 
obtained in high yield (>89%) with excellent enantioselectivity (ee 92 – 98%). Racemic 
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analogues were also prepared by catalytic hydrogenation of 57; using conditions similar to 
those developed by Eicher et al.
35
 to form racemate 59 in a total of five steps with an overall 
yield of 21% from 29. However, the major achievement of Dong et al.
36
 was the successful 
synthesis of (R)-Danshensu analogue 58 in five steps, with an overall yield of 24% from 29 
featuring a novel, highly efficient, catalytic asymmetric reduction of α-hydroxycinnamate 57 
a challenging reaction which had before not been achieved. Piperonal analogues of 58 (ee 
98%) and 59 was also prepared via a similar route, both over a total of five steps with overall 
yields of 25% and 23% respectively.  
 
In recent years, the total synthesis of (+)-Lithospermic acid (19, Figure 3) has received a lot 
of attention causing an influx of new asymmetric methodologies for the preparation of the 
(R)-Danshensu motif. As a result the procedures developed offer an array of efficient and 
flexible strategies for the synthesis of the highly desired counterpart thereby extending the 
scope of any Danshen polyphenol synthesis by allowing the preparation of structural 
analogues without sacrificing yield or risking decomposition of sensitive functional groups.  
 
In May 2012, Varadaraju et al.
37
 reported a total synthesis of (+)-Lithospermic acid (19, 
Figure 3) where the stereogenic centre present in the (R)-Danshensu chain was obtained by 
the Sharpless asymmetric dihydroxylation (ADH) of the preceding cinnamate (Scheme 10). 
Instead of the traditional approach (OsO4/(DHQ)2PHAL, NMO, t-BuOH) Varadaraju et al.
37
 
used the commercially available catalyst AD-mix-α to control the reaction and 
stereoselectively form diol 62. Then benzylic hydroxyl of 62 was selectively dehydroxylated 
to form the protected (R)-Danshensu building block 63 in a total of four steps from 
benzaldehyde 61 with an overall yield of 75% and ee of >99% (HPLC).   
 
 
 
Scheme 10 Asymmetric synthesis of (R)-Danshensu motif 63 by Varadaraju et al. 
 
In August 2012, Ghosh et al.
38
 finalised their total synthesis of (+)-Lithospermic acid (19, 
Figure 3) featuring a unique, modern approach to the chiral centre of the (R)-Danshensu 
Chapter 1   
Page | 64  
 
scaffold. Starting with aldehyde 64, Ghosh et al.
38
 carried out a MacMillan α-oxyamination 
to form α-oxyamino aldehyde 65. This was then subjected to the Pinnick oxidation to afford 
carboxylic acid 66 which was esterified with MeOH in the presence of SOCl2, resulting in the 
concurrent elimination of aniline to yield (R)-Danshensu motif 63 in a total of three steps 
with an overall yield of 34% from aldehyde 64 with an ee of 98% (HPLC). 
 
 
Scheme 11 Asymmetric synthesis of (R)-Danshensu motif 63 by Ghosh et al. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 1   
Page | 65  
 
1.2.3 Rosmarinic acid 
 
Rosmarinic acid, being one of the most abundant hydrophilics in Salvia miltiorrhiza as well 
as other genera and species, has attracted the attention of many scientists and thus its 
synthesis, both biologically and synthetically has been studied vigorously. 
 
The first synthesis of (±)-Rosmarinic acid was carried out by Albert et al. (see Reference
31
 
and the references contained within) in 1989, making it the second of the Danshen 
hydrophilics to be synthesised via a chemical means. Using the established Erlenmeyer 
synthesis of the Danshensu side chain (Scheme 2, Section 1.2.1), Rosmarinic acid was 
obtained in racemic form over a total of eight steps starting from piperonal and 3,4-
dibenzylcaffeic acid (Scheme 12).  
 
 
Scheme 12 First total synthesis of (±)-Rosmarinic acid by Albert et al. 
 
To achieve selective esterification at the secondary alcohol of Danshensu with the caffeic 
acid derivative the carboxylic acid moiety of Danshensu derivative 42 was protected as its β-
trimethylsilyl ester with N,N'-Diisopropyl-O-(β-trimethylsilylethy1)isourea (68). Protected 
Danshensu (67) was then condensed with caffeic acid derivative 69 using the Steglich 
esterification mediated by DCC/DMAP. The β-trimethylsilyl ester of 70 was then 
protonalysed with TBAF to the corresponding carboxylic acid before the benzyl and 
methylene ethers were cleaved with BBr3. Unfortunately, this original communication was 
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published as a dissertation and therefore several critical details including yields and reaction 
conditions are unknown. 
 
It was not until 1991 that the biosynthesis of Rosmarinic acid was known and understood. 
This led to a chemo-enzymatic synthesis of (R)-(+)-Rosmarinic acid where the total 
biosynthetic pathway was established, confirming (S)-phenylalanine and (S)-tyrosine as the 
two main precursors to (R)-Rosmarinic acid.
39
 Rosmarinic acid was initially prepared by the 
fermentation and extraction of Coleus blumei cell cultures. Further investigation of these cell 
cultures by Pabsch et al.
39
 revealed that an enzyme named rosmarinic acid synthase catalysed 
the esterification between lactic acid and coumaric acid intermediates and was for this reason 
isolated. Pabsch et al.
39
 used rosmarinic acid synthase to effect esterification between 
Danshensu and the caffeic acid analogue. However the primary focus of this synthesis was 
the preparation of asymmetric (R)-Danshensu, as previous syntheses of Rosmarinic acid were 
racemic and a novel approach for the introduction of chirality was required. At this time an 
efficient enantioselective procedure for the synthesis of Danshensu had not been established. 
The strategy was to use 3-(3,4-dihydroxyphenyl)pyruvic acid (72) and perform an enzymatic 
reduction of the α-keto group to form α-hydroxyacid (R)-Danshensu (3). 
 
This was achieved by D-hydroxyisocaproate hydrogenase (D-HicDH) with NADH (β-
nicotinamide-adenine dinucelotide, reduced form) as a hydrogen-delivering cofactor. The 
cofactor was regenerated with formate dehydrogenase (FDH). During oxidation of 
ammonium formate to CO2 and NH3, NAD is reduced to NADH simultaneously with the 
reduction of the pyruvic acid (Scheme 13). This procedure allows for the continuous 
production of 3 as the two enzymes are held together in polyethylene glycol (20,000)-
enlarged cofactor behind the ultrafiltration membrane of a 10mL enzyme membrane reactor. 
Using this technique up to 1 kg of enantiomerically pure 3 (ee > 99%) can be produced per 
day.  
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Scheme 13 Enzymatic synthesis of (R)-Danshensu by Pabsch et al. 
 
 
Scheme 14 Chemo-enzymatic synthesis of (+)-Rosmarinic acid (5) by Pabsch et al. 
 
The carboxylic acid functionality of caffeic acid (1) must be activated prior to the 
esterification in order to achieve optimum, reproducible yields. Caffeic acid was therefore 
transformed to the thio-ester derived from Coenzyme A (CoA). This was accomplished 
through nulceophilic displacement of the caffeic acid imidazolide prepared with CDI 
(Scheme 14). When the activated caffeic acid analogue was subjected to the esterification 
conditions it was noted that not only does rosmarinic acid synthase catalyse the esterification 
Chapter 1   
Page | 68  
 
it also hydrolyses the product back to the unactivated caffeic acid (1) and Danshensu (3). This 
severely diminishes the final yield as the unactivated caffeic acid cannot be esterified. The 
authors rationalise this observation suggesting that their type of reactor is not suitable as it 
normally operates under steady-state conditions. A continuously stirred tank reactor with a 
high enzyme concentration and short residence time is recommended as this configuration 
should provide greater yields of (+)-Rosmarinic acid (5). Overall, even though only moderate 
yields of 5 are obtained this enzymatic approach is a significant improvement over previous 
syntheses as high quantities of optically pure 3 can be prepared and no 
protection/deprotection steps are required, this being a considerable advantage as they are 
typically time consuming and tedious. 
 
In June 1996, Eicher et al.
35
 reported a partially enzymatic synthesis of (R)-(+)-Rosmarinic 
acid (5, Figure 2). Eicher et al.
35
 employed the Erlenmeyer synthesis to produce racemic 
Danshensu which was resolved with Pseudomonas sp. Lipase (PS, Amano) to provide the 
correct enantiomer (see Section 1.2.2 for discussion). Cinnamic acid 76 was prepared via the 
Doebner modification of the Knoevenagel condensation of benzaldehyde 75 with malonic 
acid in 81% yield (Scheme 15). Cinnamic acid 76 was then condensed with the free 
secondary alcohol of enantiomerically pure Danshensu analogue 54 via the Steglich 
esterification mediated by DCC/DMAP to afford pentaallyl rosmarinate 77 in 94% yield.The 
allyl groups of 77 were then removed with morpholine and catalytic amounts of Pd(PPh3)4, in 
one step to provide polyphenolic rosmarinic acid (5) with an excellent yield of 92%. This 
demonstrates the high utility of the allyl ether moiety as a proective group for phenolic 
functionalities. Upon completion of the synthesis, 5 was obtained in four linear steps with a 
magnificent overall yield of 57% starting from benzaldehyde 29. This synthesis provides a 
practical alternative to the chemo-enzymatic synthesis of (R)-(+)-Rosmarinic acid as it 
appears not to be limited by scale with the majority of the steps being high yielding. Also, 
with both enantiomers of the Danshensu analogue 54 having been synthesised it should be 
possible to prepare both enantiomers of 5 using this methodology. 
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Scheme 15 Total synthesis of (+)-Rosmarinic acid (5) by Eicher et al. 
 
One year after the first partially enzymatic route to 5 was published, a second article appeared 
in the literature describing another non-enzymatic approach to (S)-(−)-Rosmarinic Acid. 
Bogucki et al.
40
 required a synthesis of both (R) and (S)-Rosmarinic acid to study the 
dimerisation reaction of the latter in an attempt to prepare the rosmarinic acid dimers (−)-(1R, 
2S) and (+)-(1S, 2R)-Rabdosiin, another caffeic acid tetramer known to exist in the Lamiacea 
family of medicinal plants. Using the same approach as applied in previous syntheses of 5, 
the Danshensu moiety (83) was to be prepared first and then esterified with the caffeic acid 
counterpart 76. Given the most challenging part of these schemes was the introduction of 
chirality, Bogucki et al.
40
 decided to use chiral pool chemistry, making use of 
enantiomerically pure (S)-tyrosine (78) as the starting material (Scheme 16).  
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Scheme 16 Synthesis of (S)-Danshensu moiety 83 via Tyrosine by Bogucki et al. 
 
(S)-Tyrosine (78) was first subjected to Friedel-Crafts acylation, providing the hydrochloride 
salt of acetyl-(S)-Tyrosine (79) in 70% yield. The hydrochloride salt was then diazotized and 
hydrolysed via a one-pot procedure to afford α-hydroxyacid 80 in 81% yield, with retention 
of configuration for the (S)-enantiomer. The α-hydroxyacid 80 was then subjected to Baeyer 
– Villiger oxidation to provide the base sensitive phenolic acetate (81) which was hydrolysed 
in situ to (S)-Danshensu (82) with a yield of 61%. The moderate yield is thought to be 
because of losses during chromatography due to instability. This issue has been reported 
previously in racemic Danshensu syntheses (see Section 1.2.1). The phenolic and carboxylic 
hydroxyls were then protected as allyl ethers with allyl bromide (42% yield), leaving the 
secondary alcohol exposed for esterification. Triallyl-(S)-danshensu (83) was therefore 
obtained in four steps with an overall yield of 15%. The overall yield could be increased to 
30% by using intermediates 80 and 82 directly in the next step without further purification. 
 
Caffeic acid (1) was then allylated using the same conditions as for 82 to afford ester 84 in 
86% yield (Scheme 17). The allyl ester of 84 was then hydrolysed with KOH to provide 
diallyl ether 76 in 83% yield. Cinnamic acid 76 was then converted to acid chloride 85 by 
treatment with SOCl2, which readily esterified with 83 to afford (S)-pentaallyl rosmarinate 
(86) in 65% yield. A global deprotection of all allyl ethers was then achieved using 
Wilkinson‟s catalyst ((Ph3P)3RhCl)) in an aqueous medium to obtain chromatographically 
pure (S)-Rosmarinic acid (87) in 29% yield corresponding to an overall yield of 13%, with a 
longest linear sequence of five steps from 1. 
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Scheme 17 Total synthesis of (S)-Rosmarinic acid by Bogucki et al.; All = Allyl 
 
The specific rotation of this sample of (S)-Rosmarinic acid was then measured at the sodium-
D-line and it was reported to be −86 ([α]D
25
 = −86, c 0.53, 95% EtOH). The authors note that 
this is noticeably different to than that reported for the natural product ([α]D
25
 = +145, c 1.4, 
95% EtOH). This finding baffles the authors and several other experiments (Chiral GC, 
1
H 
NMR with diastereomers obtained from (R)-Moshers acid) are conducted to verify the 
enantiomeric purity of the major intermediates formed during the synthesis. Finally the 
diastereomeric amides of (S)-Rosmarinic acid and (R)-α-methylbenzylamine are prepared 
and a 
1
H NMR indicates that the prepared Rosmarinic acid is at least 90% (S) with only 
minor peaks for the (R,R) diastereomer. The authors still remain confused as to why their 
specific rotation is opposite to that reported for the natural product. It has been well 
documented that all Danshen hydrophilics have a positive rotation when exposed to polarized 
light, with the (R)-configuration at the α-carbon adjacent to the carboxylic acid moiety. 
Clearly, Bogucki et al.
40
 were not made aware of this fact and the opposite enantiomer has 
been prepared, as intended.  
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This synthesis demonstrates an original approach to (S)-Danshensu which had previously not 
been attempted but it does not compare to Eicher‟s35 novel synthesis of Rosmarinic acid. 
Even though both reaction schemes could provide both enantiomers of Rosmarinic acid, 
Eicher‟s35 synthesis results in an extremely higher overall yield, with a comparable optical 
purity of the desired product. Therefore, for these reasons Eicher‟s synthesis is superior. 
 
Although the general biosynthetic pathway of (+)-Rosmarinic acid (5) has been substantially 
characterised there was still one aspect that remained undisturbed. It was discovered by 
Pabsch et al.
39
 in 1988 that rosmarinic acid synthase catalysed the esterification of 4-
coumaroyl CoA with 3-(4-hydroxyphenyl)lactic acid, generated from (S)-phenylalanine and 
(S)-tyrosine, to form 2-O-(4-coumaroyl)-3-(4-hydroxyphenyl)lactic acid (94, Scheme 18). It 
was later discovered by Petersen
41
 that the final hydroxylation reactions are catalysed by 
cytochrome P450s yielding 5. The initial condensation product of rosmarinic acid synthase 
had been ignored and not considered a critical element of rosmarinic acids biosynthesis. 
Matsuno et al.
42
 realised this pointing out that 94 being the substrate that interacts with 
cytochrome P450 could possess interesting biochemical properties and unravel the final steps 
of the rosmarinic acid biosynthetic pathway.  
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Scheme 18 Synthesis of a key intermediate (94) for the biosynthesis of (+)-Rosmarinic acid (5) 
 
Consequently the final precursor to 5 was synthesised (Scheme 18). The same strategy used 
in previous syntheses of 5 was adapted here with the lactic acid and cinnamic acid fragments 
being prepared individually before the penultimate esterification. The carboxylic acid of 88 
was protected as its tert-butyl ester by condensation with N,N‟-diisopropyl-O-tert-
butylisourea (90) and the phenol moiety was protected as its TBDMS ether with TBDMSCl 
in the presence of Et3N/DMAP to afford silyl ether 90 in 72% yield. This procedure was 
selective for the phenolic hydroxyl and left the secondary hydroxyl untouched. The phenolic 
hydroxyl of 4-Coumaric acid (91) was also protected as its TBDMS ether and the resulting 
carboxylic acid (92) was esterified with the protected lactic acid 90 using Steglich 
esterification conditions mediated by EDCI/DMAP/HBT to afford ester 93 in 33% yield. The 
TBDMS groups were then cleaved with TBAF and TFA cleaved the tert-butyl ester of 93 to 
the carboxylic acid furnishing the desired product (94) in quantitative yield. Thus, the first 
Chapter 1   
Page | 74  
 
synthesis of the last biological precursor to 5 was completed in five linear steps (longest path) 
with an overall yield of 16% from 88.  
 
This synthesis displays an alternative procedure for the critical esterification between the 
lactic acid precursor and cinnamic acid constituent. Alas, this new technique proves 
insufficient and becomes the major reason for the resulting low overall yield. The high 
efficiency of TBDMS as a protecting group is clearly demonstrated. 
 
1.2.4 XH-14 (5-(3-Hydroxypropyl)-7-methoxy-2-(3’-methoxy-4’-
hydroxyphenyl)benzo[b]furan-3-carbaldehyde) 
 
XH-14 is known to be a potent A1-selective adenosine antagonist (IC50 = 17 nM) that is 
native to Danshen. It is different to other adenosine A1 receptor ligands as it does not contain 
any nitrogen atoms unlike the well-known antagonists 1,3-dipropyl-8-cyclopentylxanthine 
(CPX) or 4-amino-8-hydroxytriazoloquinazoline. XH-14 is also water soluble which is 
always a desirable property of any pharmaceutical as the bioactivity will be profoundly 
greater than the competition. 
 
The first synthesis of XH-14 was completed by Yang et al.
43
 Having recognized the 2-
phenylbenzo[b]furan skeleton, an efficient synthesis of this type of compound was required. 
After an extensive literature search Yang et al.
43
, decided to employ the procedure used by 
Stevenson et al. (see reference within 43) in their synthesis of Egonol where the 2-
phenylbenzo[b]furan nucleus was prepared via a reaction between highly active cuprous 
acetylides and substituted o-bromophenols (Scheme 19). The o-bromophenol constituent was 
synthesised from vanillin (95) by selective bromination at the C-3 with molecular bromine 
(Br2) in AcOH to provide 3-bromovanillin (96) in 82% yield. This was then condensed with 
methyl hydroxy malonate under Doebner-Knoevenagel reaction conditions to provide 
unsaturated ester 97 in 98% yield. This would provide the alphatic chain of XH-14. The 
cuprous acetylide was prepared from acetophenone (98), presumably obtained from vanillin. 
The phenolic hydroxyl of 98 was first protected as its benzyl ether before it was converted via 
the Vilsmeier reaction to a β-phenyl-β-chloroacrylaldehyde 100 in 63% yield. The latter was 
then treated with hot aqueous sodium hydroxide solution to afford terminal acetylene 101 in 
79% yield. Acetylene 101 was then converted to cuprous acetylide 102 by treatment with 
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cupric sulfate and hydroxylamine hydrochloride in aqueous ammonium hydroxide solution in 
72% yield.  
 
 
Scheme 19 First total synthesis of XH-14 (109) by Yang et al. 
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Cuprous acetylide 102 and methyl ferulate 97 were then refluxed in dry pyridine to provide 
2-phenylbenzo[b]furan 103 in 65% yield. Benzo[b]furan 103 was then subjected to 
hydrogenation were the double bond of the unsaturated ester was reduced and benzyl group 
eliminated to afford ester 104 in 92% yield. Ester 104 was then reduced with LiAlH4 and the 
resulting diol (105) was protected as diacetate 106 in 92% yield. The phenolic acetate of 106 
was then selectively hydrolysed with ammonia to liberate the phenol moiety to afford 107 in 
85% yield. The C-3 position of benzo[b]furan nucleus 107 was then selectively formulated by 
the Gattermann reaction using Adam‟s reagent to afford 108 in 51% yield. The low yield in 
this step is due to the formation of a C-4 isomer of 108 (7:1 for 108) which could be removed 
column chromatogrpahy. The last acetyl group in 108 was then hydrolysed with NaOH and 
XH-14 (109) was obtained as a yellow amorphous solid with an overall yield of 8%, over 11 
steps (longest linear path). 
 
With the optimised procedure in hand a series of XH-14 derivatives were then prepared for a 
structure–activity relationship (SAR) study. By manipulating the aldehyde functionality at C-
3, ten new XH-14 analogues were prepared. The pharmacological properties of the new 
analogues were not reported. Although this reaction scheme is versatile in terms of functional 
group flexibility and compatibility, it was simply too long. With an overall yield of 8% for 
109 there were clearly many areas of this synthesis open for improvement and further 
optimisation. 
 
Further SAR studies were then conducted by Scammells et al.
44
 six years later in an attempt 
to develop a XH-14 analogue with a higher affinity for the A1 adenosine receptor. The 
modifications of XH-14 were to be completed based on the known requirements for receptor 
blockade as discovered through structure – activity relationship studies of xanthines. The first 
derivative to be prepared was a 2-phenyl analogue. The benzo[b]furan scaffold 112 was 
prepared via coupling of cuprous acetylide 111 with 3-bromocinnamate 110 using the same 
conditions developed by Yang et al.
43
 in the original total synthesis (Scheme 20). The 
unsaturated ester of 112 was then reduced in one step with LiAlH4 to provide the saturated 
propanol chain (113) which was then protected as acetate 114. This was an improvement over 
Yang‟s procedure which used three steps to achieve the target. Scammells et al.44 attempted 
to replicate the modified Gatterman – Adams reaction developed by Yang et al.43 for the 
introduction of the 3-formyl group but with each of the conditions trialled, only deprotected 
starting material was isolated. Therefore a new indirect halogenation – formulation approach 
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was devised. However, after attempting to either selectively iodinate or brominate at C-3, the 
halogen always substituted for H4.
44
 Therefore the 2-phenyl analogue was left without an 
aldehyde and other derivatives were addressed. 
 
 
Scheme 20 Synthesis of a 2-phenyl analogue of XH-14 by Scammells et al. 
 
Short chain hydrocarbons were another critical feature of the xanthine series of A1 adenosine 
antagonists therefore Scammells et al.
44
 decided to incorporate propyl hydrocarbon chains 
into the XH-14 pharmacophore. Bromophenol 119 (Scheme 21) was then prepared from 4-
propylphenol by bromination followed by nucleophilic displacement of one bromine 
substituent with MeOH. This was then coupled with cuprous acetylide 109 (Scheme 19) to 
obtain the corresponding benzo[b]furan 120 in 73% yield. The benzyl ether of 120 was 
removed by hydrogenation to afford 121 in 90% yield. 5-Propylbenzo[b]furan 121 then 
smoothly underwent a Gattermann – Adams reaction to afford the 3-formyl-5-
propylbenzo[b]furan 122 in 40% yield. Compared to the 2-phenyl XH-14 analogue (114, 
Scheme 20), the difference in reactivity for substrate 122 towards the Gattermann – Adams 
reaction was proposed to be due to the presence of the free phenol in 122 creating a vast 
delocalisation of electrons, leaving C-3 electron rich and therefore a likely target for 
electrophilic attack. Thus the 4-propyl analogue of XH-14 (122) was obtained in a total of 
four linear steps with an overall yield of 11%. 
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Scheme 21 Synthesis of 5-propyl analogue 122 of XH-14 (109) by Scammells et al. 
 
A 5,7-dipropylbenzo[b]furan analogue of XH-14 was then prepared. The key feature of this 
synthesis was the preparation of the 2-bromo-4,6-dipropylphenol intermediate 127. Starting 
with 2-propylphenol (123), the phenol moiety was acylated with propanoyl chloride to form 
ester 124 in 73% yield. Ester 124 then underwent a Freis rearrangement followed by a 
Clemmensen reduction to form 2,4-dipropylphenol 126. This was then brominated with 
molecular bromine to provide the target compound with an overall yield of 18%.The 
bromophenol intermediate 127 was then coupled with cuprous acetylide 102 to afford the 
benzo[b]furan scaffold (128). The benzyl ether from 128 was removed under acidic 
hydrogenation conditions before the 3-formyl group was installed via the Gattermann – 
Adams reaction. This procedure afforded the second XH-14 derivative (130) in a total of six 
linear steps, with an overall yield of 11% from 123.  
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Scheme 22 Synthesis of a 5,7-dipropyl analogue (130) of XH-14 by Scammells et al. 
 
The six new XH-14 analogues were then tested for their affinity for the A1 adenosine 
receptor. Unfortunately, all modifications made to XH-14 drastically reduced affinity. It was 
therefore deduced that the benzofuran and xanthine ring systems interact with the adenosine 
receptor in a different fashion. However, it was determined that to achieve high receptor 
affinity the 3-formyl and 5-propanol substituents are essential. 
 
After discovering that the Gattermann-Adams insertion of aldehydes was incompatible with 
other 2-substituted XH-14 analogues, the Scammells group
45
 sought an alternative, flexible 
route to 3-formylbenzo[b]furans that would allow for the generation of a library of XH-14 
derivatives with varying constituents bound at the C-2 position. 
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Scheme 23 Improved synthesis of XH-14 (109) including Pd - catalyst CO insertion by Scammells and co-workers 
 
The new strategy was to replace the cuprous acetylide coupling with Sonogashira conditions 
(Scheme 23). Starting from vanillin, a similar 5-iodocinnamte (131) was prepared as in 
previous studies, iodine was determined to be a more efficient leaving group. The phenolic 
hydroxyl was then protected as its MOM ether before it was coupled with terminal acetylene 
101 to afford the corresponding MOM protected o-hydroxytolan (133) in 92% yield. In this 
version of the Sonogashira reaction, PdCl2(PPh3)2 proved to be a more efficient catalyst than 
commonly used Pd(PPh3)4. The MOM group was then hydrolysed with oxalic acid in MeOH 
to provide 134 in quantitative yield. The diphenylacetylene (134) was then subjected to a 
unique palladium catalysed (PdCl2), carbon monoxide (CO) insertion-cyclisation reaction. 
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These conditions provided the benzo[b]furan scaffold with a methyl-ester placed at C-3 (135) 
with a moderate yield of 68%. Catalytic hydrogenation effected simultaneous debenzylation 
and reduction of the alkene (136) in 81% yield. Both esters were then reduced with DIBAL to 
the diol (137) in 61% yield. The methylol group at C-3 was then chemoselectively oxidised 
with manganese dioxide (MnO2) to present XH-14 (109) in 87% yield. This new and 
improved synthesis obtained XH-14 in a total of six linear steps from substituted 131, with an 
overall yield of 27%. With an overall yield improvement of greater than 20%, this high 
yielding synthesis could be easily modified to accommodate a variety of different 2-
substituted analogues.  
 
A second alternative synthesis of XH-14 by Kao et al.
46
 then appeared in the literature. 
Acknowledging Scammells improvements to the XH-14 synthesis, Kao and associates 
required a synthesis of the benzo[b]furan skeleton that would allow for the individual 
assembly of the necessary components and one that could easily be adapted to the preparation 
of a series of analogues. Even though the latest Scammells
45
 synthesis appeared to be highly 
versatile it was noted by Kao et al.
46
 that the palladium catalysed cyclisation of the o-
hydroxytolan was not always efficient when applied to the synthesis of derivatives.  
 
Kao et al.
46
 envisioned that 2-substituted phenyl-3-chloromercuriobenzofuran could be a key 
intermediate for the preparation of XH-14 and other lignands (Scheme 24). As in previous 
syntheses, the starting material was vanillin (95). Vanillin was first brominated selectively at 
C-3 (96, Scheme 19) as before and the phenolic hydroxyl was protected as the methyl ether 
under phase transfer conditions catalyzed by TBAI to form compound 138. The aldehyde was 
then protected as the corresponding acetal (139) following condensation with 
dimethylpropanediol. Acetal 139 was then treated with n-BuLi to form the organolithium 
species which underwent an aldol addition with 140 to afford carbinol 141. Carbinol 141 was 
then oxidized with manganese dioxide (MnO2) to form benzophenone 142 in high yield 
(96%). Benzophenone 142 was then subjected to a Colvin rearrangement with lithium salt of 
trimethylsilyldiazomethane to provide internal acetylene 143 in 98% yield. Cyclisation of 
diphenylacetylene 143 was initiated by Hg(OAc)2 in AcOH, at room temperature with 
simultaneous cleavage of the o-methoxy group to afford the 2-phenyl-3-
chloromercuriobenzo[b]furan (144) in quantitative yield.  
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Scheme 24 Synthesis of organomercury intermediate 144 used in a total synthesis of XH-14 (109) by Kao et al. 
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Scheme 25 Synthesis of XH-14(109) from organomercury intermediate 144 by Kao et al. 
 
The first step of the final stages was to introduce an aldehyde group onto C-3 on the 
benzo[b]furan nucleus. An indirect strategy was devised where an ester would be inserted via 
electrophillic attack at C-3, promoting displacement of HgCl which could then be reduced to 
the aldehyde (Scheme 25). This was achieved by treating the 144 with a stiochiometric 
amount of PdCl2, two equivalents of MgO and LiCl under an atmospheric pressure of CO in 
MeOH at room temperature to afford the 3-methoxycarbonylbenzo[b]furan (145) in 69% 
yield. The acetal of 145 was then hydrolysed with hydrochloric acid to liberate the C-5 
aldehyde (146) in 97% yield before it was subjected to a Wittig reaction to provide the 
unsaturated ester (147) in 78% yield. Both esters were then reduced with DIBAL to afford the 
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diol 148 in 49% yield. Catalytic hydrogenation then formed the saturated hydroxyl propyl 
chain before the C-3-methanol moiety was chemoselectively oxidised with MnO2 to form 
XH-14 (109) in 24% yield. This scheme produced XH-14 in thirteen steps with an overall 
yield of 3% from vanillin. 
 
Even though this mercuric acetate driven cyclisation of diphenylacetylene 143 solved the 
problem of regioselectivity for the direct insertion of an aldehyde at C-3, it was not without 
its own issues. Kao et al.
46
 noted that the organomercury species was incredibly stable and 
therefore easy to handle but, in order to successfully convert it to the corresponding ester, a 
stoichiometric amount of PdCl2 was required. As this reagent is relatively expensive and 
mercury(II) compounds are toxic, it was deemed necessary to find an alternative electrophile 
for the cyclisation thereby eliminating the need for molar quantities of PdCl2. 
 
It was then conceived by Kao et al.
46
 that bromonium ion could serve as alternative reagent 
for the cyclisation of diphenylacetylene and provide 3-bromobenzo[b]furan derivatives that 
would allow for the generation of exceedingly diverse XH-14 analogues. To test this 
hypothesis diphenylacetylene intermediate 143 was dissolved in CHCl3 at −15
o
C before a 
solution of molecular bromine (Br2) in CHCl3 was added (Scheme 26). These conditions 
gave a mixture of C-5 acetal (150) and formyl-3-bromobenzo[b]furan (151) which when 
hydrolysed with HCl/acetone gave 5-formyl-3-bromobenzo[b]furan (151) as the sole product 
in 86% overall yield. A Wittig reaction was then conducted on the aldehyde, providing the 
unsaturated ester (151) in 88% yield. Ester 152 was then reduced with DIBAL to the 
corresponding alcohol 153 in 73% yield.  The organolithium intermediate of 153 was 
generated with t-BuLi and treated with N-formylpiperidine (NFP) to afford C-3 aldehyde 154 
in 80% yield. Aldehyde 154 was then subjected to catalytic hydrogenation without 
purification to reduce the alkene and liberate the benzyl ether to afford XH-14 (109) in one 
effort in a yield of 62%. This highly efficient, optimised scheme produced XH-14 in a total of 
eleven steps with an overall yield of 14% from vanillin.  
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Scheme 26 Bromonium ion initiated cyclisation of acetylene 143 for synthesis of benzo[b]furan scaffold in XH-14 (109) by 
Kao et al. 
 
The bromonium ion promoted cyclisation proved exceptional as the overall yield of XH-14 
was more than four times the yield obtained from the organomercury intermediate. Even-
though this overall yield was not quite as superior as that achieved by Scammells and co-
workers
45
 (14% versus 27%) the novel scheme developed by Kao et al.
46
 eliminates the need 
for regioselective insertion of the pharmacologically essential C-3 aldehyde and removes the 
need for expensive transition metal catalysts making the synthesis more economical and 
opens the window for industrial application.  
 
A group of Korean chemists then found this procedure and decided that it could be optimised 
further. Instead of using the Colvin Rearrangement to provide the internal acetylene, Bang et 
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al.
47
 resorted to the Sonogashira cross-coupling reaction originally implemented by the 
Scammells group in the second synthesis of XH-14 (Scheme 27). 
 
3-Iodovanillin (155) was prepared as the surrogate for the cross-coupling as it was noted by 
Bang et al.
47
 that iodine proved superior to bromine for the cross-coupling reaction. The same 
phenomenon was reported by the Scammells group.
45
 To prevent intramolecular cyclisation 
of the internal acetylene to the benzo[b]furan, the hydroxyl group of iodovanillin was first 
protected as its methyl ether (156) using the same conditions established by Kao et al.
46
 
Using a similar approach to Kao et al.
46
, the diphenylacetylene was then cyclised in the 
presence of brominum ion but the corresponding 3-bromobenzo[b]furan was obtained with a 
maximum yield of 30%. Switching bromine for iodine and changing the solvent to CH2Cl2 
profoundly improved the yield to 95% for 3-iodobenzo[b]furan (158). A Wittig reaction was 
then performed on 158 which stereoselectively produced only the (E)-unsaturated ester (159) 
in 93% yield. A series of reactions (Scheme 27), similar to that conducted by Kao et al.
46
 
then transformed the ester to the C-3 formyl benzo[b]furan 162. The benzyl ethers of 162 
were then liberated with BCl3 to afford XH-14 (109) in 90%. This now thoroughly optimised, 
highly efficient and versatile synthesis provided the target compound, XH-14 in only nine 
steps with an overall yield of 23% from vanillin. 
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Scheme 27 Synthesis of XH-14 (109) with improved electrophilic cyclisation procedure by Bang et al. 
 
The key differences between the 2009 and 2002 syntheses of XH-14 that produced the 
colossal increase in total yield were the replacement of iodine for bromine in the electrophilic 
cyclisation of diphenylacetylene and the absence of an aldehyde protection/deprotection. 
Bang et al. found that when the aldehyde functionality of diphenylacetylene 157 was left 
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unprotected only iodine could initiate the cyclisation efficiently.  This improvement 
shortened the synthesis by two steps, thereby simplifying the overall procedure. 
 
1.2.5 Salvianolic acid F 
 
In an attempt to synthesise Salvianolic acid A, Cotelle and co-workers
48
 were the second 
group to perform a total synthesis of Salvianolic acid F (Scheme 28). The first preparation of 
Salvianolic acid F was carried out by Ai et al.
49
 however this original synthesis was noted by 
Cotelle and co-workers
48
 to be „long, fastidious and low yielding‟. The original approach by 
the Cotelle group was to use a version of the Wittig transformation to provide the (E)-stilbene 
infrastructure present in Salvianolic acid‟s A and F (12, Figure 3, Section 1.1.2.3; 9, Figure 2, 
Section 1.1.2.2, respectfully). 2,3-Dimethoxybenzylalcohol (163) was converted in one step 
to the 1-bromobenzyl bromide 164 by the action of Br2 in CHCl3 which could then be 
converted to the triphenylphosphonium salt to provide Wittig reagent 165 in 95% yield. This 
reagent was then treated with NaOMe in the presence of benzaldehyde 61 to afford (E)-
stilbene derivative 166 in 80% yield.  
 
The next key stage of this synthesis was the introduction of a cinnamic acid functionality at 
C-1 of the (E)-stilbene scaffold to furnish tetramethyl salvianolic acid F (169). Cotelle and 
co-workers proceeded by converting bromostilbene 166 to the corresponding aldehyde by 
treating 166 with n-BuLi at -78
o
C followed by nucleophilic substitution with DMF at -20
o
C 
to afford aldehyde 167 in 85% yield.  Aldehyde 167 was then subjected to the optimised 
Wittig conditions with the phosphonium salt derived from methyl iodoacetate and PPh3 (170) 
to afford methyl cinnamate 168 in 70% yield as a mixture of E and Z isomers. Treatment of 
the isomeric mixture with KOH gave pure (E)-cinnamic acid and thereby completing the 
synthesis of tetramethyl salvianolic acid F (169) in 95% yield.  
 
Tetramethyl Salvianolic acid F could then be transformed to polyphenolic Salvianolic F by 
liberating the methyl ethers with BBr3. Given that Salvianolic acid F has the electron rich 
stilbene system, due care had to be taken during the aqueous workup to prevent cyclisation of 
the boron intermediate to a cyclic side product. After treating the tetramethyl ether with BBr3 
at room temperature for one hour the reaction mixture was immediately poured into a 
saturated, aqueous solution of K2HPO4.  
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Scheme 28 Total synthesis of Salvianolic acid F (9) by Cotelle and co-workers 
 
Using this technique, the polyphenol Salvianolic acid F (9) was obtained in 26% yield. 
Overall this synthesis is a substantial improvement over the earlier procedure developed by 
Ai et al.
49
 with tetramethyl Salvianolic acid F being prepared in a total of only six steps, 
compared to eleven and with an overall yield of 39% compared to 0.2%. It is noted by 
Cotelle and co-workers
48
 that in the future when dealing with polyphenolic compounds, 
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methyl ethers should be avoided as a protecting group and substituted for more labile groups 
(either benzyl or allyl) or to conduct the demethylation before the final step. 
 
1.2.6 Lithospermic acid 
 
Lithospermic acid was first synthesised in racemic and protected form by Jacobson et al.
50
 To 
achieve the correct substitution pattern Jacobson et al.
50
 devised a plan starting from the 
benzopyranone of isovanillin. Isovanillin was first converted to 2-allylisovanillin (170) by a 
Claisen rearrangement of O-allylisovanillin (yield not given). 2-Allylisovanillin (170) was 
then subjected to NaBH4 reduction to provide diol (171) in 90% yield. Diol 171 was then 
protected with Ac2O to form diacetate 172 in 90% yield. Ozonolysis of diacetate 172 
followed by reduction with dimethyl sulfide (Me2S) provided aldehyde 173 in 76% yield. 
Jones oxidation (H2CrO4) of the aldehyde gave acetic acid 174 in 82% yield. Removal of the 
acetate groups at 0
o
C with NaOMe liberated the diol (175) in quantitative yield before it was 
cyclised in the presence of NaOAc and refluxing Ac2O to provide the target lactone (176) in 
78% yield.  
 
 
Scheme 29 Sythesis of benzopyranone intermediate 176 for the first synthesis of (±)-Lithospermic acid by Jacobson et al. 
 
With benzopyranone 176 in hand work could commence on the second half of the reaction 
scheme. The first part was to form the dihydrobenzofuran scaffold of lithospermic acid by 
skillfully modifying 176.  
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Scheme 30 First synthesis of (±)-heptamethyl lithospermate (183) by Jacobson et al. 
 
To introduce the 2-phenyl substituent, 176 was subjected to an aldol condensation with 
benzaldehyde 61. The lactone of aldol product 177 was then opened with methanolic NaOMe 
to afford ester 178 in 62%, selectively for the (E)-isomer. The benzylic alcohol of 178 was 
then subjected to a Swern oxidation ((COCl)2/Me2SO) to yield the formyl substrate (179, 
78%) which could then be cyclised in the presence of HBr to form dihydrobenzofuran 
skeleton 180 in 67% yield. Knoevenagel condensation of the aldehyde functionality with 
malonic acid furnished cinnamic acid 181 in 75% yield. The secondary alcohol (±)-182 was 
then esterfied via acid the acid chloride (SOCl2) of the former to present heptamethyl (±)-
lithopsermate (183) and its diastereomer in 50% yield. As this synthesis was the first of its 
kind ((±)-Rosmarinic acid was synthesised ten years later; see section 1.2.3 Rosmarinic 
acid) it was not particularly efficient. This classical synthesis of methylated lithospermic acid 
required sixteen steps and as a result the overall yield was 5%. 
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The first asymmetric synthesis of (+)-Lithospermic acid was completed recently by the 
Bergman and Ellman group.
51
 Their strategy was to implement their recently developed 
method for intramolecular alkylation via directed C-H bond activation to provide the densely 
functionalised 2,3-dihydrobenzofuran scaffold of (+)-Lithospermic acid. The directing group 
in this case was to be a chiral imine generated from the appropriately substituted aromatic 
aldehyde. This was the first example employing a chiral non-racemic imine as the directing 
group in a C-H bond activation method.  
 
The aldehyde substrate was prepared by conjugate addition of isovanillin (185) to internal 
acetylene 184 (Scheme 31). Acetylene 184 was prepared by Corey-Fuchs olefination of 
benzaldehyde 61 to provide dibromoalkene 183 in 88% yield, followed by elimination and 
halogen exchange with n-BuLi and trapping of the intermediate organolithium species with 
methyl chloroformate to afford methyl ester 184 in excellent yield (93%). The conjugate 
addition was then performed between the sodium salt of 185 and internal acetylene 184 in 1:1 
MeOH and pyridine to selectively afford the (Z)-olefin (186) in a 3.2:1 ratio with the (E)-
isomer. After chromatography and recrystallisation, pure (Z)-olefin (186) was isolated in 59% 
yield.  
 
The aldehyde moiety of 186 was then condensed with (R)-(–)-aminoindane to form imine 
187 as the chiral auxiliary for the rhodium catalysed intramolecular alkylation. The C-H bond 
activation/cyclisation reaction was then performed on imine 186 with catalyst [RhCl(coe)2]2 
and ferrocenyl-PCy2 (FcPCy2) as the ligand to form the desired cis-dihydrobenzofuran (188) 
product in 88% yield and 73% ee for the (S,S)-diastereomer, after hydrolysis of the auxiliary 
(Scheme 32). Recrystallisation of crude 188 gave a yield of 56% and enhanced the 
enantiomeric purity to 99% ee. Knoevenagel condensation of aldehyde 188 with malonic acid 
provided cinnamic acid 189 in as the desired, more thermodynamically stable anti 
diasteromer in 85% yield.  
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Scheme 31 Synthesis of (R)-imine intermediate 187 used in the total synthesis of (+)-Lithospermic acid by O'Malley et al. 
 
The secondary alcohol side chain, (R)-Danshensu (3, Figure 1) was then obtained from 
commercially available (+)-Rosmarinic acid (5, Figure 2) in two steps. Alcohol 63 was then 
esterified with the carboxylic acid of dihydrobenzofuran scaffold 189 in the presence of 
EDC/DMAP to afford (+)-hepamethyl lithopermic acid (190) in 80% yield. O‟Malley et al.51 
had envisioned a global demethylation to liberate the natural product. However when this was 
put into practice, either only decomposition products were obtained or at best a moderate 
yield of the target compound. Thus, a two stage deprotection was proposed were the methyl 
esters would be saponified before the methyl ethers. Again difficulties were encountered, 
where standard hydrolysis conditions were not selective for the methyl esters. Employing a 
new procedure pioneered by Nicolau et al.
52
 where the selectivity for methyl esters could be 
achieved via Me3SnOH, diacid 191 was isolated in 93% yield with retention of enantiomeric 
purity. The methyl ethers were removed employing Brossi‟s conditions, where 
iodotrimethylsilane and quinoline are precomplexed to form quinoline adduct 192 which is 
then used neat with the methylated substrate. These conditions provided (+)-Lithospermic 
acid (19) in 35% yield.  
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Scheme 32 Total synthesis of (+)-Lithospermic acid (19) by O'Malley et al. 
 
Even though the idea of a global deprotection was somewhat premature, this novel synthesis 
of (+)-Lithopsermic acid encompasses an extensive array of novel chemistries with the first 
example of chiral amine directed C-H bond activation being a key step. In the end (+)-
Lithopermic acid was obtained in ten steps with an overall yield of 6%. 
 
Six years later in 2011, a second asymmetric synthesis of (+)-Lithopermic acid appeared in 
the literature. Employing similar asymmetric techniques to those implemented by the 
Bergmann and Ellman group, Wang et al.
53
 designed a synthesis facilitated by two key C-H 
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functionalisation reactions thereby allowing for the most efficient route to (+)-Lithospermic 
acid. First the chiral auxiliary for the construction of the dihydrobenzofuran skeleton was 
prepared (Scheme 33). Starting from O-eugenol (193), an acetic acid species (195) was 
obtained in three steps (85%) before it was esterified with Fukuyama‟s chiral auxiliary, 
pyrrolidinyl (S)-lactamide (196) under Mitsunobu conditions. The benzyl ether was then 
removed and the phenol was reprotected with 3,4-dimethoxybenzyl bromide (198) to afford 
veratroyl ether 199 in 71% yield from 197. Ester 199 was then treated with diazo transfer 
reagent p-ABSA in the presence of DBU to form α-diazo ester 200 which was isolated and 
treated immediately with Davies catalyst (Rh2(S-DOSP)4). Using this technique the carbene 
insertion proceeded smoothly at room temperature affording trans-dihydrobenzofuran 
skeleton 201 in 85% yield with good diastereoselectivity (8:1, dr). The chiral auxiliary was 
then hydrolysed with Ba(OH)2 to provide free carboxylic acid 202 in 86% yield.  
 
The Danshensu moiety (63) was then prepared from commercially available (+)-Rosmarinic 
acid (5, Figure 2) using the same procedure adopted by the Bergmann and Ellman group.
51
 
For the C-H olefination step, secondary alcohol 63 was esterified with acrylic acid in the 
presence of EDC and DMAP to form acrylate 203 in 91% yield. Upon examination of the 
conditions required for the catalytic olefination, the reaction was executed in the presence of 
Pd(OAc)2 (5 mol%), Ac-Ile-OH (N-Acetyl-L-isoleucine) (5 mol%), KHCO3 (2 equiv) in tert-
amyl alcohol at 85
o
C for 2 days under 1 atm of O2 to provide (+)-pentamethyl lithospermate 
(204) with an excellent yield of 93% (Scheme 34).  
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Scheme 33 Dihydrobenzofuran intermediate 202 used by Wang et al. in their asymmetric synthesis of (+)-Lithospermic acid 
(19) 
 
It was noted by Wang et al.
53
 that the presence of KHCO3 was essential for a successful 
reaction as it formed the potassium salt of the carboxylic acid moiety thereby promoting 
coordination of the Pd(II) complex with the carbonyl group and directing the insertion. The 
methyl ester and five methyl ethers were then deprotected using the same approach 
developed by the Bergmann and Ellman group to provide diacid 205 in 91% yield and (+)-
Lithospermic acid in 31% yield. Employing the late stage Pd-catalysed intermolecular C – H 
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olefination with the previously described carbene insertion, (+)-Lithospermic acid (19) could 
be prepared in a total of twelve linear steps with an overall yield of 8%. This highly 
convergent strategy documented the superiority of a catalytic approach over a traditional one, 
improving the asymmetric synthesis of (+)-Lithospermic acid by 2%.  
 
 
Scheme 34 C - H olefination step used by Wang et al. in the final stages of their total synthesis of (+)-Lithospermic acid (19) 
 
On the synthesis of 2,3-dihydrobenzofurans, Fischer et al.
54
 recently developed a novel 
approach to preparation of trans-2,3-dihydrobenzo[b]furans via the stereoselective reduction 
of 2-aryl-3-methanoatebenzo[b]furans. The benzo[b]furan skeleton was prepared via the 
same carbonylative annulation conditions developed by Scammells and co-workers where the 
diarylacetylene was obtained through Sonogashira cross coupling of the terminal acetylene 
with the substituted aryl iodide.
45
 The resulting 2,3-benzo[b]furan could then be 
chemoselectively reduced to trans-dihydrobenzo[b]furans in the presence of activated Mg 
and MeOH. As the desired substrates were only sparingly soluble in MeOH, THF was added 
as a cosolvent. For reproducible results it was noted by Fischer et al.
54
 that the Mg surface 
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must be free of all oxidised impurities. This was achieved by adding NH4Cl to the reaction 
mixture which was compatible with the dual solvent system.  
 
This novel procedure was then exemplified by completing a formal total synthesis of (+)-
Lithospermic acid (19) (Scheme 35). Sonogashira coupling of terminal acetylene 207 with 
aryl iodide 206 derived from isovanillin gave diarylacetylene 208 in 75% yield. The aldehyde 
moiety of 208 was then protected as its acetal in 91% yield before the acetate group was 
cleaved with Cs2CO3 in MeOH/THF at 0
o
C to afford O-hydroxydiarylacetylene 210 in 94% 
yield. Then using Scammells carbonylative annulation conditions the 2-aryl-3-
carboxymethylbenzo[b]furan (211) was formed in 80% yield. The Mg mediated reduction 
was then carried out followed by hydrolysis of the acetal to form the dihydrobenzo[b]furan 
scaffold 180 in 81% yield with a 3:1 selectivity for the trans isomer. The aldehyde 
functionality was then condensed with malonic acid, employing Knoevenagel conditions to 
form cinnamic acid 181 in 72% yield. During this transformation the diastereomeric ratio (dr) 
was increased to 6:1 for the trans isomer. The alcohol counterpart was then prepared from 
(+)-Rosmarinic acid and esterified with the cinnamic acid according to the procedure 
developed by O‟Malley et al. The diastereomeric pair was then separated by preparative 
HPLC to yield (+)-heptamethyl lithospermate 212 (30% yield). This formal synthesis 
achieved the desired product in a total of nine steps with an overall yield of 8%, from 
isovanillin.  
 
This synthesis provides a practical alternative to dihydrobenzo[b]furans, however it is not 
enantioselective and therefore preparative HPLC was required to separate the desired 
diastereomer. This severely limits the scale, by which any chiral product may be produced 
thereby making it incredibly inefficient and incomparable to the already established 
asymmetric syntheses of (+)-Lithospermic acid. 
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Scheme 35 Formal synthesis of (+)-Lithospermic acid (19) by Fischer et al. 
 
In a related formal, total synthesis of (+)-Lithospermic acid by Varadaraju et al.
37
 two 
different strategies were used to construct the (±)-trans-dihydrobenzofuran core including a 
similar stereoselective reduction of the substituted benzo[b]furan moiety formed by a 
palladium catalyzed annulation of 2-iodoisovanillin (213) with internal acetylene 184 
(Scheme 36).  The annulation was performed in the presence of palladium catalyst 
Pd(PPh3)2Cl2 and LiCl in DMF to provide 4-formylbenzo[b]furan 214 in 62% yield. 
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Benzo[b]furan 214 could then be stereoselectively reduced by the action of Mg in MeOH 
with catalytic amounts of HgCl2 to afford (±)-trans-dihydrobenzofuran 215 in 82% yield. It 
was noted by Varadaraju et al.
37
 that when HgCl2 was omitted only a small conversion of 
30% to 215 was observed. The authors postulate that the HgCl2 activates the magnesium 
allowing the reaction to proceed at a faster rate, similar to the Mg-mediated reduction 
performed by Fischer et al.
54
 where NH4Cl was added to remove metallic oxides from the Mg 
surface as they were found to impede the reaction. As a result of the hydrogenation 
conditions the aldehyde motif of 214 was reduced and was therefore oxidized back to 
aldehyde 180 via MnO2 in 95% yield. The Knoevengel conditions used by O‟Malley et al.
51
 
were then employed to install the unsaturated cinnamic acid chain in 85% yield and furnished 
dihydrobenzofuran scaffold 181 in a total of four steps from 213 with an overall yield of 
41%.  
 
 
Scheme 36 Shortened synthesis of trans-dihydrobenzofuran core 181 via Mg mediated reduction of aromatic precursor 214 
by Varadaraju et al. 
 
The second synthetic route developed by Varadaraju et al.
37
 consisted of an aldol 
condensation between methyl arylacetate derivative 219 with benzaldehyde 216 followed by 
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cyclisation in the presence of iodotrimethylsilane (TMSI) (Scheme 37). Methyl aryl acetate 
219 was prepared from benzaldehyde 216 by condensation with sulfoxide 217 to afford 
ketene-thioacetal 218 which then underwent acid-catalysed methanolysis in anhydrous 
MeOH to afford methyl ester 219 in 86% yield. The key aldol condensation was then 
executed in the presence of LDA at -78
oC to yield α-hydroxy ester 220 whose 
stereochemistry was tentatively assigned as shown in Scheme 37. Cylisation was then 
effected by TMSI in CH2Cl2 at room temperature to selectively provide trans-4-
bromodihydrobenzofuran 221 in 75% yield, confirming the stereochemical assignments made 
for 220. Heck coupling between aryl bromide 221 and t-butyl acrylate (222) provided the 
unsaturated ester in 81% which could be readily cleaved with TFA at room temperature to 
yield dihydrobenzofuran scaffold 181 with a total yield of 25% from benzaldehye 216 in six 
steps.  
 
 
Scheme 37 Alternative route for the construction of the dihydrobenzofuran core in Lithospermic acid by Varadaraju et al. 
 
Using similar Steglich esterification conditions to those employed by previous groups in their 
total synthesis of (+)-Lithospermic acid the carboxylic acid functional group of 
dihydrobenzofuran scaffold 181 was esterified with α-hydroxyester 63 (see Section 1.2.2, 
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Scheme 10 for details) to form heptamethyllithospermate in 85% yield as a mixture of 
diastereomers. Overall Varadaraju et al. have optimised the synthesis of trans-
dihydrobenzofurans from the aromatic precursors by eliminating the need for 
protection/deprotection of phenol 213 and aldehyde 214 compared to the synthetic route 
designed by Fischer et al.
54
 However, even with these changes the overall yield of 
dihydrobenzofuran 181 remains the same (41% overall yield from 2-iodoisovanillin 
derivative). Therefore Varadaraju and co-workers
37
 have provided two alternative routes to 
access the trans-dihydrobenzofuran core of (+)-Lithospermic acid which could be easily 
manipulated with different substrates and starting materials thereby contributing towards a 
collection of methods available to the scientific community for the preparation of 
lithospermic acid analogues and structural refinement of HIV integrase inhibitors.   
 
The most recent asymmetric total synthesis of (+)-Lithospermic acid was completed by 
Ghosh et al.
38
 in mid-2012 where an entirely different approach was employed for the 
construction of the trans-dihydrobenzofuran core from chromanone derivative 228 (see 
Scheme 38). To access chiral chromanone 228, β-keto ester 224 and 3,4-
dibromobenzaldehyde (225) were subjected to a Knoevenagel condensation catalyzed by 
piperidinium acetate to form alkylidene β-keto ester 226 in 27% yield. The β-keto ester was 
then cyclised in the presence of a chiral quindine-derived catalyst (227) to enantio-selectively 
provide the oxa-Michael addition product. Once detected the resulting product was treated 
with p-TsOH to form chromanone 228 in 97% yield with an ee of 91%, which was improved 
to 99% by recrystallisation from EtOAc/hexane. Chromanone 228 was then rearranged in the 
presence of phenyliodine bis(trifluoroacetate) (PIFA), HCOOH and H2SO4 in 
trimethylorthoformate to form dihydrobenzofuran 229 in 61% yield with retention of optical 
activity (99% ee) as determined by chiral HPLC. To introduce the first catechol group, the 
3,4-dibromo bisection of 229 was converted to boronate ester 230 with the aid of palladium 
N-heterocylic carbene (NHC) catalyst PEPPSI-iPr in 57% yield. The bis-pinacol borane was 
then cleaved with aqueous NaOH and H2O2 and the resulting diol was protected as ketal 231 
in 76% yield. Hydrolysis of the methyl ester in 231 with Ba(OH)2 prepared the 
dihydrobenzofuran scaffold (232) for the coupling reaction. 
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Scheme 38 Synthesis of dihydrobenzofuran intermediate 232 used by Ghosh et al. in their total synthesis of (+)-
Lithospermic acid 
 
Acrylate 203 was then prepared from α-hydroxyester 63 (see Section 1.2.2, Scheme 11 for 
details) by treatment with acryloyl chloride in the presence of DMAP/Et3N and was subjected 
to an intramolecular C-H olefination reaction with dihydrobenzofuran substrate 232. The 
conditions used by Ghosh et al.
38
 are similar to those developed by Wang et al.
53
 the main 
difference being reaction time (6 h versus 2 h, see Scheme 34). The isolated yields from both 
C-H olefination procedures are comparable (89% to 93%) demonstrating the high utility of 
this particular reaction. With (+)-heptamethyllithospermate (204) in hand Ghosh et al.
38
 
proceeded with the deprotection where the methyl ethers and ester were liberated using the 
same procedures established by O‟Malley et al.51 to provide a triphenol intermediate, where 
the acetal motif was hydrolysed with aqueous TFA to provide (+)-Lithospermic acid in 34% 
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yield. Thus, Ghosh et al.
38
 completed the contemporary total synthesis of (+)-Lithospermic 
acid in a total of nine linear steps with an overall yield of 1.7%.  
 
Even-though the overall yield from this synthetic route does not express efficiency the key 
steps within this scheme will contribute towards the increasing number of synthetic protocols 
available for medicinal chemistry research thereby allowing for the systematic preparation of 
a library of diversely functionalised analogues by reducing the chance of chemically related 
limitations.   
 
1.2.7 (+)-Salvianolic acid C 
 
In early to mid-2012 Shen et al.
55
 completed the first total synthesis of (+)-Salvianolic acid C 
(13) after it was determined by Liang et al. that 13 possess anti-proliferative activity against 
HepG2 cells with an IC50 value of 20 µM.
55
 A similar approach to that undertaken by the 
Varadaraju
37
 and Scamells groups
45
 was envisioned by Shen et al.
55
 for the construction of 
the 2-phenylbenzo[b]furan skeleton where terminal acetylene 238 could be coupled with 
benzaldehyde 234 via Sonogashira followed by intramolecular cyclisation to afford 
benzo[b]furan scaffold 239 (Scheme 39). Benzaldehye 234 was obtained from 
protocatechualdehyde (29) in two steps with an overall yield of 58%. Entry to acetylene 238 
was accomplished via benzylation of pyrocatechol (235) followed by selective iodination at 
C-4 to form iodobenzene intermediate 236 in 91% yield. This intermediate was then 
subjected to Sonogashira coupling with ethynyltrimethylsilane to form a silyl precursor 
which could be readily cleaved at room temperature via methanolysis to form the desired 
terminal acetylene 238 in 94% yield. Standard Sonogashira coupling/cyclisation conditions 
were then employed for the coupling of the precursors 234 and 238 to form 4-
formylbenzo[b]furan 239 in 63% yield. Knoevenagel condensation of the latter with malonic 
acid provided cinnamic acid 240 in 85% yield. 
 
In contrast to related syntheses, Shen et al.
55
 chose to use the commercially available, natural 
product sodium danshensu 241 as the enatiomerically pure precursor to (R)-α-hydroxyester 
243 used in the esterification (Scheme 40). Therefore, the phenols of 241 were protected as 
their corresponding benzyl ethers and the carboxylic acid was esterified with MeOH in the 
presence of p-TsOH to form α-hydroxyester 243 in 51% yield equipped for the next stage.  
As in related (+)-Lithospermic acid syntheses, cinnamic acid 240 and protected Danshensu 
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(243) were subjected to a Steglich esterification to provide (+)-methyl 
pentabenzylsalvianolate C (244) in 84% yield. With the final core structure in hand Shen et 
al. proceeded with deprotection where Me3SnOH was employed for the selective cleavage of 
methyl ester 244 to afford carboxylic acid 245 43% yield. Finally the benzyl ethers of 245 
were liberated with BBr3 to present (+)-Salvianolic acid C (13) with a surprisingly high yield 
of 40% thereby completing the synthesis in a total of five linear steps with an overall yield of 
8%. 
 
 
Scheme 39 Synthesis of benzo[b]furan intermediate 240 used in the first total of (+)-Salvianolic acid C accomplshed by 
Shen et al. 
 
In previous syntheses, reactions of this type have typically been unsuccessful. For example in 
the studies leading up to the first asymmetric synthesis of (+)-Rosmarinic acid, Eicher et al.
35
 
reported that when (±)-tetrabenzylrosmarinic acid was subjected to debenzylation with BBr3 
only a small yield of the polyphenol could be obtained due to decomposition during the 
reaction. This observation questions the result achieved by Shen et al. and provides 
precedence for further investigation into the matter. Therefore there are several aspects of this 
synthesis open for improvement  including an asymmetric synthesis of the (R)-Danshensu 
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side chain, reducing the total number of steps (stands at thirteen) and replacing the tedious 
Steglich protocol (which takes two days) with a more efficient procedure. 
 
 
Scheme 40 Total synthesis of (+)-Salvianolic acid C (13) by Shen et al. 
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1.2.7 Incomplete syntheses of Danshen polyphenols 
 
1.2.7.1 Salvianolic acid D 
 
(+)-Salvianolic acid D was first isolated by Ai et al.
49
 where the structure was confirmed by 
total synthesis. Using a similar approach to that adopted by Jacobson et al.
50
 for the first 
synthesis of (±)-heptamethyllithospermate, Ai et al. set out to prepare the key aldehyde 
intermediate (250) from the preceding lactone (247, Scheme 41). 2-Allylisovaniilin was 
prepared using the Claisen rearrangement conditions developed by Jacobson et al.
50
 The 
vanillin derivative was then reduced with NaBH4 to form diol 171 in quantitative yield before 
it was protected as diactetate 172 in 81% yield. A Lemieux-Rudolff oxidation 
(NaIO4/KMnO4) was then performed on the allyl moiety to form carboxylic acid 174 in 74% 
yield. This product was then cyclised in the presence of KOH to form the desired lactone 
(247) in 93% yield. Protection of the phenol as its methyl ether (93%) followed by base 
induced cleavage of the lactone with NaOMe formed methyl ester 249 in 17% yield after 
isolation by VLC. The benzylic alcohol of 249 was then subjected to a Swern oxidation 
((COCl)2/DMSO) to form the corresponding aldehyde (250) in 80% yield. 
 
With the aldehyde scaffold in hand the final steps were completed. Knoevenagel 
condensation of the aldehyde group with malonic acid afforded cinnamic acid 251 in 88% 
yield. The methyl ester of the latter was then saponified with 10% KOH/MeOH to afford the 
diacid core of Salvianolic D (252) in 71% yield. This authentic reaction scheme provided the 
dimethyl-diacid skeleton of Salvianolic acid D in eleven steps with an overall yield of 4%. 
 
In 2006 the synthesis of the Salvianolic acid D skeleton was revisited by Queffélec et al.
56
 
Queffélec and co-workers initially followed the same synthesis designed by Ai et al.
49
 but in 
their hands the intermediate obtained after the alkaline lactone cleavage could not be 
prepared. A different synthesis was then proposed, starting from 2,3-dimethoxybenzaldehyde, 
and the key aldehyde intermediate (250) was formed in 61% yield. However as the 
intermediate formed via this approach required chromatographic purification due to the 
formation of an isomer from the aldehyde insertion, this route was abandoned as Queffélec et 
al.
56
 required a multigram synthesis of the diacid backbone for biological testing.  
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Scheme 41 Synthesis of the diacid skeleton (252) of (+)-Salvianolic acid D by Ai et al. 
 
Following this outcome, Queffélec et al.
56
 devised a different strategy using the same starting 
materials as those in the original synthesis by Ai et al.
49
 (Scheme 42). 2-Allylisovanillin 
(170) was prepared in the same fashion and was obtained with an identical yield of 90%. The 
phenol at C-3 was then protected as methyl ether 253 and instead of proceeding to the lactone 
derivative the aldehyde at C-1 was protected as dimethyl acetal 254. This allowed the C-2 
allyl group to be chemoselectively oxidised with Lemieux-Rudloff oxidant to afford, after 
hydrolysis with HCl acetic acid 255 in 77% yield which was subsequently protected as the 
methyl ester in 96% yield to form the key aldehyde intermediate (250) in only eight steps 
with an astonishing overall yield of 52%. This was a huge improvement over the previous 
synthesis described by Ai et al.
49
 with an increase of more than 25% in the overall yield. 
Queffélec et al.
56
 then continued by conducting the Knoevenagel condensation of 250 with 
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malonic as done by Ai et al.
49
 to form cinnamic acid 251 in 94% yield. This product was then 
subjected to global demethylation with BBr3 to present, for first time the free diphenol-diacid 
skeleton of (+)-Salvianolic acid D (256) in 45% yield. In summary, not only did Queffélec 
and co-workers
56
 substantially improve the overall yield of the key aldehyde intermediate 
(250) they also completed the synthesis of the (+)-Salvianolic acid D core by deprotecting 
intermediate 251 to render the free phenol with an excellent overall yield of 22% in only 
eight linear steps. 
 
 
Scheme 42 Synthesis of the polyphenolic core of (+)-Salvianolic acid D by Queffélec et al. 
1.2.7.2 Salvianolic acid E 
 
Continuing with the quest to prepare the carboxylic acid moieties of the Salvianolic acids‟, 
Queffélec and coworkers prepared the acid part of Salvianolic acid E (260, Scheme 43).
57
 
Using the same synthesis developed by their group for the preparation of the diacid of 
Salvianolic acid D the common aldehyde precursor (250) was protected by converting the 
aldehyde functionality to the more stable acetal (257) via trimethyl orthoformate.
56
 The acetal 
was then subjected to an aldol condensation with 3,4-dimethoxybenzaldehyde under acidic 
conditions to afford the heavily conjugated product. The acidic conditions hydrolysed the 
acetal and formed the conjugated aldehyde 258 in 63% yield.  
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Scheme 43 Synthesis of the diacid infrastructure of (+)-Salvianolic acid E (260) from aldehyde intermediate 250 by 
Queffélec et al. 
 
A Knoevenagel condensation was then performed and the unsaturated carboxylic acid 259 
was obtained in 90% yield. Unfortunately the methyl ester and ethers of this unsaturated 
system could not be successfully liberated with BBr3. However it was surprising to find that 
the initial aldol product could be deprotected with BBr3 to afford polyphenolic aldehyde 261 
in 75% yield. The polyphenolic aldehyde was then condensed with malonic acid under the 
same conditions as before to provide the acid part of Salvinolic acid E (261) in 95% yield. 
Salvianolic diacid E was therefore obtained in a total of ten steps with an overall yield of 
21% from isovanillin. 
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1.3 Research Proposal 
 
Since the pharmaceutical applications of Danshen decoctions have become recognised, 
scientists have focused their attention on the identification and biological evaluation of the 
water soluble secondary metabolites native to Danshen. Common properties of Danshen 
pharmaceuticals include cardiovascular and cerebrovascular applications arising from the 
historical use of Danshen where the Chinese community would administer Danshen tea to 
lower blood pressure and promote circulation. To date twenty six compounds have been 
identified and an extensive list of therapeutic properties for those that can be isolated 
efficiently has been reported in the literature. Of the compounds identified, (+)-Salvianolic 
acid B is thought to be responsible for the majority of observed medicinal properties as it is 
the most abundant depside within Danshen and in several other species of Salvia.
6
 However, 
in-depth studies into these activities revealed that in some cases those exhibited by crude 
Danshen extracts displayed a higher potency compared to that found for individual 
polyphenols, suggesting a synergistic effect arising from a specific combination of the 
secondary metabolites present in the dose.  
 
Pharmacokinetic studies of the more abundant polyphenols suggest that when the active 
ingredients are absorbed the constituents are rapidly distributed through tissue and 
metabolised, attributing to their inherently low bioavailability. The major metabolic pathway 
of the most abundant polyphenol, (+)-Salvianolic acid B is selective methylation of the meta-
hydroxyls by COMT. The less polar metabolites have been found to enter liver cells and 
when tested for antioxidant activity, were found to exert a higher activity than commercial 
antioxidants. A hypothesis made by different researchers is that as the natural products are 
poorly absorbed; contributing towards their extremely low bioavailability perhaps the 
observed therapeutic effect of Danshen products is due to the presence of the metabolites and 
not the natural polyphenols.    
 
As (+)-Salvianolic acid B can be isolated from Danshen in quantities of >100 g, in essentially 
pure form (>95%) there is no immediate requirement for its total synthesis.
12
 In some in vivo 
studies, (+)-Salvianolic acid B and its magnesium salt have displayed a lower affinity for the 
target therapeutic action when taken orally. This could relate back to the hydrophilic nature 
of the depside preventing absorption but it has been suggested that the reason for the 
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observed low activity could be due to the large molecular weight of these compounds (MW 
(g/mol): (+)-Salvianolic acid B = 718.61; Mg
2+
 salt = 740.90) simply preventing them from 
entering the cells. As the most traditional form of administration is by drinking Danshen tea, 
this is somewhat surprising, but this hypothesis does correlate with Lipinskis rule of five.
58
 
Lipiniski states that if a drug candidate violates more than one of the rules then the likelihood 
of said drug being orally active is significantly reduced. Magnesium salvianolate B, the most 
common form of (+)-Salvianolic acid B in Danshen decoctions clearly exceeds the molecular 
weight limit of 500 daltons (1 Da = 1 g/mol) and has more than five hydrogen bond donors. 
These facts support the previous observations and confirm that there is a possibility that (+)-
Salvianolic acid B and its derivatives are not solely responsible for the apparent therapeutic 
effects of Danshen formulations.  
 
To overcome the issues of the low bioavailability of Danshen polyphenols and to investigate 
the source of the extraordinary medicinal properties of Danshen extracts the total synthesis of 
trace level secondary metabolites is required. (+)-Salvianolic acid C, a caffeic acid trimer 
present in Danshen possesses a similar structure to that of (+)-Salvianolic acid B and (+)-
Lithospermic acid but with the absence of the (2S, 3S)-dihydrobenzofuran skeleton, being 
replaced by an aromatic core. This structure appeals to synthetic chemists as there is a 
collection of procedures available for their preparation. As (+)-Salvianolic acid C also 
possess the same (R)-Danshensu chain and other similar structural characteristics to the more 
complex depsides it is possible that (+)-Salvianolic acid C could have similar medicinal 
properties due to a structure-activity relationship. With (+)-Salvianolic acid C being a simpler 
compound, its molecular weight is significantly smaller than that of (+)-Salvianolic acid B 
(MW (g/mol): 492.43 compared to 718.61, respectively) and is therefore the perfect 
candidate for total synthesis and pharmacological studies as an orally active drug. 
 
For the reasons outlined above, (+)-Salvianolic acid C was chosen as a suitable target for 
total synthesis. From the literature, compounds of this type are typically prepared by a 
convergent approach where the two halves of the target molecule are synthesized individually 
and assembled in the final stages of the synthetic route. The first disconnection in the 
retrosynthesis of (+)-Salvianolic acid C provides two key fragments, A and B (Figure 8). It is 
proposed that fragment A could be obtained from subsequent fragments C and D by an 
intramolecular annulation. Fragment C is to be prepared from building block type E via 
condensation with an appropriate ester. Finally, disconnections of the acetylene functional 
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group in D and at the methylene carbon in B show that both fragments can be prepared from 
starting material type F.   
 
 
Figure 8 Retrosynthesis of (+)-Salvianolic acid C (13) 
 
In the first total synthesis of (+)-Salvianolic acid C, Shen et al.
55
 used this approach and 
completed the synthesis in a total of five linear steps with an overall yield of 8%. As 
discussed earlier there are still several aspects of this synthesis open for improvement 
including reducing the number of steps required for the preparation of key intermediate D, a 
versatile approach to the synthesis of intermediate B and the discovery of a more efficient 
esterification protocol used to join the two key fragments A and B. Further studies into the 
total synthesis of (+)-Salvianolic acid C will expand the library of synthetic tools available to 
chemists worldwide and could potentially result in the preparation of a new class of 
secondary metabolites with novel medicinal properties. 
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2. Synthesis of the benzo[b]furan scaffold 
 
2.1 Introduction 
 
The core structure of (+)-Salvianolic acid C is similar to that contained within XH-14, (+)-
Lithospermic acid and (+)-Salvianolic acid B as they all possess a benzo[b]furan nucleus. 
With the benzo[b]furan core of XH-14 being completely aromatic, unlike the saturated furan 
motif present in the higher order depsides, the techniques used for the synthesis of this 
heavily conjugated system serve as an excellent starting point for the total synthesis of (+)-
Salvianolic acid C.  
 
In current XH-14 syntheses, the construction of the benzo[b]furan nucleus consists of a 
reaction between a substituted terminal acetylene and a 2-halophenol. This transformation has 
been performed using multiple techniques, the most common being Sonogashira coupling of 
the acetylene to the halogenated aromatic followed by a separate cyclisation to yield the 
appropriately substituted 2-phenylbenzo[b]furan. While this reaction can be performed as a 
one-pot procedure, common issues include the use of moderately expensive palladium 
catalysts and lengthy optimisation periods arising from the specificity of catalytic 
transformations. A technique that was used by Yang et al.
1
 in the original XH-14 synthesis, 
and by Scammels et al.
2
 in subsequent structure-activity relationship studies involves the 
preparation of a cuprous acetylide intermediate that can be coupled to the substituted phenol 
and cyclised, in one effort to the 2-phenylbenzo[b]furan. This highly efficient and cost 
effective procedure offers a practical alternative to the troublesome catalytic approach and 
can be adapted to the synthesis of any 2-phenylbenzo[b]furan. Therefore this procedure was 
chosen for the preparation of the benzo[b]furan skeleton of (+)-Salvianolic acid C. 
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2.2 Results & Discussion 
 
Investigation into the synthesis of the 2-phenylbenzo[b]furan core of (+)-Salvianolic acid C 
was initiated by conducting a series of model reactions to determine the precise reaction 
conditions required for the reaction between cuprous acetylides and substituted phenols. In 
the XH-14 synthesis by Yang et al.
1
, bromocinnamate precursors were prepared as the 
coupling partner where the cinnamate chain would provide the saturated hydroxypropyl chain 
in XH-14. To replicate these reaction conditions, the same cinnamate precursors were 
prepared from vanillin (Scheme 44) and reacted with cuprous phenylacetylide 111 (see 
Scheme 2) using the optimised procedures of Scammels et al.
2
 for the preparation of their 2-
phenyl analogues. This would serve as the perfect model reaction, with the starting materials 
closely resembling the functional groups present in (+)-Salvianolic acid C. 
 
 
Scheme 44 Synthesis of bromocinnamate precursor 110 for model cuprous acetylide coupling reaction 
 
Cuprous phenyl acetylide 111 was prepared using the procedure of by Yang et al.
1
 and was 
obtained as a compact, bright yellow solid in 83% yield after drying at 65
o
C overnight. These 
acetylides were found to have a rather large surface area when wet and were insoluble in 
most organic solvents. This made their isolation easy but one had to ensure that the flask to 
be used for the annulation was large enough to accommodate the wet acetylide and to allow 
even stirring during reaction. With these considerations in mind, the model reactions were 
conducted by first charging the dry flask with solid acetylide 111 followed by anhydrous 
pyridine. The resulting bright yellow suspension was then stirred vigorously while a second 
solution of crystalline cinnamate 110 in anhydrous pyridine was added dropwise via cannula. 
During this time the acetylide would start to react and the suspension would slowly become a 
dark brown solution. This solution was then heated to 130
o
C and maintained at this 
temperature overnight. Isolation of the product following the procedure used by Scammels et 
al.
2
 provided a crude material which was found to be highly contaminated with Cu-residues. 
Recrystallisation of this material from a CHCl3/Hexane mixture provided pure 2-
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phenylbenzo[b]furan 112 in 67% yield (Scheme 45), a slightly higher yield than that reported 
by Scammels et al. This could be due the extensive precautions taken to exclude moisture 
from the reagents and during the reaction. 
 
 
Scheme 45 Model cuprous acetylide coupling with cinnamate 110 and acetylide 111 
 
Typically the overall yield of any coupling reaction can be improved by exchanging the 
leaving group in the electrophile to a bulkier species allowing for easier displacement and 
faster reaction rate. Therefore it was proposed that replacing bromine for iodine in the 
aromatic cinnamate could further improve the already acceptable yield. Initial attempts to 
prepare 3-iodovanillin (155, Scheme 46) included the procedure used by Bang et al.
3
 where 
iodination with molecular iodine (I2) was initiated by Ag2SO4 in ethanol. TLC analysis of the 
crude product revealed that a complex mixture of components, the major one being starting 
material. As multiple groups had reported using this procedure for the preparation of different 
iodophenols, it was surprising to find that none or very little of the desired product formed. 
Another procedure referred to by numerous groups was one by Erdtman were the sodium salt 
of vanillin (95) could be readily iodinated with a saturated aqueous solution of I2 and 
potassium iodide (KI).
4
 Following this procedure, pure 3-iodovanillin (155) could be 
obtained in 44% yield after recrystallisation from AcOH. 3-Iodovanillin (155) was then 
subjected to Kneovenagel condensation with ethyl hydrogen malonate (262) in the hope of 
preparing ethyl iodocinnamate 131 as done previously for the bromo-derivative. 
Unfortunately the condensation conditions were not compatible with the iodinated substrate 
and a mixture of products formed. Within five minutes of heating at 100
o
C the reaction 
mixture discoloured to become dark red. This is thought to be due to elimination of iodide as 
HI which subsequently led to decomposition of the condensation product under the high 
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energy conditions. As the iodocinnamate could not be efficiently prepared, bromine was used 
as the leaving group for benzo[b]furan formation and no further optimisation on the coupling 
of cuprous acetylides was carried out.  
 
 
Scheme 46 Synthesis of iodovanillin (155) and attempted preparation of iodocinnamate 131 via Knovenagel condensation 
 
With an understanding of the chemistry behind cuprous acetylide coupling and the 
application of this to 2-phenylbenzo[b]furan synthesis, the next step was to prepare the exact 
acetylene required for the construction of the heterocyclic core of (+)-Salvianolic acid C. In 
existing XH-14 syntheses it appears the terminal acetylene derived from vanillin has been 
prepared the same way since the original synthesis by Yang et al.
1
 While this preparation 
served its purpose, the procedure was long therefore lacked efficiency. Investigation into the 
procedures available for the synthesis of similar terminal acetylenes revealed a unique 
reaction named the Seyferth-Gilbert Homologation where aldehydes or ketones could be 
transformed in a one-pot procedure to either terminal or internal acetylenes respectively.
5
 
This is a much safer technique compared to the Colvin rearrangement used by Kao et al.
6
 
which requires explosive trimethylsilyldiazomethane.  
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Scheme 47 Synthesis of the Seyferth-Gilbert reagent (268) according to a procedure by Brown et al. 
 
 
Scheme 48 Synthesis of terminal acetylene 269 via the Seyferth - Gilbert reagent (268) 
 
The major downside of the homologation was that the reagent, dimethyl 
(diazomethyl)phosphonate (268, Scheme 47) had to be prepared but new procedures were 
available for its preparation from commercially available materials. Therefore 268 was 
prepared from dimethyl methylphosphonate (266) according to a procedure by Brown et al.
7
, 
in two linear steps with an average overall yield of 24%. Rather than having to protect 
vanillin, it was chosen to use the commercially available derivative 3,4-
dimethoxybenzaldehyde (61). With reagent 268 in hand the homologation was attempted 
with the standard conditions of Gilbert et al.
5
 (-78
o
C, 24 h then 4 h at RT, Scheme 48) and 
the corresponding terminal acetylene (269) was obtained in 84% yield as a crude mixture 
(determined by GC/MS) with unreacted benzaldehyde 61. As this acetylene was going to be 
converted to the solid cuprous acetylide it was thought that there was no need to isolate the 
acetylene at this stage. Fortunately, the acetylene could be converted to acetylide 270 
(Scheme 49) in 53% yield. Clearly this yield is representative of the purity of the acetylene 
used. Thus, with the desired acetylide in hand it was decided to proceed with the coupling 
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reaction to see how the substituted acetylide would behave during the standard coupling 
conditions.  
 
Employing the same conditions used for the model reaction with phenyl acetylide 111 the 
reaction between acetylide 270 and bromocinnamate 110 was found to be complete within 
the same time and similar visual characteristics were observed (Scheme 49). Of particular 
interest, the acetylide had similar volume properties as upon addition of anhydrous pyridine 
the acetylide expanded and a flocculent suspension formed. Using a similar isolation 
procedure to that used for the first model reaction the benzo[b]furan 271 was obtained in 52% 
yield after recrystallisation from aqueous EtOH. The presence of the methyl ethers appears to 
have a negative effect on the overall yield with a decrease of 15% in the isolated yield. The 
possible reason for this could arise from the fact that while the presence of the electron 
donating methyl ethers may aid the coupling step they could also hinder the cyclisation due to 
a partial negative charge forming on the acetylene carbon adjacent to the β-ring slowing 
down the cyclisation resulting in decomposition of the intermediate. As no starting material 
was detected after isolation of the product, it was decided that no adjustment to the reaction 
conditions could improve the acceptable yield of 52%. Interestingly there was no indication 
of a diyne by-product that is known to form during palladium catalysed, Sonogashira type 
annulations. 
 
 
Scheme 49 Model cuprous aceylide coupling between cinnamate 110 and acetylide 270 
 
Upon completion of the preliminary studies into the preparation of benzo[b]furans using the 
model substrates employed by Yang et al.
1
 it was time to prepare the cinnamate that would 
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provide the correct substitution pattern for the benzo[b]furan skeleton of (+)-Salvianolic acid 
C. The key difference between XH-14 and the other polyphenols of Danshen is the position 
of the hydroxypropyl chain in XH-14 compared to the position of the unsaturated ester in (+)-
Salvianolic acid C and others. To achieve this substitution it became apparent that simply 
interchanging vanillin for isovanillin (185) at the beginning of the synthesis would place the 
aldehyde para to the methoxy and thus, after Knoevenagel condensation with ethyl hydrogen 
malonate, place the unsaturated ester at C-4 affording the correctly oriented bromocinnamate 
precursor for construction of the fundamental benzo[b]furan nucleus present within (+)-
Salvianolic acid C.  
 
 
Scheme 50 Synthesis of the bromocinnamate precursor (273) to (+)-Salvianolic acid C 
 
To prepare the cinnamate precursor to (+)-Salvianolic acid C isovanillin (185) was selectively 
brominated at C-2, using a similar procedure to the conditions employed for the bromination 
of vanillin to afford 2-bromoisovanillin (272, Scheme 50) in 69% yield. This product then 
readily underwent Knoevenagel condensation with ethyl hydrogen malonate to form E-
bromocinnamate 273 as the sole product with no trace of the cis-isomer. Before the next step 
could be attempted, further investigation in the preparation of acetylide 270 was required as 
at this stage the scale at which 270 could be prepared was quite limited.  After discovering 
that terminal acetylenes could be prepared from aldehydes via the Seyferth – Gilbert 
homologation a similar one-pot approach was highly desired. Ohira had reported that the 
anion of 268 generated during the homologation could be obtained from keto precursor 278 
(Scheme 52) by acyl cleavage in basic methanol.
8
 Further experimentation by Bestmann and 
co-workers revealed that these conditions could be applied to the synthesis of a range of 
diversely functionalised terminal acetylenes from their corresponding aldehydes due to the 
mild, practical conditions at which the of anion 268 was generated.
9,10
 These findings labelled 
ketophosphonate 278 as the Bestmann-Ohira reagent (278) and its use has become widely 
recognised. This procedure suddenly became very appealing as it seemed one could easily 
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prepare any acetylene due to the effortless conditions required for the transformation and the 
abundance of commercially available aldehydes. To allow for no limitation in scale, a 
practical synthesis of the Bestmann-Ohira reagent (278) was required. 
 
 
Scheme 51 Synthesis of Chloroacetone (276) and preparation of phosphonate 277 for the Bestmann - Ohira reagent 
 
Further reading uncovered a synthesis of 278 by Pietruszka et al.
11
 who recommended 
preparing 278 from commercially available chloroacetone (276, Scheme 51) in two steps via 
dimethyl 2-oxopropylphosphonate (277). Even though phosphonate 277 was commercially 
available, at the time it was quite expensive making its preparation essential. Unfortunately 
276 was only available by sea freight which meant it had to be prepared as well. Direct 
chlorination of acetone by a selection of methods resulted in the preparation of an inseparable 
mixture of chlorinated isomers and a low yield of the desired product.
12
 An alternative 
procedure by Kimpe et al.
13
 stated that α-chloromethylketones could be obtained by 
chlorination of methyl β-ketoestesters followed by demethoxycarbonylation with aqueous 
H2SO4. Chlorination of methyl 3-oxobutanoate (274) with SO2Cl2 proceeded smoothly at 
room temperature as stated and the monochlorinated product (275) was obtained in 95% 
yield. The next step did not proceed as described by Kimpe et al.
13
 Initial attempts resulted in 
almost complete decomposition and low yields (≤ 20%) of 276 was obtained. It was found 
that the acidic hydrolysis was occurring at a much faster rate compared to that specified in the 
procedure by Kimpe et al.
13
 When conducting the reaction at 130
o
C, the hydrolysis was 
complete within 30 min compared to 2 – 3 h and 276 could be obtained in 68% yield after 
distillation. Phosphonate 277 could then be prepared from trimethyl phosphite according to 
Pietruszka et al.
11
 in 38 – 52% yield after two distillations. 
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Scheme 52 Synthesis of Bestmann - Ohira reagent (278) according to a procedure by Pietruszka et al. 
 
To install the diazo group in the Bestmann-Ohira reagent (278, Scheme 52) Pietruszka et al.
11
 
recommended using p-acetamidobenzenesulfonyl azide (265) as the azo-transfer reagent 
which could be prepared from the sulfonyl chloride using phase transfer conditions in 
essentially quantitative yield. Generation of the anion of phosphonate 277 with NaH followed 
by addition of sulfonyl azide 265 provided the Bestmann-Ohira reagent (278) in 63 – 75% 
yield on a moderate scale (56 mmol). This amount of 278 was sufficient for preliminary 
studies in the transformation of aldehydes to acetylenes but unfortunately when it came to 
scale up further, larger quantities of phosphonate 277 could not be obtained by this route. At 
this time the price of phosphonate 277 had dropped significantly and was therefore 
purchased. Using the commercial phosphonate, quantities of up to 20 g of 278 could be 
prepared.  
 
Optimisation of the conditions required for the transformation of benzaldehyde 61 to terminal 
acetylene 269 via 278 (Scheme 53) revealed that the most important parameters were that the 
nitrogen produced as a by-product could readily leave the reaction vessel, preventing pressure 
build up and that the reaction was conducted under air as any attempt to maintain an 
atmosphere of nitrogen impeded the progress of the reaction. Also 278 must have a purity of 
at least 80 to 90% to ensure practical yields. With these conditions in mind the reaction was 
straightforward. The aldehyde starting material was dissolved in distilled MeOH at room 
temperature under air, anhydrous K2CO3 was added followed by 278. The colour of the 
reaction mixture changed from clear to green instantaneously, indicating the formation of the 
anion intermediate which is stirred at the same temperature for 24 h.  Aqueous workup 
followed by isolation of the product via flash column chromatography afforded crystalline 
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acetylene 269 in up to 87% yield. This procedure could be repeated on up to a 40 mmol scale 
to yield 5 g of pure acetylene (269) after chromatography. 
 
 
Scheme 53 Synthesis of terminal acetylene 269 via the Bestmann - Ohira reagent (278) 
 
With bulk quantities of pure acetylene 269 in hand the next stage was to re-visit the 
preparation of active cuprous acetylide 270 (Scheme 53). From the first attempt using the 
crude acetylene obtained via the conditions of Gilbert et al.
5
 it was observed that the reaction 
proceeds at a fast rate. As the acetylide is prepared by trapping the analogous anion with 
reduced copper one must make take the proper precautions and ensure that, during the 
reduction of the Cu(II) species to Cu(I), an inert atmosphere is maintained as trace amounts 
of any re-oxidised material will be detrimental to the acetylide formation. The Cu(I) species 
(presumably CuCl) is prepared by reducing Cu(II) as CuSO4.5H2O in ammonium hydroxide 
solution with  NH2OH.HCl. If this reduction is conducted correctly a mild effervescence of 
N2 is observed and the colour of the reaction changes from a deep, dark blue to a very light 
blue over a period of 2 to 3 min. The acetylene (269) is then added in a solution of THF and 
EtOH and the acetylide forms instantly, is filtered off, washed and dried at 65
o
C under 
vacuum overnight. Following this procedure, Cu-acetylide 270 was obtained in 91% yield as 
a dark yellow to orange solid. This result is a significant improvement over that achieved 
with the crude acetylene confirming the necessity for the pure acetylene in this 
transformation. It was noted within the publication by Yang et al.
1
 that these Cu(I)-acetylides 
should be used immediately, presumably due to instability. During this study the acetylides 
were stored in a refrigerator (3 – 5 oC) and after more than year of storage no discolouration 
or decrease in reactivity were observed. 
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Scheme 54 Synthesis of cuprous acetylide 270 from pure acetylene 269 and it reaction with bromocinnamate 273 
 
Using the optimised reaction conditions established from the model 2-phenylbenzo[b]furan 
experiments, the reaction between ethyl bromocinnamate 273, derived from isovanillin and 
pure acetylide 270 preceded accordingly and 2-phenylbenzo[b]furan 279 was obtained in 
51% yield after recrystallisation from EtOAc (Scheme 54). As well as the desired product, a 
diyne byproduct (280) also formed and was isolated in 12% yield. No by-products were 
found in any of the model reactions. This is thought to be due to the position of the trans-
cinnamate chain as in the model reactions it was always at C-5 not C-4. This could induce a 
steric hindrance effect thereby interfering with the insertion of the acetylide and reducing the 
overall yield. This coupled with the negative affect of the methyl ethers and the existence of a 
competing reaction are the principal reasons for the average yield of benzo[b]furan 279. As 
the reasons for the mediocre yield are purely due to the substrates used, it is believed that a 
catalytic approach would not improve the overall yield since all of the starting materials are 
consumed. 
 
The final step in the preparation of the benzo[b]furan scaffold was the hydrolysis of the ethyl 
ester in 279 to the carboxylic acid (281, Scheme 55) as is required for the assembly of the 
two fragments of (+)-Salvianolic acid C. Initial experiments involved a microwave reaction 
where a potassium fluoride-alumina (40% KF/Al2O3) dispersion is combined neat with the 
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substrate and irradiated in the microwave.
14
 This results in the formation of the potassium salt 
of the carboxylic acid. Adjustment of the pH in the aqueous phase followed by extraction 
affords the free carboxylic acid. Unfortunately this „green‟ approach was not successful and 
carboxylic acid 281 was only obtained in 12% yield.   A more traditional approach is where 
esters are saponified with alkaline NaOH solution followed by liberation of the prepared 
sodium salt with concentrated hydrochloric acid to afford the free carboxylic acid.
15
 An 
example of this type of saponification was found in the literature where DMF is used as a co-
solvent and was attempted here.
16
 Strangely, while monitoring the reaction via TLC over a 
period of an hour, a large amount of starting material was detected. This was later confirmed 
by 
1
H NMR analysis of the crude product obtained after aqueous workup. Fortunately this 
issue was overcome by switching NaOH for LiOH and changing the reaction medium to 
aqueous THF.
17
 This technique has been used by many researches in the past and is a well-
known procedure. No reaction was detected at room temperature but when the reaction 
mixture was heated to 70
o
C and maintained at this temperature for seven hours carboxylic 
acid 281 could be obtained in 83% yield after precipitation from the aqueous phase with 6M 
HCl.   
 
 
Scheme 55 Hydrolysis of the ethyl ester in 279 to form the benzo[b]furan skeleton of (+)-Salvianolic acid C, 281 
 
Using this synthetic strategy the 2-phenylbenzo[b]furan scaffold (281) of (+)-Salvianolic acid 
C was prepared in a total of four linear steps with an overall yield of 22% from isovanillin. 
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2.3 Experimental 
 
2.3.1 Model reaction studies 
 
2.3.1.1 3-Bromo-4-hydroxy-5-methoxybenzaldehyde (96)
1
 
 
 
 
To a stirred solution of vanillin (32.95 g, 0.22 mol) in AcOH (70 mL) at room temperature 
was added a solution of Br2 (38.4 g, 0.24 mol, 1.09 equiv) in AcOH (70 mL) dropwise over a 
period of 1 hour. The homogeneous solution turned red immediately and the brominated 
product began to precipitate within the first 5 to 10 minutes of Br2 addition. Upon completion 
of the addition the resulting heterogeneous solution was stirred vigorously for an additional 
hour at room temperature. H2O (20 mL) was then added and the cream coloured product was 
filtered off, washed with additional H2O (20 mL) and allowed to air dry. The crude product 
was then recrystallised from aqueous EtOH (95%, 400 mL) to obtain 96 (39.9 g, 80%) as 
white crystals. 
 
Mp = 152 – 154oC; 1H NMR (300 MHz, d6-DMSO) δ 3.91 (3H, s, OCH3), 7.42 (1H, s, ArH), 
7.72 (1H, s, ArH), 9.77 (1H, s, CHO), 10.74 (1H, brs, OH); 
13
C NMR (75 MHz, d6-DMSO) δ 
56.4 (OCH3), 109.2, 109.6, 128.7, 128.9, 148.7, 149.8, 190.4 (CHO); IR (KBr) 3293.2, 
3103.2, 3072.6, 3016.9, 3007.9, 2974.2, 2942.8, 2918.6, 2848.4, 2819.4, 2789.3, 2744.0, 
1678.7, 1591.0, 1501.6, 1463.6, 1448.2, 1426.4, 1424.2, 1354.3, 1291.8, 1157.8, 1046.7, 
970.8, 866.3, 854.5, 830.3, 794.0, 680.3 cm
-1
; LRMS (ESI) [M-H]
-
 229 (
79
Br) and 231 
(
231
Br) m/z. 
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2.3.1.2 4-Hydroxy-3-iodo-5-methoxybenzaldehyde (155)
4
 
 
 
 
To a 500 mL conical flask was added vanillin (95, 10.95 g, 71.97 mmol) followed by 
deionised H2O (100 mL). A suspension was obtained to which dilute aqueous NaOH (2M, 
40 mL) was added to form a homogenous yellow solution. A suspension of I2 (18.3 g, 
72.10 mmol, 1 equiv) in deionised H2O (200 mL) was prepared. A large excess of KI (50 g) 
was then added to the I2 suspension to successfully form a homogenous dark yellow solution. 
The I2 solution was then added dropwise to the stirred vanillin solution over the period of 1 
hour. After 15 to 30 minutes the iodinated product began to precipitate. Neat Na2S2O3.5H2O 
(18.0 g, 72.53 mmol, 1 equiv) was then added to remove excess iodide and the precipitate 
was filtered off and washed with additional deionised H2O (5 × 100 mL) and allowed to air 
dry. The crude product was then recrystallised from AcOH (300 mL) to obtain 155 (8.7 g, 
44%) as silvery-metallic crystals. 
 
1
H NMR (300 MHz, d6-DMSO) δ 3.89 (3H, s, OCH3), 7.41 (1H, s, ArH), 7.88 (1H, s, ArH), 
9.74 (1H, s, CHO), 10.79 (1H, brs, OH); 
13
C NMR (75 MHz, d6-DMSO) δ 56.2 (OCH3), 
84.2, 110.4, 130.1, 134.9, 147.3, 152.2, 190.4 (CHO); LRMS (ESI) [M-H]
-
 277 m/z. 
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2.3.1.3 Ethyl (2E)-3-(3-bromo4-hydroxy5-methoxyphenyl)prop-2-enoate (110)
1
 
 
 
 
To a stirred solution of 96 (7.73 g, 33.46 mmol) in freshly distilled pyridine (17 mL) was 
added 262 (8.81 g, 66.69 mmol, 2 equiv) followed by anhydrous pyrrolidine (0.40 mL, 
4.87 mmol, 15 mol%). A reflux condenser was then attached followed by a CaCl2 drying tube 
and the reaction mixture was heated to 100
o
C. The moderately viscous solution was stirred 
vigorously at this temperature for 6 hours. The reaction mixture was then allowed to cool and 
the majority of the pyridine was evaporated. The oily residue was then treated with dilute 
HCl (2M, 60 mL) and EtOAc (100 mL). The layers were separated and the organic layer was 
washed with brine (2 × 10 mL), dried over MgSO4, filtered and evaporated. The resulting 
cream coloured solid was then recrystallised from CHCl3/hexane (1:1, 300 mL) and dried in 
vacuo to yield 8.5 g (84%) of 110 as a light yellow crystals. 
 
Mp = 123 – 126oC; 1H NMR (300 MHz, CDCl3) δ 1.34 (3H, t, J = 7.2 Hz, CH2CH3), 3.94 
(3H, s, OCH3), 4.26 (2H, q, J = 7.0 Hz, CH2CH3), 6.30 (1H, d, J = 16.0 Hz, 
ArHC=CHCO2Et), 6.97 (1H, d, J = 1.7 Hz, ArH), 7.30 (1H, d, J = 1.9 Hz, ArH), 7.54 (1H, d, 
J = 16.0 Hz, ArCH=CHCO2Et); 
13
C NMR (75 MHz, CDCl3) δ 14.3 (CH2CH3), 56.4 (OCH3), 
60.5 (CH2CH3), 108.5, 108.6, 117.1, 125.6, 127.6, 143.2, 145.0, 147.3, 166.8 (CO2Et); IR 
(KBr) 3289.28, 3013.58, 2996.83, 2987.33, 2975.14, 2940.66, 2915.80, 2872.13, 2844.51, 
1690.37, 1633.69, 1599.72, 1572.92, 1505.20, 1477.86, 1466.88, 1418.07, 1376.96, 1363.95, 
1312.96, 1303.70, 1282.56, 1266.55, 1187.12, 1148.93, 1047.93, 1034.56, 977.34, 847.41, 
830.37 cm
-1
; LRMS (ESI) [M-H]
-
 299 (
79
Br) and 301 (
81
Br) m/z. 
 
The same procedure was attempted with 155 but the reaction was unsuccessful. During the 
first 5 minutes of reaction an intense red colour was generated. After 6 hours at 100
o
C only 
trace amounts of product could be detected via ESI-MS. This is thought to be due to the 
generation of HI during the reaction causing decomposition. 
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2.3.1.4 Ethyl (2E)-3-(7-methoxy-2-phenyl-1-benzofuran-5-yl)prop-2-enoate (112)
2
 
 
 
 
A 250 mL, oven-dried, three-necked RBF was equipped with a reflux condenser topped with 
a gas inlet tube, a rubber suba-seal, a glass stopper and a large, Teflon coated oval shaped 
magnetic stir bar. The whole apparatus was flame-dried and allowed to cool under N2. 
Freshly distilled pyridine (40 mL) was added and degassed with N2 for 1 hour. 111* (2.63 g, 
16 mmol, 1 equiv) was added and a viscous bright yellow suspension formed. In a separate, 
flame-dried 250 mL Schlenk flask a solution of 110 (4.74 g, 16 mmol) in freshly distilled, 
degassed pyridine (40 mL) was prepared under N2 and transferred via cannula to the above 
suspension. The Schlenk flask and cannula were rinsed with additional distilled, degassed 
pyridine (5 mL) and the final reaction mixture was set to reflux at 130
o
C with vigorous 
stirring for 20 hours. The dark brown solution was then allowed to cool to room temperature 
before the pyridine was evaporated. The resulting dark brown residue was then dissolved in 
CHCl3 (170 mL) and deionised H2O (50 mL) was added. The biphasic mixture was filtered 
through a Büchner funnel and the layers were separated. The aqueous layer was extracted 
again with CHCl3 (2 × 100 mL) and the combined organic layers were washed with deionised 
H2O (2 × 50 mL), dried over MgSO4, filtered through Celite and evaporated. The resulting 
dark brown residue was subjected to FCC (SiO2, 25% CH2Cl2/hexane) where the 0.407 g 
(13%) of diyne byproduct was isolated first followed by 3.74 g of crude 112. This sample of 
112 was then recrystallised from CHCl3/hexane (1:4) to obtain 3.4 g (67%) of pure 112 as 
orange crystals. 
 
1
H NMR (300 MHz, CDCl3) δ 1.37 (3H, t, J = 7.2 Hz, CH2CH3), 4.08 (3H, s, OCH3), 4.29 
(2H, q, J = 7.2 Hz, CH2CH3), 6.43 (1H, d, J = 15.8 Hz, ArCH=CHCO2Et), 7.0 (2H, m, ArH), 
7.37 (2H, m, ArH), 7.46 (2H, t, J = 14.9, 7.2 Hz, ArH), 7.77 (1H, d, J = 15.8 Hz, 
ArCH=CHCO2Et), 7.89 (2H, d, J = 7.2 Hz, ArH); 
13
C NMR (75 MHz, CDCl3) δ 14.3 
(CH2CH3), 56.1 (OCH3), 60.4 (CH2CH3), 101.6, 105.4, 114.7, 117.0, 125.1, 128.8, 128.9, 
129.8, 130.6, 131.1, 145.3, 145.4, 145.4, 157.1, 167.1 (CO2Et); IR (KBr) 3064.54, 3032.52, 
3006.65, 2983.64, 2941.73, 2902.30, 2872.77, 2842.71, 1693.57, 1627.70, 1597.54, 1473.45, 
1440.79, 1429.49, 1393.23, 1362.14, 1341.39, 1281.76, 1265.06, 1247.13, 1214.60, 1148.34, 
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1113.37, 1048.93, 1018.54, 981.88, 910.61, 855.71, 843.17, 766.30, 741.26, 693.18 cm
-1
; 
LRMS (EI) [M]
+
 322 m/z. 
 
*111 was prepared using the same procedure developed for 270 
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2.3.1.5 Dimethyl (diazomethyl)phosphonate (268) 
 
4-Acetamidobenzene-1-sulfonyl azide (265)7 
 
 
 
To a 2 L 3-necked RBF equipped with an N2 inlet tube and 2 glass stoppers was added NaN3 
(5.76 g, 87.7 mmol) followed by dry acetone (1 L) and a N2 atmosphere was achieved. This 
mixture was cooled to 0
o
C (Ice/H2O) and N-acetylsulfanilyl chloride (20.10 g, 85.6 mmol) 
was added slowly (ca. 5 min) in small portions. The reaction was allowed to warm to room 
temperature and stir for 48 hours under N2. The slurry was filtered on a pad of Celite and the 
mother liquor was evaporated to give 20.0 g of a mixture of 265 (50%) and the sulfonyl 
chloride.This product still contained some of the unreacted starting material (via 
1
H NMR 
and LRMS (ESI)) but was deemed suitable for the next reaction as the starting material  
should not interfere with the diazo transfer. For the characterisation data of this compound 
see 2.3.2.4. 
 
Dimethyl (3,3,3-trifluoro2,2-dihydroxypropyl)phosphonate (267)
7
 
 
 
 
A 250 mL Schlenk flask equipped with a small Teflon coated magnetic stir bar and rubber 
septum was connected to a Schlenk line, evacuated, flame dried and allowed to cool under 
N2. The dry flask was then charged with anhydrous THF (40 mL) followed by dimethyl 
methylphosphonate (266, 2.29 g, 2.00 mL, 18.5 mmol) and the homogenous solution was 
cooled to -78
o
C (dry ice/acetone). n-Butyllithium (8.0 mL of a 2.30 M solution in hexanes, 
18.5 mmol, 1 equiv) was added over 5 min and the solution was allowed to stir at -78
o
C for 
30 min. 2,2,2-Trifluoroethyl trifluroacetate (3.70 mL, 27.6 mmol, 1.5 equiv) was added 
rapidly (1 – 2 s) and the resulting reaction mixture was stirred at -78oC for 15 min. The 
solution was then warmed to room temperature. Et2O (250 mL) was then added to the 
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reaction mixture and the combined organic layers were washed with dilute aqueous HCl (3%, 
10 mL) followed by saturated aqueous NaHCO3 (10%, 10 mL), Brine (10 mL), dried over 
MgSO4 and evaporated to afford 4.4 g (≥ 99%) of 267 as a pale yellow oil which was used 
without purification in the next step. 
 
Dimethyl (diazomethyl)phosphonate (268)
7
 
 
 
 
A 250 mL 3-necked RBF equipped with a N2 gas inlet tube, rubber septum, glass stopper and 
Teflon coated magnetic stir was assembled, evacuated, flame dried and allowed to cool under 
N2. Freshly prepared 267 (4.4 g, 18.48 mmol, 1.1 equiv) was dissolved in freshly distilled 
CH3CN (40 mL) under N2 and transferred via cannula to the reaction vessel. The resulting 
solution was then cooled to 0
o
C (ice/H2O) and 265 (4.05 g, 16.86 mmol, 1 equiv) was added 
followed by the slow addition of anhydrous Et3N (2.30 mL, 16.5 mmol, 1 equiv). The 
resulting reaction mixture was allowed to warm to room temperature and stirred at this 
temperature overnight. The acetonitrile was then evaporated and the residual orange oil with 
white precipitate was suspended in CHCl3, filtered through a small pad of SiO2 (5 cm) and 
evaporated. This crude product was then subjected to FCC (SiO2, EtOAc) to afford 0.63 g 
(25%) of 268 as a yellow-green oil. 
 
1
H NMR (300 MHz, d6-DMSO) δ 3.65 (6H, d, JH-P = 11.9 Hz, 2 × OCH3), 4.80 (1H, d, JH-P = 
10.7 Hz, OPHC=N2); 
13
C NMR (75 MHz, d6-DMSO) δ 27.9 (d, JC-P = 222.8 Hz, OPHC=N2), 
52.7 (OCH3), 52.8 (OCH3); IR (neat NaCl plates) 3072.35, 3013.96, 2956.20, 2852.94, 
2108.10 (C=N2), 1461.59, 1299.34, 1254.14, 1185.28, 1161.41, 1028.22, 829.25 cm
-1
; LRMS 
(ESI) [M + H]
+
 151 m/z. 
 
No characterisation data was reported in the literature procedure followed for the preparation 
of 268.  
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2.3.1.6 4-Ethynyl-1,2-dimethoxybenzene (269) via a Seyferth-Gilbert reaction
5
 
 
 
 
A 250 mL oven dried Schlenk flask equipped with a small, Teflon coated magnetic stir bar 
and rubber septum was attached to a Schenk line and evacuated, flame dried and allowed to 
cool under N2. The Schlenk flask was opened briefly and t-BuOK (1.13 g, 10.12 mmol, 
1.14 equiv) was added and the flask was sealed and purged with N2 (3×). Anhydrous THF 
(20 mL) was then added via syringe and the resulting slurry was cooled to -78
o
C (dry 
ice/acetone). In a second dry flask a solution of 268 (1.51 g, 10.06 mmol, 1.14 equiv) in 
anhydrous THF (20 mL) was prepared under N2 and transferred to the reaction vessel 
dropwise via cannula. This mixture was then allowed to stir at this temperature for 5 min 
where the colour changed from a light yellow to dark yellow indicating the formation of the 
anion of 268. In a third dry flask a solution of veratraldehyde (61, 1.47 g, 8.85 mmol, 
1 equiv) in anhydrous THF (25 mL) was prepared under N2 and transferred via cannula 
dropwise to the reaction mixture where the colour changed to brown. The resulting 
homogenous solution was stirred at -78
o
C for 24 hours and then allowed to warm to room 
temperature. Stirring was continued for a further 4 hours at room temperature before the 
reaction was quenched with deionised H2O (150 mL). The biphasic mixture was extracted 
with CH2Cl2 (3 × 70 mL) and the combined organic layers were washed with brine (150 mL), 
dried over Na2SO4, filtered and evaporated to form a red oily solid. This crude product was 
examined via GC/MS and a conversion of 84% relative to the starting material was observed. 
This product was then used as is in the next step as it was proposed that the unreacted 
aldehyde would not interfere in the next step. For the characterisation data for this compound 
see 2.3.2.4. 
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2.3.1.7 Ethyl (2E)-3-[2-(3,4-dimethoxyphenyl)-7-methoxy-1-benzofuran-5-yl]prop-2-
enoate (271)
2
 
 
 
 
A 100 mL, oven-dried, three-necked RBF was equipped with a reflux condenser topped with 
a gas inlet tube, a rubber septum, a glass stopper and a large, Teflon coated oval shaped 
magnetic stir bar. The whole apparatus was flame-dried and allowed to cool under N2. 
Freshly distilled pyridine (7.0 mL) was added and degassed with N2 for 1 hour. 270* (0.60 g, 
2.67 mmol, 1 equiv) was added and a viscous bright yellow suspension formed. In a separate, 
flame-dried 50 mL Schlenk flask a solution of 110 (0.80 g, 2.66 mmol, 1 equiv) in freshly 
distilled, degassed pyridine (7.0 mL) was prepared under N2 and transferred via cannula to 
the above suspension. The Schlenk flask and cannula were rinsed with additional distilled, 
degassed pyridine (2 mL) and the final reaction mixture was set to reflux (130
o
C) with 
vigorous stirring for 20 hours. The dark brown solution was then allowed to cool to room 
temperature before the pyridine was evaporated. The resulting dark brown residue was then 
dissolved in CHCl3 (30 mL) and deionised H2O (10 mL) was added. The biphasic mixture 
was filtered through a Büchner funnel and the layers were separated. The aqueous layer was 
extracted again with CHCl3 (2 × 20 mL) and the combined organic layers were washed with 
deionised H2O (2 × 10 mL), dried over MgSO4, filtered through Celite and evaporated. The 
resulting dark brown residue was subjected to FCC (SiO2, 70% EtOAc/Hexane) where 0.74 g 
of crude 271 was obtained as a yellow solid. This sample was then recrystallised from 
aqueous EtOH (95%, 120 mL) to afford 0.53 g (52%) of 271 as fluffy white crystals. No 
diyne byproduct was found. 
 
1
H NMR (300 MHz, CDCl3) δ 1.37 (3H, t, J = 7.2 Hz, CH2CH3), 3.95 (3H, s, OCH3), 4.00 
(3H, s, OCH3), 4.08 (3H, s, OCH3), 4.29 (2H, q, J = 7.2 Hz, CH2CH3), 6.43 (1H, d, J = 
16.0 Hz, ArCH=CHCO2Et), 6.95 (3H, m, ArH), 7.36 (2H, dd, J = 10.0, 1.7 Hz, ArH), 7.48 
(1H, dd, J = 8.5, 1.7 Hz, ArH), 7.77 (1H, d, J = 15.8 Hz, ArCH=CHCO2Et); 
13
C NMR 
(75 MHz, CDCl3) δ 14.4 (CH2CH3), 56.0 (OCH3), 56.1 (2 × OCH3), 60.5 (CH2CH3), 100.4, 
105.0, 108.0, 111.2, 114.5, 116.9, 118.2, 122.9, 130.5, 131.3, 145.1, 145.3, 145.4, 149.8, 
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157.2, 167.2 (CO2Et); IR (KBr) 3012.50, 2989.62, 2972.47, 2937.70, 2840.58, 1710.58, 
1637.58, 1611.11, 1576.39, 1513.69, 1480.96, 1457.98, 1439.05, 1373.74, 1349.79, 1305.78, 
1271.75, 1262.04, 1252.17, 1230.23, 1218.07, 1175.36, 1142.76, 1109.48, 1032.89, 1023.58, 
968.22, 940.48, 862.72, 856.14, 786.17, 768.21, 739.03 cm
-1
; LRMS (ESI) [M+H]
+
 383 m/z. 
 
*270 was prepared using the same procedure developed for the pure acetylene obtained via 
the Bestmann-Ohira protocol. 
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2.3.2 Synthesis of precursors to (+)-Salvianolic acid C including 
preparation of the benzo[b]furan scaffold 
 
2.3.2.1 2-Bromo-3-hydroxy-4-methoxybenzaldehyde (272) 
 
 
 
To a stirred solution of isovanillin (185, 38.04 g, 0.25 mol) in AcOH (175 mL) at room 
temperature was added a solution of Br2 (42.35 g, 0.265 mol, 1.06 equiv) in AcOH (87 mL) 
dropwise over a period of 1 hour. The homogeneous solution turns red immediately and the 
brominated product began to precipitate within the first 5 to 10 minutes of Br2 addition. Upon 
completion of the addition the resulting heterogeneous solution was stirred vigorously for an 
additional hour at room temperature. H2O (50 mL) was then added and the cream coloured 
product was filtered off, washed with additional H2O (50 mL) and allowed to air dry. The 
crude product was then recrystallised from aqueous EtOH (95%, 1250 mL) to obtain 39.7 g 
(69%) of 272 as white crystals. 
 
Mp = 202 – 205oC; 1H NMR (300 MHz, d6-DMSO) δ 3.93 (3H, s, OCH3), 7.15 (1H, d, J = 
8.4 Hz, ArH), 7.42 (1H, d, J = 8.4 Hz, ArH), 9.93 (1H, br s, OH), 10.11 (1H, s, CHO); 
13
C 
NMR (75 MHz, d6-DMSO) δ 59.5 (OCH3), 110.4, 113.4, 122.0, 126.7, 144.0, 153.3, 190.8 
(CHO); IR (KBr) 3202.79, 3019.97, 2979.42, 2942.76, 2894.70, 1663.40, 1588.30, 1563.45, 
1494.07, 1460.27, 1429.51, 1277.13, 1236.33, 1205.90, 1170.06, 1130.80, 1022.26 cm
-1
; 
HRMS (EI) calculated for C8H7
79
BrO3 [M]
+
: 229.9579, found: 229.9607. 
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2.3.2.2 Ethyl (2E)-3(2-bromo-3-hydroxy-4-methoxyphenyl)prop-2-enoate (273) 
 
 
 
To a stirred solution of 272 (11.55 g, 50 mmol) in freshly distilled pyridine (26 mL) was 
added 262 (13.21 g, 100 mmol, 2 equiv) followed by anhydrous pyrrolidine (0.63 mL, 
7.5 mmol, 15 mmol%). A reflux condenser was then attached followed by a CaCl2 drying 
tube and the reaction mixture was heated to 100
o
C. The moderately viscous solution was 
stirred vigorously at this temperature for 6 hours. The reaction mixture was then allowed to 
cool and the majority of the pyridine was evaporated. The oily residue was then treated with 
dilute HCl (2M, 120 mL) and EtOAc (200 mL). The layers were separated and the organic 
layer was washed with Brine (2 × 50 mL), dried over MgSO4, filtered through a small pad 
(5 cm) of SiO2 and evaporated. The resulting pink solid was then recrystallised from hot 
EtOAc (130 mL) and dried in vacuo to yield 11.2 g (74%) of 273 as a light pink crystalline 
solid. 
 
Mp. = 135 – 136oC; 1H NMR (300 MHz, d6-DMSO) δ 1.25 (3H, t, J = 14.3, 7.1 Hz, 
CH3CH2), 3.87 (3H, s, OCH3), 4.18 (2H, q, J = 21.4, 14.3, 7.1 Hz, CH3CH2), 6.50 (1H, d, J = 
16 Hz, C=CHCO2Et), 7.02 (1H, d, J = 8.7 Hz, ArH), 7.43 (1H, d, J = 8.7 Hz, ArH), 7.90 (1H, 
d, J = 15.8 Hz, ArCH=C), 9.69 (1H, br s, OH); 
13
C NMR (75 MHz, d6-DMSO) δ 14.17 
(CH3CH2), 56.22 (OCH3), 60.05 (CH3CH2), 110.82, 112.92, 118.27, 118.78, 126.22, 142.66, 
144.00, 149.82, 166.07 (CO2Et); IR (KBr) 3379.80, 3000.79, 2984.60, 2966.86, 2941.57, 
2873.44, 2842.73, 1698.21, 1631.66, 1591.38, 1490.29, 1467.14, 1453.32, 1443.39, 1276.45, 
1257.79, 1190.11, 1172.10, 1139.40, 1029.15, 986.69, 972.88 cm
-1
; HRMS (EI) calculated 
for C12H13
79
BrO4 [M]
+
: 299.9997, found: 299.9984. 
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2.3.2.3 Dimethyl (1-diazo-2-oxopropyl)phosphonate (278) 
 
4-Acetamidobenzene-1-sulfonyl azide (265)11 
 
 
 
To a stirred suspension of 4-acetamidobenzenesulfonyl chloride (264, 50.24 g, 215 mmol) in 
1,2-DCE (400 mL) was added TBAB (173 mg, 0.54 mmol, 0.25 mol%), followed by a 
solution of NaN3 (21.4 g, 329 mmol, 1.53 equiv) in deionised H2O (100 mL). The resulting 
heterogeneous solution was stirred vigorously overnight at room temperature, until two clear 
phases were formed. The layers were separated and the organic layer was washed with H2O 
(2 × 100 mL), dried over MgSO4, filtered through a pad of Celite and evaporated at 40
o
C to 
yield 265 (43.7 g, 84%) as an off-white, crystalline solid that was sufficiently pure for use in 
the next step. 
 
1
H NMR (300 MHz, CDCl3) δ 2.23 (3H, s, CH3CONH), 7.72 (1H, brs, CH3CONH), 7.78 
(2H, d, J = 8.9 Hz, ArH), 7.90 (2H, d, J = 8.9 Hz, ArH); 
13
C NMR (75 MHz, CDCl3) δ 24.7 
(CH3CONH), 119.6 (2 × ArCH), 128.9 (2 × ArCH), 132.3, 144.1, 169.3 (CH3CONH); IR 
(KBr) 3303.52, 3264.61, 3185.68, 3112.37, 3050.09, 2120.30, 2131.56 (N=N=N), 1677.10, 
1586.01, 1535.32, 1497.91, 1405.37, 1366.00, 1315.66, 1265.82, 1166.16, 1086.70, 1041.95, 
1010.89, 839.14, 753.19, 707.66, 634.09, 613.58, 588.04, 544.58, 516.34 cm
-1
; LRMS (ESI) 
[M-H]
-
 239 m/z. 
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Methyl 2-chloro-3-oxobutanoate (275)
13
 
 
 
 
A 1L three-necked RBF equipped with a glass stopper, rubber septum, N2 gas inlet tube and 
magnetic stirrer was evacuated, flame dried and allowed to cool under N2. Methyl 3-
oxobutanoate (77.47 g, 0.67 mol) was then added followed by anhydrous CH2Cl2 (530 mL). 
The flask was then re-sealed and evacuated and purged with N2 (3×). SO2Cl2 (57 mL, 
94.91 g, 0.70 mol, 1.05 equiv) was then added dropwise via syringe and the resulting solution 
was stirred at room temperature for an additional hour. The reaction mixture was then poured 
into H2O (700 mL), transferred to a separating funnel and shaken vigorously. The layers were 
separated and organic layer was washed with brine (140 mL), dried over MgSO4, filtered 
through a pad of Celite (5 cm) and evaporated to afford 275 as a crude faint yellow liquid. 
This liquid was then distilled (78
o
C, 0.5 mmHg) to yield 275 (85.8 g, 95%) as a colourless 
liquid. 
 
1
H NMR (300 MHz, CDCl3) δ 2.39 (3H, s, CH3CO), 3.85 (3H, s, OCH3), 4.79 (1H, s, HCCl); 
13
C NMR (75 MHz, CDCl3) δ 30.3 (CH3CO), 55.6 (OCH3), 62.3 (HCCl), 158.4 (CO2Me), 
187.1 (CH3CO); IR (neat NaCl plates) 3009.86, 2959.57, 2849.02, 1732.62, 1647.30, 
1616.84, 1438.75, 1360.09, 1260.96, 1360.09, 1260.96, 1196.24, 1173.10, 1151.51, 1069.74, 
1030.77, 987.84, 910.34, 898.25, 861.04, 839.02, 785.06, 769.94, 746.96 cm
-1
; LRMS (EI) 
[M]
+
 150 (
35
Cl) and 152 (
37
Cl) m/z 
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Chloroacetone (276)
13
 
 
 
 
To a 1L single neck RBF equipped with a large, oval shaped magnetic stirrer was added 275 
(60.04 g, 0.4 mol) followed by deionised H2O (195 mL) and H2SO4 (98%, 106 mL, 195 g, 
1.99 mol, 5 equiv). A reflux condenser was then fitted and the resulting solution was stirred 
vigorously, heated to 130
o
C (oil bath) and maintained at this temperature for 30 min. The 
progress of the reaction was monitored by 
1
H NMR for disappearance of the OCH3 signal at 
≈ 3.8 ppm corresponding to the starting material. The reaction mixture was then allowed to 
cool to room temperature before being poured into deionised H2O (1.4 L). The biphasic 
mixture was then transferred to a separating funnel and extracted with CH2Cl2 (3 × 250 mL). 
The combined organic layers were then washed with H2O (400 mL), brine (300 mL) dried 
over MgSO4, filtered through a pad of Celite (5 cm) and evaporated to afford 276 as a crude, 
brown liquid. This liquid was then distilled under partial vacuum (90
o
C, 10 mmHg) to yield 
276 (25.2 g, 68%) as a light yellow liquid. 
 
1
H NMR (300 MHz, CDCl3) δ 2.32 (3H, s, CH3CO), 4.09 (2H, s, CH2Cl); 
13
C NMR 
(75 MHz, CDCl3) δ 27.0 (CH3CO), 48.7 (CH2Cl), 200.2 (CH3CO); IR (neat NaCl plates) 
2986.18, 2939.30, 1744.50, 1725.10, 1401.12, 1359.68, 1303.89, 1262.09, 1228.31, 1163.05, 
1024.67, 829.82, 762.93, 666.58, 568.63 cm
-1
; LRMS (CI) [M+H]
+
 93 (
35
Cl) and 95 
(
37
Cl) m/z. 
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Dimethyl (2-oxopropyl)phosphonate (277)
11
 
 
 
 
A 100 mL, three-necked RBF equipped with a rubber septum, glass stopper and reflux 
condenser attached to a N2 gas inlet tube was assembled, evacuated; flame dried and allowed 
to cool under N2. The glass stopper was removed and KI (20.04 g, 121 mmol) was added. 
The vessel was sealed and evacuated and purged with N2 (3×). Anhydrous acetone (24 mL) 
and CH3CN (32 mL) were then added via syringe to form a white suspension. Chloroacetone 
(10.0 mL, 11.62 g, 126 mmol, 1.05 equiv) was then added to the suspension via syringe and 
the resulting heterogeneous mixture was stirred at room temperature for 1 h, during which 
time a creamy yellow suspension formed. P(OMe)3 (14.2 mL, 14.9 g, 120 mmol) was then 
added dropwise via syringe and stirring was continued overnight at room temperature. After 
14 h of stirring at room temperature, the reaction mixture was heated to 50
o
C to ensure 
complete conversion. The reaction mixture was then allowed to cool to room temperature, 
filtered through a pad of Celite and evaporated to form the crude product. High vacuum 
distillation of the crude liquid (142 – 148oC, 0.5 mmHg) gave 13.43 g (64%) of impure 277. 
A second distillation (140 – 144oC, 0.4 mmHg) provided pure phosphonate 277 (7.9 g, 38%) 
as a colourless liquid. 
 
1
H NMR (300 MHz, CDCl3) δ 2.31 (3H, m, CH3CO), 3.09 (2H, d, JH,P = 22.9 Hz, CH2), 3.78 
(6H, d, JH,P = 11.1 Hz, 2 × OCH3); 
13
C NMR (75 MHz, CDCl3) δ 31.1 (s, CH3CO), 41.9 (d, 
JC,P = 127.7 Hz, CH2), 52.7 (d, JC,P = 6.05 Hz, CH3CO); 
31
P NMR (121 MHz, CDCl3) δ 
35.65; IR (neat NaCl plates) 3004.59, 2959.87, 2923.45, 2855.38, 1715.36, 1463.40, 1425.92, 
1403.49, 1361.64, 1261.74, 1186.11, 1053.89, 1030.75, 830.52 cm
-1
; LRMS (EI) [M]
+ 
166 
m/z 
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Dimethyl (1-diazo-2-oxopropyl)phosphonate (278)
11
 
 
 
 
A 500 mL three-necked RBF was equipped with a large, oval shaped, magnetic stir bar, a 
rubber suba-seal, an N2 gas inlet tube and a glass stopper. The flask was then charged with 
277 (21.59 g, 129.96 mmol, 1.083 equiv) and evacuated and refilled with N2 three times. 
Anhydrous toluene (140 mL) was the added via syringe and the stirred homogenous solution 
was then cooled to 0
o
C (ice/H2O). NaH (4.8 g of a 60% dispersion in mineral oil, 120 mmol) 
was then added in portions. H2 gas was evolved and at this point a viscous white suspension 
of the Na
+
 salt was obtained and the stirrer stopped. Swapping the magnetic stirrer for a 
mechanical one had no effect on the isolated yield. A second solution of 265 (28.83 g, 
120 mmol) in anhydrous THF (50 mL) was then prepared under N2 and slowly transferred via 
Cannula to the reaction mixture. At this point the viscous suspension slowly discoloured to 
orange-brown and the stirrer started again. The ice/H2O bath was then removed and the 
reaction mixture was stirred overnight (16 hours) at room temperature. Petroleum ether 
(100 mL, Bp. = 40 – 60oC) was added and the light brown precipitate was filtered off through 
a thin, wide pad of Celite. The filter cake was rinsed with Et2O (5 × 100 mL) and the 
combined mother liquors were evaporated and dried under high vacuum (≤ 0.2 mmHg) to 
yield 17.06 g (68%) of crude yellow oil. This product was then subjected to FCC (SiO2, 70% 
EtOAc/Hexane) to obtain 13.2 g (53%) of 95% (
1
H NMR) pure 278 as a light green oil. This 
product was pure enough to use in the following transformation. 
 
1
H NMR (300 MHz, CDCl3) δ 2.25 (3H, d, JH,P = 2.27 Hz, CH3CO), 3.83 (6H, d, JH,P = 11.9, 
2.1 Hz, 2 × OCH3); 
13
C NMR (75 MHz, CDCl3) δ 27.0 (s, CH3CO), 53.5 (d, JC,P = 5.5 Hz, 2 
× OCH3), 128.5 (d, JC,P = 61.1 Hz, C=N2), 189.7 (d, JC,P = 13.2 Hz, CH3CO); 
31
P NMR 
(121 MHz, CDCl3) δ 14.30 Hz; IR (neat NaCl plates) 3002.88, 2958.16, 2854.68, 2124.59 
(C=N2), 1659.60, 1460.02, 1365.40, 1274.88, 1182.53, 1027.74, 970.50, 927.75, 835.88, 
803.84, 783.57 cm
-1
; LRMS (ESI) [M+H]
+
 193 m/z. 
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2.3.2.4 4-Ethynyl-1,2-dimethoxybenzene (269) via a Bestmann-Ohira reaction
9,10
 
 
 
 
A 1 L RBF was charged with veratraldehyde (61, 6.65 g, 40.0 mmol) followed by anhydrous 
K2CO3 (11.06 g, 80 mmol, 2 equiv) and an oval shaped magnetic stir bar. Freshly distilled 
MeOH (440 mL) was then added followed by a solution of 278 (9.22 g, 48 mmol, 1.2 equiv) 
in freshly distilled MeOH (4 mL) making [CHO] equal to 90 mM. The vessel was sealed with 
a rubber suba-seal and a needle was quickly placed in the seal to vent the N2 gas evolved. 
Progress of the reaction was monitored via TLC (32% EtOAc/Hexane) and after 24 of stirring 
at room temperature a maximum conversion of 88% to the acetylene was observed via 
GC/MS. The reaction mixture was then diluted with Et2O (400 mL) and washed with dilute 
aqueous NaHCO3 solution (400 mL, 5% (aq, w/v)). The layers were separated and the 
aqueous layers were re-extracted with Et2O (2 × 200 mL). The combined ethereal layers were 
then washed with Brine (3 × 200 mL), dried over MgSO4, filtered through a pad of Celite and 
evaporated. The yellow residue was then subjected to FCC (SiO2, 10% EtOAc/Hexane) to 
obtain 5.1 g (79%) of 269 as white crystals. 
 
Mp. = 73 – 74oC; 1H NMR (300 MHz, CDCl3) δ 3.01 (1H, s, CH), 3.88 (3H, s, OCH3), 3.90 
(3H, s, OCH3), 6.81 (1H, d, J = 8.3 Hz, ArH), 7.0 (1H, d, J = 1.9 Hz, ArH), 7.11 (1H, dd, J = 
8.3, 1.9 Hz, ArH); 
13
C NMR (75 MHz, CDCl3) δ 55.8 (OCH3), 55.8 (OCH3), 75.6 (C≡CH), 
83.7 (ArC≡C), 110.9, 114.1, 114.7, 125.4, 148.5, 149.8; IR (KBr) 3259.03, 3250.87 (C≡CH), 
2969.89, 2938.99, 2843.36, 1596.96, 1579.07, 1510.33, 1452.19, 1446.01, 1407.53, 1323.65, 
1262.34, 1239.51, 1151.68, 1137.43, 1025.01 cm
-1
; HRMS (EI) calculated for C10H10O2 
[M]
+
: 162.0681, found: 162.0681. 
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2.3.2.5 Copper(I) (3,4-dimethoxyphenyl)ethyne (270)
1
 
 
 
 
In a 1 L conical flask, CuSO4.5H2O (7.49 g, 30.0 mmol, 1 equiv) was dissolved in NH4OH 
(30 mL, 28% (aq)) at room temperature and allowed to stir under a high flow of N2 for 5 min. 
Deionised H2O (120 mL) was added followed by NH2OH.HCl (5.59 g, 80.4 mmol, 
2.68 equiv). The dark blue solution then turned light blue and a mild effervescence was 
observed. This is thought to be due to the oxidation state of the Cu species changing from 2
+
 
to 1
+
. The light blue solution was cooled to 0
o
C (ice/H2O) and a solution of 269 (4.87 g, 
30 mmol) in THF (27 mL) and absolute EtOH (27 mL) was added slowly. A bright yellow 
solid formed immediately and was filtered off. The yellow solid was washed with H2O (5 × 
50 mL), EtOH (5 × 50 mL) and Et2O (5 × 50 mL) before being dried overnight (14 to 
16 hours) at 65
o
C in a vacuum oven (10 mmHg) to obtain 6.2 g (91%) of 270 as a dark 
yellow-orange solid. This cuprous acetylide is stable for over a year when stored in the 
refrigerator (3 – 5oC) in a tightly sealed vial. 
 
Mp. = 233 – 234 oC, IR (KBr) 2990.83, 2959.05, 2926.95, 2829.87, 1633.96, 1594.28, 
1578.25, 1508.40, 1462.06, 1436.18, 1406.14, 1322.32, 1265.96, 1237.60, 1137.45, 
1026.87 cm
-1
. 
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2.3.2.6 Ethyl (2E)-3-[2-(3,4-dimethoxyphenyl)-7-methoxy-1-benzofuran-4-yl]prop-2-
enoate (279)
2
 
 
 
 
A 500 mL, oven-dried, three-necked RBF was equipped with a reflux condenser topped with 
a gas inlet tube, a rubber suba-seal, a glass stopper and a large, oval shaped magnetic stir bar. 
The whole apparatus was flame-dried and allowed to cool under N2. Freshly distilled pyridine 
(107 mL) was added and degassed with N2 for 1 hour. 270 (4.49 g, 20 mmol, 1 equiv) was 
added and a viscous bright yellow suspension was obtained. In a separate, flame-dried 
250 mL Schlenk flask a solution of 273 (6.02 g, 20 mmol) in freshly distilled, degassed 
pyridine (53 mL) was prepared under N2 and transferred via cannula to the above suspension. 
The Schlenk flask and cannula were rinsed with additional distilled, degassed pyridine 
(5 mL) and the final reaction mixture was set to reflux at 130
o
C with vigorous stirring for 
20 hours. The dark brown solution was then allowed to cool to room temperature before the 
pyridine was evaporated. The resulting dark brown residue was then dissolved in CHCl3 
(230 mL) and deionised H2O (80 mL) was added. The biphasic mixture was filtered through a 
Büchner funnel and the layers were separated. The aqueous layer was extracted again with 
CHCl3 (2 × 200 mL) and the combined organic layers were washed with deionised H2O (2 × 
80 mL), dried over MgSO4, filtered through Celite and evaporated to obtain 14.2 g of crude 
material. 
 
With the crude product still highly contaminated with Cu salts and residues it was found best 
to conduct the purification over three steps. First the dark residue was subjected to FCC 
(SiO2, 2:1 EtOAc/Hexane) on a short column to remove the black/brown band to provide 
6.4 g of a mixture of 279 and diyne by-product 280. This mixture was subjected to a second 
round of FCC (SiO2, CH2Cl2 then EtOAc) where 0.8 g (12%) of 280 was eluted first with 
CH2Cl2 and 4.57 g of 279 eluted second with EtOAc. This sample of 279 was recrystallised 
from EtOAc to afford 2.9 g (51%) of pure 279. 
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Ethyl (2E)-3-[2-(3,4-dimethoxyphenyl)-7-methoxy-1-benzofuran-4-yl]prop-2-enoate 
(279) 
 
Mp. = 144 – 145oC; 1H NMR (300 MHz, CDCl3) δ 1.38 (3H, t, J = 7.2 Hz, CH3CH2), 3.96 
(3H, s, OCH3), 4.03 (3H, s, OCH3), 4.09 (3H, s, OCH3), 4.31 (2H, q, J = 7.2 Hz, CH2CH3), 
6.48 (1H, d, J = 16.0 Hz, C=CHCO2Et), 6.81 (1H, d, J = 8.5 Hz, ArH), 6.96 (1H, d, J = 
8.6 Hz, ArH), 7.20 (1H, s, ArH), 7.40 (2H, m, ArH), 7.53 (1H, dd, J = 8.5, 1.8 Hz, ArH), 
7.94 (1H, d, J = 16.3 Hz, ArHC=C); 
13
C NMR (75 MHz, CDCl3) δ 14.3 (CH3CH2), 55.8 
(OCH3), 56.0 (2 × OCH3), 60.2 (CH2CH3), 99.0, 106.4, 108.0, 111.1, 116.1, 118.2, 119.8, 
122.6, 124.8, 130.4, 142.3, 143.5, 146.5, 149.1, 149.8, 157.2, 167.4 (CO2Et); IR (KBr) 
2984.83, 2932.52, 2906.20, 2837.30, 1700.61, 1614.74, 1578.29, 1516.78, 1506.08, 1464.76, 
1406.47, 1260.50, 1217.54, 1173.39, 1141.17, 1097.68, 1046.61, 1024.89, 970.71; HRMS 
(EI) calculated for C22H22O6 [M]
+
 382.1416, found 382.1418. 
 
4-[4-(3,4-Dimethoxyphenyl)buta-1,3-diyn-1-yl]-1,2-dimethoxybenzene (280) 
 
Mp. = 187 – 188oC; 1H NMR (300 MHz, CDCl3) δ 3.89 (6H, s, 2 × OCH3), 3.91 (6H, s, 2 × 
OCH3), 6.82 (2H, d, J = 8.4 Hz, 2 × ArH), 7.02 (2H, d, J = 2.0 Hz, 2 × ArH), 7.15 (2H, dd, J 
= 8.6, 2.0, Hz, 2 × ArH); 
13
C NMR (75 MHz, CDCl3) δ 55.8 (4 × OCH3), 77.7 (2 × ArC≡C), 
81.4 (2 × ArC≡C), 110.9 (2 × ArC), 113.7 (2 × ArC), 114.6 (2 × ArC), 126.0 (2 × ArC), 
148.5 (2 × ArC), 150.2 (2 × ArCOCH3); IR (KBr) 2979.79, 2955.15, 2933.07, 2844.47, 
2142.99 (C≡C), 1593.39, 1572.27, 1508.49, 1444.93, 1320.93, 1262.72, 1229.89, 1176.57, 
1138.03, 1018.78 cm
-1
; HRMS (EI) calculated for C20H18O4 [M]
+
: 322.1205, found: 
322.1274. 
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2.3.2.7 (2E)-3-[2-(3,4-Dimethoxyphenyl)-7-methoxy-1-benzofuran-4-yl]prop-2-enoic acid 
(281) 
 
 
  
To a stirred solution of 279 (2.00 g, 5.23 mmol) in THF/H2O (110 mL, 5:1) under N2 was 
added an aqueous solution of LiOH (26.15 mL, 1 M (aq)). The biphasic mixture was then 
heated to 70
o
C and stirred at this temperature for 7 hours. Deionised H2O (200 mL) and 
EtOAc (100 mL) were added and the layers were separated. The EtOAc layer was discarded 
and the pH of the aqueous phase was adjusted to 1 with dilute HCl (6 M). The free carboxylic 
acid then precipitated and was filtered off on a glass frit funnel, washed with Et2O (2 × 
100 mL) and dried in vacuo to liberate 1.5 g (83%) of 281 as a bright yellow solid. This 
product was sufficiently pure for the next step but could be recrystallised from a small 
volume of THF at room temperature. 
 
Mp. = 250 – 251oC; 1H NMR (300 MHz, d6-DMSO) δ 3.82 (3H, s, OCH3), 3.89 (3H, s, 
OCH3), 4.01 (3H, s, OCH3), 6.57 (1H, d, J = 16.1 Hz, C=CHCO2H), 6.95 (1H, d, J = 8.5 Hz, 
ArH), 7.07 (1H, d, J = 8.1 Hz, ArH), 7.55 (3H, m, ArH), 7.79 (1H, s, ArH), 7.85 (1H, d, J = 
16.1 Hz, ArHC=C), 12.33 (1H, br s, CO2H); 
13
C NMR (75 MHz, d6-DMSO) δ 55.6 (OCH3), 
55.8 (OCH3), 56.0 (OCH3), 99.9, 107.1, 108.5, 111.9, 117.3, 117.8, 119.5, 122.1, 125.1, 
130.2, 141.5, 142.8, 146.2, 149.1, 149.9, 156.8, 168.4 (CO2H); IR (KBr) 3434.77, 2999.44, 
2967.28, 2939.72, 2840.48, 2590.53, 1665.44, 1609.03, 1516.72, 1499.59, 1405.67, 1283.58, 
1258.88, 1183.40, 1140.84, 1102.83, 1026.77, 972.69 cm
-1
; HRMS (ESI) calculated for 
C20H17O6 [M – H]
-
: 353.1025, found: 353.1029 
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2.3.2.8 Ethyl hydrogen malonate
18
 (262) 
 
Ethyl potassium malonate (282) 
 
 
 
In a 5 L, three-necked RBF equipped with a condenser, dropping funnel and mechanical 
stirrer was placed anhydrous diethyl malonate (400 g, 2.5 mol) followed by absolute EtOH 
(1600 mL). To this solution was added a second solution of KOH (140 g, 2.5 mol, 1 equiv) in 
absolute EtOH (1600 mL) over a period of 1 hour. During the addition a white crystalline 
precipitate formed. After stirring for an additional 3 hours and standing overnight the mixture 
was heated to boiling and the solution was hot filtered to remove dipotassium malonate. 
Upon cooling of the filtrate, 282 crystallised, was filtered off and washed with a small 
amount of cold Et2O and dried in vacuo. Concentration of the mother liquor yielded another 
crop of crystals. The total yield of 282 was 338.7 g (80%), which was obtained as glistening 
white flakes. 
 
Ethyl hydrogen malonate (262) 
 
 
 
282 (130 g, 0.76 mol) was dissolved in deionised H2O (73 mL) at room temperature. The 
resulting homogenous solution was then cooled to 0
o
C (ice/H2O). Concentrated HCl (67 mL, 
35%, aq) was then added dropwise to the chilled solution over a period of 1 hour. The 
ice/H2O bath was then removed and the reaction mixture was allowed to warm to room 
temperature. The mixture was then extracted with Et2O (5 × 100 mL) and the combined 
ethereal layers were washed with brine (100 mL), dried over MgSO4, filtered and evaporated. 
The resulting residue was then dried under high-vacuum (≤ 0.2 mmHg) for 3 hours to yield 
101 g (≥ 99%) of 262 as a clear liquid. 
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1
H NMR (300 MHz, d6-DMSO) δ 1.18 (3H, t, J = 7.2 Hz, CH2CH3), 3.35 (2H, s, 
O2CCH2CO2), 4.09 (2H, q, J = 7.2 Hz, CH2CH3); 
13
C NMR (75 MHz, d6-DMSO) δ 14.1 
(CH2CH3), 41.7 (O2CCH2CO2), 167.1, 168.3; IR (neat NaCl plates) 3582.92, 3506.18, 
3194.31, 2988.47, 2945.64, 2670.63, 1737.06, 1468.47, 1446.82, 1415.67, 1373.25, 1326.96, 
1204.41, 1158.95, 1098.01, 1030.80 cm
-1
; LRMS (ESI) [M-H]
-
 131 m/z. 
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3. Asymmetric synthesis of a (+)-Danshensu derivative 
 
3.1 Introduction 
 
Of the Danshen polyphenols that possess the (+)-Danshensu moiety, only two have been 
prepared via total synthesis. Hence there is a limited number of known (+)-Danshensu 
syntheses. Therefore, an intermediate goal for this project was to study the preparation of the 
(+)-Danshensu motif and develop a procedure that could be applied to large scale preparation 
of the critical intermediate.  
 
Investigation into the first total synthesis of (+)-Lithospermic acid revealed that (+)-
Danshensu was obtained from commercially available (+)-Rosmarinic acid by controlled 
chemical manipulation and degradation.
1
 As this method of preparation was encompassed by 
limitations including scale and overall efficiency, the need for a new type of flexible 
methodology is demonstrated as this synthesis drastically reduces the possibility for the 
preparation of danshensu analogues, restricting biological evaluation and targeting of 
different therapeutic properties. 
 
3.2 Results & Discussion 
 
3.2.1 MacMillan’s α-oxyamination of aldehyde 283 
 
Upon first examination of the structure of (+)-Danshensu it was proposed that the chiral 
centre present at C2 could be formed by an asymmetric α-hydroxylation of saturated 
aldehyde precursor 283 (Scheme 56). The resulting α-hydroxy aldehyde could then be readily 
oxidised to the carboxylic acid whereby the carboxyl functional group would be protected to 
allow for selective attack at the C2 hydroxyl.  
 
 
Scheme 56 Retrosynthesis A of (+)-Danshensu moiety 63 
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A new protocol that was recently developed by MacMillan and co-workers
2
 consists of a 
proline catalysed α-oxyamination of aldehydes with nitrosobenzene (refer to Chapter 1, 
section 1.2.2). As this reaction appeared simple and offered high degrees of asymmetric 
induction it seemed to be the most suitable type of oxidation for the desired transformation as 
the aminoxyaldehyde product could be easily converted to the corresponding hydroxyl 
product by catalytic cleavage. Even though the typical application of this chemistry is to the 
synthesis of chiral 1,2-diols it was thought that the reaction could be stopped after the 
nitrosobenzene insertion to obtain the α-substituted aldehyde product.   
 
 
Scheme 57 Synthesis of saturated aldehyde 283 
 
To attempt this transformation saturated aldehyde 283 had to be prepared as it was not 
commercially available at the time. The chosen synthetic path was to start with 4-allyl-1,2-
dimethoxybenzene (284) and conduct an oxidation across allyl double bond to form 
cinnamaldehyde 285 followed by a selective reduction of the alkene to form the desired 
saturated aldehyde (Scheme 57). Cinnamaldehyde 285 was prepared according to a 
procedure by Iliefski et al.
3
 using DDQ as the oxidant to afford 285 in 81% yield after FCC. 
Chemoselective reduction of the alkene was then accomplished by modification of a method 
Chapter 3   
Page | 156  
 
by Mori et al.
4
 where alkenes and acetylenes can be selectively reduced under catalytic 
conditions in the presence of diphenylsulfide (Ph2S). The standard conditions employed by 
Mori et al.
4
 required anhydrous MeOH, 10% Pd/C as the catalyst and only 0.01 equivalents 
of Ph2S. Using these conditions resulted in complete reduction of the alkene moiety but the 
saturated aldehyde was converted to the more stable acetal (286) under the methanolic 
conditions. Switching anhydrous MeOH for THF gave a mixture of two predominant 
compounds (287 & 288) resulting from over-reduction of the aldehyde. Exchanging THF for 
anhydrous EtOAc afforded a crude mixture with saturated aldehyde 283 being the major 
product. Increasing the amount of Ph2S to 0.1 equivalents improved the yield for aldehyde 
283 which was isolated by FCC in 50% yield. In an attempt to improve this yield a different 
type of reduction was attempted whereby NaBH4 is used with catalytic amounts of 
RuCl3.H2O to effect chemoselective reduction of functionalised alkenes. This catalytic 
system proved incompatible with the cinnamaldehyde substrate and a complex mixture of 
products was obtained. 
 
With a sufficient quantity of 283 in hand experimentation with MacMillan‟s α-oxyamination 
could commence. At the time this novel chemistry appeared in the literature there were three 
different publications, from three different research groups all claiming different reaction 
conditions for the same type of transformation. This made choosing the appropriate 
conditions a complex task. The original publication by Zhong
5
 stated that when the reaction 
was conducted at room temperature with DMSO as the solvent and 20 mol% of L-proline 
used with the aldehyde component in slight excess (1.2 equivalents) the nitrosobenzene 
insertion was complete in 10 to 20 minutes. Unfortunately the yield of the isolated aldehyde 
was less than 50%. Zhong
5
 circumvented this issue by isolating the primary alcohol after 
NaBH4 reduction thereby preserving the desired chiral centre. In the second publication by 
MacMillan and co-workers
2
 the optimum conditions for the asymmetric α-oxyamination were 
to conduct the reaction at 4
o
C in CHCl3 with 2 mol% L-proline, 2 equivalents of aldehyde 
and 1 equivalent of nitrosobenzene. Using these conditions the nitrosobenzene insertion could 
be completed in 2 to 4 hours with yields of ≥ 80% for the α-aminoxyaldehyde and ee values 
of ≥ 98% for the (R) enantiomer. In a third publication by Hayashi et al.6 it was determined 
that CH3CN proved superior to CHCl3 as CH3CN allowed the reaction to proceed at a much 
lower temperature (-20
o
C) thereby reducing the possibility of the homo-dimerisation of 
nitrosobenzene which is known to proceed at 0
o
C and preventing self aldol condensations of 
the aldehyde. Therefore, the optimum conditions for the nitrosobenzene insertion were to use 
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CH3CN as the solvent, conduct the reaction at -20
o
C with 30 mol% of L-proline, 3 
equivalents of aldehyde and 1 equivalent of nitrosobenzene. Due to the volatility of the 
aminoxy aldehydes they could not be successfully isolated so no isolated yields for the 
aldehyde products were published. However, Hayashi et al.
6
 mentioned in their discussion 
that „good yields and excellent enantioselectivities‟ were obtained for the majority of their 
substrates which is reflected in their data for the isolated alcohols.  
 
 
Scheme 58 Attempted MacMillan α-oxyamination of aldehyde 283 
 
After taking into consideration each of these reports for the organocatalytic transformation it 
was decided to start with the optimised conditions recorded by Hayashi et al.
6
 as the 
temperature at which the reaction was conducted (-20
o
C) seemed the most appealing as it 
would prevent the majority of side reactions that are known to occur. The organocatalytic α-
oxyamination was conducted in an aerobic atmosphere since it was noted by MacMillan and 
co-workers
2
 that conducting the reaction under inert conditions had little effect on the yield 
and degree of enantioselectivity. Initial experiments were conducted by adding L-proline to a 
stirred solution of 283 and nitrosobenzene in analytical grade CH3CN at -20
o
C (Scheme 58). 
The green solution was stirred at this temperature in a cooling bath for 1 hour before it was 
transferred to a freezer (-30
o
C) and left undisturbed for 24 hours. As stated in all three 
publications the colour began to change from green to yellow over time. After aqueous 
workup the crude product was analysed by TLC to find one major spot (40% EtOAc/Hexane, 
Rf = 0.26) and a faint spot corresponding to 283. The major spot was isolated by column 
chromatography, analysed and was determined to be a by-product resulting from the desired 
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α-aminoxyaldehyde (289) undergoing an aldol addition with 283. The desired free α-
aminoxyaldehyde was not found.  
 
The reaction was repeated with distilled CH3CN but the same products were observed on the 
TLC plate after aqueous workup. Changing the reaction conditions to those decribed by 
Zhong
5
 didn‟t change the outcome and the same aldol product was determined to be the 
major product by TLC and was confirmed by ESI-MS. As the aldol addition occurred at -
20
o
C in CH3CN (wet and anhydrous) and at room temperature in DMSO it was deduced that 
any other conditions would afford the same result, as the aldol product appeared to be 
forming below and above 0
o
C and both DMSO and CH3CN solvents. Therefore it was 
decided that a different approach was required. 
 
In 2012 a total synthesis of (+)-Lithospermic acid by Ghosh et al.
7
 reported that this same 
technique was used successfully for the preparation of (+)-Danshensu. Using a modification 
to the procedure developed by MacMillan and co-workers, with CHCl3 as the solvent the α-
aminooxyamination preceded at 0
o
C and the oxidised product was successfully isolated. 
Unfortunately only an overall yield was given for the final product after removal of the 
aniline group and oxidisation of the CHO. These conditions are similar to those attempted 
here but at the same time are significantly different. It therefore seems quite unlikely that this 
process would have been successful during this project.    
 
3.2.2 Sharpless Asymmetric Dihydroxylation (AD) reaction with cinnamate 
292 
 
Following the unsuccessful oxidation of precursor 283 it was realised that the same target 
compound could be achieved in a smaller number of steps by starting from the correctly 
substituted cinnamate and oxidising the alkene moiety to either the diol or epoxide (Scheme 
59). The Sharpless asymmetric dihydroxylation of trans-cinnamates is a well-known 
technique that has been employed in many complex and distinguished total syntheses for the 
introduction of optically pure synthons, including α-hydroxy esters and diols. One example of 
the application of Sharpless‟s ADH reaction is in the total synthesis of Taxol. Where the (2R, 
3S) chiral centres present in the C13 side chain are prepared from methyl cinnamate 
following the standard procedure developed by Sharpless and co-workers where the alkene 
functionality is oxidised by K2OsO2(OH)4-(DHQ)2PHAL catalytic system (Figure 9).
8
 The 
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osmium species is in turn re-oxidised by N-methylmorpholine N-oxide (NMO) to recycle the 
reacted osmium and turnover the catalytic cycle. The use of NMO as the re-oxidant allows 
the reaction to be conducted at particularly high concentrations allowing this reaction to be 
conducted on a molar scale. OsO4 can be exchanged for the osmium salt above which is 
slightly cheaper and safer. 
 
 
Figure 9 Taxol and the retrosynthetic analysis of the C13 side chain 
 
 
Scheme 59 Retrosynthesis B of (+)-Danshensu moiety 63 
 
This reaction seemed suitable for the preparation of (+)-Danshensu given the high efficiency 
of the oxidation and relatively low cost. Even-though the oxidants, OsO4 or potassium osmate 
(VI) dihydrate (K2OsO2(OH)4) are expensive, they are only used in catalytic amounts along 
with the chiral ligand (DHQ)2PHAL making the whole operation affordable. The use of the 
chiral ligand (+)-(DHQ)2PHAL controls the regioselectivity of the oxidation furnishing a 1,2-
diol with 2R, 3S configuration when trans-cinnamates are used as the starting material 
(Figure 10).
9
 This is the correct orientation for the C2 hydroxyl in (+)-Danshensu, leaving 
the labile benzylic hydroxyl at C3 which can be removed by hydrogenation. 
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Scheme 60 Preparation of diol 62 via Shapless AD reaction 
 
 
Figure 10 Mechanism for Sharpless asymmetric dihydroxylation (ADH); NR3 = Chiral ligand 
 
As the desired cinnmate with the correct substitution pattern is not commercially available it 
was decided to start from cinnamic acid 293 and convert this to the methyl (E)-cinnamate by 
esterification with MeOH (Scheme 60). This could be accomplished by Fischer esterification 
using a catalytic amount of H2SO4 (29 mol%) to form methyl cinnamate 292 in 83% yield 
after recrystallisation from CHCl3/Hexane.
10
 Given the history of the Sharpless AD reaction 
it was not surprising to find that similar 2R,3S diols from related methyl cinnamates had been 
prepared before. In a publication by Lawrence et al.
11
 the 2R,3S diol of methyl 3,4,5-
trimethoxycinnamate had been prepared using OsO4 as the osmium source and NMO as the 
re-oxidant. Following this procedure (2R,3S) diol 62 was prepared in 27% yield after 
recrystallisation from boiling toluene. Repetition of this reaction with double the amount of 
OsO4 (0.4 mol% compared with 0.2 mol%) increased the yield of 62 to 39% after 
recrystallization from toluene. This result was consistent with that achieved by Lawrence et 
al.
11
 with similar electron rich substrates but the yield was still not practical. In an attempt to 
optimise these conditions the oxidation was repeated with 1 mol% OsO4 but no further 
improvement to the isolated yield could be achieved. Raising the reaction temperature to 
50
o
C or exchanging magnetic stirring for highly efficient ultrasonication had no effect on 
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reaction rate or yield. Throughout this period of experimentation it was noted that the 
reaction rate was decreasing; with initial reactions taking only 24 hours to final reactions 
taking up to a week. This was thought to be due to the prepared OsO4 solution (in t-BuOH) 
slowly degrading over time as the colour slowly changed from light yellow to light brown 
due to atmospheric contamination, even though it was stored in an air tight bottle under an 
inert atmosphere. 
 
At this point it was decided that perhaps a different, more stable source of osmium was 
required. Searching through the Aldrich catalogue and the literature it was discovered that 
there are AD mixes commercially available that researches had used as an efficient, cost 
effective source of osmium and the other reagents required.
12
 Unfortunately this product did 
not fit into the budget so another approach was required. There are many alternative 
methodologies that can be used for the oxidation of alkenes. A novel procedure that is 
reasonably new to the library of techniques available is a palladium (II) mediated oxidation of 
alkenes. Despite these protocols not being enantioselective they offered an alternative, simple 
approach to the oxidation of functionalised olefins which avoids the use of toxic osmium. Of 
these palladium mediated oxidation the protocol by Dong and co-workers
13
 appeared the 
most convenient as all of the materials, except for the palladium catalyst, were readily 
available. There was another contemporary procedure by Park et al.
14
 that was also 
operationally appealing but this methodology required a peracetic acid solution which was 
only available to Australia by sea freight making it exceedingly impractical. The palladium 
(II) catalyst, [Pd(dppp)(OH2)2](OTf)2 was prepared according to a procedure by Stang et 
al.
15,16
 and the oxidation was attempted with the same cinnamate prepared for the ADH 
reaction. Following the procedure developed by Dong and co-workers
13
 the reaction was 
conducted on a 0.5 mmol scale under air and closely monitored by TLC (Scheme 61). After 
stirring at 50
o
C overnight the reaction was determined to be complete and the reaction 
mixture was concentrated. The crude product was then analysed by GC/MS and again by 
TLC to reveal that a complex mixture of products formed. In the GC trace there was a major 
peak corresponding to iodobenzene, a typical by-product from the co-oxidant PhI(OAc)2, and 
a group of peaks corresponding to starting material, the diacetylated product (294) and diol 
295 resulting from incomplete acetylation after the oxidation. In an attempt to improve the 
ratio of products in favour of the oxidised compounds the reaction was conducted at room 
temperature. This made the diacetylated compound a major product, but due to high levels of 
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contaminants (iodobenzene, starting material and unknowns) the oxidised product could not 
be isolated in sufficient purity or yield. 
 
 
Scheme 61 Palladium catalysed diacetoxylation of cinnamate 292 according to Dong et al. 
 
 
Following the disappointing results observed from direct oxidation of both the aldehyde and 
cinnamate substrates it was decided that a simpler, systematic approach would provide a 
purer product without the problems associated with extensive optimisation and exotic 
reagents. 
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3.2.3 Erlenmeyer synthesis via azalactone intermediate 297 
 
After attempting the asymmetric approach and noticing that either only moderate yields of 
the desired product could be obtained or there were issues associated with selectivity and 
isolation it was determined that an efficient racemic approach could provide the desired 
product on scale due to the operational simplicity of racemic over enantioselective 
methodologies. 
 
In the first total synthesis of (±)-Danshensu by Fen et al.
17
 the core structure was prepared by 
the Erlenmeyer synthesis. The key reaction is a condensation between N-acetyl glycine and 
protocatechualdehyde to form an azlactone which can be converted to a α-hydroxy acid by a 
series of linear steps. This process was further optimised by Wong et al.
18
 and has since then 
been used by Eicher et al.
19
 in the first total synthesis of (+)-Rosmarinic acid (Refer to 
section 1.2 for further reading). As this process had already been optimised for the 
preparation of racemic danshensu and only once employed to prepare the optically active 
form it was considered that, if an efficient quantity of racemic material could be generated, a 
new procedure could be developed for the resolution step as only an ee of 85% was achieved 
by Eicher et al.
19
 leaving room for further research and development.    
 
 
Scheme 62 Model Erlenmeyer reaction 
 
Combining the knowledge from the initial publication by Fen et al.
17
 and the modifications 
by Wong et al.
18
 a model reaction was carried out with protocatechualdehyde (29) as the 
starting material as this was the reaction previously optimised (Scheme 62).  The reaction 
proceeded as stated in the literature, the only modification being the addition of extra Ac2O to 
allow for even stirring. When the reaction was complete the crude mixture was poured in cold 
water and a yellow gum separated that hardened overnight. The solid mass was then collected 
and recrystallised from boiling water to provide a second yellow oil which crystallised over 
the period of a week. The yellow crystalline product was collected and confirmed to be α-
Chapter 3   
Page | 164  
 
(acetylamino)cinnamic acid 34 via 
1
H NMR analysis and ESI-MS analysis. The reaction was 
then repeated with 3,4-dimethoxybenzaldehyde (61) which would provide the desired, 
protected danshensu derivative (Scheme 63).  The same physical characteristics were 
observed during the reaction and after 4 hours at 100
o
C the dark brown mixture was poured 
into chilled (0
o
C) water. Within 5 to 10 minutes orange crystals began to separate and collect 
on the bottom of the flask. The crystalline product was collected and recrystallised from 
boiling water as done for the model reaction. Characterisation of the recrystallised material 
by 
1
H NMR revealed that a mixture of two major compounds were present. After MS 
analysis it was deduced that azlactone 297 and α-(acetylamino)cinnamic acid 296 were the 
compounds present. This was surprising as no azlactone was detected from the model 
reaction.   
 
 
Scheme 63 Preparation of azlactone 297 and the following hydrolysis to 296 
 
It is clear that the azlactone formed from the model reaction is less stable, presumably due to 
the presence of the moderately electron withdrawing acetyl esters and therefore more easily 
hydrolysed to α-(acetylamino)cinnamic acid 34. As simple recrystallisation of azalactone 297 
was not sufficient for conversion to 296 a different procedure was sought after. Further 
reading in the literature uncovered an alternate process for azlactone hydrolysis where 
acetone was used as a co-solvent with deionised water to affect complete hydrolysis of the 
azlactone ring.
18
 The Erlenmeyer reaction between protected benzaldehyde 61 and N-
acetylglycine was repeated and azlactone 297 was isolated by recrystallization from a 
CHCl3/hexane mixture as an intensely coloured, orange crystalline solid in 38% yield. Pure 
azlactone 297 was then hydrolysed in aqueous acetone where α-(acetylamino)cinnamic acid 
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296 was isolated as a white microcrystalline solid in 79% yield (Scheme 63). Analysis of this 
product via 
1H NMR confirmed the identity of this compound as α-(acetylamino)cinnamic 
acid 296 with a purity of >95%. Trace amounts of azlactone 297 were present but the 
quantity was negligible. Compared to the procedure by Wong et al.
18
 this technique did not 
require the addition of NaOAc as the isolated yield for this compound was proportional to 
that obtained with this modification. The next step consisted of an acidic hydrolysis of 
pseudo amino acid 296 to the corresponding α-hydroxycinnamic acid (298) (Scheme 64). 
This reaction proceeded as stated in the literature and cinnamic acid 298 was isolated in 90% 
yield after precipitation from the reaction mixture. The result was consistent with that 
reported by Wong et al.
18
 where only the α-hydroxycinnamic acid was observed in the 1H 
NMR with no trace of the ketone product due to keto-enol tautomerism, which was thought to 
be major product in the original publication by Fen et al.
17
 Surprisingly, only 1M HCl was 
required to achieve complete conversion unlike the 3M HCl used by Wong et al.
18
  
 
 
Scheme 64 Final three steps in the Erlenmeyer synthesis of (±)-Danshensu derivative 300 
 
With the final hydrolysis complete, the next stage of this synthetic pathway was to reduce the 
double bond in cinnamic acid 298 to provide the saturated core of (+)-Danshensu. The 
standard procedure reported by Fen et al.
17
 was to perform a Clemmensen reduction with a 
zinc-mercury amalgam in presence of dilute HCl. The same procedure was used by Wong et 
al.
18
 but toluene was added as a co-solvent which is reported to improve the isolated yield by 
decreasing the amount of the reduced compound in the aqueous phase.
20
 The zinc amalgam 
was prepared according to a procedure by Caesar
21
 and was used immediately in the 
reduction. Following the optimised procedure of Wong et al.
18
 the Clemmensen reduction 
was executed and after acid-base extraction from the reaction mixture the reduced product 
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(299) was isolated in 38% yield. This is approximately half of the yield quoted by Wong et 
al.
18
  
 
Critical points to remember when conducting a Clemmensen reduction are to ensure the 
surface of the zinc is oxide free before and after amalgamation and that an even 
coating/distribution of mercury is achieved. The best technique to use when working with 
metals to ensure a homogenous mixture is ultra-sonication. To improve the quality of the 
amalgam, zinc dust was used and washed with 3% HCl before amalgamation. After addition 
of the mercuric chloride solution to the zinc suspension the heterogenous mixture was 
sonicated for 10 to 15 minutes. The reduction was repeated with this amalgam but the yield 
of 299 only increased to 46%. During these two attempts it was noted that the reaction was 
slow to start but once it did the reaction became exothermic and self-driven. Therefore the 
amalgam was prepared as before and added to the toluene solution followed by dilute HCl. 
The reaction mixture was then briefly sonicated and the suspension began to reflux without 
external heating. The vessel was quickly transferred to a heating bath and set to maintain 
reflux for 6 hours. Isolation of the product by acid-base extraction followed by 
recrystallisation from boiling toluene afforded the target compound (299) as a white, 
amorphous solid in 72% yield. Using this procedure increased the yield of 299 by almost 
30%. This is thought to be due to a highly active amalgam forming in the reaction mixture 
during the second sonication as the HCl added for the Clemmensen reduction would also 
remove any oxides that had formed during the addition of the amalgam. It was noted by 
Wong and co-workers
18
 that the majority of α-hydroxy acids prepared by this route tended to 
be unstable and that due care is required. Unfortunately the same instability was observed in 
this study as when the crude material was subjected to consecutive recrystallisation from 
boiling toluene the yield would decrease by approximately 25%.  
 
To stabilise the product it was decided to prepare a sample of the more stable methyl ester. 
Due to the sensitivity of this compound it was preferred to use a mild method for direct 
esterification. After searching through the literature it was discovered that acetyl chloride 
(AcCl) is an excellent reagent for the generation of HCl in the Fischer esterification as it had 
been used for the conversion of carboxylic acids to esters in complex products. As the 
reaction was typically conducted in refluxing MeOH it was perfect for microwave synthesis 
as MeOH has one of the largest dipole moments. To test this hypothesis the reaction was 
conducted on a 1 mmol scale with 0.3 equivalents of AcCl at 70
o
C (Scheme 64). The reaction 
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was complete in less than 10 minutes (TLC) and after standard aqueous workup the product 
was isolated in 73% yield after FCC. It was proposed that the mediocre yield could be due to 
decomposition of the product under the high energy conditions. The reaction was repeated on 
a 5 mmol scale and after shortening the hold time to 5 minutes α-hydroxy ester 300 was 
isolated in 94% in pure form without having to resort to chromatography.  With both the acid 
and ester forms of (±)-danshensu in hand experimentation on the challenging resolution step 
could begin. 
 
3.2.4 Resolution by diastereomic salt formation 
 
Removal of the double bond from the core structure introduces a chiral centre at C2 forming 
the first racemic compound (299, Scheme 64). As this compound is a α-hydroxy acid it is a 
suitable substrate for optical resolution by diastereomic salt formation with two sites for salt 
formation. Following this logic, α-hydroxy ester 300 is also a suitable candidate for 
resolution by diastereomic salt formation however the salt complex would not form as readily 
due to the weak electron withdrawing properties of secondary alcohols. 
 
In a comparative study by Storz et al.
22
 where the main focus was on the process research for 
(R)-cyclohexyl lactic acid it was discovered that the phenyl lactic acid precursor could be 
resolved with a chiral amine base. The chiral amines that proved to be most suitable for the 
lactic acid moiety were (+)-dehydroabietylamine, (S)-phenylglycinol and (S)-phenylalaninol. 
Both (S)-phenylglycinol and (S)-phenylalaninol gave maximum yields for the (R)-
diastereomic salt with excellent ee values (> 99%) for the free (R)-acid after acid/base 
extraction. As (+)-danshensu has (R) configuration, as do all of the danshen polyphenols, (S)-
phenylalaninol was chosen as the first chiral auxiliary to trial as it could prepared from the 
cheap amino acid (S)-phenylalanine by simple reduction of the carboxylic acid. Of course the 
same procedure could be used to prepare (S)-phenylglycinol from the amino acid precursor 
but (S)-phenylalanine is significantly less expensive. Therefore, (S)-phenylalaninol (302) was 
prepared according to procedure by Abiko et al.
23
 where the reduction of the carboxylic acid 
was achieved by B2H6 generated in situ from NaBH4-H2SO4 reagent (Scheme 65). The 
reaction proceeded as stated in the report by Abiko et al.
23
 Extraction with EtOAc afforded 
the crude product which was recrystallised from EtOAc/hexane to afford (S)-phenylalaninol 
as white fluffy crystals in 89% yield. The structure was confirmed by NMR with an extra pair 
of multiplets appearing at ≈ 3.5 ppm in the 1H NMR corresponding to a new set of methylene 
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protons adjacent to the hydroxyl and complete disappearance of the carboxyl quaternary 
carbon signal in the 
13
C NMR.    
 
 
Scheme 65 Preparation of chiral auxiliary (S)-phenylalaninol (302) 
 
 
Scheme 66 Attempted resolution of 299 by diastereomic salt formation with (S)-phenylalaninol (302) 
 
Using the optimised conditions developed by Storz et al.
23
 the resolution of α-hydroxy acid 
299 with chiral amine (S)-phenylalaninol (302) was attempted. Following the standard 
procedure 299 and 302 were suspended in analytical grade 2-butanone and heated to effect 
dissolution (Scheme 66). After filtration, the mother liquor was allowed to cool slowly to 
room temperature to allow for crystallisation of the (R)-diastereomic salt (304). After 2 hours 
undisturbed at room temperature, no precipitate formed. As salt 304 should precipitate out 
first the clear solution was left to stir in an attempt to induce crystallisation. After a week of 
stirring at room temperature still no salt formed. The solution was then concentrated and left 
cool under the same conditions but no salt formed. With still no sign of salt formation it was 
thought that perhaps more energy was required to initiate complexation. In the absence of a 
seed crystal, this was the last option, so the clear solution was set to reflux for 8 hours. The 
mixture was then allowed to slowly cool to room temperature and was placed in a 
refrigerator. After more than a month of refrigeration there was no change to the clear 
solution and it was decided to try a different approach. 
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As diastereomic salt resolution is the most popular technique used in industry for the 
separation of racemic mixtures it was decided that once the appropriate auxiliary was 
discovered the resolution would proceed with ease on a laboratory scale, where the conditions 
can be easily manipulated. Investigation into other types of resolutions revealed a series of 
reports by Fogassy and co-workers
24-28
 that described the application of O,O‟-
dibenzoyltartaric acid derivatives to the resolution of racemic alcohols. One publication from 
the set that was of particular interest included a procedure describing a coordination-mediated 
resolution where the calcium salt of tartaric acid derivative 309 (Scheme 67) was prepared in 
situ to create a coordinating group to assist with crystallisation and the discrimination 
between enantiomers.
29
  
 
Fogassy and co-workers
29
 then used these complexes for the resolution of racemic carboxylic 
acids but noticed that only small molecular weight acids could be successfully resolved due 
to the formation of crowded salt mixtures resulting from hydrogen bonding between 
complexes due to coordinated water. To bypass this issue Fogassy and co-workers
29
 proposed 
that their methodology could be applied to resolution of α-hydroxy esters as this would 
replace salt formation with coordination bonds creating a simpler complex thereby allowing 
for the resolution of larger compounds increasing the scope of this resolution. When this 
protocol was tested it was observed that the acidic calcium ion readily coordinates with α-
hydroxy esters to form a crystalline complex that precipitates out of solution following the 
addition of an anti-solvent.  
 
As the general approach to the optical resolution of α-hydroxy acids with a chiral base was 
unsuccessful it was considered that α-hydroxy ester 300 (Scheme 64) could be resolved using 
this technique. There is very little information in the literature on the preparation of these 
tartaric acid derivatives. The typical approach to the preparation of (2R, 3R)-O,O‟-
dibenzoyltartaric acid derivatives (the most common enantiomer used in resolution) is to 
combine L-(+)-tartaric acid with a three molar excess of neat benzoyl chloride and heat by 
conventional heating for three hours.
30
 The use of an extra equivalent of benzoyl chloride 
results in dehydration during benzoylation and an anhydride product is obtained. As the 
whole operation would consist of two individual steps it was decided to develop a microwave 
technique for the preparation of these derivatives that would allow for their rapid preparation 
within the laboratory (Scheme 67). 
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Scheme 67 Microwave enchanced synthesis of chiral tartaric acid derivatives 309 & 310 
 
Initial experiments were conducted in sealed vessel. However it was observed that once the 
reaction mixture reached boiling point the pressure inside the vessel went beyond the 
limitations of the microwave, so as a safety precaution the temperature was dropped to 80
o
C. 
At these settings the reaction still progressed but a large portion of the tartaric acid remained 
unreacted. Eventually it was realised that the reaction was progressing at an incredibly fast 
rate and the HCl gas by-product was being generated faster than it could be released from the 
microwave vial, which would be expected for a neat reaction. When the closed vial was 
switched to open vessel and the temperature increased to 150
o
C the reaction was complete in 
5 minutes and a solid mass formed on the bottom of the flask (Scheme 67). The product was 
removed from the flask and washed with cold benzene to remove the benzoic acid by-product 
and trace amounts of unreacted tartaric acid as stated by Butler et al.
31
 in their improved 
procedure. However this was not sufficient and the anhydride product was still highly 
contaminated. Recrystallisation from boiling xylene liberated anhydride 307 as fine white 
crystals in 59% yield free from any contaminants.  Even-though the recrystallization lowered 
the yield by 20% it was essential to ensure a pure product at this stage as if the benzoic acid 
remained after the hydrolysis it would be difficult to separate from the target diacid. This 
reaction could be conducted on a 60 mmol scale meaning over 10 g of material could be 
prepared in a less than an hour. The same was noted for opposite enantiomer (308, Scheme 
67). 
 
The improved procedure by Butler et al.
31
 stated that anhydride 307 could be converted to 
diacid 309 by boiling with H2O. It was noted that when 
1
H NMR spectra of anhydride 307 
was recorded in d6-DMSO (Figure 11) a second singlet suspected of originating from diacid 
309 appears at δ 6.70. This evidence suggested that anhydride 307 could be readily 
hydrolysed back to the diacid at room temperature, but this was not the case.  
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Figure 11 1H NMR (300 MHz, d6-DMSO) of a mixture of Anhydride 307 and diacid 309, displaying the integrals for the 
methylene (CH2) protons 
 
When a suspension of 307 in H2O was irradiated at 110
o
C for 5 minutes 309 was isolated in 
23% yield after recrystallisation from benzene. With the observation that 307 appeared to 
hydrolysed when it came into contact with any H2O, this finding was surprising to say the 
least. Fogassy and co-workers
28
 suggested using a dilute acid solution to effect hydrolysis. 
Therefore a precise amount of concentrated HCl was added to the reaction mixture and after 
30 minutes of irradiation at 80
o
C, 309 could be isolated in 98% yield in pure form without 
recrystallisation (Scheme 67). Overall (2R, 3R)-O,O‟-dibenzoyltartaric acid (309) was 
prepared in a total of two linear steps with an overall yield of 58%, a similar overall yield of 
57% was noted for the opposite enantiomer (310, Scheme 67)  This is similar to that obtained 
with conventional heating but the same result was achieved in a fraction of the time due to 
the unique heating characteristics of microwave chemistry.  
 
To test the solubility of the complex formed between (2R, 3R)-O,O‟-dibenzoyltartaric acid 
and Ca
2+
 (311), the latter was prepared by adding CaO to an EtOH solution of 309 to form a 
suspension which was heated to reflux (Scheme 68). After 10 to 15 minutes of heating, the 
suspension was filtered and the Ca
2+
 complex was isolated by partial evaporation of the 
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mother liquor in quantitative yield. This proved that complex 311 is soluble in boiling EtOH 
and confirms the conditions reported by Fogassy and co-workers
28
. Following this 
conformation, the resolution experiments were carried out by generating complex 311 in situ 
and adding racemic α-hydroxy ester 300 to the hot EtOH solution. The next step was to 
isolate the diastereomic complex by crystallisation from the EtOH solution, but no technique 
attempted resulted in either precipitation or crystallisation. Concentration of the EtOH 
solution afforded a light yellow oil which could not be crystallised with any of the solvents 
suggested by Fogassy and co-workers
28
. Aqueous EtOH formed a cloudy solution but after an 
extended period of refrigeration, no crystallisation occurred (Scheme 68). The fact that an oil 
instead of a white solid was obtained after evaporation suggests that multiple organic species 
were present but due to the complex sample matrix they could be separated by crystallisation.  
 
 
Scheme 68 Attempted resolution of 300 by diastereomic salt formation with tartartic acid derivative 309 
 
A possible explanation to why no or limited complexation occurred could be attributed to the 
methyl ethers in α-hydroxy 300 interfering with the preferential co-ordination of the 
secondary alcohol by binding to the calcium ion before or after thereby creating a complex 
mixture of diastereomers that could not be resolved. This reasoning could also explain why 
no diastereomic salt formed between α-hydroxy acid 299 and (S)-phenylalaninol as the same 
methyl ethers present could also interfere with the desired interaction between the α-hydroxy 
acid moiety and amine and alcohol functional groups (Scheme 66).   
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While it should be possible to resolve either of these compounds with the appropriate chiral 
acid or base auxiliary it was simply taking too long. While this procedure would make the 
synthesis highly efficient there is an infinite number of possible auxiliaries and to trial each 
scenario with different solvent systems would be incredibly time consuming and tedious. For 
these reasons was decided to abandon this idea and discover a new route. After pursuing this 
route stock quantities of both compounds was starting to dissipate and while the quantities of 
racemate 300 generated by the Erlenmeyer synthesis were sufficient for preliminary studies 
on the resolution they were not satisfactory to allow for a practical quantity of the single 
enantiomers obtained after the optimisation was complete. A decision had to be made; repeat 
the Erlenmeyer scheme in the hope a higher overall yield can be achieved or propose a new 
strategy.  
     
3.2.5 Application of Darzens glycidic ester synthesis to the preparation of 
(+)-Danshensu derivative 63 
 
Another possible route to (+)-danshensu that was yet to be explored was to obtain α-hydroxy 
ester 300 from the epoxide precursor (314, Scheme 69). While the internal epoxide (314) 
could be prepared either enantioselectively or in racemic form by oxidation of the cinnamate 
synthon (292) it was suspected that the oxidation would only proceed in low yield. From 
previous experiments involving oxidation of related functionalised alkenes only limited 
quantities of the oxidised product could be obtained or the product was unstable, as seen in 
the Sharpless AD of 292. To produce the α-hydroxy ester the epoxide could be either reduced 
or subjected to nucleophilic attack by an appropriate nucleophile. 
 
 
Scheme 69 Retrosynthesis of (±)-Danshensu motif 300 
 
 Upon reviewing the literature it was discovered that recently Ju et al.
32
 prepared a library of 
(±)-danshensu derivatives via the epoxide route (see section 1.2.1 for further details). Further 
reading revealed that a similar methodology was used by Kelley et al.
33
 where a (+)-
danshensu standard was prepared by hydrogenation of epoxide 314 followed by resolution 
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with (+)-α-methylbenzylamine the purpose being to assist in the characterisation of (+)-
Lithospermic acid. 
 
In both cases the internal expoxide (314) was obtained by Darzens condensation, otherwise 
known as Darzens glycidic ester condensation or synthesis (Scheme 70).  Darzens 
condensation is a well-known technique that has existed for just over a century since it was 
discovered by the French organic chemist Auguste George Darzens in 1904.
34
 The typical 
starting materials for the condensation are either an aromatic aldehyde or ketone and an alkyl 
ester of 2-chloroacetic acid. The alkyl esters of 2-chloroacetic acid can be readily exchanged 
for the related amide, ketone or even 2-phenyl substituted α-chloro synthons allowing for the 
construction of a variety of functionalised internal epoxides. If the halogen present within the 
alkyl α-haloacetate is replaced with either an iodine or bromine atom β-keto esters are 
obtained after the condensation due to the preferential displacement of the halogen during the 
SN2 mechanism. These observations outline the high level of versatility and functional group 
tolerance for the Darzens condensation and how one can generate a broad selection of 
synthetically appealing substrates for chemical investigation.  
 
 
Scheme 70 Mechanism of Darzen's condensation 
 
The reaction proceeds by generating an anion at the methylene carbon of the α-chloroacetate 
species with strong bases such as NaOEt, NaNH2 or t-BuOK (:B, Scheme 70). Potassium 
carbonate (K2CO3) can be used when 2-phenyl substituted α-chloroacetates are employed as 
the α-haloester. The anion then attacks the electron deficient carbon of the carbonyl 
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constituent to form an aldol addition intermediate (A). A second mole equivalent of base then 
deprotonates the secondary alcohol in intermediate A which undergoes intramolecular 
cyclisation to produce α,β-epoxy esters of type B in step, via the SN2 mechanism. It is 
possible for the reaction to proceed in the opposite direction where secondary alcohol A is 
protonated and leaves the intermediate as water to form a second anion which rearranges to a 
α-chlorocinnamate by-product (C). Variations of this mechanism and the mechanism for the 
many modifications to Darzens condensation are discussed at great length in a review by 
Ballester.
35
    
 
With a theoretical understanding of Darzens condensation it was decided to investigate the 
conditions of Ju et al.
32
 for the synthesis of epoxide 314.   The procedure stated to use ethyl 
chloroacetate as the α-halo ester and to employ NaOMe as the base. The reaction was 
conducted by adding a dichloromethane (CH2Cl2) solution of ethyl 2-chloroacetate and the 
aromatic aldehyde to a chilled solution of NaOMe in MeOH (Scheme 71). After quenching 
the reaction mixture with H2O and isolating the crude product by extraction a yellow oil was 
obtained. Attempts to isolate the product by recrystallisation proved futile as only a small 
percentage of the theoretical yield (< 5%) was isolated when it was known that all the starting 
material had been consumed (TLC).  As the product was known to be a volatile solid it was 
speculated that the pure compound could be isolated via distillation at reduced pressure as 
had been done previously for similar α,β-epoxy esters.36 Unfortunately the conditions 
required to achieve distillation of the sensitive epoxide could not be achieved and all material 
was lost due to polymerisation. 
 
 
Scheme 71 Darzens condensation according to Ju et al. 
 
The fact that 314 could not be isolated by crystallisation suggests that it was not the 
predominant product present in the crude mixture. It is proposed that during reaction not only 
does the NaOMe act as base to catalyse the reaction but it also trans-esterifies the ethyl ester 
of the product (or α-halo ester) with MeOH to form a mixture of two alkyl α,β-epoxy esters. 
It appears this result was intended by Ju et al.
32
 but in this study having the two reactions 
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occurring simultaneously adversely affected the isolated yield and possibly altered the 
reaction kinetics to produce other byproducts. With this in mind the reaction was repeated 
with NaOEt in EtOH and ethyl 2-chloroacetate.  
 
Scheme 72 Second attempt at Darzen's condensation 
 
Following the same procedure a second oil was obtained after extraction from the aqueous 
phase. Upon analysis of the crude material it was noted that desired epoxide (315, Scheme 
72) was the major product by GC and 
1
H NMR but small peaks corresponding to the starting 
aldehyde and byproducts were also present. As this product was the ethyl ester it was 
suspected of being more volatile than its methyl analogue so a second attempt was made to 
isolate one of these compounds by distillation. Initially this distillation looked promising, as 
once the still pot was heated above 100
o
C vapours started to travel up to the still head. 
Unfortunately, after approximately half an hour of holding at this temperature no distillate 
formed in the receiving flask. After this time the crude mixture began to discolour and 
polymerised (confirmed by 
1
H NMR). Even-though both these products could have been 
isolated by chromatography this would be detrimental to the efficiency of the process and 
was to be used only as a last resort. 
 
At this point of the investigation it was proposed that, since it was known from the report by 
Kelley et al.
33
 the α,β-epoxy methyl ester was a solid, the synthesis should be optimised for 
the preparation of this compound to aid the isolation step. The article published by Kelley et 
al.
33
 refers to a paper by Ban and Oishi
37
 for the preparation of the α,β-epoxy ester 314 used 
in their synthesis of (+)-danshensu. This procedure suggested using methyl 2-chloroacetate as 
the α-halo ester presumably to prevent any side reactions similar to those discussed above. 
This procedure uses an excess of the α-haloester theoretically to prevent self condensation 
during the aldol addition to the aromatic aldehyde. However this could be premature as the 
anion generated from any α-halo ester has a strong nucleophilic character owing to its 
resonance structures making it very unlikely to condense with it-self. Given that this 
particular alkyl ester of 2-chloroacetic acid was only available to Australia by ship in terms of 
efficiency it made sense to prepare it.  
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Scheme 73 Darzens condensation with methyl chloroacetate (317) according to Ban and Oishi 
 
It was predicted that methyl 2-chloroacetate (317) could be prepared by direct esterification 
of 2-chloroacetic acid (316) with MeOH. After searching through the literature a Romanian 
patent was found that described a procedure for the preparation of simple alkyl esters of 2-
chloroacetic acid by this route.
38
 Following this procedure methyl 2-chloroacetate (317) could 
be prepared on a molar scale and was obtained in 40% yield after distillation from the 
reaction mixture (Scheme 73). The condensation was attempted again following the 
procedure of Ban and Oishi
37
. This procedure featured a unique temperature control protocol 
and used an equivalent excess of both the α-halo ester and base, a completely different 
approach to that employed by Ju et al.
32
  Another key difference was the absence of CH2Cl2 
leaving MeOH as the sole solvent. In the absence of CH2Cl2 the reaction was carried out by 
adding a neat solution of methyl 2-chloroacetate and benzaldehyde 61 to the concentrated 
solution of NaOMe at -10
o
C, over the period of 3 hours. Performing Darzens condensation in 
this way was thought to be critical to the success of the reaction as during the addition of the 
two reactants a thick white paste formed which stopped the magnetic stirrer that had not been 
observed in previous attempts. This was consistent with the observations reported by Ban and 
Oishi
37
 and is thought to be due to the formation of sodium enolate of the carboxyl moiety. 
After the addition the temperature was raised to -5
o
C and held at this temperature for 2 hours 
before the cooling bath was removed the reaction mixture was allowed to reach room 
temperature. As the temperature rose above 0
o
C stirring became easier as the sodium enolate 
converted back to the ester. Stirring was continued for an additional 3 hour at room 
temperature before it was quenched with a cooled solution of AcOH in H2O. The product 
instantly precipitated out of solution and was collected and recrystallised from MeOH to 
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yield a pasty white solid which corresponded to approximately 80% of the theoretical yield. 
This product was analysed by GC/MS and was determined to consist of two predominant 
species in a 2:1 ratio. The major peak corresponded to α,β-epoxy ester 314 with the second to 
an unknown that was suspected to contain chlorine from the isotope pattern in the mass 
spectrum. The two products were separated by FCC where the by-product eluted first 
followed by the epoxide. Epoxide 314 required a second recrystallisation to achieve a 
practical purity reducing the overall yield to 40%. The by-product was characterised by NMR 
and was determined to be α-chlorocinnamate (319, Scheme 18) resulting from dehydration of 
the aldol intermediate (see earlier discussion for mechanism). The formation of this by-
product was not mentioned in the report by Ban and Oishi
37
 but it is known to be an 
unpreventable by-product of Darzens condensation.   
 
The yield obtained here was only half that reported by Ban and Oishi
37
. It was noted during 
the preparation of the methoxide base that the saturation point of the methanol was reached 
before all the sodium could react. This meant that the same concentration of NaOMe used by 
Ban and Oishi
37
 (20% (w/w)) could not be achieved. Additional anhydrous MeOH was added 
but the volume needed to consume the unreacted sodium was too large and small amounts of 
unreacted sodium were left in the reaction. The reaction was repeated with commercial 
NaOMe but approximately 50% of the solid remained undissolved in the same volume of 
anhydrous MeOH at room temperature. As a result, after performing the reaction following 
the same procedure the crude product consisted of mainly unreacted benzaldehyde 61.   
 
After determining the poor solubility of commercial NaOMe in anhydrous MeOH it was 
decided to resort back to generating the methoxide base. The reaction was repeated on the 
same scale with slightly more anhydrous MeOH to reduce the final concentration of fresh 
NaOMe to 18% (w/w) (Scheme 74). As the magnetic stirrer couldn‟t maintain homogenous 
stirring after precipitation of the salt a mechanical stirrer was fitted which should prevent any 
issues arising from insufficient stirring. Freshly distilled MeOH was added first followed by 
finely divided, clean sodium. With efficient stirring the formation of NaOMe proceeded 
rapidly but once the initial exotherm dissipated the evolution of H2 gas ceased and unreacted 
sodium remained. Raising the speed of the stirrer by 10% had no effect so the basic solution 
was heated to reflux and maintained at this temperature until all the sodium was reacted. The 
solution was then allowed to cool to room temperature before being cooled to -10
o
C for the 
addition of the other reagents. The reaction proceeded as before but this time an even thicker 
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suspension of the sodium salt was obtained at -10
o
C. Upon completion of the reaction and 
quenching a similar pasty white solid was obtained that corresponded to 65% of the 
theoretical yield. From this product a pure compound could be obtained after simple 
recrystallisation without having to resort to FCC and could be isolated in 49% yield.   
 
 
Scheme 74 Optimised Darzens condensation of benzaldehyde 61 with methyl chloroacetate (317) 
 
This outcome was the combined effect of using efficient stirring and achieving complete 
consumption of the sodium metal used to prepare the methoxide base. The optimised 
procedure was then up-scaled to 0.3 mol where 35 g of α,β-epoxy ester could be obtained in 
one procedure. Characterisation of α,β-epoxy ester 314 revealed trans-configuration resulting 
from the formation of the anti-aldol product after nucelophillic attack of the α-halo ester 
anion on the electron deficient carbon of the aldehyde moiety (Figure 12). Only trace 
amounts of the cis-isomer were observed. 
 
To convert the trans-α,β-epoxy ester (314) to the α-hydroxy ester (300) the most popular 
procedure was to hydrogenate the latter over a palladium on carbon (Pd/C) catalyst. Ju et al.
32
 
accomplished this by conducting the hydrogenation in anhydrous MeOH over 10% Pd/C at 
atmospheric pressure. Kelley et al.
33
 achieved the same hydrogenation using anhydrous 
EtOAc, 5% Pd/C and 3 atm of H2. The use of MeOH in a hydrogenation should be avoided as 
fires are known to occur from over-activation of the palladium catalyst followed by vacuum 
filtration of the catalyst at the end of the experiment which draws air through the filter cake 
causing sparks and then ignition of solvent vapours. Therefore a new approach was devised 
from a combination of both methods and it was proposed that the same result could be 
achieved by using anhydrous EtOAc as the solvent, 10% Pd/C and an atmospheric pressure 
of H2.  
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Figure 12 The formation of trans and cis epoxides by Darzens condensation 
 
 
Scheme 75 Low pressure hydrogenation of α,β-epoxide 314 to α-hydroxy ester 300 
 
For a first attempt the reaction was conducted on a 10 mmol scale. After adding the catalyst 
to the stirred solution of 314 in EtOAc under N2 the black suspension was evacuated and 
purged with H2 two times and on the third the apparatus was filled and sealed (Scheme 75). 
The progress of the reduction was monitored by TLC and after 8 hours of vigorous stirring at 
room temperature the reaction was complete. After filtration of the suspension and 
evaporation of the mother liquor, 300 was isolated in 89% yield after FCC. Initially attempts 
were made to isolate the racemic mixture by recrystallisation but without a seed crystal this 
was not possible. Determination of the purity via GC/MS revealed 300 was present as a 
single product with a purity exceeding 98% which was confirmed by melting point and 
NMR. A series of experiments followed whereby the scale was slowly increased up to 
80 mmol and 17 g of a racemic mixture of 300 could be obtained in one effort with the same 
level of purity. It was noticed that this product had a particularly high affinity for CH2Cl2 and 
unique conditions were required for complete evaporation of the normally volatile solvent 
(vacuum oven, 45
o
C, overnight).  
 
After optimisation of the process α-hydroxy ester 300 was obtained in only two steps with an 
overall yield of 44% from 3,4-dimethoxybenzaldehyde. This was a huge improvement from 
the Erlenmeyer synthesis where the same product was obtained in five steps with an overall 
yield of 18%. This equates to more than double the previous yield and demonstrates how 
simplicity is the key when producing precursors on scale. Now that a sufficient quantity of 
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racemate 300 was in hand the final step of this operation was to develop an efficient 
procedure for the resolution of the racemic mixture.   
 
In the synthesis by Kelley et al.
33
 the racemic mixture was separated by forming the 
diastereomic salt with (+)-α-methylbenzylamine. After hydrolysis (R)-dimethyldanshensu 
was obtained in optically and analytically pure form (mp = 102 – 103oC, [α]D
26
 = + 29
o
 (c 2.0, 
MeOH)). However this methodology was quite labour intensive as the diastereomic salt 
required five recrystallisations from CH3CN to achieve this level of optical purity. With no 
mention of yield by Kelley et al.
33
 it is assumed that either the yield was quantitative or not 
worth reporting. Either way this provides precedence for further investigation into the 
resolution of (±)-danshensu as an efficient or industrially viable procedure is still waiting to 
be discovered.  
 
3.2.6 Resolution of (±)-Danshensu racemate 300 
 
A popular method for the resolution of α-hydroxy esters or acids is lipase catalysed kinetic 
resolution otherwise known as lipase catalysed enantioselective transesterification. The 
procedure offers operational simplicity as the need for an inert atmosphere is avoided as the 
typical conditions involve the addition of H2O. This has the advantage over dynamic kinetic 
resolution where an inert atmosphere is essential to maintain the active transitional metal 
catalyst. Other advantages of using a lipase include their excellent stereoselectivity for a wide 
variety of substrates and a range of lipases are commercially available.  
 
Kinetic resolution of racemic alcohols operates on the basis that the two different 
enantiomers react at different rates with a chiral entity (kR ≠ kS).
39
 This process is most 
commonly catalysed by lipases where the enzyme differentiates between the two enantiomers 
of the racemic mixture, allowing one enantiomer to be converted to the product faster. The 
most common method used in lipase-catalysed kinetic resolution is transesterification in 
organic solvents from a suitable acyl donor. The two most commonly used acyl donors are 
vinyl acetate and isopropenyl acetate as they are enol esters. The by-product from vinyl 
acetate is vinyl alcohol which undergoes keto-enol tautomerism forming the corresponding 
keto compound acetaldehyde and the isopropenyl alcohol formed from isopropenyl acetate 
tautomerises to acetone. This makes the transesterification irreversible and the process faster 
compared to reaction using free carboxylic acid. Secondary alcohols, such as α-hydroxy 
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esters are excellent substrates for optical resolution by lipase catalysed kinetic resolution 
which can be explained by the mechanism by which they interact with the enzyme. 
 
The stereoselectivity of lipases can be explained by the active site model for lipases which 
consists of two pockets of different sizes, a large one and a small one as illustrated in Figure 
13.
39
 The fast reacting enantiomer binds to the active site with the large substituent in the 
large pocket and the smaller substituent in the smaller pocket. When the other enantiomer 
reacts its orientation is much less compatible and consequently reacts at a slower rate. 
 
 
Figure 13 The active site model for lipases derived from Kazlauskas' rule; Orientation A - The fast acting enaniomer; 
Orientation B - The slow reacting enantiomer 
 
 
The α-hydroxy ester present within (±)-danshensu is therefore the perfect substrate for kinetic 
resolution with a similar structure to phenyllactic acids, with the bulky phenyl ring and small 
methyl ester. In fact other groups within this area of research realised this and in the first total 
synthesis of (+)-rosmarinic acid by Eicher et al.
19
 the (R)-chiral centre present in the 
danshensu motif was obtained by lipase catalysed kinetic resolution of the racemic precursor. 
After two consecutive resolutions of the racemic mixture Eicher et al.
19
 achieved an ee of 
85% for the allyl protected substrate used to prepare the all allyl-protected (+)-rosmarinate. 
This stands to be improved as it is known that optically pure products (ee ≥ 99%) can be 
achieved by this procedure. 
 
In 1998 Adam et al.
40
 published an article describing the application of lipase catalysed 
kinetic resolution for the preparation of optically active α-hydroxy acids.  For 3-phenyllactic 
acid the lipase that achieved the best resolution was from the Burkholderia species. In this 
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study Adam et al.
40
 screened a collection of lipases against a broad spectrum of α-hydroxy 
acids and determined that, for all of the hydroxy acids attempted, the alcohol left unacetylated 
was the (R)-enantiomer by exciton-coupled circular dichroism (ECCD). The acetylated 
product was confirmed to be the (S)-enantiomer. With a similar chiral centre present in the 
danshensu racemic mixture this study confirmed that this compound was suitable for kinetic 
resolution, especially since it was the (R)-enantiomer that was required. 
 
Using the lipase suggested by Adam et al.
40
 the first attempt at resolution by lipase catalysed 
transesterification was carried out following their general procedure. Using TBME as the 
solvent, vinyl acetate as the acyl donor and the lipase from Burkholderia cepacia no 
conversion was observed by GC and NMR (Scheme 76). The reaction was attempted with 
the α-hydroxy acid (299) but still no conversion was observed via TLC, after stirring at room 
temperature for 6 hours. As these conditions were not suitable, the resolution was attempted 
with the conditions developed by Eicher et al.
19
 and after 72 hours of stirring at ambient 
temperature (10% (w/w) lipase) less than 5% of the racemic alcohol was acetylated (by 
GC/MS). After using two procedures from different authors and recognising that neither 
could be successfully applied to this scenario it was realised that other experimental 
parameters were involved.  
 
 
Scheme 76 Lipase mediated kinetic resolution of 300 according to Adam et al. and Eicher et al. Adam conditions 10% 
(w/w) lipase, 3 equiv Vinyl acetate, anhydrous TBME, T = RT, t = 6; Eicher conditions 45% (w/w) lipase, 3 equiv Vinyl 
acetate, 1% aqueous TBME, T = RT, t = 72 
 
From the reports of enzymatic kinetic resolution carried out in other total syntheses it was 
observed that almost all of the lipase catalysed resolutions were conducted at room 
temperature; but this fact was quite misleading. Further reading about the lipase from 
Burkholderia cepacia revealed that the optimum temperature for maximum activity is 50
o
C. 
As these conditions were vastly different from the typical conditions found in the literature 
there was some speculation about how a 100% increase in temperature would affect the 
outcome of the reaction. When the resolution was conducted at 50
o
C, using the same 
conditions as before, only a 15% increase in acetylated product was observed by GC/MS 
Chapter 3   
Page | 184  
 
after 48 hours. From this point extensive optimisation of the conditions for the resolution was 
conducted (Table 29) and the optimum conditions were to perform the resolution at 50
o
C, 
use 10 molar equivalents of freshly distilled vinyl acetate
41
, 1 weight equivalent of lipase and 
aqueous TBME as the reaction medium as used by Eicher et al.
19
 With these conditions up to 
54% conversion to the acetylated product was observed by GC/MS, which was the desired 
result given the composition of a racemic mixture. Even though a new bottle of vinyl acetate 
was being used it was observed that, when it was distilled prior to the reaction on the same 
day, the resolution was complete in two days compared to three which was consistent with 
the literature.
41
 Another factor thought to influence the outcome of the reaction was to 
conduct the reaction under N2 as this prevented solvent evaporation which was an issue even 
with a condenser attached considering the long reaction time coupled with the high volatility 
of TBME.   
 
Table 29 Optimisation of the lipase mediated kinetic resolution of α-hydroxy ester 300; Solvent used was aqueous TBME 
(1%) # Reaction conducted under N2; * Vinyl acetate was distilled ; All reaction were conducted on a 1 mmol scale 
Conditions 
Lipase 
(Wt. equiv.) 
Vinyl acetate 
(Molar equiv.) 
T (
o
C) t (h) 
Relative % (by GC/MS) 
(R)-OH (S)-OAc 
A 0.45 3 RT 72 95.6 4.4 
B 0.45 3 50 48 80.5 19.5 
C 0.50 8* 50 48 59.8 40.2 
D 0.50 10* 50 48 51.7 45.4 
E# 1.0 10* 50 48 45.6 54.1 
 
The procedure was then up-scaled five times (5 mmol) and the resolution was repeated on 
this scale. Using the same conditions as for the 1 mmol experiment, a conversion of only 40% 
to the acetylated product was observed by GC/MS. The resolution was repeated on this scale 
and a similar ratio of free alcohol to acetylated product was observed via GC/MS. The crude 
mixture from the latter was then subjected to a second round of resolution in a separate 
experiment but the ratio of starting material to product could not be improved. Multiple 
reasons for this observation were proposed the most pertinent ones being insufficient stirring 
of the lipase suspension in the larger volume, the byproduct from the acyl donor (vinyl 
acetate) interfering with the lipase and the presence of the acetylated product interfering with 
the lipase. The by-product from the acyl donor, vinyl acetate, should be the corresponding 
aldehyde (acetaldehyde) due to keto-enol tautomerism of vinyl alcohol (Scheme 77). 
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However, after each experiment there was a strong vinegar odour emanating from the crude 
mixture after evaporation of the TBME which would most likely be due to acetic acid. If the 
resolution was conducted in a pure organic solvent, the formation of the carboxylic acid 
could be avoided as the reaction was performed under N2 preventing oxidation of the 
aldehyde. However, due to the addition of H2O to aid dissolution of the semi-polar α-hydroxy 
ester the aldehyde is oxidised and acetic acid is obtained. As a more polar alternative to the 
TBME/H2O mixture as the reaction medium could interfere with the separation of organic 
products from enzyme thereby impeding reaction rate and overall ratio of products it was 
proposed that after the first stage of resolution the acetylated product be separated from the 
(R)-enriched racemic mixture to prevent any interference with the lipase, allowing maximum 
activity and reaction rate. 
 
 
Scheme 77 Formation of acetic acid (323) from vinyl acetate during up-scale of lipase mediated kinetic resolution 
 
A separation scheme was then devised; keeping in mind that chromatography should only be 
used as a last resort as it severally reduces efficiency. An interesting account of lipase 
catalysed kinetic resolution was discovered by Yamano et al.
42
 where the acetylated product 
could be separated from the optically active alcohol by protecting the secondary alcohol with 
sulphurtrioxide pyridine complex (SO3.py). The complex formed between the secondary 
alcohol and SO3.py was water soluble and therefore the acetylated product could be separated 
by extraction from the aqueous phase. What made this procedure appealing was that the 
original unacetylated product could be recovered from the SO3.py complex by hydrolysis 
with hydrochloric acid followed by a second extraction. This technique seemed ideal for the 
separation of the (R)-enriched sample of α-hydroxy ester (300) from the (S)-acetylated 
product as there appeared to be no limit on scale and it avoided laborious chromatography. 
Thus after a resolution following the optimised conditions for a 1 mmol scale experiment, the 
unreacted secondary alcohols present within the crude mixture were sulphated with SO3.py 
according to the procedure of Yamano et al.
42
 and the acetylated product was obtained in 
87% yield but only 33% of resolved (R)-OH was recovered from the SO3.py complex 
(calculated for the 1:1 ratio of R:S in the racemate 300) which did not equate to the 
conversion percentage observed in the GC trace (Scheme 78). This was essentially due to 
SO3.py complex 324 being so stable that it could not be hydrolysed with acid at room 
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temperature. As there was a possibility that the secondary hydroxyl could be hydrolysed 
above room temperature to form the cinnamate elevated temperature hydrolysis was not 
attempted. As the (R)-configured α-hydroxy ester (63) could not be isolated in this way it was 
decided that chromatography was the only option. If the (S)-enantiomer of 63 was required 
this procedure would have been ideal as the acetylated product was isolated in good yield and 
purity as confirmed by GC/MS. 
 
 
Scheme 78 Separation of a resolved mixture my sulfation of enantioenriched 300 with SO3.Py complex 
 
The kinetic resolution of 300 was attempted again using the optimised procedure where it 
was planned to separate the acetylated product from the (R)-enriched mixture of 300 by FCC 
and subject the latter to a second round of resolution. This time working on a 10 mmol scale, 
after 48 hours at 50
o
C a conversion of 41% to the acetylated product was observed by 
GC/MS which was consistent with the smaller scale experiments. The (S)-acetylated product 
was then removed from the crude oil by FCC to afford 1.6 g of the (R)-enriched fraction of α-
hydroxy ester 300 corresponding to 6.7 mmol. The (R)-enriched fraction was then subjected 
to a second resolution where the additional 10% of the (S)-enantiomer was acetylated as 
confirmed by GC/MS. The two products were then isolated by FCC to afford a total yield of 
81% for (S)-OAc and 86% for (R)-OH. Now with the resolution completely optimised the 
next stage was to investigate the scale on which this operation could be conducted.  
When the lipase catalysed kinetic resolution was carried out on a 25 mmol scale a conversion 
of only 19% to the acetylated product was observed by 
1
H NMR and GC.  
Even after separating the acetylated product from the unreacted racemate and re-subjecting 
the enriched fraction to a second round of resolution the same ratio of acetylated to free 
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alcohol achieved in the 10 mmol scale experiment could not be achieved. It was proposed 
that this was essentially due to the fact that the same level of homogeneity between the lipase 
suspension and the organic solution could not be achieved on the larger scale with magnetic 
stirring. As the reaction could not be carried on a scale large enough to accommodate a vessel 
suitable for mechanical stirring reducing the reaction scale was the only option. 
 
 
Scheme 79 Optimised process for the kinetic resolution of 300 
 
To increase productivity it was found best to conduct the resolution in a batch style 
experiment where two 10 mmol scale resolutions were conducted side by side. After the first 
round of resolution both reaction mixtures would be combined, separated and subjected to a 
second resolution in the same flask. When conducting the resolution in this way the largest 
scale the experiment was performed was 13 mmol. This meant that up to 4.8 g of the racemic 
mixture could be resolved at one time. After performing this experiment in duplicate the 
average yield for (R)-OH was 47% and for (S)-OAc 47% (Scheme 79). Samples of the 
acetylated compound were then deacetylated via methanolysis with K2CO3 in anhydrous 
MeOH to afford the free (S)-enantiomer of α-hydroxy ester (325) in 69% yield (Scheme 80).  
 
 
Scheme 80 Deacetylation of 320 via methanolysis 
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Even though the scale that this kinetic resolution could be performed on was quite limited the 
efficiency of the racemic approach is demonstrated when both enantiomers of the desired 
compound can be prepared with ease. After optimisation of the resolution step the desired 
enantiomer of Danshensu, (R)-OH (63) was obtained in only three steps with an overall yield 
of 20% and the opposite enantiomer, (S)-OH (325) in four steps with an overall yield of 14%. 
This kinetic resolution coupled with Darzens condensation provides an efficient approach to 
(+)-Danshensu that allows for scalable preparation of the chiral synthon. With an adequate 
method of preparation in hand this process can be used to prepare the essential chiral 
precursor for related polyphenols of the Salvianolic acid family. This methodology replaces 
the technique used by O‟Malley et al.1 where the (+)-danshensu moiety was obtained from 
commericial (+)-rosmarinic acid that limited the scope for the preparation of derivatives and 
the possibility of structure activity relationship studies. 
 
3.2.7 Determination of enantiomeric excess (ee) for Danshensu derivatives 
 
To check and confirm the stereochemistry and enantiomeric composition of the prepared 
danshensu derivatives an experiment was required. In the absence of chiral HPLC it was 
proposed that, if a diastereomer of the Danshensu derivative was prepared with an optically 
pure compound of known chirality, the physical properties of the two diastereomers would be 
different enough to allow for differentiation between the response of either molecule and 
therefore allow determination of enantiomeric composition or enantiomeric excess (ee). 
 
The first approach was to develop a GC/MS method for the determination of ee. Providing 
the molecular weight of the diastereomer is less than 650 u and is volatile this would be the 
most accurate technique. It was decided an amino acid as a source of a second chiral centre as 
they are available in both optically pure forms. The amino acid of choice was L-proline as it 
is a cyclic amine, is reasonably affordable and should provide the least amount of tailing for a 
GC peak that can be accurately integrated. These issues can be resolved by preparing the α-
methoxy-α-trifluoromethylphenylacetate (MPTA) ester from Mosher‟s acid chloride as is the 
normal approach for the determination of ee by diastereomer formation as the esters are 
typically volatile. Further, with the presence of a trifluoromethyl group, the diastereomic ratio 
can even be calculated following simple 
19
F NMR.  Unfortunately the expense of both 
Mosher‟s acid and the acid chloride makes it an unviable option. 
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Before diastereomer formation could be attempted the secondary amine present in L-proline 
must be protected. In analytical chemistry, a common procedure for amino acid analysis is to 
derivatise the carboxyl group as a simple alkyl ester and protect the amine functionality with 
either a trimethylsilane (TMS) group or derivatise it as the trifluoroacetyl (TFA) amide. Both 
these techniques improve the volatility and reduce polarity of the amino acid and are 
therefore suitable options. As it was planned to esterify the protected amino acid via the acid 
chloride, labile TMS could not be used as a protecting group as it is readily hydrolysed by 
acid, therefore TFA was to be used. Although amide functional groups tend to have a tailing 
affect in GC, the cyclic structure of proline should prevent any compound from being 
retained on the column for an extended period. To preserve the optical purity of L-proline, the 
amine was protected as the TFA amide (327) via 2,2,2-trifluoroethyl trifluoroacetate 
following a procedure by Curphey
43
 (Scheme 81). Standard procedures with trifluoroacetic 
anhydride or trifluoroacetic acid are notoriously known to cause racemisation during 
protection.  
 
 
Scheme 81 Preparation of N-TFA proline (327) 
 
A direct esterification technique, with racemic danshensu (300) was initially attempted with 
H2SO4 as the catalyst but only trace amounts of the desired diastereomers were detected via 
GC/MS. The most common procedure to effect esterification of protected amino acids with 
alcohols is via the acid chloride, therefore there are numerous examples of their preparation 
in the literature. The standard procedure is to use thionyl chloride (SOCl2), neat and/or with 
solvent. This was attempted using neat SOCl2 and the resulting acid chloride was esterified 
immediately with racemic danshensu (Scheme 82). The crude product was then analysed by 
GC/MS and two small peaks corresponding to the diastereomers were detected. However the 
yield from the reaction was poor. This could have been due to numerous reasons ranging 
from incomplete activation of the carboxylic acid, decomposition during the activation or the 
esterification did not go to completion. As the activation with SOCl2 took 12 hours it was 
thought this was the predominant reason and milder conditions could be necessary.  
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Scheme 82 Attempted preparation of L-proline diastereomers 329 & 330 for the determination of ee 
 
Acid chloride formation with the Vilsmeier reagent generated from DMF and oxalyl chloride 
((COCl)2) was therefore attempted and the same esterification was carried out (Scheme 82). 
Unfortunately the same low yield was obtained but the diastereomers were still found in the 
GC trace. Several variations were made to this procedure but in all cases only small yields of 
the diastereomers were obtained. It was noted that occasionally deprotected diastereomers 
were found in the crude mixtures along with unreacted (±)-danshensu. This suggested that 
either the acid chloride was unstable or fragmenting during acetylation or esterification. It 
was then suggested that perhaps a more stable proline derivative be used.  
 
 
Scheme 83 Synthesis of N-Me proline (331) 
 
An interesting procedure by Aurelio et al.
44
 was uncovered for the preparation of N-
methylated amino acids via the common 5-oxazolidinones. This procedure was attempted and 
N-methyl proline (331) was obtained in 95% yield after recrystallisation from MeOH/Et2O 
(Scheme 83). Both procedures for acid chloride formation were then attempted followed by 
the esterification but only chlorinated by-products were detected by GC/MS. This result 
confirmed that the preparation of diastereomers with L-proline and its derivatives is not a 
simple task and that for the purposes of this project a different approach was required.   
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Further reading into the determination of ee via these methods revealed that camphor 
derivatives are excellent chiral selectors and have been used for this purpose in the past as a 
chiral auxiliary to discriminate between enantiomers. The camphor moiety chosen was (1S)-
(+)-camphorsulfonic acid (332) otherwise known as Reychler‟s acid which could be readily 
esterified with the secondary alcohol of any danshensu derivative via its sulfonyl chloride. 
Camphor products are commercially available and are significantly more affordable than 
Mosher‟s acid or the acid chloride of the latter. As 332 was on hand, the sulfonyl chloride 
(333) was prepared following a procedure by Smiles and Hilditch
45
 with the modifications of 
Sutherland et al.
46
 to afford 333 in 89% yield as colourless crystals after recrystallisation 
from petroleum ether (Scheme 84).  
 
 
Scheme 84 Preparation of (1S)-(+)-camphorsulfonyl chloride (333) 
 
 
Scheme 85 Synthesis of camphorsulfone diastereomers for the determination of ee 
 
As before with the proline experiments the enantiomeric recognition of the camphor motif 
was tested by esterifying sulfonyl chloride 333 with racemic danshensu (300). Following a 
procedure by Saba et al.
47
 the camphor diastereomers were prepared in quantitative yield and 
analysed in crude form by 
1
H NMR (Scheme 85). Fortunately a distinct 
1
H NMR spectrum of 
the mixture of diastereomers was obtained where the CH3 signals from the camphor motifs 
from the two diastereomers could be easily integrated to express the enantiomeric excess (ee) 
of the racemic mixture which was calculated to be 0%. To determine which pair of CH3 
peaks in the 
1
H NMR corresponded to the (R,S) and (S,S) diastereomers a (+)-danshensu 
standard was required. Consequently, methyl (+)-dimethyldanshensu (63 standard) was 
attained from commercial (+)-rosmarinic acid in two steps according to a procedure by 
O‟Malley et al.1 and was isolated with an overall yield of 56% (Scheme 86). The (+)-
danshensu standard was then esterified with sulfonyl chloride 333 and the crude diastereomer 
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was analysed by 
1
H NMR to give a representative spectrum. This combined with the 
1
H 
NMR spectrum from the racemic mixture would then be used to determine the ee of the 
resolved products. 
 
 
Scheme 86 Preparation of (+)-Danshensu standard from (+)-Rosmarinic acid 
 
The isolated (R) and (S)-danshensu derivatives (63 and 325) prepared via Darzens 
condensation were then esterified with sulfonyl chloride 333 and their ee values were 
determined by integration of the CH3 singlets in the 
1
H NMR from the camphor moiety. It is 
noteworthy to mention that other peaks were suitable for integration, for example the 
doublets arising from the methylene protons next the sulfonyl group. But it was believed that 
the CH3 singlets would give a better response as they corresponded to three protons compared 
to two and would therefore more accurately represent the ee. The results from these 
experiments are displayed in Table 30.  
 
Table 30 Determination of ee for (R) and (S)-danshensu derivatives 
Sample + (1S)-CSC Diastereomer δ CH3 (ppm) Integral ee (%) 
Racemic 
(R,S) 0.80 100.11 
0 
(S,S) 0.75 98.83 
Standard 
(R,S) 0.79 100.0 
100 
(S,S) - - 
(R)-OH 1
st
 resolution 
(R,S) 0.79 99.97 
47 
(S,S) 0.75 35.91 
(R)-OH 2
nd
 resolution 
(R,S) 0.79 100.02 
96 
(S,S) 0.75 4.01 
(S)-OH 2
nd
 resolution 
(R,S) 0.79 3.96 
96 
(S,S) 0.75 99.98 
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Surprisingly, only one pair of the camphor CH3 peaks was suitable for integration with a 
difference in chemical shift (δ) of 0.05 ppm compared to 0.01 ppm. The chemical shift of the 
(R,S) CH3 singlet from the danshensu standard matches perfectly with that from the prepared 
danshensu derivatives. The effect of the second resolution can be seen here where the ee for 
the (R)-enantiomer of danshensu increases from 47 to 96%. Overall this experiment confirms 
that the acetylated danshensu derivative from the lipase catalysed kinetic resolution has (S)-
configuration and the unacetylated product therefore has (R)-configuration. Also, from the 
calculation of ee, it is observed that a much higher optical purity was obtained for the (R)-
enantiomer of the danshensu derivative (ee 96%) compared to that achieved by Eicher et al.
19
 
in their kinetic resolution. Consequently from the data obtained the resolution procedure 
developed in this project is superior to the methodology used by Eicher et al.
19
 with an 
increase of more than 10% in optical purity for the (R)-enantiomer of danshensu. 
 
3.2.8 Possible alternative procedure for the preparation of (+)-Danshensu 
 
During the final stages of the optimised racemic pathway, an alternative asymmetric route 
was discovered where optically pure (R)-α-hydroxy esters could be prepared from amino acid 
L-serine. It has been reported by Larchevêque and Petit
48,49
 that (R)-potassium glycidate is 
obtained from L-serine in two steps by treatment of the α-bromo acid obtained from the 
amino acid after diazotisation with ethanolic potassium hydroxide solution with an excellent 
overall yield of 71%. The potassium carboxylate can then be transformed to a variety of 
esters by phase transfer catalysis. The ethyl ester (ethyl glycidate) is a particularly interesting 
chiral synthon as it can undergo regiospecific Grignard type reactions with lithium or 
magnesium cuprates to form α-hydroxy esters in good yields ranging from 68 to 90%.49 As 
amino acids are commericially available in both enantiomerically pure forms, they are 
excellent chiral building blocks to be used in asymmetric synthesis as they remove the 
element of chiral induction that is that most challenging component of any synthetic scheme.   
The „chiral pool‟ approach was initially thought of at the beginning of this section of research 
but was dismissed quickly as it was the (R)-enantiomer of the expensive amino acid D-DOPA 
that was required to produce α-hydroxy ester (63) with the same stereochemistry. With the 
approach of Larchevêque and Petit
48
 the economical L-(S)-amino acid can be used to 
prepared (R)-α-hydroxy esters through the epoxide intermediate 340 (Scheme 87) whereby 
the chirality from the natural amino acid is inverted by cyclisation of the α-bromo acid 
intermediate.   
Chapter 3   
Page | 194  
 
Other examples from the literature where this methodology has been used for the preparation 
of enantiomerically pure α-hydroxy esters include a study by Mori and Takikawa50 where 
both enantiomers of Ipsdienol were prepared from the enantiomers of serine in overall yields 
of 16-21%. Of particular interest were the studies carried out by Shie et al.
51
 where a 3-
phenyl substituted (R)-α-hydroxyester was prepared from (R)-methyl glycidate, which 
closely resembles the structure of (+)-danshensu. Also in a medicinal investigation by 
Litchfield et al.
52
 a critical (R)-α-hydroxy ester precursor was prepared by nucleophilic 
addition of a Grignard reagent to (R)-methyl glycidate, prepared by the same procedure from 
L-serine. After reading how other groups from this area of research had utilised the chemistry 
developed by Larchevêque and Petit
48
 for the preparation of enantiomerically pure α-hydroxy 
esters one simply had to investigate if a similar approach could be used to develop a second 
novel procedure for the synthesis of the (+)-danshensu moiety. 
 
 
Scheme 87 Synthesis of methyl (R)-glycidate (340) and ethyl (R)-glycidate (341) from L-serine (337)  
 
Potassium (R)-glycidate (339) was prepared with ease according to procedures of 
Larchevêque and Petit
48
 and was obtained in 72% overall yield from L-serine (Scheme 87). 
The only change made to the procedure was in the basic ring closure of α-bromo acid 338 
where it was noted that when the addition of the KOH solution was carried out at -5
o
C 
instead of -20
o
C, and held at this temperature overnight a slightly higher yield for potassium 
(R)-glycidate was achieved (93%, corrected for KBr content). As in more recent publications 
methyl (R)-glycidate seems to be preferred over the ethyl ester an attempt was made to 
prepare this ester according to an additional procedure written by Larchevêque and Petit
48
. 
Following their procedure, the best yield obtained for the methyl ester (340) was only 24% 
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(Scheme 87). Multiple reasons came to mind for this low conversion with the most likely 
issues being either the volatile ester was lost on the rotary evaporator or the phase transfer 
catalyst (BTAC) used was simply not sufficiently active for this reaction. After repeating the 
reaction with recrystallised catalyst and performing the evaporation step below room 
temperature with only a mild vacuum (≥ 50 mmHg) no improvement to the depressingly low 
yield was ascertained. Exchanging the reaction solvent from CH2Cl2 to CH3CN had only 
adverse effects on the reaction and a complex mixture of products was observed in the crude 
mixture.  In an attempt to reduce the volatility of the ester an attempt was made to prepare the 
ethyl ester using the same conditions but with iodoethane. Unfortunately this did not resolve 
the issue and ethyl (R)-glycidate (341, Scheme 87) was isolated in 32% yield.  
 
Further reading in the literature uncovered an alternative procedure for the alkylation of 
carboxylate salts catalysed by ionic liquids. A publication by Brinchi et al.
53
 described the 
application of alkyl imidazolium salt ionic liquids to the esterification of carboxylate salts 
with alkyl halides. The imidazolium salts were stabilised by a methanesulfonate anion and 
were used neat with the sodium carboxylate and alkyl halide. The downfall to this process 
was that, in the early stages of the reaction, heat was required which reduced the substrate 
scope for the reaction. A more recent publication by Dighe et al.
54
 describes a different 
approach where room temperature ionic liquids are used as catalysts in combination with 
DMSO to effect alkylation of sodium carboxylate salts at room temperature. When DMSO 
and the ionic liquid [BBIM]Br were used in a ratio of 1:0.1 (w/w) the reaction was complete 
in only 15 minutes for the model substrate. Dighe et al.
54
 rationalise this observation by 
explaining that when DMSO and the ionic liquid are used together they create a more polar 
and acidic reaction medium that can polarise the C-halide bond making it more susceptible to 
nulceophilic attack by the highly reactive carboxylate anion in this reaction medium. With the 
mild conditions for this reaction and the excellent isolated yields for the prepared alkyl esters 
this appeared to be a suitable surrogate for the technique employed by Larchevêque and 
Petit.
48
  
 
Dighe et al.
54
 suggest to use ionic liquid [BBIM]Br as the catalyst but since [BMIM]Cl is 
commericially available and was on hand at the time it was speculated that this salt could be 
used in place of the latter by converting it to a room temperature ionic liquid as was required. 
The chloride counterion of [BMIM]Cl was exchanged for BF4
-
 according to a procedure by 
Dupont et al.
55
 The solid chloride salt became a liquid at room temperature and ionic liquid 
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[BMIM]BF4 was isolated in 92% yield by extraction from the aqueous phase. Following the 
conditions of Dighe et al.
54
 the reaction between potassium (R)-glycidate and iodoethane was 
performed at room temperature in the presence of distilled DMSO and [BMIM]BF4 (1:0.1, 
w/w) under N2 (Scheme 88). The reaction was complete in 2.5 hours, during which time the 
potassium salt slowly dissolved and esterified with the alkyl halide. Following the same 
workup procedure developed by Dighe et al.
54
 ethyl (R)-glycidate (341) was isolated in 63% 
yield. The crude product was remarkably clean, with no contamination from iodine or 
DMSO, after a brine wash. This was a huge improvement over the result obtained from the 
original conditions and demonstrates the unique capabilities of ionic liquids over traditional 
methodologies.  
 
 
Scheme 88 Ionic liquid catalysed alkylation of 339; synthesis of ethyl (R)-glycidate (341) 
 
The alkylation was then repeated on a 50 mmol scale and ethyl ester 341 was obtained in the 
same yield and purity as the previous experiment. With the practical quantity of 341 in hand 
experimentation on the ring opening of the epoxide could begin. As mentioned earlier, to 
convert this glycidic ester to α-hydroxy esters organocuprate type reagents are used which 
undergo regioselective Grignard type reactions at the β-carbon of the epoxide ring. The 
general technique used to prepare the organocuprates was to start with either the aryl or alkyl 
halide, prepare the Grignard reagent or organolithium and add the copper catalyst to the 
formed organometallic to create the organocuprate or Gilman reagent. For the (+)-danshensu 
core structure the aryl halide of choice was 4-bromoveratrole (342) or 4-bromo-1,2-
dimethoxybenzene, which is conveniently commercially available (Scheme 89). As Gilman 
reagents are typically prepared from organolithium compounds, which are generally easier to 
prepare due to the higher reactivity of lithium sources over magnesium metal it was decided 
to prepare the organolithium intermediate of 4-bromoveratrole. The most common copper 
catalyst used to prepare Gilman reagents is copper(I) bromide precomplexed with dimethyl 
sulfide, Cu(I)Br.SMe2. As it is recommended to prepare this catalyst rather than purchase it, it 
was prepared according to the procedures of Matsuo et al.
56
 and was obtained as colourless 
crystals in 55% yield.  Using the procedure reported by Mori and Takikawa
50
 as a guide the 
reaction was carried out by first generating the organolithium from 4-bromoveratrole and n-
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BuLi (343) and forming Gilman reagent 344 by transferring the organolithium solution to a 
second solution of the copper(I) catalyst under N2. During this addition the colour of the 
solution changed from clear to orange then yellow, suggesting formation of the cuprate. The 
yellow solution was then allowed to stir for an hour before ethyl (R)-glycidate (341) was 
transferred in solution to the yellow reaction mixture. After stirring for a few hours at room 
temperature, the reaction was quenched and the product was isolated according to the 
procedures of Mori and Takikawa
50
. The crude product was then analysed by GC/MS to 
reveal that all of the aryl bromide had reacted but a significant amount of the epoxide 
remained untouched and therefore no α-hydroxy ester was detected. 
 
 
Scheme 89 Attempted Gilman ring opening of epoxide 341 
 
Even though a colour change was observed after organolithium 343 was added to the copper 
catalyst it is not clear whether Gilman reagent 344 formed due to the presence of unreacted 
epoxide 341 and the formation of a blue Cu
2+
 complex during the quench. The presence of 
1,2-dimethoxybenzene (346, Figure 14) in the GC trace confirms that either the 
organometallic intermediate was quenched before copper complexation or after. It was 
observed during lithiation of 4-bromoveratrole that the organolithium product precipitated out 
of the THF solution at -78
o
C. Additional THF was added but the lithiated intermediate 
remained out of solution. Insufficient solvation of organolithium 343 could interfere with the 
copper insertion and lead to a low conversion to Gilman reagent 344. If the Gilman reagent 
did form the most likely reason the reaction did not proceed is the low temperatures at which 
the organocopper reagent was added to epoxide 341. After the transfer, the reaction mixture 
was stirred below 0
oC and the temperature wasn‟t allowed to rise. It is possible that aryl 
Gilman reagent 344 requires a higher temperature to initiate reaction compared to the 
aliphatic reagents used by Mori and Takikawa
50
.   
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A butylated product (347, Figure 14) resulting from attack of the lithium intermediate by the 
butyl anion from n-BuLi is also observed in the GC trace. This could interfere with 
organocopper formation by reducing the molar amount of the organolithium species available 
for copper insertion. This is a common issue with aromatic systems and can be overcome by 
using a different source of lithium; either lithium metal or t-BuLi could be used for example.  
 
 
Figure 14 Products from the attempted Gilman reaction 
 
The conclusion from these observations is that there are many elements to the ring opening of 
epoxides with Gilman reagents and even though there are many reports in the literature of 
this chemistry being applied to variety of substrates, every reaction is different and therefore 
a unique set of conditions is required for each transformation. Unfortunately due to the late 
discovery of this approach no further experiments were conducted on this scheme as at this 
time (+)-danshensu had already been prepared in a sufficient quantity and enantiomeric 
purity. Therefore as it was not critical to the success of this project to pursue this route, it was 
decided to continue on to the next step of the major scheme and postpone this route to (+)-
danshensu.  
 
If in the future it is decided to conduct a Structure Activity Relationship Study (SARS) on 
(+)-danshensu derivatives or (+)-Salvianolic acid C this procedure would suit the preparation 
of analogues as any aryl halide could be substituted for 4-bromoveratrole to extend the 
aliphatic carbon chain or to include other functional groups. This would provoke further 
investigation into the formation of Gilman reagents and their use as nucleophiles in the ring 
opening of glycidic esters.  
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3.3 Experimental 
 
3.3.1 Synthesis of starting materials for MacMillan’s α-oxyamination and 
the experimental reaction conditions 
 
3.3.1.1 (2E)-3-(3,4-Dimethoxyphenyl)prop-2-enal (285)
3
 
 
 
 
To a 3L, three-necked RBF, equipped with a mechanical stirrer and two glass stoppers was 
added 4-allyl-1,2-dimethoxybenzene (284, 5.8452 g, 32.80 mmol) followed by reagent grade 
CH2Cl2 (1170 mL) and deionised H2O (130 mL) to create a H2O saturated solution.  The 
stirrer was started and additional deionised H2O (330 mL) was then added followed by 
recrystallised DDQ (16.3770 g, 72.15 mmol, 2.2 equiv). Upon addition of the DDQ the 
cloudy, colourless heterogeneous mixture became a red-orange suspension indicating 
immediate formation of the oxidised product. The reaction mixture was then stirred 
vigorously at room temperature for 1 hour. During this time, a solution of ascorbic acid 
(12.73 g, 72.28 mmol, 2.2 equiv) in deionised H2O was prepared and when the reaction was 
complete (TLC, 9% EtOAc/PhMe) it was added to the stirred reaction mixture to quench any 
unreacted DDQ. After an additional 10 minutes of stirring at room temperature the solids 
were filtered off and the phases were separated. After a second extraction of the aqueous 
phase with CH2Cl2 (200 mL), the combined organic layers were washed with brine (200 mL), 
dried over MgSO4, filtered and evaporated to yield a crude red oil. The crude product was 
then subjected to FCC (SiO2, 9% EtOAc/PhMe) to yield an orange solid (5.22 g, 83%). This 
product was then recrystallised from PhH/hexane to afford 4.86 g (77%) of 285 as pale 
orange crystals. 
 
Mp = 79 – 83oC; 1H NMR (CDCl3, 300 MHz) δ 3.94 (3H, s, OCH3), 3.95 (3H, s, OCH3), 
6.63 (1H, dd, J = 15.9, 7.7 Hz, ArCH=CHCHO), 6.92 (1H, d, J = 8.3 Hz, ArH), 7.09 (1H, s, 
ArH), 7.18 (1H, d, J = 8.1 Hz, ArH), 7.43 (1H, d, J = 15.7 Hz, ArCH=CHCHO), 9.68 (1H, d, 
J = 7.7 Hz, CHO); 
13
C NMR (CDCl3, 75 MHz) δ 55.8 (OCH3), 55.9 (OCH3), 109.8, 111.1, 
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123.3, 126.6, 126.9, 149.3, 151.9, 193.4 (CHO); IR (KBr) 3000.71, 2953.76, 2837.08, 
1753.20, 1712.75, 1631.30, 1598.20, 1515.69, 1464.89, 1441.78, 1421.21, 1263.83, 1240.48, 
1197.06, 1156.84, 1139.51, 1075.93, 1024.73, 980.29 cm
-1
; LRMS (EI) [M]
+
 192 m/z 
 
3.3.1.2 3-(3,4-Dimethoxyphenyl)propanal (283)
4
 
 
 
 
A 250 mL oven dried Schlenk flask was assembled with a rubber septum and a Teflon 
coated, oval shaped magnetic stir bar while hot and allowed to cool under N2. To the dry 
apparatus was then added under N2 285 (4.8114 g, 25 mmol) followed by 10% Pd/C 
(0.4815 g, 10% (w/w) of substrate), Ph2S (418 µL, 2.5 mmol, 10 mol%) and anhydrous 
EtOAc (100 mL). The loaded Schlenk flask was then transferred to a vacuum/H2 manifold 
where it was evacuated and purged with H2 (×3) under vigorous stirring. After the third 
evacuation the black suspension was vigorously stirred under H2 (≈ 1 atm) for 24 hours. 
Upon completion of the reaction (TLC, 50% EtOAc/Hexane) the black suspension was 
filtered over Celite and the mother liquor was evaporated to afford a crude yellow oil. The 
crude product was then subjected to FCC (SiO2, 0 – 20 – 50% EtOAc/Hexane) to afford 
2.44 g (50%) of 283 as a transparent yellow oil.  
  
1
H NMR (CDCl3, 300 MHz) δ 2.77 (2H, m, CH2CHO), 2.92 (2H, m, ArCH2), 3.86 (3H, s, 
OCH3), 3.88 (3H, s, OCH3), 6.74 (2H, m, ArH), 6.81 (1H, m, ArH), 6.83 (1H, t, J = 2.8, 
1.5 Hz, CHO); 
13
C NMR (CDCl3, 75 MHz) δ 27.7 (CH2CHO), 45.5 (ArCH2), 55.8 (OCH3), 
55.9 (OCH3), 111.3, 111.6, 120.1, 132.9, 147.5, 149.0, 201.7 (CHO); IR (neat NaCl plates) 
3000.0, 2937.14, 2835.09, 2725.74, 1723.29, 1607.63, 1590.96, 1516.70, 1465.44, 1419.27, 
1389.17, 1332.31, 1261.44, 1237.54, 1190.73, 1157.02, 1141.94, 1028.29, 938.72, 867.16, 
808.29, 765.16 cm
-1
; LRMS (EI) [M]
+
 194 m/z 
 
Chapter 3   
Page | 201  
 
3.3.1.3 Conditions used for MacMillan’s α-oxyamination; attempted synthesis of (2R)-3-
(3,4-dimethoxyphenyl)-2-[(phenylamino)oxy]propananal (289) 
(4R)-5-(3,4-dimethoxyphenyl)-2-[(3,4-dimethoxyphenyl)methyl]-3-hydroxy-4-
[(phenylamino)oxy]pentanal (290) 
 
 
 
Conditions A
6
 
 
To a 25 mL RBF equipped with a small Teflon coated magnetic stir bar and a glass stopper 
was added 283 (294.6 mg, 1.52 mmol) followed by CH3CN* (3 mL) and nitrosobenzene 
(54.2 mg, 0.51 mmol, 50 mol%) at room temperature. The green solution was then cooled 
to -20
o
C (dry ice/o-xylene) before L-proline was added (18.0 mg, 0.16 mmol, 11 mol%). The 
green reaction mixture was then stirred under air, in the cooling bath for 1 hour before it was 
transferred to a freezer (-30
o
C) and left undisturbed for 24 hours. Upon completion of the 
reaction, as evidenced by the colour of the reaction mixture changing from green to yellow, 
the reaction mixture extracted with EtOAc (3 × 20 mL) and the combined organic layers were 
washed with brine (50 mL), dried over MgSO4, filtered and evaporated to form a yellow 
residue. The crude product was then subjected to FCC (SiO2, 0 – 40% EtOAc/hexane) to 
afford 162 mg (65%) of 290 as an orange foam.  
 
*The reaction was conducted with HPLC grade and anhydrous CH3CN. Both conditions gave 
the same outcome. 
 
Conditions B
5
 
 
To a 25 mL RBF equipped with a small Teflon coated magnetic stir bar and a glass stopper 
was added 283 (235 mg, 1.21 mmol), DMSO (2 mL) and nitrosobenzene (108 mg, 1.0 mmol, 
0.83 equiv). The solution became green and L-proline (24.5 mg, 0.21 mmol, 17 mol%) was 
added. The resulting solution was then stirred at room temperature for 20 minutes at which 
point the colour of the solution had changed from green to yellow-orange. The reaction 
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mixture was then extracted with EtOAc (3 × 20 mL) and the combined organic layers were 
washed with brine (20 mL), dried over MgSO4, filtered and evaporated to form a yellow 
residue. The crude product was then subjected to FCC (SiO2, 40% EtOAc/hexane) to afford 
93 mg (31%) of 290 as an orange foam.  
 
LRMS (ESI) [M+H]
+
 496 m/z 
 
We did not consider performing a complete characterisation (ie HRMS) for 290 as it was a 
side product and not our intended product. 
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Figure 15 1H NMR (300 MHz, d6-DMSO) of aldol product 290 from MacMillan α-oxyamination 
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3.3.2 Synthesis of diol 62 via the Sharpless asymmetric dihydroxylation 
(ADH) 
 
3.3.2.1 Methyl (2E)-3-(3,4-dimethoxyphenyl)prop-2-enoate (292)
10
 
 
 
 
To a 1L, three-necked RBF equipped with a large Teflon coated, oval shaped magnetic stir 
bar was added 3,4-dimethoxycinnamic acid (293, 46.84 g, 225 mmol) followed by anhydrous 
MeOH (500 mL) and concentrated H2SO4 (98% (aq), 3.4 mL, 63.78 mmol, 29 mol%). A 
reflux condenser was fitted and the flask was suspended in an oil bath. The stirred suspension 
was then heated to reflux (T (oil bath) = 100
o
C) and maintained at this temperature for 
5 hours during which time a solution formed. The apparatus was then removed from the oil 
bath and allowed to cool overnight. Excess MeOH was then evaporated to afford a yellow oil. 
The oil was then dissolved in Et2O (600 mL) and transferred to a separatory funnel. The 
ethereal layer was then washed with deionised H2O (400 mL) followed by saturated aqueous 
NaHCO3 (10% (w/w), 3 × 100 mL), H2O (100 mL), brine (100 mL), dried over MgSO4, 
filtered and evaporated to form a light yellow solid. The crude product was then recrystallised 
from CHCl3/hexane to yield 42.12 g (84%) of 292 as colourless crystals. 
 
Mp = 66 – 69oC; 1H NMR (CDCl3, 300 MHz) δ 3.81 (1H, s, CO2CH3), 3.92 (6H, s, 2 × 
OCH3), 6.32 (1H, d, J = 16.1 Hz, ArCH=CHCO2CH3), 6.88 (1H, d, J = 8.3 Hz, ArH), 7.06 
(1H, d, J = 1.9 Hz, ArH), 7.12 (1H, dd, J = 8.1, 1.9 Hz, ArH), 7.65 (1H, d, J = 15.9 Hz, 
ArCH=CHCO2CH3); 
13
C NMR (CDCl3, 75 MHz) δ 51.3 (CO2CH3), 55.6 (OCH3), 55.7 
(OCH3), 109.4, 110.8, 115.2, 122.3, 127.1, 144.5, 149.0, 150.9, 167.4 (CO2CH3); IR (KBr) 
2944.42, 2840.42, 1696.90, 1641.82, 1626.30, 1596.42, 1581.29, 1511.03, 1464.70, 1439.80, 
1422.50, 1282.86, 1251.44, 1232.11, 1177.92, 1161.94, 1144.60, 1040.28, 1022.23, 984.36, 
870.19, 857.70, 815.15, 756.73, 604.88, 567.14 cm
-1
; LRMS (EI) [M]
+
 222 m/z 
 
 
 
Chapter 3   
Page | 205  
 
3.3.2.2 Methyl (2R,3S)-3-(3,4-dimethoxyphenyl)-2,3-dihydroxypropanoate (62)
11
 
 
 
 
To a 100 mL single neck RBF equipped with a Teflon coated magnetic stir bar was added 
(DHQ)2PHAL (77.9 mg, 0.10 mmol, 0.5 mol%) followed by 292 (4.45 g, 20.0 mmol), t-
BuOH (10 mL), aqueous NMO (50% (w/w), 6.0 mL, 29.2 mmol) and a solution of OsO4 
(0.04 M, 1.2 mL, 0.2 mol%). The flask was then sealed with glass stopper and the reaction 
mixture was stirred at room temperature, under air for 24 hours. Upon completion of the 
reaction (TLC, 50% EtOAc/Hexane) a saturated aqueous solution of Na2SO3 (10% (w/w), 
30 mL) was added. After an additional hour of stirring at room temperature deionised H2O 
(30 mL) was added and the reaction mixture was extracted with EtOAc (2 × 50 mL). The 
combined organic layers were then washed with dilute aqueous HCl (1 M, 4 × 25 mL), dried 
over MgSO4, filtered through a pad of SiO2 (3 – 5 cm) and evaporated to form a cream 
coloured solid. The crude product was then recrystallised from boiling PhMe (10 mL) to 
afford 1.74 g (39%) of 62 as fine colourless crystals.    
 
1
H NMR (300 MHz, d6-DMSO) δ 3.58 (3H, s, CO2CH3), 3.72 (3H, s, OCH3), 3.73 (3H, s, 
OCH3), 4.10 (1H, dd, J = 11.5, 7.4 Hz, CH(OH)CO2CH3), 4.76 (1H, dd, J = 9.8, 5.7 Hz, 
ArCH(OH)), 5.30 (1H, d, J = 7.4 Hz, OH), 5.41 (1H, d, J = 5.9 Hz, OH), 6.85 (2H, m, ArH), 
6.96 (1H, d, J = 1.3 Hz, ArH); 
13
C NMR (75 MHz, CDCl3) δ 52.1 (CO2CH3), 55.4 (OCH3), 
55.5 (OCH3), 74.0 (CH(OH)CO2CH3), 74.9 (ArCH(OH)), 109.4, 110.5, 118.3, 132.3, 148.2, 
148.4, 172.8 (CO2CH3); LRMS (EI) [M-H]
-
 255 m/z 
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3.3.3 The diacetoxylation of cinnamate 292 according to Dong and co-
workers
13
 
 
3.3.3.1 Preparation of [Pd(dppp)(OH2)2](OTf)2
15,16
 
 
PdCl2(dppp) 
 
To a 250 mL, single neck RBF equipped with a Teflon coated magnetic stir bar was added 
PdCl2(SEt)2 (0.8946 g, 2.5 mmol) followed by anhydrous CH2Cl2 (50 mL) to form an orange 
solution. A solution of 1,3-Bis(diphenylphosphino)propane (dppp, 1.0306 g, 2.5 mmol) in 
anhydrous CH2Cl2 (50 mL) was then added in one portion and the colour of the reaction 
mixture changed from orange to yellow instantly. After stirring for 15 minutes at room 
temperature, MeOH (50 mL) and the solution was concentrated to induce crystallisation of 
the product. The yellow precipitate was then filtered off on a coarse glass frit, washed with 
additional MeOH and dried under vacuum to afford PdCl2(dppp) (1.39 g, 94%) as a faint 
yellow, microcrystalline solid.  
 
1
H NMR (300 MHz, CD2Cl2) δ 1.99 (2H, m, CH2), 2.41 (4H, m, 2 × CH2), 7.49 (12H, m, 
ArH), 7.77 (8H, m, ArH); 
31
P NMR (121 MHz, CD2Cl2) δ 11.35; LRMS (ESI) [(M-Cl)+OH]
+
 
571 m/z 
 
Pd(dppp)(OTf)2 
 
An oven dried 250 mL Schlenk flask was assembled with a Teflon coated magnetic stir bar 
and a rubber septum while hot and then evacuated. The flask was then flame dried under 
vacuum and allowed to cool under N2. The septum was then removed briefly for the addition 
of PdCl2(dppp) (0.885 g, 1.5 mmol) and replaced. Anhydrous CH2Cl2 (150 mL) was then 
added via syringe to form a yellow solution. AgOTf (1.16 g, 4.51 mmol, 3 equiv) was then 
weighed out in a glove box and quickly transferred to the reaction vessel by removing the 
septum again. The suspension was then stirred under N2 at room temperature overnight 
(17 h). The solid were then filtered off and the combined mother liquors were concentrated to 
25 mL and anhydrous Et2O was added to precipitate the product. The crystalline complex 
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was then filtered off and dried under vacuum to afford Pd(dppp)(OTf)2 (1.15 g, 91%) as a 
yellow solid.  
 
1
H NMR (300 MHz, CD2Cl2) δ 2.30 (2H, m, CH2), 2.72 (4H, m, 2 × CH2), 7.40 (12H, m, 
ArH), 7.60 (8H, m, ArH); 
31
P NMR (121 MHz, CD2Cl2) δ 17.23; 
19
F (282 MHz, CD2Cl2) δ -
78.67; LRMS (ESI) [(M-OTf)+H]
+
 667 m/z 
 
[Pd(dppp)(OH2)2]
2+
(OTf)2
2-
 
 
An oven dried 250 mL Schlenk was assembled with a Teflon coated magnetic bar and rubber 
septum while hot and then evacuated. The flask was then flame dried and allowed to cool 
under N2. The septum was then removed briefly for the addition of Pd(dppp)(OTf)2 
(0.8175 g, 1 mmol) and replaced. Anhydrous CH2Cl2 (120 mL) was then added via syringe 
followed by the addition of deionised H2O (120 µL, 6.66 mmol, 6.7 equiv). The solution was 
then allowed to stir under N2 for 1 hour at room temperature. The reaction mixture was then 
concentrated to 25 mL and anhydrous n-pentane (120 mL) was then added via syringe with 
stirring. The solvent was then decanted by syringe and the residue was dried under vacuum to 
afford [Pd(dppp)(OH2)2]
2+
(OTf)2
2-
 (0.78 g, 92%) as a microcrystalline yellow solid. 
 
1
H NMR (300 MHz, d6-Acetone) δ 3.2 (4H, m, 2 × CH2), 3.81 (2H, m, CH2), 5.62 (4H, s, 2 × 
OH2), 7.53 (12H, m, ArH), 7.89 (8H, m , ArH); 
31
P NMR (121 MHz, d6-Acetone) δ 17.39; 
19
F (282 MHz, d6-Acetone) δ -78.86; LRMS (ESI) [M-2OTf]
+
 555 m/z 
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3.3.3.2 Methyl 2,3-bis(acetyloxy)-3-(3,4-dimethoxyphenyl)propanoate (294)
13
 
 
 
 
To a 25 mL, single neck RBF equipped with a small Teflon coated magnetic stir bar and glass 
stopper was added 292 (111 mg, 0.5 mmol) followed by [Pd(dppp)(OH2)2].(OTf)2 (10.2 mg, 
0.012 mmol, 2.4 mol%), AcOH (5 mL), deionised H2O (27 µL, 1.5 mmol, 3.0 equiv) and 
PhI(OAc)2 (178 mg, 0.55 mmol, 1.1 equiv) at room temperature. A reflux condenser was 
fitted and the resulting solution was then stirred at 50
o
C for 2 h*. After complete 
consumption of 292 (TLC, 45% EtOAc/Hexane) the reaction mixture was allowed to cool to 
room temperature, Ac2O (0.5 mL, 5.3 mmol, 10.6 equiv) was added and stirring was 
continued overnight at room temperature. All volatiles were then evaporated to afford a 
yellow residue which was analysed by GC/MS. 
 
LRMS (EI) [M]
+
 340 m/z 
 
*This reaction was also performed at room temperature (8 days) with the same acetylation 
procedure. 
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3.3.4 Erlenmeyer synthesis of methyl (±)-dimethoxydanshensu (300)
18
 
 
3.3.4.1 N-Acetylglycine
57
 
 
 
 
To a 2L beaker situated below a mechanical stirrer was added deionised H2O (100 mL). The 
stirrer was started and NaOH (60.06 g, 1.50 mol) was added in portions. While the caustic 
solution was still warm glycine (75.09 g, 1.0 mol) was added in one portion. The reaction 
mixture was cooled by the addition of ice (≈ 500 g), the stirrer speed was increased and Ac2O 
(118 mL, 127.44 g, 1.25 mol) was added quickly (1 – 3 seconds). The slightly yellow 
solution was then stirred vigorously for 5 minutes to ensure completion of the reaction. The 
basic solution was then acidified with concentrated HCl (35% (w/w)) to pH 1 to convert the 
sodium carboxylate salt of N-acetylglycine to the free acid, which precipitated out of 
solution. The product was the filtered off and dried in a vacuum oven (50
o
C, 10 mmHg) 
overnight to afford N-acetylglycine (86.6 g, 74%) as a white solid which was determined to 
be satisfactorily pure by 
1
H and 
13
C NMR. 
 
1
H NMR (300 MHz, d6-DMSO) δ 1.84 (3H, s, CH3CONH), 3.71 (2H, d, J = 3.8 Hz, CH2), 
8.16 (1H, s, NHAc), 12.48 (1H, brs, CO2H); 
13
C NMR (75 MHz, d6-DMSO) δ 22.5 
(CH3CONH), 41.0 (CH2), 170.4 (CO2H), 171.8 (CH2CONH); LRMS (ESI) [M-H]
-
 116 m/z 
 
3.3.4.2 3,4-Dihydroxybenzaldehyde (Protocatechualdehyde, 29)
58
  
 
 
 
An oven dried 1L, three-necked RBF was assembled with an oven dried 250 mL pressure 
equalising funnel, a reflux condenser fitted with an N2 gas inlet, a large Telfon coated oval 
shaped magnetic stir bar and a glass stopper while hot and then evacuated. The whole 
apparatus was then flame dried under vacuum and allowed to cool under N2. Vanillin 
(38.05 g, 0.25 mol) was then added to dry flask followed by anhydrous CH2Cl2 (450 mL) and 
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anhydrous AlCl3 (36.77 g, 0.28 mol, 1.12 equiv). The suspension was then cooled to 0
o
C 
(Ice/H2O) and anhydrous pyridine (88.40 g, 1.12 mol, 4.5 equiv) was introduced to the 
pressure equalising funnel and added to the reaction mixture drop-wise. Upon completion of 
the addition the cooling bath was replaced by an oil bath and the reaction mixture was heated 
to reflux (T (oil bath) = 45
o
C) and maintained at this temperature with vigorous stirring for 
24 hours during which time the colour of the solution changed from dark orange to an 
opaque, dark red-orange solution. The reaction mixture was then allowed to cool to room 
temperature before the AlCl-complex was hydrolysed with concentrated HCl (35% (w/w)). 
The two phases were then separated, the lower CH2Cl2 phase containing unreacted vanillin 
leaving the demethylated product in the aqueous phase. The aqueous phase was then 
extracted with Et2O (3 × 100 mL) and the combined ethereal layers were dried over MgSO4, 
filtered through a pad of Celite and evaporated to afford 13.04 g (38%) of crude 29 as a grey 
solid. The crude product was then recrystallised from boiling PhMe to afford 29 (8.7 g, 25%) 
as fine yellow crystals.   
 
1
H NMR (300 MHz, d6-DMSO) δ 6.90 (1H, d, J = 7.9 Hz, ArH), 7.25 (2H, m, ArH), 9.7 (1H, 
s, CHO), 9.82 (2H, brs, 2 × OH); LRMS (ESI) [M-H]
-
 137 m/z 
 
3.3.4.3 Model Erlenmeyer reaction – 3-[3,4-Bis(acetyloxy)phenyl]-2-acetamidoprop-2-
enoic acid (34)
17
 
 
 
 
An oven dried 100 mL, three-necked RBF was assembled with a reflux condenser topped 
with a N2 gas inlet, a Telfon coated oval shaped magnetic stir bar and two glass stoppers 
while hot and then evacuated. The whole apparatus was then flame dried under vacuum and 
allowed to under N2. 29 (3.4558 g, 25 mmol) was then added to the dry flask followed by N-
acetylglycine (2.9362 g, 25 mmol, 1 equiv) and anhydrous NaOAc (2.9444 g, 36 mmol, 
1.44 equiv). The three solids were then stirred neat until a homogenous mixture was 
achieved. Excess anhydrous Ac2O (20 mL) was then added and the heterogeneous mixture 
was stirred vigorously, heated to 100
o
C and maintained at this temperature under N2 for 
2 hours. The reaction mixture was then allowed to cool to room temperature and the viscous 
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solution was poured into a chilled solution (3 – 5oC) of deionised H2O (120 mL). A yellow 
gum separated from the aqueous solution and was left to solidify overnight. The next day the 
yellow solid was collected and recrystallised from boiling deionised H2O to afford 34 (3.0 g, 
37%) as an orange, crystalline solid.    
 
1
H NMR (300 MHz, d6-DMSO) δ 1.98 (3H, s, NHCOCH3), 2.28 (3H, s, ArOCOCH3), 2.29 
(3H, s, ArOCOCH3), 7.19 (1H, s, ArCH=C), 7.30 (1H, d, J = 8.3 Hz, ArH), 7.52 (2H, m, 
ArH), 9.51 (1H, s, NH), 12.74 (1H, brs, CO2H); LRMS (ESI) [M-H]
-
 320 m/z 
 
3.3.4.4 4-[(3,4-Dimethoxyphenyl)methylidene]-2-methyl-4,5-dihydro-1,3-oxazol-5-one 
(297)
18
 
 
 
 
An oven dried 1 L, three-necked RBF was assembled with a reflux condenser topped with a 
N2 gas inlet, a Teflon coated oval shaped magnetic stir bar and two glass stoppers while hot 
and then evacuated. The whole apparatus was then flame dried under vacuum and allowed to 
cool under N2. 61 (58.184 g, 350 mmol) in powder form was then added to the dry flask 
followed by N-acetylglycine (41.086 g, 351 mmol) and anhydrous NaOAc (28.781 g, 
351 mmol). The three solids were then stirred neat until a homogenous mixture was achieved. 
Excess anhydrous Ac2O (200 mL) was then added and the heterogeneous mixture was stirred 
vigorously, heated to 100
o
C and maintained as this temperature under N2 for 4 hours. Upon 
cooling of the viscous slurry a heavy precipitate formed which was filtered off with deionised 
H2O rinses and dried under vacuum. The red solid was then dissolved in CHCl3 (400 mL), 
dried over MgSO4 and filtered. Hexane was then added to the mother liquor and 
recrystallisation was carried out to afford 297 (33 g, 38%) as bright orange crystals.  
 
1
H NMR (300 MHz, CDCl3) δ 2.40 (3H, s, CH3), 3.952 (3H, s, OCH3), 3.965 (3H, s, OCH3), 
6.92 (1H, d, J = 8.3 Hz, ArH), 7.10 (1H, s, ArCH=C), 7.52 (1H, dd, J = 8.7, 1.5 Hz, ArH), 
7.95 (1H, d, J = 2.1 Hz, ArH); 
13
C NMR (75 MHz, CDCl3) δ 15.5 (CH3), 55.8 (OCH3), 55.8 
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(OCH3), 110.7, 113.7, 126.3, 127.2, 130.4, 164.7 (CCH3), 167.9 (CO2); LRMS (ESI) [M+H]
+
 
248 m/z 
 
3.3.4.5 3-(3,4-Dimethoxyphenyl)-2-acetamidoprop-2-enoic acid (296)
18
 
 
 
 
To a 1 L single, wide necked RBF equipped with a large Teflon coated oval shaped magnetic 
stir bar was added 297 (20.14 g, 81.5 mmol) followed by reagent grade acetone (203 mL) and 
deionised H2O (203 mL). A reflux condenser was then fitted and the orange solution was 
heated to reflux (T (oil bath) = 120
o
C) and maintained at this temperature with vigorous 
stirring for 5 hours. Over this period of time the colour of the reaction mixture changed from 
orange to faint yellow. The solution was then allowed to cool to approximately 50
o
C and 
activated charcoal was added. The black suspension was then heated back to reflux and hot 
filtered under gravity with additional aqueous acetone (50% (v/v)) rinses. The combined 
mother liquors were then allowed to slowly cool to room temperature overnight. The next day 
the white crystals were filtered off, washed with a chilled aqueous acetone solution of the 
same composition and dried under vacuum to afford 296 (17.1 g, 79%) as light, voluminous 
colourless crystals.  
 
1
H NMR (300MHz, d6-DMSO) δ 1.99 (3H, s, NHCOCH3), 3.76 (3H, s, OCH3), 3.78 (3H, s, 
OCH3), 6.99 (1H, d, J = 8.5 Hz, ArH), 7.20 (2H, m, ArCH=C & ArH), 7.31 (1H, d, J = 
1.9 Hz, ArH), 9.40 (1H, s, NH), 12.51 (1H, brs, CO2H); 
13
C NMR (75 MHz, d6-DMSO) δ 
22.6 (NHCOCH3), 55.4 (OCH3), 55.6 (OCH3), 111.6, 112.8, 123.9, 125.1, 126.4, 132.2, 
148.4, 149.9, 166.7 (CO2H), 169.2 (NHCOCH3); LRMS (ESI) [M-H]
-
 264 m/z 
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3.3.4.6 3-(3,4-Dimethoxyphenyl)-2-hydroxyprop-2-enoic acid (298)
18
 
 
 
 
To a 1 L, single wide necked RBF equipped with a large Teflon coated magnetic stir bar was 
added 296 (10.61 g, 40 mmol) followed by a dilute aqueous solution of HCl (1M, 400 mL). A 
reflux condenser was then fitted and the suspension was heated to reflux (T (oil bath) = 
160
o
C) and maintained at this temperature with vigorous stirring for 8 hours. After 
approximately 45 minutes a solution had formed. The faint yellow solution was then allowed 
to cool to room temperature where the hydrolysed product precipitated out of solution. The 
solid was the filtered off, washed with deionised H2O (100 mL) and dried under vacuum to 
afford 298 (8.1 g, 90%) as a crystalline yellow solid. To achieve a quantitative yield the 
combined mother liquors can be extracted with EtOAc but the product obtained after 
evaporation of the EtOAc extract is significantly lower in purity compared to the precipitated 
product. 
 
1
H NMR (300MHz, d6-DMSO) δ 3.74 (3H, s, OCH3), 3.76 (3H, s, OCH3), 6.38 (1H, s, 
ArCH=C), 6.93 (1H, d, J = 8.5 Hz, ArH), 7.32 (1H, dd, J = 8.7, 1.9 Hz, ArH), 7.43 (1H, d, J 
= 1.9 Hz, ArH), 8.99 (1H, brs, OH), 13.04 (1H, brs, CO2H); 
13
C NMR (75 MHz, d6-DMSO) δ 
55.5 (2 × OCH3), 110.4, 111.71, 113.0, 122.8, 128.0, 140.3, 148.5 (2 × COCH3), 166.7 
(CO2H); LRMS (ESI) [M-H]
-
 223 m/z 
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3.3.4.7 3-(3,4-Dimethoxyphenyl)-2-hydroxypropanoic acid (299)
18
 
 
 
 
Preparation of Zn(Hg) amalgam
21
 
  
To a 250 mL conical flask equipped with a Teflon coated, bar shaped magnetic stir bar was 
added deionised H2O (90 mL) followed by concentrated HCl (35% (w/w), 3 mL). HgCl2 (6 g) 
was then added and the aqueous suspension was stirred magnetically at room temperature 
until a solution formed (10 to 15 minutes). During this time Zn dust (< 10 µm, 30 g) was 
washed with dilute aqueous HCl (3% (w/w), 5 × 150 mL) to remove any metallic oxides from 
the surface of the zinc. The activated zinc was then quickly added to Hg
2+
 solution and the 
resulting zinc suspension was sonicated and agitated with a glass rod for 15 minutes. The 
resultant amalgam was the filtered off and washed with absolute EtOH (150 mL) followed by 
anhydrous Et2O (150 mL). It is best to use the amalgam as quickly as possible to prevent 
aerobic oxidation of the active amalgam surface.   
 
To a 500 mL, singled-neck RBF equipped with a large Teflon coated oval shaped magnetic 
stir bar was added 298 (7.864 g, 35 mmol) followed by PhMe (35 mL), freshly prepared 
Zn(Hg) amalgam (32 g) and dilute aqueous HCl (3M, 210 mL). The suspension was then 
stirred briefly before it was sonicated for 10 minutes to initiate the reaction. Once the aqueous 
emulsion began to produce heat it was quickly assembled with a reflux condenser and 
suspended above a pre-heated oil bath (90
o
C). The suspension was then vigorously stirred at 
this temperature for 6 hours.  The suspension was then filtered while hot under vacuum and 
the mother liquor was allowed to cool. The combined mother liquors were then thoroughly 
extracted with EtOAc (5 × 70 mL). The combined organic layers were then extracted with 
dilute aqueous Na2CO3 solution (5% (w/w), 3 × 70 mL). The pH of the combined aqueous 
layers was then adjusted to 1 with concentrated HCl, extracted again with Et2O (5 × 70 mL), 
dried over MgSO4, filtered through a thin pad (3 – 5 cm) of Celite and evaporated to afford 
5.43 g (72%) of crude 299. The crude product was then recrystallised from boiling PhMe* 
(100 mL) to afford 299 (3.4 g, 43%) as a white solid. 
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*CH3CN could also be used as the recrystallisation solvent to obtain colourless crystals.       
1
H NMR (300 MHz, d6-DMSO) δ 2.70 (1H, dd, J = 13.8, 8.1 Hz, ArHCH), 2.88 (1H, dd, J = 
13.6, 4.5 Hz, ArHCH), 3.70 (3H, s OCH3), 3.72 (3H, s, OCH3), 4.11 (1H, dd, J = 8.1, 4.5 Hz, 
CH), 6.73 (1H, dd, J = 8.1, 1.9 Hz, ArH), 6.83 (2H, m, ArH); 
13
C NMR (75 MHz, d6-DMSO) 
δ 39.7 (CH), 55.4 (CH2), 111.7, 113.4, 121.4, 130.6, 147.4, 148.4, 175.3 (CO2H); LRMS 
(ESI) [M-H]
-
 225 m/z 
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3.3.4.8 Methyl (±)-3-(3,4-dimethoxyphenyl)-2-hydroxypropanoate (300) 
 
 
 
To an oven dried 35 mL microwave vial equipped with a Teflon coated oval shaped magnetic 
stir bar was added 299 (1.1353 g, 5.0 mmol) followed by anhydrous MeOH (10 mL). The 
clear solution was then stirred while AcCl (15 drops) was added at room temperature. The 
microwave vial was then sealed with a Teflon cap and placed in CEM microwave cavity and 
subjected to the reaction program. The reaction was complete in 6.5 minutes after cooling 
below 60
o
C. The excess MeOH was then evaporated to afford a yellow oil which was 
dissolved in EtOAc (25 mL). The organic layer was then washed with deionised H2O (5 mL). 
The aqueous layer was then extracted with additional EtOAc (2 × 25 mL) and the combined 
organic layers were washed with saturated aqueous NaHCO3 (10% (w/w), 30 mL), brine 
(30 mL), dried over MgSO4, filtered through a pad of SiO2 (3 – 5 cm) and evaporated to 
afford a clear oil. This oil was then dried under high vacuum (≤ 0.5 mmHg) and chilled in a 
refrigerator to afford 300 (1.14 g, 94%) as white crystals which were determined to be 
satisfactorily pure by 
1
H NMR.  
 
*Refer to the characterisation data obtained for the same compound (300) prepared by 
Darzen‟s condensation. 
 
Microwave conditions 
 
T(
o
C) 70 
Ramp t (min) 10 
Hold t (min) 5 
Pressure (PSI) 10 
Power (W) 100 
Power Max On 
Stirring High 
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3.3.5 Attempted resolution of methyl (±)-dimethyldanshensu (300) by 
diastereomic salt formation 
 
3.3.5.1 (S)-L-Phenylalaninol (302)
23
 
 
 
 
An oven dried 1 L, three-necked RBF was assembled with a 100 mL pressure equalising 
funnel, a reflux condenser equipped with a N2 gas inlet and a glass stopper while hot and then 
evacuated. The whole apparatus was then flame dried under vacuum and allowed to cool 
under N2. L-Phenylalanine (301, 24.80 g, 150 mmol) was then added to the dry flask 
followed by anhydrous THF (150 mL) and NaBH4 (14.4 g, 381 mmol, 2.54 equiv). The white 
suspension was then cooled to 0
o
C (Ice/H2O) and a freshly prepared solution of concentrated 
H2SO4 (10.1 mL, 18.6 g, 190 mmol, 1.3 equiv) in anhydrous Et2O (20 mL) was introduced to 
the pressure equalising funnel and added to the reaction mixture dropwise over a period of 5 
hours. The cooling bath was then removed and the reaction mixture was allowed to stir at 
room temperature overnight. Any unreacted boron complexes were then quenched with 
MeOH (15 mL). The solution was then concentrated to approximately 75 mL and dilute 
aqueous NaOH solution (5M, 150 mL) was added. All volatiles were then removed by 
evaporation at reduced pressure and the caustic solution was heated to reflux (T (oil bath) = 
120
o
C) and maintained at this temperature for 3 hours. The turbid aqueous solution was then 
filtered over a pad of celite (3 – 5 cm) with additional deionised H2O rinses. The total volume 
of mother liquor was then made up to approximately 150 mL and the aqueous solution was 
extracted with EtOAc (4 × 100 mL). The combined organic layers were then washed with 
brine (100 mL), dried over MgSO4, filtered and evaporated to afford the crude product as a 
faint yellow solid. The crude product was then recrystallised from EtOAc/hexane to afford 
302 (18 g, 79%) as fine, voluminous white crystals.  
 
1
H NMR (300 MHz, CDCl3) δ 2.54 (1H, dd, J = 13.6, 8.7 Hz, ArHCH), 2.81 (1H, dd, J = 
13.5, 5.3 Hz, ArHCH), 3.13 (1H, m, CH), 3.39 (1H, dd, J = 10.6, 7.4 Hz, HCHOH), 3.65 
(1H, dd, J = 10.6, 4.0 Hz, HCHOH), 7.22 (3H, m, ArH), 7.31 (2H, m, ArH); 
13
C NMR 
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(75 MHz, d6-Acetone) δ 40.1 (ArCH2), 60.4 (CH), 71.1 (CH2OH), 127.0, 129.2, 129.8, 140.5; 
LRMS (ESI) [M+H]
+
 152 m/z 
 
3.3.5.2 Attempted resolution of 300 with (S)-L-Phenylalaninol (302)
22
 
 
To 100 mL, single-neck RBF equipped with a small Teflon coated oval shaped magnetic stir 
bar was added 300 (0.9063 g, 4 mmol) followed by 302 (0.6754 g, 4.5 mmol, 1.13 equiv) and 
2-butanone (27 mL). A reflux condenser was then fitted and the suspension was heated to 
70
o
C to create a clear solution. The solution was then hot filtered and the mother liquor was 
allowed to slowly cool to room temperature. This resulted in no crystal formation or 
precipitation so the solution was stirred at 0
o
C (Ice/NaCl). After 2 hours of stirring, still no 
sign of crystallisation so the cooling bath was removed and the solution was stirred 
vigorously at room temperature in the hope initiating crystallisation by nucleation. After 
stirring at room temperature for 1 week no precipitate formed. In a final effort to induce salt 
formation the RBF was equipped with a reflux condenser and the solution was set to reflux (T 
(oil bath) = 100
o
C) and maintained at this temperature for 7 hours. The solution was then 
allowed to slowly cool to room temperature and was then placed in a refrigerator overnight (3 
– 5oC). After more than a month of refrigeration no precipitate formed. 
 
3.3.5.3 Microwave assisted synthesis of tartaric acid derivatives 
 
(3R,4R)-4-(Benzoyloxy)-2,5-dioxooxolan-3-yl benzoate (307)
31
 
 
 
 
To a 100 mL, single-neck RBF equipped with a Teflon coated oval shaped magnetic stir bar 
was added (2R, 3R)-tartaric acid (305, 9.026 g, 60 mmol) followed by freshly distilled 
benzoyl chloride (27.052 g, 192 mmol, 3.2 equiv). The suspension was then stirred briefly at 
room temperature before it was placed inside the CEM microwave cavity and fitted with an 
air condenser attached to length of tubing allowing the corrosive vapours to be channelled to 
the fume hood. The suspension was then subjected to the reaction program. The reaction was 
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complete in 14.5 minutes after cooling below 60
o
C. After cooling to room temperature a solid 
mass formed in the bottom of the flask. The solid mass was then removed from flask, ground 
with a mortar and pestle, washed with cold benzene (2 × 20 mL) and allowed to air dry to 
afford the crude product as a semi white solid. The crude product was then recrystallised 
from boiling xylene (130 mL) and the resulting crystals were dried in a vacuum oven (80
o
C, 
10 mmHg) to afford 307 (12.10 g, 59%) as fine white crystals.  
 
1
H NMR (300 MHz, CDCl3) δ 6.00 (2H, s, 2 × CH), 7.51 (4H, m, m-ArH), 7.68 (2H, m, p-
ArH), 8.10 (4H, m, o-ArH); 
13
C NMR (75 MHz, CDCl3) δ 72.9 (2 × CH), 127.2, 128.8, 
130.4, 134.7, 163.5 (CO2), 165.5 (CO2) 
 
*The reaction was also performed with the opposite enantiomer (2S, 3S)-tartaric acid (306). 
It was noted that reaction proceeded at a slightly faster rate but was complete in 
approximately the same time as for the L-enantiomer. After recrystallisation from xylene 
(120 mL) and drying in a vacuum oven (80
o
C, 10 mmHg) overnight, 308 (12.1 g, 59%) was 
obtained as fine white crystals with an identical yield to that achieved for the L-enantiomer. 
The 
1
H and 
13
C NMR spectra were identical to that obtained for the (2R, 3R) enantiomer. 
 
T(
o
C) 150 
Ramp t (min) 20 
Hold t (min) 5 
Pressure (PSI) - 
Power (W) 100 
Power Max On 
Stirring High 
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(2R, 3R)-2,3-Bis(benzoyloxy)butanedioic acid (309)
28
 
 
 
 
To a 35 mL microwave vial equipped with a small Teflon coated oval shaped magnetic stir 
bar was added 307* (4.66 g, 13.7 mmol) followed by deionised H2O (20 mL) and 
concentrated HCl (35% (w/w), 640 µL). The suspension was then stirred briefly at room 
temperature before it was placed inside the CEM microwave cavity and subjected to the 
reaction program. The progress of the reaction was monitored by removing the vial from the 
microwave and inspecting the mixture for unreacted, suspended anhydride. While the 
microwave vial was still warm it was subjected to a second run through the reaction program. 
The reaction was complete in a total of 40.4 minutes after cooling below 60
o
C. At this point a 
yellow oil formed on the bottom of the microwave vial. The reaction mixture was then 
allowed to cool to room temperature overnight, during which time the oil solidified to form a 
solid crystalline mass. The solid mass was then ground in a mortar and pestle, washed with a 
small volume of chilled (0
o
C) deionised H2O (10 mL) and dried under vacuum to afford 309 
(4.8 g, 98%) as a white solid.  
 
1
H NMR (300 MHz, d6-DMSO) δ 6.00 (2H, s, 2 × CH), 7.51 (4H, m, m-ArH), 7.68 (2H, m, 
p-ArH), 8.10 (4H, m, o-ArH); 
13
C NMR (75 MHz, d6-DMSO) δ 72.9 (2 × CH), 127.2, 128.8, 
130.4, 134.7, 163.5 (CO2), 165.5 (CO2); IR (KBr) 3555.54, 3414.04, 3073.93, 2960.22, 
2939.46, 1749.97, 1718.49, 1703.57, 1635.40, 1601.76, 1584.96, 1492.97, 1453.03, 1411.36, 
1351.55, 1334.65, 1318.46, 1268.36, 1215.40, 1178.86, 1142.69, 1117.43, 1095.27, 1070.12, 
1045.91, 1025.51, 1002.89, 889.23, 709.71, 682.90, 647.90 cm
-1
; LRMS (ESI) [M-H]
-
 357 
m/z 
 
*The hydrolysis was also performed with the opposite enantiomer 308 on a 6.8 mmol scale. 
The reaction was complete in 40 minutes where a yellow oil formed on the bottom of the 
microwave vial. The oil solidified overnight and was treated as before to obtain 310 (2.4 g, 
97%) as a white solid.  
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T(
o
C) 80 
Ramp t (min) 10 
Hold t (min) 30 
Pressure (PSI) 100 
Power (W) 100 
Power Max Off 
Stirring High 
 
3.3.5.4 Formation of Calcium (Ca
2+
) complex 311
29
 
 
 
 
To a 250 mL, single-neck RBF equipped with a Teflon coated magnetic stirrer was added 309 
(1.6819 g, 4.7 mmol) followed by CaO (0.2644 g, 4.7 mmol) and EtOH (150 mL). A reflux 
condenser was then fitted and the suspension was set to reflux (T (oil bath) = 150
o
C) for 
3 hours. The cloudy solution was then allowed cool to approximately 50
o
C and was filtered. 
The combined mother liquors were then concentrated to approximately 100 mL and complex 
311 precipitated out of solution. The product was then filtered and dried under vacuum to 
afford 311 (1.9 g, > 99%) as a white solid.  
 
Complex 311 could also be isolated directly by using an aqueous solution of EtOH (90% 
(v/v)) as the reaction medium. After a short period of heating the solution was allowed to 
cool to room temperature and the complex precipitated out of solution. In this way the 
complex was isolated in 61% yield. 
 
3.3.5.5 Attempted resolution of 300 with (2R, 3R)-tartaric acid derivative 309
29
 
 
To a 250 mL, single-neck RBF equipped with a Teflon coated oval shaped magnetic stir bar 
was added 309 (1.6840 g, 4.7 mmol) followed by EtOH (150 mL) and CaO (0.2641 g, 
4.7 mmol). A reflux condenser was the attached and the suspension was then heated to reflux 
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and maintained at this temperature for 15 minutes with vigorous stirring. The suspension was 
then allowed to cool to 60
o
C and was filtered. 300 (1.132 g, 4.7 mmol) was then added to the 
mother liquor and the solution was allowed to stir for an additional 15 minutes at room 
temperature before it was placed in an ice bath at 0
o
C (Ice/NaCl) and allowed to stir at this 
temperature for 2 hours. At this point no precipitate formed and deionised H2O (30 mL) was 
added to create a cloudy solution. The cloudy solution was then refrigerated for an extended 
period of time (6 months) but crystallisation of the diastereomer could not be achieved. 
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3.3.6 Synthesis of Methyl (2R)-3-(3,4-dimethoxyphenyl)-2-
hydroxypropanoate (63) via Darzens condensation followed by lipase 
catalysed kinetic resolution 
 
3.3.6.1 Methyl 2-chloroacetate (317)
38
 
 
 
 
In a 2L three-necked RBF equipped with a 250 mL pressure equalising addition funnel, 
reflux condenser, glass stopper and large Teflon coated oval shaped magnetic stir bar, a 
solution of 2-chloroacetic acid (316, 469.93 g, 5.0 mol) in AR grade MeOH (321.19 g, 
10.0 mol, 2 equiv) was prepared. Concentrated H2SO4 (250.12 g, 2.6 mol, 50 mol%) was then 
added quickly (within 5 min) via the addition funnel. An exothermic reaction is observed. 
After 30 min of stirring two separate layers are formed and the temperature of the reaction 
had returned to room temperature. The two layers are separated. The initial top layer (acidic, 
pH = 1) was washed with deionised H2O (750 mL) and the layers were separated. The first 
and second bottom layers were then combined and washed with saturated aqueous NaHCO3 
(500 mL, 10% (w/v)), deionised H2O (500 mL) and dried over MgSO4. The crude product 
was then distilled over MgSO4. The first fraction (5 – 10 mL) was discarded and the fraction 
boiling at 129 – 130oC/760 mmHg was collected. The isolated yield of 317 was 216.3 g 
(40%). 
 
1
H NMR (300 MHz, CDCl3) δ 3.81 (3H, s, CO2CH3), 4.08 (2H, s, CH2); 
13
C NMR (75 MHz, 
CDCl3) δ 40.3 (CH2), 52.4 (CO2CH3), 167.3 (CO2CH3); HRMS (EI) calculated for C3H5ClO2 
[M]
+
: 107.9978 found: 107.9975 
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3.3.6.2 Methyl 3-(3,4-dimethoxyphenyl)oxirane-2-carboxylate (314)
37
 
 
 
 
The apparatus, consisting of a 1L three-necked RBF equipped with a mechanical stirrer, 
250 mL pressure equalising addition funnel fitted with a rubber septum and a reflux 
condenser topped with an N2 gas inlet was assembled, flame dried under vacuum and cooled 
under N2. Freshly distilled MeOH (300 mL) was then added via cannula through the addition 
funnel. The stirrer was started and hexane washed Na metal (18.75 g, 0.81 mol, 2.7 equiv) 
was added in portions by removing and replacing the condenser. After approximately half of 
the Na was added, the rate of formation of NaOMe slowed. The stirrer speed was increased 
and the second half of the Na was added at a faster rate. At this point the formation of 
NaOMe ceased and unreacted Na remained. The vessel was heated with a bunsen burner to 
reflux and maintained this temperature for 15 to 30 min until all Na had reacted. The cloudy 
solution was then allowed to cool to room temperature while the next reagents were prepared. 
 
An oven dried 250 mL schlenk flask was assembled with a rubber septum, flame dried and 
cooled under N2. Ground 3,4-dimethoxybenzaldehyde (61, 49.86 g, 0.3 mol, 1 equiv) was 
added to the Schlenk flask followed by methyl chloroacetate (317, 87.97 g, 0.81 mol, 
2.7 equiv). This flask was evacuated and purged with N2 (3×) then swirled until a 
homogenous solution was achieved. The contents of this flask were then transferred via 
cannula to the addition funnel. The methanolic NaOMe solution was then cooled to -10
o
C 
(ice/NaCl, -20
o
C) and the yellow-orange solution in the addition funnel was added drop-wise 
over a period of 3 hours with vigorous stirring. During the addition a thick white precipitate 
formed and even stirring became difficult. The temperature of the ice bath was raised to -
10
o
C (reaction temperature 5
o
C) and the reaction was stirred for a further 2 hours. The ice 
bath was then removed and the reaction mixture was allowed to warm to room temperature 
over 3 hours. During this time stirring became easier, the colour of the solution changed to 
yellow and a free flowing white precipitate formed. The crude mixture was then poured into a 
chilled solution of AcOH (15 mL) in deionised H2O (585 mL) with additional deionised H2O 
rinses. A white precipitate formed immediately, was filtered off and dried in vacuo yielding 
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59.28 g (83%) of an off white pasty solid. This crude solid was then dissolved in the 
minimum amount of EtOAc at room temperature and charcoal was added. The black 
suspension was stirred for 20 minutes at room temperature, dried over MgSO4 and filtered. A 
sufficient amount of hexane was added to the filtrate to induce cloudiness and 
recrystallization was carried out. The recrystallization was repeated 3 times for a total yield 
of 34.9 g (49%) where 314 was obtained as white crystals. 
 
Mp. = 60 – 62 oC; 1H NMR (300 MHz, DMSO) δ 3.73 (3H, s, CO2CH3), 3.75 (6H, s, 2 × 
OCH3), 3.87 (1H, d, J = 1.9 Hz, trans-CHCO2CH3), 4.09 (1H, d, J = 1.9 Hz, trans-CHAr), 
6.90 (1H, s, ArH), 6.95 (2H, d, J = 0.9 Hz, ArH); 
13
C NMR (75 MHz, CDCl3) δ 52.3 
(CHCO2CH3), 55.7 (OCH3), 55.7 (OCH3), 56.3 (CO2CH3), 57.8 (ArCH), 107.9, 110.9, 
118.7, 127.0, 149.5 (2 × ArCOCH3), 168.5 (CO2CH3); IR (KBr) 3007.27, 2952.81, 2843.58, 
1726.20, 1610.76, 1595.57, 1520.52, 1452.98, 1437.99, 1413.59, 1307.46, 1267.75, 1242.14, 
1224.48, 1155.11, 1141.17, 1025.15 cm
-1
; HRMS (EI) calculated for C12H14O5 [M]
+
: 
238.0841, found: 238.0905. 
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3.3.6.3 Methyl (±)-3-(3,4-dimethoxyphenyl)-2-hydroxypropanoate (300)
32
 
 
 
 
An oven dried 250 mL, two-necked RBF was assembled with a tubing adapter including a 
two way Teflon tap, a second tubing adapter with a two way Teflon tap attached to a balloon 
and a Telfon coated oval shaped magnetic stir bar while hot and evacuated. The flask was 
then flame dried under vacuum and allowed to cool under N2. 314 (19.35 g, 81.22 mmol) was 
then added to the dry flask followed by anhydrous EtOAc (122 mL) and 10% Pd/C (1.35 g, 
7% w/w per gram of 314). Both Quick-fit joins were then greased and the reaction vessel was 
the flask was then attached to a vacuum/H2 manifold and evacuated and purged with H2 (×3). 
After the third evacuation the balloon was then filled with H2 and the vessel was closed to 
maintain positive H2 atmosphere. The black suspension was then vigorously stirred at room 
temperature for 8 hours. Progress of the reaction was monitored via TLC (32% 
EtOAc/hexane + 1% Et3N) and upon completion the H2 was vented (fume-hood), the black 
suspension filtered through a pad of Celite with anhydrous EtOAc rinses (3×) and the 
combined filtrates were evaporated. The resulting crude light green to yellow oil was then 
subjected to FCC (SiO2, 10% Et2O/CH2Cl2) to afford 300 as yellow to light green oil. This oil 
was then dried in a vacuum oven (50
o
C, 10 mmHg) overnight to present 300 (16.7 g, 85%) as 
a white solid. 
 
Mp. = 49 – 50 oC; 1H NMR (300 MHz, CDCl3) δ 2.69 (1H, d, J = 6.4 Hz, OH), 2.93 (1H, dd, 
J = 14.3, 6.8 Hz, HCH), 3.09 (1H, dd, J = 14.0, 4.4 Hz, HCH), 3.79 (3H, s, CO2CH3), 3.868 
(3H, s, OCH3), 3.875 (3H, s, OCH3), 4.45 (1H, m, CH), 6.78 (3H, m, ArH); 
13
C NMR 
(75 MHz, CDCl3) δ 39.9, 52.2, 55.6, 55.6, 71.2, 111.0, 112.5, 121.3, 128.6, 147.8, 148.6, 
174.3 (CO2CH3); IR (KBr) 3394.35, 3006.58, 2989.98, 2948.49, 2908.85, 2833.13, 1726.60, 
1593.98, 1516.78, 1461.85, 1444.87, 1264.10, 1241.89, 1214.18, 1157.30, 1141.84, 1098.59, 
1028.05 cm
-1
; HRMS (EI) calculated for C12H16O5 [M]
+
: 240.0998, found: 240.1012. 
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3.3.6.4 Methyl (2R)-3-(3,4-dimethoxyphenyl)-2-hydroxypropanoate (63) and Methyl 
(2S)-2-(acetyloxy)-3-(3,4-dimethoxyphenyl)propanoate (320) 
 
This lipase catalysed resolution was conducted in batches. A typical experiment would 
consist of two 10 mmol scale reactions run side-by-side. Upon completion they were filtered 
on the same sintered glass funnel, thereby combining the products from both reactions. 
Described below is a procedure for one of these batches. 
 
To a 100 mL single neck RBF equipped with an oval shaped, Teflon coated magnetic stir bar 
was placed ground 300 (2.40 g, 10 mmol) followed by TBME (25 mL) and deionised H2O 
(250 µL). The resulting mixture was then stirred until homogenous and Amano lipase PS 
from Burkholderia cepacia (2.40 g, 1 wt equiv) was added followed by freshly distilled vinyl 
acetate (9.4 mL, 10 equiv). A reflux condenser with N2 inlet was attached and the 
heterogeneous reaction mixture was placed under N2, set to 50
o
C (oil bath) and stirred 
vigorously (1000 rpm) at this temperature for 48 hours.  
 
The two reaction mixtures were then cooled to room temperature and filtered through a pad 
of Celite/MgSO4 on the same sintered glass funnel. The filter cake was rinsed with EtOAc 
(3×) and the combined filtrates were evaporated to afford an oily yellow residue. This 
mixture was analysed by 
1
H NMR (CDCl3) and conversion to the acetylated product (320) 
was estimated to be 37%. This crude mixture was then separated by FCC (SiO2, 0 – 10% 
Et2O/CH2Cl2) to provide 3.17 g of (R)-enantiomer enriched 300 and 1.80 g of 320. The (R)-
enriched fraction of 300 was then dried under high vacuum (≤ 0.05 mmHg) to remove 
residual AcOH still present after FCC and resubjected to a second round of resolution.  
 
To a 100 mL single neck RBF equipped with an oval shaped, Teflon coated magnetic stir bar 
was added (R)-enriched 300 (3.17 g, 13.19 mmol) followed by TBME (33 mL), deionised 
H2O (330 µL) and freshly distilled Vinyl acetate (12.30 mL, 10 equiv). A reflux condenser 
with N2 inlet was attached, and the heterogeneous reaction mixture was placed under N2, set 
to 50
o
C (oil bath) and stirred vigorously (1000 rpm) at this temperature for 48 hours. The 
reaction mixture was then cooled to room temperature, filtered through a pad of 
Celite/MgSO4 on a sintered glass funnel. The filter cake was rinsed with EtOAc (3×) and the 
combined filtrates were evaporated. The crude viscous yellow oil was then subjected to FCC 
(SiO2, 0 – 10% Et2O/CH2Cl2) to afford 2.26 g (47% based on a maximum yield of 50%) of 63 
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as a white crystalline solid and 0.85 g of 320 as a yellow oil bringing the total yield to 2.65 g 
(47% based on a maximum yield of 50% from the racemate). 
 
 
 
[α]D
24
 + 9.078
o
 (c 1.085 in CH2Cl2); Mp. = 64 – 65 
o
C; 
1
H NMR (300 MHz, CDCl3) δ 2.70 
(1H, d, J = 6.2 Hz, OH), 2.93 (1H, dd, J = 13.9, 6.7 Hz, HCH), 3.09 (1H, dd, J = 14.1, 
4.5 Hz, HCH), 3.79 (3H, s, CO2CH3), 3.868 (3H, s, OCH3), 3.875 (3H, s, OCH3), 4.45 (1H, 
m, CH), 6.79 (3H, m ArH); 
13
C NMR (75 MHz, CDCl3) δ 39.9, 52.2, 55.6, 55.6, 71.2, 111.0, 
112.5, 121.3, 128.6, 147.8, 148.6, 174.3 (CO2CH3); IR (KBr) 3393.52, 3006.56, 2990.09, 
2948.48, 2929.96, 2908.76, 2833.15, 1726.38, 1593.95, 1516.83, 1461.85, 1444.96, 1421.62, 
1264.09, 1242.03, 1214.53, 1157.38, 1141.87, 1098.66, 1028.03 cm
-1
; HRMS (EI) calculated 
for C12H16O5 [M]
+
: 240.0998, found: 240.1042. 
 
 
 
 
[α]D
24
 - 2.8
o
 (c 0.726 in CH2Cl2); 
1
H NMR (300 MHz, CDCl3) δ 2.06 (3H, s, COCH3), 3.05 
(2H, m, CH2), 3.69 (3H, s, CO2CH3), 3.83 (3H, s, OCH3), 3.84 (3H, s, OCH3), 5.16 (1H, q, J 
= 13.0, 8.3, 4.7 Hz, CH), 6.74 (3H, m, ArH); 
13
C NMR (75 MHz, CDCl3) δ 20.5 (COCH3), 
36.8, 52.1, 55.6, 55.7, 73.0, 110.9, 112.2, 121.2, 128.1, 147.9, 148.6, 170.0 (COCH3), 170.1 
(CO2CH3); IR (neat, NaCl plates) 3001.58, 2955.31, 2938.67, 2837.52, 1747.50 (COCH3), 
1608.74, 1592.04, 1517.42, 1464.78, 1454.62, 1441.09, 1374.96, 1263.88, 1238.64, 1158.83, 
1142.94, 1074.81, 1028.43 cm
-1
; HRMS (EI) calculated for C14H18O6 [M]
+
: 282.1103, found: 
282.1150. 
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3.3.6.5 Procedure for the separation of acetylated product 320 by sulphation of alcohol 
300 with SO3.py
42
 
 
To the RBF containing the crude mixture from the resolution (6.15 mmol) was added a 
Teflon coated, oval shaped magnetic stir bar followed by pyridine (10 mL) and DMF (2 mL). 
To the resulting solution was then added SO3.Pyridine complex (1.5915, 10 mmol) and the 
solution was stirred at room temperature for 2 hours. The reaction mixture was then diluted 
with EtOAc (70 mL) and the layers were separated. The combined EtOAc layers were then 
dried over MgSO4, filtered through a thin pad of SiO2 (3 – 5 cm) and evaporated to afford the 
acetyated product 320 (0.62 g, 44%). The aqueous layers were then evaporated (60
o
C, 
5 mmHg) and freeze dried (0.02 mmHg). The dehydrated material was then dissolved in a 
solution of methanolic HCl (1.1 M) and brine (50 mL). The solution was then extracted with 
EtOAc (3 × 50 mL). The combined organic layers were then washed with dilute aqueous HCl 
(2M, 50 mL), brine (50 mL), dried over MgSO4, filtered through a thin pad of SiO2 (3 – 
5 cm) and evaporated to afford pure 63 (0.20 g, 27%)  as a white solid. 
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3.3.6.6 Methyl (2S)-3-(3,4-dimethoxyphenyl)-2-hydroxypropanoate (325) 
 
 
 
To a 100 mL, single neck RBF equipped with an oval shaped, Teflon coated magnetic stir bar 
was added 320 (2.65 g, 9.37 mmol) followed by freshly distilled MeOH (23 mL). This 
mixture was stirred at room temperature until homogeneous and anhydrous K2CO3 (1.31 g, 
9.48 mmol, 1.01 equiv) was added. The resulting suspension was stirred at room temperature 
for 30 min. The progress of the reaction was monitored via TLC (10% Et2O/CH2Cl2) and 
upon completion the reaction mixture was evaporated. To the resulting yellow – green 
residue was added deionised H2O (100 mL) and the aqueous layer was extracted with EtOAc 
(3 × 50 mL). The combined organic layers were then washed with brine (50 mL), dried over 
MgSO4, filtered through a pad of SiO2 on a sintered glass funnel and evaporated to afford 
1.56 g (69%) of 325 as white crystals. This product was determined to be pure via 
1
H NMR 
and GC/MS and did not require further purification. 
 
[α]D
24
 - 12.9
o
 (c 1.031 in CH2Cl2); Mp. = 65 – 66 
o
C; 
1
H NMR (300 MHz, CDCl3) δ 2.70 
(1H, d, J = 6.2 Hz, OH), 2.93 (1H, dd, J = 14.2, 6.6 Hz, HCH), 3.09 (1H, dd, J = 14.2, 
4.4 Hz, HCH), 3.79 (3H, s, CO2CH3), 3.868 (3H, s, OCH3), 3.874 (3H, s, OCH3), 4.45 (1H, 
m, CH), 6.78 (3H, m, ArH); 
13
C NMR (75 MHz, CDCl3) δ 39.9, 52.1, 55.6, 55.6, 71.2, 111.0, 
112.5, 128.6, 147.8, 148.5, 174.3 (CO2CH3); IR (KBr) 3394.24, 3006.45, 2989.98, 2948.50, 
2929.89, 2908.79, 2833.13, 1726.68, 1593.92, 1516.75, 1461.80, 1444.98, 1421.73, 1264.09, 
1242.05, 1214.56, 1157.41, 1141.97, 1098.81, 1028.10 cm
-1
; HRMS (EI) calculated for 
C12H16O5 [M]
+
 240.0998, found 240.0971. 
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3.3.7 Determination of enantiomeric excess (ee) for the (R) and (S) 
danshensu derivatives (63 & 325) 
 
3.3.7.1 Preparation of protected proline auxiliaries  
 
N-Trifluoroacetyl-(2S)-proline (327)
43
 
  
 
 
An oven dried 50 mL, three-necked RBF was assembled with a rubber septum, a N2 gas inlet 
adapter and a glass stopper while hot and then evacuated. The flask was then flame dried and 
allowed to cool under N2. L-Proline (326, 1.1546 g, 10 mmol) was then added and the flask 
was evacuated and purged with N2 (3×). Anhydrous MeOH (5 mL) was then added by 
syringe followed by Et3N (1.4 mL, 10 mmol, 1 equiv). To the resulting suspension was added 
2,2,2-tifluoroethyl trifluoroacetate (1.7 mL, 12.7 mmol, 1.3 equiv) at room temperature. A 
solution formed immediately and the reaction was complete. The MeOH and excess Et3N 
were then evaporated to afford a crude oil which was dissolved in deionised H2O (5 mL) and 
dilute aqueous HCl (5% (w/w), 5 mL). The aqueous solution was then extracted with EtOAc 
(3 × 20 mL) and the combined organic layers were washed with brine (20 mL), dried over 
MgSO4, filtered, evaporated and dried overnight in a vacuum desiccator to form a solid. The 
crude product was then sublimed (60
o
C, 2.5 mmHg) to afford pure 327 (0.8 g, 39%) as white 
crystals. 
 
1
H NMR (300 MHz, CDCl3) δ 2.22 (4H, m, 2 × CH2), 3.80 (2H, m, CH2), 4.67 (1H, m, CH), 
10.09 (1H, brs, CO2H); 
19
F NMR (282 MHz, CDCl3) δ -72.80; LRMS (EI) [M]
+
 211 m/z 
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N-methyl-(2S)-proline (331)
44
 
 
 
 
To a 100 mL, two-necked RBF equipped with a tubing adapter attached to a balloon, a 
second free tubing adapter and a Telfon coated, oval shaped magnetic stir bar was added L-
proline (326, 2.0062 g, 17.4 mmol) followed by MeOH (20 mL). To resulting solution was 
added an aqueous solution of HCHO (37% (w/w), 1.4 mL, 0.56 g, 18.8 mmol, 1.08 equiv) 
followed by 10% Pd/C (0.50 g). The flask was then attached to vacuum/H2 manifold and 
evacuated and purged with H2 (3×). On the third evacuation the balloon was filled and the 
vessel was sealed, taken off the manifold and placed in a fume hood. The black suspension 
was then vigorously stirred under the H2 atmosphere (≈ 1 atm) overnight (16 hours) at room 
temperature. The black suspension was filtered over a pad of Celite and the combined 
filtrates were evaporated to afford a crude oil. The oil was then dissolved in EtOH/PhH (1:1, 
100 mL) and evaporated a second time to afford a solid which was then recrystallised from 
MeOH/Et2O to afford pure 331 (2.15 g, 95%) as white crystals.   
 
1
H NMR (300 MHz, d6-DMSO) δ 1.71 (1H, m, HCH), 1.89 (2H, m, CH2), 2.19 (1H, m, 
HCH), 2.68 (3H, s, CH3), 2.84 (1H, m, CH), 2.74 (2H, m, CH2); LRMS (EI) [M]
+ 
129 m/z 
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3.3.7.2 Attempted preparations of N-protected proline diastereomers 
 
Method A – Acid chloride formation 
 
To a 3 mL screw cap vial equipped with a small Teflon coated, bar shaped magnetic stir bar 
was added the proline derivative (50 µmol) followed by distilled SOCl2 (1 mL). The resulting 
solution was then allowed to stir overnight at room temperature. Excess SOCl2 was the 
evaporated and the resulting R-COCl was dissolved in CH2Cl2 and used immediately. 
 
Method B – Acid chloride formation 
 
To a 3 mL screw cap vial equipped with a small Teflon coated, bar shaped magnetic stir bar 
was added the proline derivative (50 µmol) followed by anhydrous CH2Cl2 (0.5 mL) and 
DMF (1 drop). Neat (COCl)2 (100 µL) was then added and the solution was allowed to stir at 
room temperature overnight. The reaction mixture was then concentrated and the resulting R-
COCl was dissolved in CH2Cl2 (100 µL) and used immediately. 
 
Attempted esterification of (2S)-prolyl chlorides with (±)-danshensu (300) 
 
To the CH2Cl2 solution of the prolyl chloride (as described above) was added 300 (50 µmol) 
followed by anhydrous pyridine (4 µL, 50 µmol, 1 equiv). The reaction mixture was then 
stirred at room temperature for 6 hours and the analysed by GC/MS. 
 
LRMS (EI) [M]
+
 433 m/z 
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3.3.7.3 Preparation of Camphorsulfonic diastereomers 
 
(1S)-(+)-10-Camphorsulfonyl chloride (333)
45,46
 
 
 
 
To a 50 mL, single-necked RBF was added (1S)-(+)-10-Camphorsulfonic acid (332, 5.0 g, 
21.5 mmol) followed by freshly distilled SOCl2 (10 mL, 137.1 mmol, 6.4 equiv) and 2 – 3 
boiling chips. The flask was swirled, fitted with a reflux condenser and placed on a steam 
cone (110
o
C). A vigorous evolution of SO2 occurred and the sulfonic acid dissolved. The 
reaction mixture was then heated on the steam cone for 30 min and allowed to cool to room 
temperature. Excess SOCl2 was evaporated on the pump through the condenser and the 
resulting oil was dried under high vacuum (≤ 0.20 mmHg) to form 5.23 g of an oily solid. 
This crude product was then recrystallised from petroleum ether (150 mL, Bp. = 40 – 60oC) 
to afford 4.82 g (89%) of 333 as glistening white crystals. 
 
[α]D
24
 + 17.4
o
 (c 1.063 in CH2Cl2); Mp. = 62 – 65 
o
C (lit.
45
 67 – 68oC); 1H NMR (300 MHz, 
CDCl3) δ 0.93 (3H, s, CH3), 1.15 (3H, s, CH3), 1.50 (1H, sept, J = 25.7, 21.6, 16.5, 12.6, 9.3, 
3.6 Hz, HCH), 1.78 (1H, sept, J = 27.8, 23.4, 18.5, 13.9, 9.3, 4.6 Hz, HCH), 2.00 (1H, d, J = 
18.7 Hz, CH), 2.12 (2H, m, CH2), 2.46 (2H, m, CH2), 3.73 (1H, d, J = 14.5 Hz, HCH), 4.32 
(1H, d, J = 14.5 Hz, HCH); 
13
C NMR (75 MHz, CDCl3) δ 19.6, 19.7, 25.2, 26.8, 42.3, 42.73, 
48.2, 59.6, 64.2, 212.7; IR (KBr) 2970.91, 2960.35, 2940.14, 2926.50, 2894.73, 1743.58, 
1367.89, 1171.11, 1053.61 cm
-1
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General procedure for the esterification of 333 with the danshensu derivatives
47
 
 
 
 
To a 5 mL screw cap vial equipped with a small Teflon coated, bar shaped magnetic stir bar 
was added the danshensu derivative (50 µmol) followed by anhydrous CH2Cl2 (250 µL) and 
Et3N (10.5 µL, 75 µmol, 1.5 equiv). The stirred reaction mixture was then cooled to 0
o
C 
(ice/H2O) and 333 (13.8 mg, 55 µmol, 1.1 equiv) was added slowly. A white precipitate 
formed immediately (Et3N.HCl) and the suspension was stirred at 0
o
C for 30 min then 30 min 
at room temperature. The reaction mixture was then quenched with cold (0
o
C) deionised H2O 
(1 mL) and additional CH2Cl2 (4 mL) was added. The layers were separated and the 
combined organic layers were washed with dilute aqueous HCl (1 mL, 10%), saturated 
aqueous NaHCO3 (1 mL, 10%), deionised H2O (1 mL), dried over MgSO4, filtered and 
evaporated. The resulting light yellow residue was then dried under high vacuum (≤ 
0.2 mmHg) for an hour and analysed by 
1
H NMR (CDCl3).  
 
These diastereomers were only used to determine the ee of danshensu derivatives 325 and 63, 
therefore a complete characterisation of these products was determined uneccesary and was 
not carried out. The 
1H NMR‟s obtained for the calculation of ee are include in the Appendix. 
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3.3.7.4 Preparation of Methyl (+)-dimethyldanshensu (63) standard from (+)-
Rosmarinic acid
1
 
 
Methyl (+)-tetramethylrosmarinate (336)
1
 
 
 
 
An oven dried 1 L, three-necked RBF was assembled with a reflux condenser attached to a 
N2 gas inlet adapter, a large Teflon coated oval shaped magnetic stir bar and two glass 
stoppers while hot then evacuated. The flask was then flame dried under vacuum and allowed 
to cool under N2. (+)-Rosmarinic acid (3.09 g, 8.58 mmol) was then added followed by 
anhydrous acetone (400 mL), Me2SO4 (10.79 g, 85.55 mmol, 10 equiv) and anhydrous 
K2CO3 (11.83 g, 85.59 mmol, 10 equiv). The flask was then evacuated and purged with N2 
(3×) and the resulting suspension was the heated to reflux and maintained at this temperature 
for 14h. The suspension was then allowed to cool to room temperature and diluted with Et2O 
(100 mL) and saturated aqueous NH4Cl (10% (w/w), 100 mL). The layers were then 
separated and the aqueous layer was re-extracted with Et2O (2 × 100 mL). The combined 
ethereal layers were then washed with brine (100 mL), dried over MgSO4, filtered through a 
plug of SiO2 (3 – 5 cm) and evaporated to afford a dark yellow oil. The crude product was 
then subjected to FCC (SiO2, 2% Et2O/CH2Cl2) to afford pure 336 (1.96 g, 53%) as a bright 
yellow foam. 
 
1
H NMR (300 MHz, CDCl3) δ 3.18 (2H, m, CH2), 3.76 (3H, s, CO2CH3), 3.865 (3H, s, 
OCH3), 3.875 (3H, s, OCH3), 3.92 (3H, s, OCH3), 3.93 (3H, s, OCH3), 5.38 (1H, dd, J = 7.7, 
5.3 Hz, CH), 6.34 (1H, d, J = 16.1 Hz, ArCH=CHCO2), 6.84 (4H, m, ArH), 7.09 (2H, m, 
ArH), 7.66 (1H, d, J = 15.9 Hz, ArCH=CHCO2); 
13
C NMR (75 MHz, CDCl3) δ 37.1 (CH2), 
52.3 (CO2CH3), 55.8 (2 × OCH3), 55.9 (OCH3), 55.9 (OCH3), 73.0 (CH), 109.6, 111.0, 
111.2, 112.5, 114.6, 121.4, 122.9, 127.1, 128.4, 146.0, 148.1, 148.8, 149.2, 151.4, 166.3 
(CO2), 170.4 (CO2CH3); IR (KBr) 3000.71, 2953.76, 2837.08, 1753.20, 1712.75, 1631.30, 
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1598.20, 1515.69, 1464.89, 1441.78, 1421.21, 1341.50, 1308.22, 1263.83, 1240.48, 1197.06, 
1156.84, 1139.51, 1075.93, 1024.73, 980.29, 848.42, 806.92, 763.71 cm
-1
; LRMS (ESI) 
[M+H]
+
 431 m/z 
 
Methyl (+)-dimethyldanshensu (63) Standard
1
 
 
 
 
To a 100 mL, three-necked RBF equipped with a rubber septum, N2 gas inlet adapter, glass 
stopper and a Teflon coated, oval shaped magnetic stir bar was added 336 (1.103 g, 
2.56 mmol) followed by anhydrous MeOH (15 mL). The flask was then flushed with N2 and 
NaOMe (138 mg, 2.55 mmol , 1 equiv) was added in portions. The resulting solution was 
then allowed to stir under N2 at room temperature for 2 hours. The reaction mixture was then 
quenched by the addition of saturated aqueous NH4Cl (10% (w/w), 20 mL) and the resulting 
biphasic solution was extracted with EtOAc (3 × 20 mL). The combined organic layers were 
then washed with brine (20 mL), dried over MgSO4, filtered through a pad of Celite (3 – 
5 cm) and evaporated to afford a yellow residue. The crude product was then subjected to 
FCC (SiO2, 2% Et2O/CH2Cl2) to afford pure 63 (0.33 g, 54%) as white crystals after drying 
under reduced pressure (< 0.5 mmHg) at room temperature. 
 
1
H NMR (300 MHz, CDCl3) δ 2.70 (1H, d, J = 6.2 Hz, OH), 2.93 (1H, dd, J = 14.0, 6.6 Hz, 
ArHCH), 3.09 (1H, dd, J = 14.0, 4.3 Hz, ArHCH), 3.79 (3H, s, CO2CH3), 3.865 (3H, s, 
OCH3), 3.875 (3H, s, OCH3), 4.45 (1H, m, CH), 6.78 (3H, m, ArH); 
13
C NMR (75 MHz, 
CDCl3) δ 40.1 (CH2), 52.4 (CO2CH3), 55.8 (OCH3), 55.8 (OCH3), 71.3 (CH), 111.1, 112.7, 
121.4, 128.7, 148.0, 148.8, 174.5 (CO2CH3); IR (KBr) 3390.53, 3006.32, 2990.27, 2948.26, 
2930.06, 2908.88, 2833.31, 1727.13, 1721.04, 1593.83, 1516.44, 1432.40, 1421.96, 1362.42, 
1323.79, 1295.60, 1280.17, 1264.07, 1241.89, 1215.73, 1157.66, 1142.43, 1099.52, 1028.33, 
971.55, 855.81, 790.99, 741.26, 629.17 cm
-1
; LRMS (EI) [M]
+
 240 m/z 
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3.3.8 Attempted synthesis of ethyl (2R)-dimethyldanshensu (345) from (S)-
serine via ethyl (R)-glycidate (341) 
 
3.3.8.1 (2S)-2-Bromo-3-hydroxypropanoic acid (338)
48
 
 
 
 
To a 1 L, three-necked RBF equipped with a N2 bubbler, a tubing adapter, a glass stopper and 
a large Teflon coated oval shaped magnetic stir bar was added (S)-L-serine (337, 52.55 g, 
0.50 mol) followed by deionised H2O (400 mL), KBr (202.36 g, 1.7 mol, 3.4 equiv) and 
concentrated HBr solution (48% (w/w), 125 mL, 1.1 mol, 2.2 equiv). The reaction mixture 
was cooled to -10
o
C (NaCl/Ice) and N2 is bubbled through the solution with stirring. Neat 
NaNO2 (42.83 g, 0.62 mol, 1.2 equiv) was then added to the stirred solution portion-wise 
over a period of 30 minutes. After each addition the reaction mixture discoloured to yellow-
brown indicating the presence of HNO2 which was allowed to leave the solution between 
each addition of NaNO2. Upon completion of the NaNO2 addition the N2 purge was stopped 
and the reaction mixture was then allowed to stir at room temperature 6 hours. Excess 
nitrogen oxides were then removed from the reaction mixture by a final purge with N2 for 
1 hour. The clear solution is then extracted with Et2O (6 × 200 mL) and the combined organic 
layers were washed with brine (300 mL), dried over MgSO4, filtered through a plug of Celite 
and evaporated to afford 338 (63.7 g, 77%) as a viscous blue oil. The product was deemed to 
be satisfactorily pure by 
1
H NMR and was stored in a freezer (-30
o
C) for an indefinite period 
of time. During this time the colour of the oil slowly changed from blue to green but no 
difference in reactivity was noted.   
 
1
H NMR (300 MHz, d6-DMSO) δ 3.86 (1H, dd, J = 11.5, 5.9 Hz, HOHCH), 3.99 (1H, dd, J = 
11.5, 8.1 Hz, HOHCH), 4.32 (1H, dd, J = 7.9, 5.7 Hz, CH); 
13
C NMR (75 MHz, d6-DMSO) δ 
46.2 (CH), 64.3 (CH2), 170.2 (CO2H); LRMS (ESI) [M-H]
-
 168 m/z 
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3.3.8.2 Potassium (2R)-oxirane-2-carboxylate (339)
48
 
 
 
 
An oven dried 300 mL Schlenk flask was assembled with a 100 mL pressure equalising 
funnel and a large Teflon coated, oval shaped magnetic stir bar while hot then evacuated. The 
apparatus is then flame dried under vacuum and allowed to cool under N2. The dry flask is 
then suspended in a water jacket which is connected to re-circulating chiller. 338 (25.48 g, 
151 mmol) is then added by removing the addition funnel followed by anhydrous EtOH 
(125 mL). The apparatus is then sealed again and evacuated and purged with N2 (3×). The 
chilling unit was then activated (-5
o
C) and the suspension stirred to create a homogenous 
temperature throughout the water jacket and reaction mixture. Meanwhile a filtered solution 
of KOH (19.2 g, 342 mmol, 2.3 equiv) in anhydrous EtOH (110 mL) was prepared and added 
to the pressure equalising funnel. After 15 minutes of temperature equilibration the KOH 
solution was to the reaction mixture over 2 hours. Upon completion of the addition the 
temperature was raised to 0
o
C and the reaction mixture was stirred at this temperature 
overnight. The white precipitate, consisting of a 1:1 mixture of KBr and 339 was filtered off 
and dried on the Büchner funnel. The crude product was then recrystallised from aqueous 
EtOH (97.5% (v/v), 662 mL) to afford 339 (17.7 g, 93%) as white crystals. 
 
1
H NMR (300 MHz, D2O) δ 2.74 (1H, dd, J = 5.9, 2.8 Hz, HCH), 2.91 (1H, dd, J = 5.7, 
4.7 Hz, HCH), 3.33 (1H, dd, J = 4.9, 2.8 Hz, CH); 
13
C NMR (75 MHz, d6-DMSO/D2O) δ 
46.2 (CH2), 64.3 (CH), 176.7 (CO2K); LRMS (ESI) [M-K]
-
 87 m/z 
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3.3.8.3 3-Butyl-1-methyl-1H-imidazol-3-ium tetrafluoroborate ([BMIM]BF4)
55
 
 
To a 1 L, single-necked RBF equipped with a large Teflon coated, oval shaped magnetic stir 
bar was added 3-butyl-1-methyl-1H-imidazol-3-ium chloride ([BMIM]Cl, 91.54 g, 0.52 mol) 
followed by deionised H2O (30 mL). A solution of KBF4 (66.23 g, 0.53 mol) in deionised 
H2O (200 mL) was then added followed by additional deionised H2O (100 mL). The flask 
was then sealed with a glass stopper and the homogenous solution was stirred at room 
temperature for 2 hours. The H2O was then evaporated under reduced pressure at 80
o
C to 
form a viscous suspension of KCl and [BMIM]BF4. CH2Cl2 (200 mL) was then added to 
dissolve [BMIM]BF4 and the suspension was dried over MgSO4 (35 g) and allowed to stand 
for 1 hour. The suspension was then filtered over a thin pad of Celite, evaporated and dried 
under high vacuum (≤ 0.2 mmHg) to afford [BMIM]BF4 (108.8 g, 92%) as a light yellow 
liquid. 
 
1
H NMR (300 MHZ, D2O) δ 0.87 (3H, t, J = 14.7, 7.4 Hz, CH3CH2), 1.27 (2H, sextet, J = 
37.2, 30.0, 22.5, 14.9, 7.4 Hz, CH2CH2CH3), 1.80 (2H, pentet, J = 29.5, 21.9, 14.5, 7.4 Hz, 
CH2CH2CH2), 3.84 (3H, s, CH3), 4.14 (2H, t, J = 14.2, 7.2, CH2CH2), 7.40 (2H, dt, J = 14.5, 
3.6, 1.7 Hz, ArH), 8.65 (1H, s, ArH); 
19
F NMR (282 MHz, D2O) δ -150.51. 
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3.3.8.4 Ethyl (2R)-oxirane-2-carboxylate (341) 
 
 
 
To a 250 mL, single-necked RBF equipped with a medium sized, oval shaped Telfon coated 
magnetic stir bar was added DMSO (125 g) followed by [BMIM]BF4 (12.55 g) in ratio of 
1:0.1. Distilled EtI (15.78 g, 101 mmol, 2 equiv) was then added followed by 339 (7.01 g, 
50 mmol, corrected for 9.5% (w/w) KBr). An air condenser attached to a N2 gas inlet was 
then fitted and the solution was evacuated and purged with N2 (3×).  The reaction mixture 
was then vigorously stirred under N2, at room temperature for 2.5 hours. Ice was then added 
to quench the reaction and whole mixture was thoroughly extracted with Et2O (3 × 100 mL). 
The combined organic layers were then washed with deionised H2O (100 mL), brine (3 × 
50 mL), dried over MgSO4, filtered through a pad of Celite (3 – 5 cm) and evaporated to form 
341 (3.7 g, 63%) as a faint yellow liquid. This product was analysed by 
1
H and 
13
C NMR and 
determined to be satisfactorily pure and did not require further purification.  
 
1
H NMR (300 MHz, CDCl3) δ 1.31 (3H, dd, J = 14.4, 7.2 Hz, CH3CH2), 2.96 (2H, m, CH2), 
3.44 (1H, dq, J = 4.2, 2.6 Hz, CH), 4.26 (2H, ABq, 2H, J = 14.0, 7.2, 4.2 Hz, CH2CH3); 
13
C 
NMR (75 MHz, CDCl3) δ 13.8 (CH3), 46.0 (CH2), 47.0 (CH), 61.3 (CH2CH3), 169.0 
(CO2Et); LRMS (CI) [M+H]
+
 117 m/z 
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3.3.8.5 Methyl (2R)-oxirane-2-carboxylate (340)
55
 
 
 
 
An oven dried 250 mL, three-necked RBF was assembled with a reflux condenser attached to 
a N2 gas inlet adapter, two glass stoppers and large Teflon coated, oval shaped magnetic stir 
bar while hot then evacuated. The apparatus was then flamed dried under vacuum and 
allowed to cool under N2. 339 (6.9830 g, 50.10 mmol corrected for 9.5% (w/w) KBr) was 
then introduced into the dry flask followed by BTAC (13.4584 g, 59.09 mmol, 1.2 equiv), 
anhydrous CH2Cl2 (60 mL) and Me2SO4 (5.70 mL, 60.24 mmol, 1.2 equiv). The suspension 
was then stirred vigorously under N2 for 20 hours. The CH2Cl2 was then evaporated at room 
temperature under mild vacuum (50 mmHg) and the resulting residue was triturated with 
Et2O (4 × 50 mL). The combined Et2O washes were then dried over MgSO4, filtered through 
a thin pad of Celite (3 – 5 cm) and evaporated using the same procedure as before (20oC, 
40 mmHg) to afford 340 (1.2 g, 24%) as a colourless oil. 
 
1
H NMR (300 MHz, CDCl3) δ 2.94 (2H, m, CH2), 3.43 (1H, dd, J = 4.0, 2.6 Hz, CH) 3.77 
(3H, s, CO2CH3); LRMS (CI) [M+H]
+
 103 m/z 
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3.3.8.6 Attempted synthesis of ethyl (2R)-3-(3,4-dimethoxyphenyl)-2-hydroxypropanoate 
(345) via Gilman catalysed epoxide opening of 341 
 
Preparation of CuBr.SMe2
56
 
 
On the day of preparation Cu(I)Br (25 g) was added to a 500 mL single-necked RBF, washed 
with MeOH (4 × 50 mL) and dried under high vacuum (< 0.2 mmHg) for 2 hours. The green 
solid was then dissolved in anhydrous SMe2 (70 mL) at room temperature and a vigorous 
reaction occurred. The red suspension was then allowed to cool to room temperature and 
filtered. The complex started to precipitate out of the mother liquor and anhydrous hexane 
(200 mL) was added to liberate a white solid. The product was then filtered off under N2, 
washed with additional anhydrous hexane (5 × 100 mL) and dried under N2 at room 
temperature with protection from light for 2 hours. Following this procedure, CuBr.SMe2 
(19.71 g, 55%) was obtained as white crystals. The pure product was stored in a desiccator 
over SiO2 desiccant with protection from light.     
 
Mp. (Exp) 111 - 115
o
C; (Mp. (Lit) 132
o
C) 
 
Ethyl (2R)-3-(3,4-dimethoxyphenyl)-2-hydroxypropanoate (345)
50
 
 
 
 
An oven dried, 100 mL Schlenk flask was assembled with a Teflon coated, oval shaped 
magnetic stir and a glass stopper while hot then evacuated. The flask was then flamed dried 
under vacuum and allowed to cool under N2. The flask was then sealed, removed from the 
Schlenk line and 4-bromoveratrole (342, 0.233 g, 1.07 mmol) was weighed out directly into 
the dry flask. A rubber septum was then fitted and the flask was evacuated and purged with 
N2 (3×). Anhydrous THF (20 mL) was then added by syringe and the solution was cooled to -
78
o
C (dry ice/isopropanol). A solution of n-BuLi (2.5 M solution in hexanes, 1 mL, 
2.5 mmol, 2.3 equiv) was then added via syringe. After 5 minutes of stirring at this 
temperature a white precipitate of the organolithium species formed. This suspension was 
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then allowed to stir at this temperature for 30 minutes to ensure complete transformation to 
the organolithium intermediate 343. 
 
Meanwhile, an oven dried 100 mL, three-necked RBF was assembled with a N2 gas inlet 
adapter, a rubber septum, glass stopper and a Teflon coated oval shaped magnetic stir bar 
while hot then evacuated. The flask was then flame dried under vacuum and allowed to cool 
under N2. The copper catalyst, CuBr.SMe2 (43.8 mg, 0.21 mmol, 20 mol%) was then added 
followed by anhydrous THF (10 mL). The flask was then cooled to -50
o
C (Ice/saturated 
aqueous CaCl2) and evacuated and purged with N2 (3×). The suspension of organolithium 
343 was then added to this flask via cannula. Upon completion of the transfer the solution 
slowly changed colour to orange then yellow. The yellow solution was then allowed to stir at 
-30
o
C to -50
o
C for 15 minutes to ensure complete formation of the Gilman reagent (344). 
 
A second oven dried, 50 mL Schlenk flask was then assembled with a Teflon coated, oval 
shaped magnetic stir bar and glass stopper while hot and then evacuated. The flask was then 
flamed dried under vacuum and allowed to cool under N2. The flask was then sealed, 
removed from the Schlenk line and 341 (0.240 g, 1.9 mmol, 1.8 equiv) was weighed out 
directly into the dry flask. A rubber septum was then fitted and the flask was evacuated and 
purged with N2 (3×). Anhydrous THF (10 mL) was then added by syringe to create a 
solution. This solution of 341 was then transferred to the yellow solution of the Gilman 
reagent (344) at -30
o
C via cannula.  
 
The final reaction mixture was then stirred at -30
o
C in the cooling bath and allowed to rise to 
0
o
C over 2 hours. The reaction mixture was then quenched with saturated aqueous NH4Cl 
(10% (w/w), 20 mL) and extracted with Et2O (3 × 50 mL). The combined ethereal layers 
were then washed with deionised H2O (50 mL), brine (50 mL), dried over MgSO4, filtered 
through a plug of Celite (3 – 5 cm) and evaporated to form the crude product which was 
analysed by GC/MS. Peaks corresponding to 341 (117 m/z), debrominated 4-bromoveratrole 
(138 m/z) and butylated 4-bromoveratrole (194 m/z) were observed in the GC trace. No 
peaks or molecular ions corresponding to the desired α-hydroxy ester (345) were found and 
the reaction was deemed unsuccessful.   
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4.0 Esterification of (+)-Danshensu derivative with 
benzo[b]furan scaffold and attempted deprotection 
 
4.1 Introduction 
 
In most syntheses of Danshen polyphenols a common step in the retrosynthetic analysis is the 
disconnection of the internal ester bond to afford a cinnamic acid scaffold and a secondary 
alcohol. The most popular technique for joining these two precursors is the Steglich 
esterification where the carboxylic acid moiety is activated in situ, forming an activated ester 
intermediate which is a suitable electrophile for nucleophilic attack by primary, secondary or 
tertiary alcohols. However when this protocol is used to esterifiy the secondary alcohol (+)-
Danshensu, the reaction is typically slow and requires a high molar excess of the 
carbodiimide reagent and the base catalyst DMAP which can interfere with the isolation of 
the formed ester.  While the yield of the isolated ester typically ranges from 30 to 80% this 
procedure is still exceedingly inefficient and improvements to this critical step of these and 
related syntheses are still awaiting development.  
 
Once the ester is formed the deprotection step is generally carried out. While different 
protecting groups have been used for the carboxyl and phenolic functional groups in Danshen 
polyphenol preparations, in all total syntheses of (+)-Lithospermic acid, the latest and most 
structurally related of the Danshen secondary metabolites to be synthesised, all active 
functionalities of the target compound were protected by the methyl ether (see Chapter 1 
section 1.2.6 for further reading). This of course led to the development and optimisation of a 
unique demethylation procedure and the natural product was obtained in 35% yield.
1
 Since its 
development, two other research groups in the field have used this methodology and achieved 
a similar yield for the demethylated product (31% and 34%).
2,3
 For these reasons and others it 
was decided to use the same strategy as the starting materials are readily available thereby 
eliminating a protection step, and an optimised procedure for the removal of all five methyl 
ethers in one effort was established. 
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4.2 Results & Discussion 
 
4.2.1 Application of Steglich esterification conditions to the esterification of 
281 with 63 
 
There are numerous esterification procedures and reagents available to the organic chemist. 
The esterification reagents can be subdivided into two groups: a group of acid chlorides 
which react with the carboxylic moiety to form a mixed anhydride and a second group of 
reagents which form an activated ester by the inclusion of a bulky, sometimes cationic 
leaving group. Both of these techniques of esterification activate the carboxyl moiety in-situ 
making them one pot procedures eliminating the need to isolate active intermediate. The 
activation and following esterification are generally conducted at room temperature or below 
making this approach a mild technique for the esterification of sterically hindering or 
relatively inert alcohols compared to the esterification of simple alkyl alcohols. This coupled 
with the in-situ activation is what makes these protocols highly desirable to the chemist as it 
reduces any scheme by one step and in some cases simplifies the overall procedure by 
preventing the isolation of the unstable intermediate.   
 
As discussed previously, the method of choice for esterifying the (+)-danshensu motif in 
danshen polyphenol syntheses is the Steglich protocol, which has been used successfully in 
total syntheses of (+)-Rosmarinic acid and (+)-Lithospermic acid. The most recent example 
of this technique at the time of experimentation was in the first total synthesis of (+)-
Lithospermic acid by O‟Malley et al.1 where carbodiimide EDC was used with catalyst 
DMAP. Similar esterifications have also been done by this technique with other 
carbodiimides. Therefore given the similarities between what is in the literature and the 
reaction at hand it was proposed that the same technique could be used here. Following the 
procedure used by O‟Malley et al.1 the reaction between 281 and 63 was performed under the 
same conditions, with precisely the same molar equivalents of EDC and DMAP (Scheme 
90). At the beginning of the reaction 281 was a suspension in anhydrous CHCl3 but once 
EDC was added a yellow solution formed. This was thought to be due to the formation of the 
active ester and wasn‟t suspected of interfering with the reaction. After stirring for three 
hours at room temperature the carboxylic acid (281) disappeared but unreacted alcohol (63) 
still remained (by TLC). After stirring for three days at room temperature, 63 was still 
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detected by TLC. At this point the reaction was stopped and the crude product analysed. No 
trace of the desired ester was detected by ESI or 
1
H NMR. As carboxylic acid 281 was 
insoluble in the CHCl3 solution of alcohol 63 before the addition of EDC it is possible that 
the desired activation did not occur, especially since no activated ester was found in the crude 
mixture. Other aprotic solvents suitable for this reaction are THF, Et2O, CH2Cl2, DMF and 
CH3CN. Of these solvents 281 is soluble in large volumes of THF and readily in DMF.  
Therefore the reaction was repeated with DMF using the conditions of Neises and Steglich
4,5
. 
After 24 hours of stirring at room temperature the carboxylic acid disappeared (by TLC), the 
reaction was stopped and the crude product was analysed to reveal the same result as the 
previous reaction with unreacted alcohol detected in the crude mixture.  
 
 
Scheme 90 Attempted synthesis of 348 by Steglich esterification with carbodiimide EDC 
 
At this point it could not be determined exactly why the esterification wasn‟t occurring. The 
activated ester appeared to be forming but no evidence of this could be found. One possibility 
was that the activated ester was being lost in the workup as the crude mixture was filtered 
through a SiO2 pad prior to analysis or it was lost in the aqueous phase during extraction. On 
the other hand if the activated ester was forming, why wasn‟t any esterified product found? 
The possible explanations that come to mind are that the active ester was not acidic enough 
and therefore could not readily exchange with DMAP to perform the esterification. Another 
factor that would supress the rate of esterification is the low level of nucelophilicity of the α-
hydroxy ester (63) due to the electron donating effect of the secondary alcohol. In an attempt 
to resolve these issues the Steglich esterification was repeated again with DIC as a similar 
esterification has been achieved with this carbodiimide.
6
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Scheme 91 Attempted synthesis of 348 by Steglich esterification with carbodiimide DIC 
 
As before the reaction was conducted using the conditions of Neises and Steglich
4
 using 
DMF as the solvent and after 24 hours of stirring at room temperature the major product was 
unreacted alcohol (63) with still no activated ester detected (349, Scheme 91). As THF could 
be used the reaction was repeated with this solvent and additional DMAP (50 mol% 
compared to 10 mol%). Again the crude product was analysed and this time activated ester 
349 was detected in the MS and 
1
H NMR along with small amounts of the desired ester 348. 
This was a significant achievement but the yield of the ester was still insignificant compared 
to the amount of unreacted alcohol and activated ester. A plausible explanation for the 
difference in reactivity observed from these conditions can be attributed to the additional 
DMAP and the lower polarity of THF. With this information further adjustments were made 
to reaction conditions in an attempt to improve the yield of ester 348 including longer 
reaction time (from 2 to 4 days), using stoichiometric amounts of DMAP and even switching 
the carbodiimide to DCC but the yield could not be increased over 10%. With all of the 
known procedures for carbodiimide mediated esterification attempted it was clear that a 
different approach was required.   
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4.2.2 Attempted synthesis of 348 with Castro’s reagent (BOP) 
 
As discussed above a possible reason for the low yield of esterification by carbodiimide 
activation was that in the active ester the carbon in the imine double bond was not acidic 
enough, due to the presence of the electron donating groups in the cinnamic acid scaffold. 
This would lead to a low rate of exchange with DMAP, ultimately leading to low yields of 
the ester. A typical approach to improve the rate of esterification is to add 1-
hydroxybenzotriazole (HOBt) to the reaction mixture which forms a highly active ester after 
exchange with the imine intermediate formed between the carbodiimide and carboxylic acid. 
The HOBt ester easily exchanges with DMAP, as it is bulkier and partially charged therefore 
the esterification should proceed at a faster rate. Rather than using pure, explosive HOBt in 
the current procedure it was proposed that the Steglich carbodiimides could be exchanged 
with Castro‟s reagent (BOP) which incorporates both HOBt and a phosphonium salt which 
both form very active esters and act as leaving groups in the esterification.  
 
 
Scheme 92 Attempted synthesis of ester 348 via Castro's reagent (BOP) 
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Following the standard conditions of Kim and Patel
7
 the BOP catalysed esterification was 
attempted (Scheme 92). Disappointingly, the same result as the Steglich esterification with 
DIC was found where only the active esters (350 and 351) were isolated and no trace of the 
desired esterified product could be identified in either the MS or 
1
H NMR spectra. This result 
confirms that these „one-pot‟ esterification methodologies are not suitable for the 
esterification of cinnamic acid 281 with danshensu derivative 63 due to the low acidity of the 
active esters coupled with the low level of nucleophilicity of the secondary alcohol and an 
alternative procedure was required.  
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4.2.3 Synthesis of Methyl (+)-pentamethylsalvianolate C (348) via acid 
chloride intermediate 
 
In the total synthesis of (S)-(-)-rosmarinic acid by Bogucki et al.
8
 the acid chloride of the 
cinnamic acid scaffold was used to effect esterification of the (S)-danshensu motif (see 
Chapter 1, section 1.2.3). From the previous attempts at the esterification in this study it was 
deduced that a powerful esterification intermediate is required to promote esterification due 
to the electron flow in the cinnamic acid building block and danshensu moieties. Acid halides 
undergo esterification as the halogen readily leaves the intermediate when the alcohol attacks 
the electron deficient carbonyl carbon. As the carbonyl carbons in acid halides are 
significantly more electrophilic than the atoms from the leaving groups formed in the 
Steglich and Castro esterifications, perhaps these conditions could provide the desired result. 
 
 
Scheme 93 Synthesis of 348 according to Bogucki et al. 
 
Following the optimised conditions of Bogucki et al.
8
 acid chloride 352 was prepared in 
quantitative yield by refluxing a mixture of 281 in CCl4 and SOCl2 for 24 hours (Scheme 93). 
The freshly prepared acid chloride (352) was then esterified with danshensu derivative 63 
according to Bogucki et al.
8
 with Et3N as a scavenger for HCl and a conversion of 59% to the 
esterified product (348) was observed by 
1
H NMR. This was a significant improvement over 
that achieved from the attempted „one-pot‟ procedures but a substantial amount of alcohol 63 
remained unreacted. The acid chloride (352) generated by this means, even though it 
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contained no starting material was highly impure and unstable ultimately contributing 
towards a reduction in yield for ester 348. This can be rationalised by the extended reaction 
time in which 352 was generated leading to slight decomposition of the highly active product 
indicated by discolouration.  
 
 
Scheme 94 First synthesis of acid chloride 352 by microwave and the following esterification with 63 
 
In an attempt to speed up the activation step to yield a purer acid chloride, the preparation of 
352 was attempted in a microwave reactor (Scheme 94). After 30 minutes at 135
o
C the 
reaction was complete and acid chloride 352 was obtained in quantitative yield as a yellow 
solid. The esterification was then attempted with this acid chloride at reflux instead of room 
temperature and ester 348 was obtained in 90% yield (by 
1
H NMR). From both acid 
chlorides, an insoluble yellow solid was obtained from the reaction mixture after the 
esterification. The 
1
H NMR of this product was indicative of a highly symmetrical compound 
with a series of overlapping resonances in the aromatic region. The ESI-MS of this unknown 
gave a molecular ion of 690 ([M+H]
+
 = 691 m/z). These two pieces of data plus an IR 
spectrum (distinctive stretches from 1700 to 1800 cm
-1
) confirmed that the yellow solid was 
anhydride 353 resulting from self-condensation of the acid chloride. A series of experiments 
followed where several variations were made to the reaction conditions in an attempt to 
prevent anhydride formation (Table 31).  
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Table 31 Optimsation of the esterification of acid chloride 352 with danshensu derivative 63 
Conditions 
Ratio of 
reagents 
(352:63:Base) 
Base 
Temperature 
(
o
C) 
Time 
(Hours) 
% NMR 
yield of 
348 
% Yield 
(353) 
A 1.8:1:4 Et3N RT 5 59 2 
B 2:1:2 Et3N 0 – RT 20 18 10 
C 2:1:8 Et3N 60 – 70 4 90 11 
D 1.2:1:4 Et3N 60 – 70 3 79 7.7 
E 2:1:4 DIPEA 60 – 70 3 0 10 
F 2:1:4 Et3N 60 – 70 4 99 10 
 
As the anhydride formed from both samples of acid chloride 352 it is clear that the by-
product did not form as a result of microwave irradiation. The ratio of 352 to 63 was reduced 
from 2:1 to 1.2:1, but this had little effect on the yield of anhydride 353 and severely reduced 
the yield of ester 348. Reducing the temperature from reflux (60-70
o
C) to below RT did not 
prevent anhydride formation and also reduced the yield of ester 348. Exchanging the tertiary 
amine base Et3N for more selective Hünig‟s base (DIPEA) resulted in anhydride 353 being 
the sole product. As acid chloride 352 is completely soluble in CH2Cl2 the chance of any 
starting carboxylic acid being present is very unlikely. As every reaction was conducted 
under anhydrous conditions with every precaution taken to reduce moisture content (flame 
dried glassware, freshly distilled solvent for both steps, under N2) it is still not clear how 
exactly anhydride 353 formed. 
 
It was speculated that perhaps anhydride formation could be prevented by using a less 
reactive acid halide that would be selective for esterification. Acid fluorides are a common 
alternative to acid chlorides as they can be readily prepared, are more stable and in some 
cases are reported to be more reactive.
9
 Therefore it was chosen to prepare the acid fluoride 
of 356 and subject it to the same esterification conditions to observe whether or not the 
anhydride by-product still formed. A convenient procedure for the preparation of acyl 
fluorides is via exchange with cyanuric fluoride as the acid halide can be obtained in high 
yields under mild conditions. Due to the restricted availability of cyanuric fluoride it is much 
more efficient to prepare it. Consequently, cyanuric fluoride (355) was prepared according to 
a procedure by Groβ et al.10 from cyanuric chloride (354) by halogen exchange with NaF and 
was obtained in 40% yield (Scheme 95). Acid fluoride 356 was then prepared following the 
general procedure of Groβ et al.10 and 356 was obtained with an average yield of 45%. 
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Interestingly this acid fluoride had a rather unique chromophore and would fluoresce bright 
yellow in natural sunlight. A similar set of esterification reactions were then conducted with 
acid fluoride 356 (Table 32).  
 
 
Scheme 95 Preparation of acid fluoride 356 and its esterification with 63 
 
Table 32 Optimisation of the esterification of acid fluoride 356 with danshensu derivative 63 
Conditions 
Ratio of reagents 
(356:63) 
Temperature 
(
o
C) 
Time 
(Hours) 
% NMR yield 
A 1.2:1:4 60 – 70 4 45 
B 1.2:1:4 60 – 70 17 27 
C 1.5:1:4 60 – 70 17 56 
 
Surprisingly the hypothesis was true and no anhydride product was found. However acid 
fluoride 356 was particularly stable and even after refluxing overnight in the presence of Et3N 
acid fluoride 356 was still present (by TLC). This crude mixture was analysed by 
1
H NMR 
and a maximum conversion of 56% to ester 348 was achieved. This was 33% less than the 
maximum conversion achieved with the corresponding acid chloride (352) and therefore it 
was decided to return to the more active, chlorinated acyl halide as even though the anhydride 
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by-product formed it was easier to remove than unreacted alcohol (63) and acid fluoride 
(356) and esterification with 352 is significantly faster. 
 
There was still one technique that could be employed to prevent anhydride formation or 
improve the yield of esterification with either acyl halide. From the initial attempts of 
esterification via the „one-pot‟ procedures it was observed that the secondary alcohol in the 
danshensu derivative lacks nulecophilicity. It was proposed that this deficiency could be 
aiding anhydride formation by making esterification less favourable. A common technique 
used to improve nucleophilicity is to activate the alcohol by preparing the alkoxide. 
Danshensu derivative 63 was added to a white suspension of sodium hydride (NaH) in DMF 
and the colour instantly changed to yellow (Scheme 96). The acid chloride was then added to 
this solution and the reaction mixture was stirred at room temperature overnight. The crude 
mixture was then analysed to reveal that only carboxylic acid 281 was present. Clearly the 
alcohol (63) was unstable in the presence of the strong base (NaH) as indicated by the rapid 
colour change during the reaction, leaving no coupling partner for the acid chloride. This 
would render the acid chloride unreactive and leave it to be quenched during the aqueous 
workup. Following this result it was concluded that the formation of anhydride 353 cannot be 
prevented as any reaction pathway that could potentially bypass its construction was 
unsuccessful. This confirms that most efficient pathway is to proceed via the acid chloride 
route as it returns the most practical procedure and reproducible yields.   
 
 
Scheme 96 Attempted preparation of alkoxide 357 and the following esterification 
 
The next step in this section of experimental work was to upscale the process for the 
preparation of acid chloride 352 and thereby the esterification. As carbon tetrachloride (CCl4) 
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was currently being used as the solvent for this step it was decided that an alternative solvent 
must be found due to rules and regulations restricting the manufacture of CCl4, making it a 
finite resource. Since this development, chemical manufacturers and researchers have 
discovered many replacement solvents for CCl4 including DCE, tetrachloroethane (C2H2Cl4) 
and the structural isomers thereof. As all of these isomers contain acidic hydrogen atoms they 
were deemed unsuitable for use in the preparation of acid chloride 352 as it was observed that 
this acyl halide was particularly acid sensitive. Tetrachloroethylene (C2Cl4) is another 
common substitute for CCl4 and is currently used by the dry cleaning industry. With its 
relatively high boiling point (121
o
C) and structural similarities to CCl4 it appeared to be the 
ideal solvent for the microwave assisted synthesis of 352. The microwave conditions were 
then adjusted for C2Cl4 and after 1 hour at 135
o
C the reaction was complete and acid chloride 
352 was obtained as a bright, yellow microcrystalline solid in quantitative yield (Scheme 97). 
This acid chloride was then esterified with danshensu derivative 63 and the reaction went to 
completion under the optimised conditions, with no trace of unreacted 63. The anhydride 
(353) and ester (348) were then isolated from the crude mixture in yields of 20% and 71% 
respectively. It is noteworthy to mention that the yield for the anhydride doubled when using 
the acid chloride prepared in C2Cl4. 
 
 
Scheme 97 Optimised procedure for the synthesis of methyl (+)-pentamethylsalvianolate C (348) 
 
After optimisation of the microwave assisted synthesis of acid chloride 352 and the 
esterification the whole process required only 5 hours reaction time to afford methyl (+)-
pentamethylsalvianolate C (348) in 71% isolated yield. This is a considerable improvement to 
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the Steglich conditions used by O‟Malley et al.1 and others in related (+)-lithospermic acid 
syntheses were the esterification between the cinnamic acid and danshensu moieties required 
2.5 days reaction time to achieve a similar isolated yield of 80%.   
 
4.2.4 Deprotection of Methyl (+)-pentamethylsalvianolate C (348) 
 
With the two key building blocks assembled the last steps were to deprotect the carboxyl and 
phenol moieties of the protected substrate (348) to liberate the natural polyphenolic acid. It 
was planned to use a similar strategy to that used by O‟Malley et al.1 in their total synthesis 
of (+)-lithospermic acid as similar challenges were faced where two methyl esters and five 
methyl ethers had to be removed to form the natural product (see Chapter 1, section 1.2.6). 
Intially O‟Malley et al.1 anticipated a global demethylation of both methyl esters and all 
methyl ethers in one step, but after some model reactions it was observed that this was not 
feasible as the yield for the globally deprotected product was low. This led to O‟Malley et al.1 
conducting the deprotection over two steps were the methyl esters were hydrolysed first and 
the isolated diacid was demethylated in a separate reaction. Since this discovery every other 
group who has completed a total synthesis of (+)-lithospermic has either used this 
protection/deprotection strategy or intended to by completing a formal synthesis of the 
methylated derivative. Therefore as other researches in the field have successfully applied 
this two-step methodology to the demethylation of methylated (+)-lithospermic acid the same 
technique was to be applied here. 
 
The first step in the deprotection was to selectively hydrolyse the methyl ester in methyl (+)-
pentamethylsalvianolate C (348). In the (+)-lithospermic acid syntheses discussed above the 
selective hydrolysis of either one or two methyl esters was accomplished with trimethyltin 
hydroxide (Me3SnOH). While this reagent is affordable it was speculated that another 
technique could be found to achieve the same result given the extensive library of techniques 
available for ester hydrolysis.
11
 In the final step of the preparation of the benzo[b]furan 
building block 281, lithium hydroxide (LiOH) successfully saponified the ethyl ester 
precursor in 83% yield (see Chapter 2, section 2.2).  As this procedure was simple and 
provided the carboxylic acid in high yield it was proposed that the same procedure could be 
used for the hydrolysis of the methyl ester in 348. Unfortunately when the same procedure 
was attempted with ester 348, LiOH was not selective for the methyl ester and hydrolysed the 
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internal ester bond between carbons C1' and C2'' to form the original cinnamic acid precursor 
(281) and the carboxylic acid of danshensu derivative 358 (Scheme 98).  
 
 
Scheme 98 Attempted hydrolysis of the methyl ester in 348 with LiOH and Ba(OH)2.8H2O 
 
Barium oxide octahydrate (Ba(OH)2.8H2O) has been reported to be selective for methyl 
esters under the right conditions. In the total synthesis of Swinholide A by Paterson et al.
12
 a 
heavy excess of Ba(OH)2 was used to selectively hydrolyse a methyl ester a room 
temperature. The theory behind this observation is that the barium cation (Ba
2+
) is rather 
large and, due to steric hindrance, can only occupy certain areas of space and will often target 
esters that are less sterically hindered. Using the conditions of Paterson et al.
12
 as a reference 
the hydrolysis of methyl ester 348 with Ba(OH)2.8H2O was attempted first at room 
temperature. After 6 days of stirring at room temperature only a small percentage of 
hydrolysis occurred and the starting ester (348) could be easily visualised by TLC. The 
reaction mixture was then heated to reflux and after 40 hours at this temperature the reaction 
was complete (Scheme 98). However when the crude product was analysed by ESI-MS and 
NMR it became evident that the same hydrolysis of the internal ester occurred as in the 
previous experiment with LiOH and none of desired acid was found.  
 
After attempting these traditional hydrolysis techniques it was realised that perhaps 
Me3SnOH is really the only reagent available for the selective hydrolysis of methyl esters. 
Therefore the tin reagent was purchased and the hydrolysis was attempted according to the 
standard conditions of Nicolaou et al.
13
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Scheme 99 Synthesis of (+)-pentamethylsalvianolic acid C (359) 
 
Similar characteristics were observed for this hydrolysis where no reaction occurred at room 
temperature but once the temperature was raised to 80
o
C the reaction was complete in 
23 hours (Scheme 99). The tin reagent was only 77% selective for the methyl ester (
1
H 
NMR) and the same two by-products were found in the crude mixture. As all three products 
were carboxylic acids this made purification by column chromatography difficult and the 
majority of time the best result after chromatography was an enriched mixture of the target 
compound due to co-elution. The target compound (359) was therefore purified by 
preparative TLC and was obtained as a yellow foam in 71% yield. Even though this 
compound was soluble in most organic solvents the NMR spectra could only be recorded 
deuterated MeOH and DMSO. The reaction was repeated on a 0.35 mmol scale to afford 
165 mg of carboxylic acid 359 as a bright yellow foam. This product was only purified by CC 
and did contain small amounts of the two by-products but the relative amounts of fragments 
358 and 281 compared to the parent compound were determined negligible and this product 
was used at this purity (>90%) in the subsequent demethylation. 
 
From the total syntheses of (+)-lithospermic acid by O‟Malley et al.1, Wang et al.2 and Ghosh 
et al.
3
 it is know that permethylated compounds of this type can be successfully deprotected 
with iodotrimethylsilane – quinolone adduct. The downside to this process is that the entire 
operation must be performed in a glove box due to the sensitivity of the adduct to moisture. 
Therefore before this technique was attempted several model demethylations were carried out 
in an attempt to find an alternative procedure. The substrates chosen for the model reactions 
were danshensu derivative 300, methyl cinnamate 292, cinnamic acid 293 and 2-
arylbenzo[b]furan 279 (Scheme 100). As some of the classical demethylation procedures 
were already determined to be incompatible with permethylated compounds by O‟Malley et 
al.
1
 (including BBr3.SMe2, NaCN/DMSO, EtSNa/DMF, AlBr3/EtSH/PhH and TMSI/CHCl3) 
the literature was searched for new developments in the area of demethylation. Of the 
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procedures found the methodologies that appeared suitable were demethylation by the in situ 
generation of HI from Iodocyclohexane/DMF
14
, the in situ preparation of iodotrimethylsilane 
(TMSI) from TMSCl/NaI/CH3CN
15
, the application of boron complex BF3.SMe2 to 
demethylation
16
, demethylation by ionic liquid [BMIM]Al2Cl7
17
 and the use of pyridinium 
hydrobromide complex (Py.HBr) for the selective demethylation as have been performed on 
morphine and its analogues.
18
 
 
 
Scheme 100 Model demethylations 
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These methodologies were tested with the model substrate that was most structurally related 
to the compounds demethylated by the authors of each study. All of these techniques were 
unsuccessful and the majority of time only complete decomposition was observed or the 
reagent was unreactive and no demethylation occurred. The only procedure that showed any 
promise was the demethylation by HI generated from iodocyclohexane in DMF from the 
procedure by Zuo et al.
14
 In this instance danshensu derivative 300 was chosen as the model 
substrate and after 5 hours of heating in DMF the reaction had gone to completion as the 
starting material was no longer detected by TLC. Analysis of the crude mixture revealed that 
a mixture of mono- and di-phenols were present and trace amounts of the globally 
demethylated compound (360). Of the procedures where only complete decomposition was 
observed (TMSI and Py.HBr) it is possible that demethylation did occur but the conditions 
required were too vigorous and the deprotected product could not be isolated before it 
decomposed under the harsh conditions. As all of substrates are electron rich with multiple 
electron donating groups there are many sites for coordination or attack by a Lewis acid and 
this could be a plausible explanation for why the decomposition occurs so quickly given the 
mechanism by which demethylation occurs.  
 
 
Scheme 101 Attempted synthesis of TMSI - Quinoline adduct 362 
 
From the results obtained above there was reason to believe that the TMSI-quinoline 
approach would be selective for the methyl ethers since from the attempted model 
demethylations no selectivity was observed as the lewis acids used were not pre-complexed 
which could allow for a controlled, mild demethylation. It was suggested by O‟Malley et al.1 
to prepare the TMSI-quinoline adduct in a glove-box and store the salt there as it is extremely 
hygroscopic. These observations are consistent with that from the original publication by 
Minamikawa and Brossi
19
. In the absence of a suitable glove box this operation was 
performed using standard Schlenk, air-free techniques (Scheme 101). The complex formed 
immediately after the addition of TMSI and a free flowing yellow suspension in hexane was 
obtained. This solid was then filtered off under N2 and allowed to dry under a low, steady N2 
flow. The yellow solid was then analysed by 
1
H NMR and none of TMS adduct 362 was 
found. This is thought to be due to the product being exposed to moist air briefly during 
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transfer either the transfer of the solid after filtration or during preparation of the NMR 
sample. In either case adduct 362 was simply too unstable to be handled in this way. 
 
 
Scheme 102 Attempted demethylation of 359 via 'one-pot' TMSI - Quinoline procedure 
 
In the original publication by Minamikawa and Brossi
19
 it is suggested to generate adduct 362 
in the presence of the methylated substrate and conduct the demethylation as a one pot 
procedure without isolating the fragile intermediate. This was attempted using the same 
conditions used by O‟Malley et al.1 and others. Using strictly anhydrous conditions, to the 
solution of carboxylic acid 359 in Quinoline was added TMSI in one portion and a yellow 
precipitate formed (Scheme 102). The suspension was then heated to 110
o
C and a dark red 
solution formed. During the time of reaction yellow crystals formed on the inner wall of the 
reaction tube and would periodically be dissolved in the condensed quinolone vapours, 
become part of the reaction mixture and form again. This observation was consisted with 
procedure used by O‟Malley et al.1 to isolate 362 and therefore suggested that adduct 362 
was stable under these conditions. The crude product was then inspected for any sign of 
demethylation but after attempting to isolate any product by chromatography only 
decomposition was observed as the product isolated were in no way similar to the starting 
material or predicted the chemical structure of the demethylated product (13). As these results 
were similar to those obtained for the model demethylations it was realised that compounds 
of this type were not stable to acidic high energy conditions. In a second publication by 
Minamikawa and Brossi
20
 it was noted that improved selectivity can be achieved by 
exchanging quinolone for stronger base DABCO (1,4-diazabicyclo[2.2.2]octane]) with o-
dichlorobenzene as a solvent but since no selectivity was observed for the quinolone system 
these conditions were not attempted. If this demethylation is achievable it would most likely 
occur under mild conditions with very limited external heating.   
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The typical reagent used for the deprotection of methyl ethers present in complex, electron 
rich substrates is borontribromide (BBr3) due to the mild conditions that the reagent 
functions. There are numerous examples in the literature where BBr3 has been successfully 
used to deprotect methyl ethers and related functional groups in complex natural product 
precursors including the total synthesis of Hopeahainol A (364, Scheme 103) by Nicolaou et 
al.
21
 and other members of the resveratrol class of compounds by Snyder et al.
22,23
 Even 
though O‟Malley et al.1 noted that BBr3 was incompatible with their model substrate it was 
speculated that BBr3 could be used for the deprotection of carboxylic acid 359 as this 
substrate is predominantly aromatic and compared to other examples from the literature 
where BBr3 has successfully performed demethylation in more complex, electron rich 
systems this deprotection appeared trivial. Borontribromide (BBr3) has also been used by 
Cotelle and co-workers
24-26
 in the total synthesis of Salvianolic acid F and partial syntheses of 
(+)-Salvianolic acids D and E (see Chapter 1, sections 1.2.5, 1.2.7.1 and 1.2.7.2 
respectively). 
 
 
Scheme 103 Final step in the total synthesis of Hopeahainol A (364) by Nicolaou et al. 
 
It is suggested in the general procedures of McOmie et al.
27
 that when using BBr3 
approximately 1 molar equivalent of BBr3 be used per methyl ether (OMe) and an extra 
equivalent for any other electron donating groups present. It was also noted in the same 
publication that for catechol methyl ethers only 1 mole equivalent of BBr3 per catechol group 
would be sufficient as it is suspected that when the boron coordinates it is predicted to form a 
five membered ring intermediate that performs the demethylation. Another key element of 
BBr3 demethylation is the concentration of the methylated substrate in the reaction mixture. 
Typically the reaction mixture is dilute where the volume of solvent increases in proportion 
to the complexity of the substrate and the number of methyl ethers to be cleaved. These 
specifications were consistent with the BBr3 demethylations found in the literature, but 
CH2Cl2 appeared to be the solvent of choice, not PhH or pentane which were the alternatives 
mentioned by McOmie et al.
28
 Other factors that are known to influence the degree of 
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demethylation by BBr3 are the temperature and the type of quench used to decompose the 
boron complex. 
 
 
Scheme 104 First attempt at the BBr3 mediated demethylation of 359 
 
With a theoretical understanding of BBr3 demethylation the deprotection of 359 was 
attempted with CH2Cl2 as the solvent (2 mL), 6 equivalents of BBr3 (1 per OMe and 1 for the 
CO2H) and starting temperature of -78
o
C (Scheme 104). After the addition of BBr3 at -78
o
C 
the reaction mixture was allowed to stir in the same bath 2 hours before the flask was 
transferred to a -10
o
C bath and the reaction was allowed to slowly warm to room temperature 
overnight. After the addition of BBr3 at -78
o
C a deep red suspension formed and as the 
reaction mixture began to warm up the suspension became a solution. The next day the 
reaction was quenched by the addition of cold H2O and the crude product isolated by 
standard aqueous workup. Analysis of the crude product revealed that no demethylation 
occurred. Surprisingly only fragmentation across the bond between carbons C1' and C2'' 
occurred and fragments 281 and 365 were isolated. This was a depressing result as it meant 
that no matter what conditions were used the same fragmentation is likely to occur as these 
conditions used the smallest possible amount of BBr3 and the reaction was started at -78
o
C. 
 
It was considered that perhaps the reason for fragmentation across the internal ester was the 
severity of the water quench and that if a milder quench was used any boron that was 
coordinated to the internal ester could be removed without fragmenting the cinnamate 
skeleton. Fortunately there were examples in the literature were other researchers in the field 
faced the same issue. In the first studies towards the total synthesis of Salvinorin A by 
Lingham et al.
29
 selectivity for BBr3 mediated cleavage of an ether bridge over acetyl and 
methyl esters was achieved by using a quenching solution of 2,4,6-collidine in CH2Cl2 
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(Scheme 105). After addition of BBr3 at -1
o
C the reaction mixture was stirred at this 
temperature for 10 min before it was poured into a vigorously stirred solution of 2,4,6-
collidine in CH2Cl2.     
 
Scheme 105 BBr3 mediated ether bridge cleavage by Lingham et al. 
 
From the first experiment no demethylation was observed with 6 molar equivalents of BBr3 at 
-78
o
C. It was noted from the literature that when BBr3 deprotection is started at this 
temperature the rate of demethylation is slow as the boron intermediates do not form at this 
temperature. Therefore the BBr3 demethylation was repeated starting from -20
o
C as it was 
thought selectivity for the methyl ethers over the ester could be achieved if the coordination 
of boron was accelerated as done by Lingham et al.
29
 (Scheme 105) and Taub et al.
30
 in the 
total synthesis of macrolide Zearalenone. Using 10 equivalents of BBr3 (1.7 equivalents per 
electron donating group) and five times the volume of CH2Cl2, once the reaction mixture 
reached 0
o
C it was quickly poured into a vigorously stirred solution of 2,4,6-collidine in 
CH2Cl2 (Scheme 106). After isolation of the crude product by extraction from the aqueous 
phase with EtOAc it was tested by TLC (CHCl3/MeOH/HCO2H, 85:10:5) and three spots 
were detected when the plate was developed with a solution of 2% AlCl3/MeOH and 
visualised under UV. There were two spots towards the solvent front with Rf values of 0.82 
and 0.92 with third spot being strongly retained near the base line (Rf = 0.28). As the lower 
spot was most strongly retained it was suspected of being a polyphenolic acid (368) while the 
other two spots were predicted to be by-products as a result of ester cleavage. The crude 
mixture was then analysed by ESI-MS and three predominant ions were detected in negative 
mode corresponding to a tetraphenolic acid (368) and the two predicted by-products (369 and 
370) resulting from ester fragmentation (Scheme 106).  
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Scheme 106 Second attempt at BBr3 mediated demethylation of 359 with collidine quench 
 
With the mild collidine quench and a 10 times molar excess of BBr3 four out of the five 
methyl ethers were removed, but the yield of this product was anticipated to be low as only 
10 mg of crude material was recovered after extraction. An attempt was made to isolate 
tetraphenol by CC on SiO2 deactivated with formic acid (HCO2H). By TLC the spot at Rf = 
0.28 separated easily and could be visualised eluting from the column as a thick yellow band. 
The fractions were combined to yield only 13% of 368 as a dark orange residue which could 
only be taken up in solvents like MeOH and CH3CN by the addition of HCO2H to the solvent 
mixture. A dry sample of 368 was then analysed by 
1
H NMR (d4-MeOH) where the identity 
of the tetraphenol methyl ether was confirmed by the presence one singlet at δH 4.06 (Figure 
16). The remaining peaks in the spectrum could not be accurately characterised as a result of 
overlapping resonances and peak broadening affects due to the presence of water in the 
sample. Fortunately there was enough detail to categorise the type of functional group 
responsible with a group of aromatic and olefinic protons between δH 6.5 – 8. Occasionally 
acidic protons were seen between δH 8.5 – 10 which would confirm the presence of a 
phenolic compound. From this analytical data and the observations noted during 
chromatographic isolation it was confirmed that a tetraphenol was present and most likely has 
structure 368 but complete characterisation could not be carried out due to contamination 
from the two phenolic byproducts as they could not be quantitatively removed by CC. The 
other possibility is that this compound is unstable due to the redox effects of polyphenols.   
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Figure 16 1H NMR (300 MHz, d4-MeOH) spectrum of 368 after purification by column chromatography (CC)
Chapter 4    
Page | 271  
 
To thoroughly characterise this compound and confirm the structure further optimisation of 
the reaction conditions was necessary. An interesting approach to BBr3 demethylation by 
Balaydin
31
 was found where boron alkoxides were quenched with acetic acid (AcOH) to form 
acetylated products directly after treatment with BBr3. As the acetylated products are more 
stable and reduced in polarity, generally the yields for the demethylation are higher as all 
decreases in yield due to issues encountered during isolation by chromatography are 
prevented and electron rich polyphenols are stabilised preventing losses due to oxidation.  As 
the acetyl groups can be readily hydrolysed this approach was ideal for the demethylation of 
359. 
 
 
Scheme 107 Third attempt at BBr3 mediated demethylation of 359 with AcOH quench 
 
To try this style of quench the demethylation of 359 was attempted again using similar 
conditions to those employed for the previous experiment except 12 molar equivalents of 
BBr3 were used (Scheme 107). The BBr3 was added at -20
o
C and once the temperature had 
reached -6.5
o
C a solution of anhydrous AcOH in CH2Cl2 was transferred to the reaction via 
cannula. The colour of the solution immediately changed from deep purple to yellow, 
indicating the boron alkoxide had been quenched. The crude product was then isolated using 
according to the procedure of Balaydin
31
 and analysed. Surprising only two methyl ethers 
were cleaved and the AcOH did not acetylate the free phenols, instead it formed an anhydride 
with the carboxylic moiety and anhydride 371 was isolated in 35% yield as the predominant 
product.  
 
As even more BBr3 had been used the controlling factor was clearly the temperature. This 
reaction was then repeated using the same molar excess of BBr3 and AcOH, but the reaction 
was quenched at 0
o
C. However these conditions were not suitable and only the original 
fragmentation products (369 and 370) were isolated. The reaction was repeated a third time 
using the same molar ratios but the reaction was quenched at -3
o
C. Using these conditions 
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tetraphenol 368 was detected by TLC and ESI-MS but no trace of anhydride 371 was 
detected. Unfortunately the yield of 368 was significantly lower than that obtained from the 
collidine quench at 0
o
C but these experiments illustrated the effect of temperature during the 
quench. As the yield for tetraphenol 368 was lower when the demethylation was quenched by 
AcOH at -3
o
C compared to the collidine quench at 0
o
C it raised the question if the collidine 
quench was conducted at -3
o
C would the yield for 368 be improved?  
 
 
Scheme 108 Optimum conditions for the BBr3 demethylation of 359 
 
The demethylation of 359 was repeated with 12 molar equivalents of BBr3 and once the 
cooling bath was between -4 to -3
o
C the reaction mixture was quickly poured into the 
vigorously stirred 2,4,6-collidine solution (Scheme 108). The crude product was then isolated 
as before and the same pattern of spots was seen on the TLC plate, with a large spot 
corresponding to tetraphenol 368 (Rf = 0.28) suggesting that a higher yield had been 
achieved. The crude mixture was then subjected to CC and all three compounds co-eluted as 
before, however this time this result was intended as it was planned to isolate tetraphenol 368 
by preparative TLC. Using the solvent mixture as that used for CC the crude mixture was 
applied to the plate and run. A thick yellow band separated and could be seen by the naked 
eye without the need for UV light. Unfortunately the compound could never be successfully 
extracted from the SiO2 gel and was lost. Occasionally very small amounts could be eluted 
but only enough for an MS and a poor 
1
H NMR. The conclusion was that there were only 
trace amounts of 368 present initially and therefore the yield was considerably lower than 
anticipated. 
 
The demethylation and following isolation were attempted again and the same physical 
characteristic were observed with a thick yellow band on the TLC plate with the same Rf 
value (0.28), but the compound could not be isolated. From these two attempts it was 
confirmed that the yield of 368 was simply too low for isolation and therefore the structure of 
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368 was not confirmed. However from the crude NMRs and MS it is certain that tetraphenol 
368 was synthesised but it could not be unambiguously characterised.  
 
As the methyl ethers of 359 could not be successfully cleaved the synthesis of (+)-Salvianolic 
acid C was not completed by this route. As partial demethylation of pentamethyl derivative 
359 was observed it is believed that under the correct conditions complete deprotection is 
possible but due to the restricted time frame that this work was conducted these conditions 
were not found. However leaving the methyl ethers attached to the molecule may still render 
it biologically active as studies have shown that the major metabolic pathway for (+)-
Salvianolic acid B is methylation by COMT (catechol O-methyltransferase) (see Chapter 1, 
section 1.1.5).  Therefore instead of synthesising natural (+)-Salvianolic acid C a methylated 
analogue, (+)-pentamethylsalvianolic acid C (359) has been prepared in a total of thirteen 
steps (longest linear path is seven steps) with an overall yield of 11% starting from 
isovanillin.    
 
If the total synthesis of (+)-Salvianolic acid C was attempted again methyl ethers would not 
be used as a protecting group due to the difficulty associated with their removal using current 
methodologies. However for this synthesis the methyl ether is one of the best protecting 
groups to use as they are not acid sensitive and are therefore compatible with the acid 
chloride esterification conditions developed. Other protecting groups with the same stability 
exist (for example, allyl ethers) but their use in this route would extend the synthetic route by 
at least one additional step, if not more due to chemoselectivity issues as the protected 
building blocks are not commercially available compared to the methylated starting materials 
used here.  
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4.3 Experimental 
 
4.3.1 Synthesis of ester 348 by Steglich esterification
6
 
 
4.3.1.1 Methyl (+)-pentamethylsalvianolate C (348) 
 
 
 
An oven dried 50 mL, three-necked RBF equipped with a rubber septum, gas inlet adapter, a 
Teflon coated oval shaped magnetic stir and a glass stopper was assembled while hot then 
evacuated. The flask was then flame dried and allowed to cool under N2. Ground 281 (50 mg, 
0.141 mmol) was then added followed by anhydrous THF (10 mL) and the suspension was 
stirred under N2 at room temperature until a solution had formed. DMAP (26.7 mg, 
0.219 mmol, 1.6 equiv) was then added to the yellow solution followed by 63 (34 mg, 
0.141 mmol, 1 equiv). DIC (33 mg, 0.261 mmol, 1.9 equiv) was then dissolved in a small 
amount of anhydrous THF (≈ 2 mL) and added to the yellow solution at room temperature. 
The reaction mixture was then allowed to stir at room temperature, under N2 for 93 hours.  
The reaction mixture was then filtered through a pad of SiO2 (3 – 5 cm) with Et2O and the 
combined mother liquors were evaporated to afford the crude product which was analysed by 
1
H NMR and ESI-MS. For the characteriation data of this compound see 4.3.2.4. 
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4.3.2 Synthesis of ester 348 by acid fluoride activation
10
 
 
4.3.2.1 Cyanuric fluoride (355)
10
 
 
 
 
To an oven dried, 500 mL three-necked RBF equipped for distillation at atmospheric pressure 
(still head, thermometer, condenser, collection, still receiver, RBF) with additional 
thermometer extending to the bottom of the flask and a glass stopper was added cyanuric 
chloride (25.0 g, 136 mmol) and NaF (34.20 g, 815 mmol, 6 equiv) followed by warm 
sulfolane (132.16 g, 1.1 mol, 8 equiv). The stirrer was started and the flask was heated with a 
Bunsen burner. Once the temperature of the reaction reached 150 – 160oC a clear liquid 
distilled across registering a temperature of 70 – 80oC on the still thermometer, finishing at 
88
o
C. Once the reaction mixture reached 180 – 200oC 355 started to come across and finished 
at 250
o
C. The reaction was complete in less than 1 hour. The crude product was then distilled 
a second time under N2 (73 – 74
o
C) to obtain 355 (7.1 g, 39%) as a clear, colourless liquid. 
The 
13
C NMR spectrum matched that from the literature.
10
 
 
13
C NMR (75 MHz, CDCl3) δ 173.7 (3C, dt, J
13
C-
19
F = 240.4, 38.0, 18.7 Hz, 3 × ArC); 
19
F 
NMR (128 MHz, CDCl3) δ -29.78 
 
 
 
 
 
 
 
 
 
 
 
Chapter 4    
Page | 276  
 
4.3.2.2 (2E)-3-[2-(3,4-dimethoxyphenyl)-7-methoxy-1-benzofuran-4-yl]prop-2-enoyl 
fluoride 356
10
 
 
 
 
An oven dried 50 mL, three-necked RBF equipped with a gas inlet adapter, Teflon coated, 
oval shaped magnetic stir bar and a glass stopper was assembled while hot then evacuated. 
The flask was then flame dried and allowed to cool under N2. 281 (50 mg, 0.141 mmol) was 
then added followed by anhydrous CH2Cl2 (5 mL) and pyridine (22.8 µL, 0.282 mmol, 2 
equiv). The suspension was then stirred at room temperature and 355 (24.3 µL, 0.282 mmol, 
2 equiv) was added to form a fuming solution. The solution was then allowed to stir at room 
temperature for 6 hours during which time a white precipitate formed (pyridine salts) and the 
fumes dissipated. Pentane (5 mL) was then added followed by deionised H2O (10 mL) and 
the layers were separated. The combined organic layer was then dried over MgSO4, filtered 
through a pad of Celite (3 – 5 cm) and evaporated to afford 356 (23.7 mg, 47%) as a yellow 
solid. 
 
1
H NMR (300 MHz, CDCl3) δ 3.96 (3H, s, OCH3), 4.03 (3H, s, OCH3), 4.11 (3H, s, OCH3), 
6.38 (1H, dd, J = 16.1, 7.2 Hz (
13
C – 19F), ArCH=CHCOF), 6.84 (1H, d, J = 8.5 Hz, ArH), 
6.97 (1H, d, J = 8.3 Hz, ArH), 7.16 (1H, s, ArH), 7.42 (2H, m, ArH), 7.53 (1H, dd, J = 8.3, 
1.9 Hz, ArH), 8.07 (1H, d, J = 15.9 Hz, ArCH=CHCOF) 
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4.3.2.3 Methyl (+)-pentamethylsalvianolate C (348) 
 
 
 
To a 25 mL, singled necked RBF equipped with a Teflon coated, oval shaped magnetic stir 
bar containing freshly prepared 356 (23.7 mg, 0.067 mmol, 1.14 equiv) was added 63 
(14.2 mg, 0.059 mmol) followed by anhydrous CH2Cl2 (5 mL). Anhydrous Et3N (32 µL, 
0.232 mmol, 4 equiv) was then added and a reflux condenser attached to a gas inlet adapter 
was then fitted and the solution was evacuated and purged with N2 (3×). The reaction mixture 
was then heated to reflux and maintained at this temperature for 17 hours. The yellow 
solution was then allowed to cool to room temperature and the CH2Cl2 was evaporated to 
form a residual oil. This oil was then dissolved in EtOAc (50 mL) and washed with dilute 
aqueous HCl (2M, 2 × 50 mL), deionised H2O (50 mL), saturated aqueous NaHCO3 (10% 
(w/w), 2 × 50 mL), deionised H2O (50 mL) and brine (50 mL). The combined organic layers 
were then dried over MgSO4, filtered through a pad of SiO2 (3 – 5 cm) and evaporated to 
form the crude product which was analysed by 
1
H NMR to give a yield of 56%. For the 
characterisation of this compound see 4.3.2.4. 
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4.3.3 Synthesis of ester 348 via acid chloride activation
8
 
 
4.3.3.1 (2E)-3-[2-(3,4-dimethoxyphenyl)-7-methoxy-1-benzofuran-4-yl]prop-2-
enoyl chloride 352 via conventional heating
8
 
 
 
 
To a 25 mL, single necked RBF equipped with a Teflon coated, oval shaped magnetic stir bar 
was added 281 (50 mg, 0.141 mmol) followed by freshly distilled CCl4 (5 mL) and SOCl2 
(31 µL, 0.423 mmol, 3 equiv).  A reflux condenser was then fitted topped with CaCl2 drying 
tube and the reaction was brought to reflux (T (oil bath) = 80
o
C) and maintained at this 
temperature overnight. The reaction mixture was then allowed to cool to room temperature 
before the CCl4 and excess SOCl2 were evaporated to afford an orange residue. This residue 
was then re-dissolved in CH2Cl2 (5 mL) and evaporated again to afford 352 (52 mg, 97%) as 
an orange solid.  
 
4.3.2.2 (2E)-3-[2-(3,4-dimethoxyphenyl)-7-methoxy-1-benzofuran-4-yl]prop-2-
enoyl chloride 352 via microwave 
 
 
 
To a 35 mL CEM microwave vial equipped with a Teflon coated, oval shaped magnetic stir 
bar was added 281 (500 mg, 1.41 mmol) followed by freshly distilled tetrachloroethylene 
(C2Cl4, 20 mL). Freshly distilled SOCl2 (515 µL, 7.06 mmol, 5 equiv) was then added and the 
vessel was sealed with a Teflon cap. The reaction mixture was briefly mixed by vortex to 
ensure an even distribution of reagents throughout the solvent. The vessel was then placed 
Chapter 4    
Page | 279  
 
inside in the CEM Discover microwave and irradiated at 135
o
C (see microwave conditions 
below) with stirring for a hold time of 30 min. The vessel was cooled to 60
o
C and subjected 
to a second round of irradiation at 135
o
C for a hold time of 30 min. After two cycles of 
irradiation, the vial was vented while warm (40 to 50
o
C) and the contents were transferred to 
a 100 mL RBF and the volatiles were evaporated. The yellow residue was then suspended in 
C2Cl4 and enough CH2Cl2 was added to affect dissolution. The yellow solution was then 
evaporated and dried under high vacuum (≤ 0.2 mmHg) for 1 hour to afford 352 (0.56 g, > 
99%) as a yellow to orange, crystalline solid. This product was used immediately in the next 
step.   
 
Microwave conditions 
 
Temperature (
o
C) 135 
Ramp time (min) 60 
Hold time (min) 30 
Pressure (PSI) 150 
Power (W) 250 
Power Max On 
Stirring High 
 
4.3.2.3 Attempted synthesis of Methyl (+)-pentamethylsalvianolate C (348) by alkoxide 
coupling 
 
 
 
An oven dried 50 mL, three-necked RBF was assembled with a gas inlet adapter, a Teflon 
coated, oval shaped magnetic stir bar, a rubber septum and a glass stopper while hot and then 
evacuated. The flask was then flamed dried and allowed to cool under N2. NaH in mineral oil 
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(60% (w/w) dispersion, 9 mg, 0.23 mmol, 3.8 equiv) was then added and the flask was 
evacuated and purged with N2 (3×). The NaH dispersion was then washed with anhydrous 
hexane (3 × 5 mL) by adding and decanting the supernatant via syringe and dried under house 
vacuum. The anhydrous NaH was then suspended in anhydrous DMF (2 mL) and 63 
(14.6 mg, 0.061 mmol) was added. A solution of freshly prepared 352 (26 mg, 0.071 mmol, 
1.2 equiv) in anhydrous DMF (3 mL) was then prepared in a second dry flask and added to 
the NaH suspension dropwise via cannula and the reaction mixture was allowed to stir at 
room temperature for 20 hours. The reaction mixture was then diluted with EtOAc (100 mL) 
and the combined organic layers were washed with deionised H2O (3 × 50 mL), brine 
(50 mL), dried over MgSO4, filtered through a pad of Celite (3 – 5 cm) and evaporated to 
afford the crude product which was analysed by 
1
H NMR. For the characterisation data of 
this compound see 4.3.2.4. 
 
4.3.2.4 Synthesis of Methyl (+)-pentamethylsalvianolate C (348) by acid chloride 
esterification
8
 
 
 
 
To a 100 mL RBF, which contained freshly prepared 352 (562 mg, 1.52 mmol, 2 equiv) and 
an oval shaped, Teflon coated magnetic stir bar was added 63 (183 mg, 0.76 mmol, 1 equiv). 
Both reagents were then dissolved in anhydrous CH2Cl2 (25 mL) and the reaction vessel was 
equipped with an oven dried reflux condenser and gas inlet adapter. The flask was then 
evacuated and purged with N2 (3×) and anhydrous Et3N (424 µL, 3.04 mmol, 4 equiv) was 
added. The intense red solution began to fume and the reaction mixture was heated to reflux 
(50 – 60oC) and maintained at this temperature with vigorous stirring for 4 hours. The red-
orange solution was then allowed to cool to room temperature and was placed in the fridge 
overnight to precipitate anhydride byproduct and Et3N.HCl. The anhydride was filtered off 
(0.21 g, 20%) and the mother liquor evaporated to yield an orange-red residue. This residue 
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was then subjected to VLC (SiO2, 0 – 4% Et2O/CH2Cl2) to yield 348 (311 mg, 71%) as an 
intense red to orange foam. 
Methyl (+)-pentamethylsalvianolate C (348)  
 
[α]D
24
 + 43.1
o
 (c 1.005 in CH2Cl2); 
1
H NMR (300 MHz, CDCl3) δ 3.21 (2H, dd, J = 5.2, 
2.0 Hz, CH2), 3.78 (3H, s, CO2Me), 3.86 (3H, s, OCH3), 3.88 (3H, s, OCH3), 3.96 (3H, s, 
OCH3), 4.03 (3H, s, OCH3), 4.09 (3H, s, OCH3), 5.41 (1H, dd, J = 7.6, 5.5 Hz, CH), 6.50 
(1H, d, J = 15.9 Hz, C=CHCO2), 6.82 (4H, m, ArH), 6.97 (1H, d, J = 8.5 Hz, ArH), 7.17 (1H, 
s, ArH), 7.39 (2H, m, ArH), 7.53 (1H, dd, J = 8.5, 2.1 Hz, ArH), 7.96 (1H, d, J = 16.3 Hz, 
ArCH=C); 
13
C NMR (75 MHz, CDCl3) δ 37.2 (CH2), 52.4 (CO2CH3), 55.8 (OCH3), 55.8 
(OCH3), 56.0 (OCH3), 56.2 (OCH3), 56.2 (OCH3), 73.1 (CH), 99.2, 106.6, 108.2, 111.2, 
111.3, 112.5, 114.9, 118.5, 119.7, 121.4, 122.7, 125.8, 128.4, 130.7, 143.7, 144.1, 146.9, 
148.1, 148.8, 149.2, 150.1, 157.6, 166.7 (CO2), 170.5 (CO2CH3); IR (KBr) 2999.40, 2951.62, 
2935.35, 2835.91, 1751.76, 1709.19, 1611.52, 1578.20, 1515.84, 1463.31, 1440.49, 1293.66, 
1255.09, 1218.13, 1142.02, 1097.99, 1025.42, 970.96 cm
-1
; HRMS (ESI) calculated for 
C32H32O10Na [M + Na]
+
: 599.1893, found: 599.1889. 
 
(2E)-3-[2-(3,4-dimethoxyphenyl)-7-methoxy-1-benzofuran-4-yl]prop-2-enoyl (2E)-3-[2-
3-[2-(3,4-dimethoxyphenyl)-7-methoxy-1-benzofuran-4-yl]prop-2-enoate (353) 
 
Mp. = 128 – 130oC; 1H NMR (300 MHz, d6-DMSO) δ 3.82 (6H, s, 2 × OCH3), 3.88 (6H, s, 2 
× OCH3), 4.05 (6H, s, 2 × OCH3), 6.86 (2H, d, J = 16.4 Hz, 2 × C=CHCO2), 7.07 (4H, m, 
ArH), 7.56 (4H, m, ArH), 7.76 (4H, m, ArH), 7.92 (2H, s, ArH), 8.14 (2H, d, J = 16.4 Hz, 2 × 
ArCH=C); 
13
C NMR (75 MHz, d6-DMSO) δ 55.6 (2 × OCH3), 55.8 (2 × OCH3), 56.2 (2 × 
OCH3), 100.1 (2 × ArC), 107.4 (2 × ArC), 108.6 (2 × ArC), 112.0 (2 × ArC), 114.7 (2 × 
ArC), 118.0 (2 × ArC), 118.9 (2 × ArC), 122.0 (2 × ArC), 127.2 (2 × ArC), 130.6 (2 × ArC), 
142.8 (2 × ArC), 146.2 (2 × ArC), 147.2 (2 × ArC), 149.1 (2 × ArC), 150.0 (2 × ArC), 157.2 
(2 × ArC), 163.5 (CO2CO), 168.0 (COCO2); IR (KBr) 2998.89, 2934.95, 2836.34, 1757.53 
(CO2CO), 1705.68 (COCO2), 1610.27, 1576.95, 1514.60, 1501.74, 1462.73, 1441.38, 
1405.07, 1292.65, 1277.39, 1253.25, 1217.72, 1180.48, 1165.61, 1140.33, 1098.63, 1074.75, 
1024.92, 969.12 cm
-1
; HRMS (ESI) calculated for C40H34O11Na [M + Na]
+
 713.1999, found 
713.1989. 
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4.3.4 Saponification of the methyl ester in methyl (+)-
pentamethylsalvianolate C (348)
13
 
 
4.3.4.1 (+)-Pentamethylsalvianolic acid C 359
13
 
 
 
 
An oven dried 100 mL, three-necked  RBF was assembled with a rubber septum, reflux 
condenser with gas inlet adapter, glass stopper and a small Teflon coated magnetic stir bar 
while hot and then evacuated. The whole apparatus was then flame dried under vacuum and 
allowed cool under N2. 348 (100 mg, 0.173 mmol) was then added to the vessel followed by 
freshly distilled 1,2-DCE (30 mL). A yellow solution was then obtained and Me3SnOH 
(157 mg, 0.867 mmol, 5 equiv) was added. The reaction mixture was then heated to 80
o
C and 
held at this temperature for 23 hours. Progress of the reaction was monitored by TLC (4% 
Et2O/CH2Cl2) and upon completion the reaction mixture was allowed to cool to room 
temperature and the 1,2-DCE was evaporated. The resulting yellow residue was redissolved 
in EtOAc (100 mL) and transferred to a separatory funnel. The organic layer was washed 
with dilute aqueous HCl (2M, 3 × 50 mL), brine (50 mL) dried over MgSO4, filtered through 
a pad of MgSO4 and evaporated to yield a yellow-green residue. This residue was subjected 
to CC (SiO2 deactivated with 0.5% AcOH, 10 – 20% Acetone/CH2Cl2 followed by 20% 
Acetone/CH2Cl2 + 0.5% AcOH) to provide 359 (91 mg, 93%) as a yellow foam. An 
analytically pure sample was generated by subjecting this sample to preparative-TLC (SiO2, 
10% Acetone/CH2Cl2 + 0.5% AcOH) and collecting the yellow band at Rf = 0.36 providing 
359 (69 mg, 71%) as a light green solid. 
 
[α]D
22
 + 0.7
o
 (c 1.060 in CH2Cl2); Mp. = 118 – 120
o
C; 
1
H NMR (300 MHz, d6-DMSO) δ 3.01 
(1H, dd, J = 13.8, 9.5 Hz, HCH), 3.18 (1H, dd, J = 14.6, 3.5 Hz, HCH), 3.68 (3H, s, OCH3), 
3.73 (3H, s, OCH3), 3.83 (3H, s, OCH3), 3.89 (3H, s, OCH3), 4.02 (3H, s, OCH3), 5.10 (1H, 
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dd, J = 9.5, 2.7 Hz, CH), 6.64 (1H, d, J = 15.9 Hz, C=CHCO2H), 6.84 (2H, s, ArH), 6.99 
(2H, d, J = 8.6 Hz, ArH), 7.09 (1H, d, J = 8.8 Hz, ArH), 7.58 (3H, m, ArH), 7.78 (1H, s, 
ArH), 7.85 (1H, d, J = 16.2 Hz, ArCH=C); 
13
C NMR (75 MHz, d6-DMSO) δ 36.8 (CH2), 
55.3 (OCH3), 55.4 (OCH3), 55.6 (OCH3), 55.8 (OCH3), 56.0 (OCH3), 74.4 (CH), 99.9, 107.2, 
108.6, 111.6, 112.0, 113.2, 116.2, 117.9, 119.3, 121.1, 122.1, 125.6, 130.1, 130.4, 142.0, 
142.8, 146.4, 147.3, 148.3, 149.1, 149.9, 156.8, 166.1 (CHCO2), 171.1 (CO2H); IR (KBr) 
3435.48, 2923.65, 2851.76, 1702.70, 1614.45, 1515.73, 1463.76, 1404.95, 1255.32, 1158.28, 
1141.06, 1097.82, 1024.86, 971.20 cm
-1
; HRMS (ESI) calculated for C31H29O10 [M - H]
-
 
561.1761, found 561.1764 
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4.3.5 Attempted demethylations of 359 
 
4.3.5.1 Attempted synthesis of (+)-Salvianolic acid C (13) by demethylation of 359 with 
TMSI – Quinoline1 
 
 
 
An oven dried 10 mL, quick-fit tube was assembled with a small Teflon coated, oval shaped 
magnetic stir bar and a rubber septum while hot and then evacuated by needle – tubing 
adapter. The tube was then flame dried and allowed to cool under N2. 359 (21.2 mg, 
0.038 mmol) was then added and the tube was sealed and the tube was evacuated and purged 
with N2 (3×). Anhydrous quinoline (0.37 mL, 3.2 mmol, 80 equiv) was then added and a 
solution yellow solution formed. TMSI (0.25 mL, 1.8 mmol, 47 equiv) was then added via 
syringe and a yellow precipitate formed immediately. The suspension was then stirred at 
room temperature for 15 minutes before it was heated to 110
o
C. The reaction mixture was 
stirred at this temperature for 5 hours during which time a dark red solution formed. The dark 
solution was then allowed to cool to room temperature, vented and dilute aqueous HCl (1M, 
5 mL) was added slowly. The solution was then extracted with CHCl3/MeOH (3:1 (v/v), 3 × 
50 mL) and the combined organic layers were dried over MgSO4, filtered through a pad of 
Celite (3 – 5 cm) and evaporated to afford the crude product which was analysed by TLC 
(SiO2, CHCl3/MeOH/HCO2H 85:10:5) and 
1
H NMR.  
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4.3.5.2 Attempted synthesis of (+)-7-methoxysalvianolic acid C (368) by BBr3 
demethylation of 359 with AcOH quench; Synthesis of anhydride 371
31
 
 
 
 
An oven dried 50 mL, three-necked RBF was equipped with a gas inlet adapter, rubber 
septum, a Teflon coated, oval shaped magnetic stir bar and a glass stopper while hot and then 
evacuated. The flask was then flame dried and allowed to cool under N2. 359 (21 mg, 
0.037 mmol) was then added and the flask was evacuated and purged with N2 (3×). 
Anhydrous CH2Cl2 (12.5 mL) was then added the yellow solution was cooled to -20
o
C 
(NaCl/Ice). A solution BBr3 (1M in CH2Cl2, 0.43 mL, 0.43 mmol, 12 equiv) was then added 
via syringe and a deep durple suspension formed. The reaction mixture was then stirred in the 
cooling bath as the temperature slowly rose to -6.5
o
C. During this time a solution of AcOH 
(0.10 mL, 1.75 mmol, 47 equiv) in anhydrous CH2Cl2 (5 mL) was prepared in a second dry 
flask and once the temperature of the cooling bath reached -6.5
o
C the AcOH solution was 
transferred to the purple suspension via cannula. A yellow solution formed immediately and 
was stirred at room temperature 2.5 hours. A cold (0
o
C), dilute aqueous solution of Na2CO3 
(5% (w/w), 5 mL) was then added followed by chilled deionised H2O (5 mL) and the layers 
were separated. The aqueous layer was then extracted a second time with CH2Cl2 (20 mL) 
and the combined organic layers were dried MgSO4, filtered through a pad of Celite (3 – 
5 cm) and evaporated to afford 371 (7.5 mg, 35%) as an orange solid.  
 
LRMS (ESI) [M+H]
+
 = 577 m/z 
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4.3.5.3 Unconfirmed synthesis of (+)-7-methoxysalvianolic acid C (368) by BBr3 
demethylation of 359 with collidine quench
29
 
 
 
 
An oven dried 250 mL, three-necked RBF was equipped with a rubber septum, N2 inlet, glass 
stopper and Teflon coated magnetic stir bar while hot and then evcuated. The flask was then 
flame dried and allowed to cool under N2. In a separate dry flask, 359 (82 mg, 0.146 mmol) 
was dissolved in freshly distilled CH2Cl2 (50 mL) and transferred via cannula to the apparatus 
above. The yellow solution was then cooled to - 20
o
C (Ice/NaCl), and a solution of BBr3 (1M 
in CH2Cl2, 1.8 mL, 1.75 mmol, 12 equiv) was added in one portion and a deep purple 
complex formed immediately. The reaction mixture was then stirred under N2 while closely 
monitoring the temperature of the cooling bath.  Once the temperature of the cooling bath had 
reached between - 3 to - 4
o
C the dark red reaction mixture was poured quickly into a 
vigorously stirred solution of distilled 2,4,6-collidine (17.65 g, 145 mmol, 83 equiv per mole 
of BBr3) in CH2Cl2 (183 mL). A red suspension formed and was stirred at room temperature 
for 30 min. This solution was then transferred to a separatory funnel and the CH2Cl2 layer 
was washed with dilute aqueous HCl (1M, 200 mL). The layers were separated and the 
CH2Cl2 layer was discarded. The aqueous layer was then vigorously extracted with EtOAc (5 
× 50 mL). The combined EtOAc layers were dried over MgSO4, filtered through a pad of 
MgSO4 and evaporated to form a red residue. This residue was first subjected to CC (SiO2, 0 
– 10% MeOH/CHCl3 + 5% HCO2H). The fractions thought to contain 368 were then 
subjected to preparative-TLC (SiO2, 10% MeOH/CHCl3 + 5% HCO2H) where a thick yellow 
band at Rf = 0.28 (visualised under UV, 350 nm) was collected and extracted off the SiO2 
with acetone to provide only minute quantities of 368 a dark orange residue. 
 
LRMS (ESI) [M-H]
-
 = 505 m/z 
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5.0 Studies towards the synthesis of (+)-Salvianolic acid D 
and the preparation of chalcone-salvianolic acid C hybrids 
 
5.1 Introduction 
 
From the family of salvianolic acids present within Danshen, only a select few have been 
successfully prepared via total synthesis. Salvianolic acids D & E have attracted the attention 
of organic chemists due to their simple structures, and syntheses of their cinnamic acid 
scaffolds have been reported.
1,2
 However no attempts have been made to incorporate the (R)-
danshensu moiety presumably due to either the difficulties associated with chemoselective 
esterification or the preparation of the chiral secondary alcohol itself. (+)-Salvianolic acid D 
is structurally related to (+)-Salvianolic acid C possessing the same trans-cinnamate core and 
(R)-danshensu side chain as is characteristic in all salvianolic acids. As cinnamate 273 was a 
key precursor to methyl (+)-pentamethylsalvianolate C (348) it is proposed that this same 
building block could be readily modified to provide the diacid skeleton of (+)-Salvianolic 
acid D (8, Figure 17). The purpose of this was to develop a synthetic scheme that would 
allow for the addition of the chiral danshensu side chain into the Salvianolic acid D core 
thereby providing access to the complete, natural polyphenol. 
 
 
Figure 17 The structural similarities between Methyl (+)-pentamethylsalvianolate C (348) and (+)-Salvianolic acid D (8) 
 
(+)-Salvianolic acid C, like other members of the family possesses a cinnamate backbone that 
constitutes a key element of the core structure. Replacement of the cinnamate with an enone 
moiety leads to chalcones and the bioactivity of the latter have been intensely investigated.  
Chalcones are part of the flavonoid family of compounds and are known to be 
pharmacologically active as anti-inflammatory, antibacterial, antioxidant, antimalarial, 
antifungal and anticancer agents.
3-6
 In the pursuit of developing synthetically appealing 
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Danshen pharmaceuticals it was proposed that exchange of the cinnamate moiety of (+)-
Salvianolic acid C with a chalcone functionality could lead to the potential development of 
potent drug candidates as both pharmacophores have a high level of efficacy for an array of 
biological functions (Figure 18). 
 
 
Figure 18 Proposed structure of a salvianolic acid C - chalcone hybrid 
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5.2 Results & Discussion 
 
5.2.1 Model reaction studies for the preparation of the arylacetic acid motif 
present in (+)-Salvianolic acid D 
 
5.2.1.1 Synthesis of arylacetonitrile precursor 376 
 
The key structural differences between Salvianolic acids D & C is the presence of an acetic 
acid group in salvianolic acid D in place of the 2-substituted benzo[b]furan ring in (+)-
Salvianolic acid C. To allow for selective esterification at the cinnamic carboxylic acid the 
acetic acid group must either be protected or installed after the esterification. As the 
carboxylic acid in cinnamate 273 is already protected as an ester it would be preferable not 
use the protection strategy as the chemoselective hydrolysis of one ester over another is 
problematic. It would be possible to use two protecting groups of varying stability and 
sensitivity but switching protecting groups during a synthesis severely reduces efficiency. As 
an alternative to protecting group chemistry it was considered that a carboxylic acid precursor 
be used that could be transformed to the acetic acid group after esterification with the 
protected danshensu derivative.   
 
 
Scheme 109 Retrosynthetic analysis for arylacetonitrile route 
 
One of the most common precursors to carboxylic acids is nitrile groups as they can be 
readily converted to carboxylic acids by hydrolysis in aqueous acid (Scheme 109). As 
cinnamate 273 is a bromophenol it was considered that electrophilic substitution at the 
activated carbon with an appropriately substituted alkylcyanide could provide the desired 
arylacetonitrile building block. After a literature search, an interesting procedure by Frejd et 
al.
7
 was found where arylzinc chlorides are alkylated by bromoacetonitrile in the presence of 
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catalytic amounts of Ni(acac)2 and phosphine ligand cyclohexyldiphenylphosphine 
((C6H11)PPh2) or triphenylphosphine (PPh3). To test this chemistry a series of model 
reactions were carried out with 4-bromoveratrole (374) as the starting material.  
 
Initially attempted were made to prepare organozinc reagent 375 by direct insertion of 
activated zinc. The first approach was to treat 4-bromoveratrole with DIBAL activated zinc 
dust (< 10 µm) according to procedure by Girgis et al.
8
 developed for a Reformatsky 
reaction. Unfortunately 374 remained unreacted and was recovered in almost pure form from 
the reaction mixture. Further reading revealed that the reaction between aryl bromides and 
active zinc is generally slow and requires extended reaction times and high temperatures.  
One technique to resolve the issue of low reactivity is to prepare a highly active form of zinc 
metal (oxidation state 0) by the reduction of the ionic salt. This produces a fine oxide free 
powder, with a high surface area and is commonly referred to as Rieke zinc named after the 
inventor Reuben D Rieke.
9
  
 
 
Scheme 110 Preparation of organozinc 375 via Rieke zinc and the following model coupling with BrCH2CN 
 
Following the procedures of Rieke and co-workers
10
 highly active zinc was prepared by the 
reduction of Zn(II)Cl2 with lithium naphthalenide to produce a fine, dark grey to black 
suspension in THF. The aryl bromide, 4-bromoveratrole (374) was then added neat to the 
black suspension and mixture was heated to reflux and maintained at this temperature for four 
hours (Scheme 110). Once the reaction was complete the unreacted zinc suspension was 
allowed to settle to allow for transfer of organozinc 375. Organozinc reagent 375 was then 
reacted with bromoacetonitrile according to the conditions of Frejd et al.
7
 The crude product 
was analysed and arylacetonitrile 376 was detected in 30% yield (by GC/MS). However a 
large amount of 374 was still present. Clearly the zinc insertion did not go to completion and 
only a small amount of zinc bromide 375 was available for attack by bromoacetonitrile. It is 
presumed that the reason for the low yield of zinc insertion was due to contamination of the 
batch of active zinc by moisture from the ZnCl2 used. As every precaution was taken to 
Chapter 5 
Page | 293  
 
reduce moisture content (ZnCl2 was recrystallised, stored under N2 and weighed out in a 
glove box) it was realised that zinc bromide 375 could simply not be efficiently prepared in 
this manner due to the slow rate of zinc insertion. 
 
 
Scheme 111 Preparation of organozinc 375 by transmetallation of organolithim 377 with ZnCl2 and the following coupling 
with BrCH2CN 
 
The traditional technique to prepare organozinc reagents is by transmetallation of the 
organolithium precursor with the zinc halide. Following the procedure of Negishi et al.
11
 
arylzinc chloride 375 was obtained as a white suspension in THF after the addition of 
organolithium 377 to a THF solution of ZnCl2 (Scheme 111). The following coupling 
reaction with bromoacetonitrile was then carried out according to Frejd et al.
7
 and the crude 
product was analysed as before. When organozinc 375 was prepared in this way the majority 
of 4-bromoveratrole (374) was consumed and only trace amounts were present in the GC 
trace. However with an excess of organozinc chloride 375 in the coupling reaction the major 
product was biaryl 378 as a result of homocoupling making the yield of aryacetonitrile 376 
(40%) similar to that obtained from the previous experiment. As this was only the model 
reaction it was decided that the arylacetonitrile route was not feasible and an alternative 
approach was required. 
 
 
 
 
 
Chapter 5 
Page | 294  
 
5.2.1.2 Access to arylacetic acid by lactone 383 
 
A second possible route to arylacetic acid 373 is via a lactone precursor (380) that could be 
opened later in the synthesis. The first approach was to prepare ester 379 by esterifying the 
phenol moiety of cinnamate 273 with bromoacetyl bromide and then to cyclise the resulting 
ester by an intramolecular Reformatsky cyclisation (Scheme 112). As before, it was decided 
to first conduct a series of model reactions to test the chemistry 
 
 
Scheme 112 Retrosynthetic analysis for lactone precrusor 380 
 
The model substrate chosen was 2-bromophenol (381) which was readily esterified with 
bromoacetyl bromide at room temperature in the presence of pyridine to provide α-
bromoester 382 in essentially quantitative yield (Scheme 113). It was noted that this 
compound was particularly acid sensitive as when it was passed through a SiO2 gel column 
the colour of the column changed from white to purple and only 50% of the compound was 
recovered. As this compound therefore couldn‟t be purified by chromatography and an 
attempt was made to isolate the pure compound by short path distillation as has been reported 
on numerous occasions for the target lactone (383).
12
 Unfortunately 382 decomposed before 
it could be distilled and the majority of the compound was lost. The fractions obtained from 
the distillation were tested for any trace of the either the starting material or lactone products. 
When the two 
1
H NMR spectra were compared it could be seen that the relative amount of an 
impurity present in the crude mixture had increased due to the appearance of a second set of 
peaks in the aromatic region (Figure 19). This was an interesting result as since the splitting 
pattern of the aromatic peaks were similar it is possible that the apparent impurity or by-
product was in fact the lactone which meant that α-bromoester 382 could be cyclised. The 
esterification was then repeated and 382 was obtained in quantitative yield as a light brown 
oil and was used without further purification in the following reaction.  
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Figure 19 1H NMR (300 MHz, CDCl3) of the aromatic region of 382 before (Top) and after (Bottom) attempted distillation
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Scheme 113 Synthesis of α-bromo ester 382 and attempted intramolecular reformatsky cyclisation 
 
Reformatsky reactions are generally performed by preparing an organozinc reagent or zinc 
enolate by the reaction of α-halo esters with activated zinc. The enolisation of the ester aids 
the zinc insertion, increasing the rate of reaction as visualised by an increase in temperature. 
The zinc enolates can then react with electrophiles, typically ketones and aldehydes to form 
secondary and tertiary alcohols. This suggests that 382 is a suitable substrate for Refromatsky 
as it is an α-bromo ester, the preferred halogenated acetate and with an electron deficient 
carbon close by it is anticipated that the cyclisation should proceed with ease. Following the 
procedure by Girgis et al.
8
 as before for the preparation of Reformatsky enolates by DIBAL 
activated zinc the zinc addition was performed at 40
o
C and after all of 382 was added the 
reaction mixture was heated to reflux and maintained at this temperature for three hours 
(Scheme 113). The crude product was then isolated and analysed by 
1
H NMR to reveal that 
no reaction had occurred as the chemical shift of the singlet corresponding to the methylene 
protons had not changed indicating that the α-bromoester (382) was still present. Once again 
it appears that the zinc insertion did not happen as a large proportion of added zinc remained 
in bottom of the flask even though it was completely oxide free (silver appearance). It‟s 
possible that the presence of the electron withdrawing phenyl ring is preventing the zinc 
insertion by delocalising the electrons between the ring and the ester carbonyl essentially 
deactivating the active site for zinc insertion between the methylene carbon and bromine 
atom. As the lactonisation could not be achieved a different approach was required.  
 
A common procedure used to prepare 2(3H)-benzofuranones (phenyl lactones) is via a 
coupling reaction between the sodium salt of a dialkylmalonate and the sodium salt of 2-
bromophenol with Cu(I)Br as the catalyst. The initial report of this reaction was by Setsune et 
al.
13
 where the sodium salt of diethylmalonate was reacted with the sodium salt of 2-
bromophenol (381) in the presence of a stoichiometric amount of Cu(I)Br (1.2 equivalents) to 
afford 3-carboethoxy-2(3H)-benzofuranone (384) in 59% yield after distillation 
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(Scheme 114). Since this publication others have tried to repeat this result and in 1999 a 
second account of this reaction was reported by Hang et al.
14
 who reported that when this 
reaction was attempted by them difficulties were encountered during the isolation as the 
crude product was highly contaminated by copper salts owing to the stoichiometric amounts 
of Cu(I)Br used. Hang et al.
14
 also noted that 384 was particularly sensitive as it decomposed 
on SiO2, similar to the stability observed for α-bromoester 382 in this study. To resolve these 
issues Hang et al.
14
 optimised these conditions and reported that when the reaction was 
performed with dimethylmalonate, catalytic amounts of Cu(I)Br could be used and yield for 
the benzofuranone (385) was 50% (by 
1
H NMR) after 24 hours. Unfortunately this product 
could not be readily isolated by recrystallisation and therefore Hang et al.
14
 developed a new 
isolation procedure were 385 was isolated as the corresponding sodium salt by deprotonation 
of the acidic methine carbon in the malonate motif of the condensed product with NaHCO3 in 
the presence of NaCN to remove any trace copper residues. Using this procedure 
benzofuranone 385 was isolated as the sodium salt in 79% yield.  
 
 
Scheme 114 Previous couplings of dialkyl malonates with 2-bromophenol (381) 
 
This procedure was ideal for the purposes of this work as the 3-carbomethoxy-2(3H)-
benzofuranone (385) could be prepared on a multigram scale. The presence of the ester is not 
concerning as it can be readily removed by decarboxylation in hot aqueous DMSO with the 
addition of NaCl if necessary.
15
 Using 2-bromophenol as the model substrate the reaction 
with the sodium salt of dimethylmalonate was performed using the optimised conditions of 
Hang et al.
14
, where NaH was employed as the base to generate the sodium salts in situ. After 
six days at 80
o
C under N2 the reaction mixture was allowed to return to room temperature and 
the dioxane was evaporated. Following the isolation procedure described an aqueous solution 
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of NaCN in saturated NaHCO3 was added to the CH2Cl2 solution but after an hour of stirring 
at room temperature no precipitate formed. The crude product was then recovered from the 
organic layer as brown liquid and was left to stand overnight at room temperature. The next 
day a crystalline product was recovered and analysed to reveal a different result than 
expected. Upon inspection of the 
1
H NMR only aromatic peaks were seen with no sign of the 
methyl ester. The product had a molecular ion [M]
+
 of 184 m/z which was eight mass units 
greater the expected mass. As the splitting patterns and integral ratios in the 
1
H NMR were 
representative of a highly symmetrical compound it was determined that the product was in 
fact a diarylether (386) resulting from the homocoupling of 2-bromophenol (381, Scheme 
115). This by-product was not reported by either Setsune et al.
13
 or Hang et al.
14
 and was an 
odd result. As the procedure of Hang et al.
14
 was followed exactly with every precaution 
taken to exclude moisture (distilled dioxane, flame dried glassware) it is unclear as to why 
none of the benzofuranone (385) product formed. One theory is that the formation of dioxane 
386 was thermodynamically preferred and therefore the 2-bromophenol was consumed before 
it could react with the sodium salt of dimethylmalonate.  
 
 
Scheme 115 Attempted coupling of dimethyl malonate with 2-bromophenol (381), preparation of diaryl ether 386 
 
The conclusion from these model reactions is that the modification of cinnamate 273 to 
represent the diacid core of (+)-Salvianolic acid D is not a simple task. As both reactions with 
the model substrate were unsuccessful it is clear that either more time must be spent on the 
optimisation of one of these reactions or an entirely different route is required. As the time 
allowed for this side project was limited the adaption of cinnamate precursor 273 to 
preparation of (+)-Salvianolic acid D will be the subject of future work. 
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5.2.2 Synthesis of salvianolic acid C-chalcone hybrid and related 
compounds 
 
Chalcones are generally prepared by performing an aldol condensation between a substituted 
benzaldehyde and a ketone where the α-carbon of the ketone is deprotonated by a strong base 
to form an enolate which attacks the electron deficient carbon of the aldehyde precursor to 
form a secondary alcohol (Figure 20). Under the basic conditions the hydroxyl leaves as 
water hence the reaction is classified as a condensation. It is possible to stop the reaction after 
the addition of the enolate and this is known as an aldol addition. 
 
 
Figure 20 Mechanism of the Aldol condensation 
 
As the pharmacophore of (+)-Salvianolic acid C is unknown it was decided to incorporate as 
much of the original structure of the natural product into the chalcone hybrid. This meant 
that, since the cinnamate chain of (+)-Salvianolic acid C is joined at C4 of the 2-
phenylbenzo[b]furan moiety, the chalcone functional group should be placed in similar 
proximity.  Consequently a synthesis of a 2-phenylbenzo[b]furan with either a ketone or 
aldehyde positioned at C4 was required. As the ketone could be prepared from the aldehyde if 
desired, it was chosen to prepare and use 4-formyl-2-phenylbenzo[b]furan as the key building 
block in the preparation of the hybrid compounds of type shown in Figure 18. 
 
To allow for a rapid generation of a library of chalcone hybrids a short versatile synthesis of 
the 4-formylbenzofuran was required. In the total synthesis of (+)-pentamethylsalvianolic 
acid C the benzofuran core was prepared by a variation of the Sonogashira reaction where an 
acetylene precursor was cyclised with bromophenol 273 to afford the heteroaromatic product. 
Even though this procedure was efficient and simple the acetylene had to be prepared making 
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the process lengthy and reducing the overall yield. After a literature search an interesting 
paper by Hagihara et al.
16
 was found where a series of 2-phenylbenzo[b]furans were prepared 
by an intramolecular Wittig reaction between a phosphonium salt and aryl acid chlorides 
where the acid chloride esterifies at the phenol first and the electron rich methylene carbon 
attacks the electron deficient carbonyl carbon from the acid chloride to form a an oxoanion 
which readily dehydrates to form 2-phenylbenzo[b]furans in yields of up to 85% (Figure 21).  
 
 
Figure 21 Mechanism for the intramolecular Wittig benzo[b]furan reaction 
 
This procedure was especially appealing as it avoided the use of acetylenes, troublesome 
transition metal catalysis and allowed for the preparation of a variety of C2-substituted 
benzofurans by variation of the acid chloride of which many are commercially available. 
Then first step was to synthesise the phosphonium salt (392) which required 6-bromo-2-
hydroxy-3-methoxybenzaldehyde (390). Although 390 is commercially available it is 
expensive and is commonly prepared in-house. Therefore 390 was obtained from ortho-
vanillin (387) in three steps with an overall yield of 67% (Scheme 116).
17,18
 The acetylation 
was attempted with pyridine/Ac2O but the yield of the recrystallised product was only 60%.
19
 
Phosphonium salt 392 was prepared according to the procedures of Hagihara et al.
16
, in two 
steps by NaBH4 reduction of the aldehyde in 390 to afford benzyl alcohol 391 which was 
then converted to phosphonium salt 392 in one step by the action of HBr/PPh3 in refluxing 
CH3CN. Using this methodology 392 was obtained in a total of five steps with an overall 
yield of 57% from ortho-vanillin (387). 
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Scheme 116 Synthesis of phosphonium salt 392 for intramolecular Wittig cyclisation 
 
 
Scheme 117 Synthesis of 4-bromobenzo[b]furan 394 by intramolecular Wittig cyclisation 
 
With a sufficient quantity of phosphonium salt 392 in hand the intramolecular Wittig reaction 
could be attempted. To be consistent with the 2-phenylbenzo[b]furan prepared in the 
synthesis of the methylated analogue of (+)-Salvianolic acid C, 3,4-dimethoxybenzoyl 
chloride (393) was chosen as the counterpart for the Wittig condensation. Following the 
general procedure of Hagihara et al.
16
 the acid choride 393 was added to a suspension of 
phosphonium salt 392 in anhydrous PhMe followed by the addition of Et3N (Scheme 117). 
The suspension was then heated to reflux and maintained at this temperature for three hours. 
After a standard aqueous workup the product (394) was isolated in pure form by 
recrystallisation from MeOH in 46% yield. This was an improvement to the procedure by 
Hagihara et al.
16
 where the product was isolated by chromatography but the yield of this 
benzofuran (394) was significantly lower than that reported by Hagihara et al.
16
 for similar 
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compounds. The reaction was repeated multiple times but the yield was consistent and 
remained between 46 to 50%. This is a similar result to that achieved in the first study where 
the 2-phenylbenzo[b]furan core was obtained in 51% yield after the cuprous acetylide – 
Sonogashira reaction. As the two yields are almost identical the negative affect of the 
substituents is clear where, as described for the first reaction (see Chapter 2, section 2.2), the 
methyl ethers hinder the cyclisation by increasing the electron density at the carbonyl carbon 
after the esterification which decreases the rate of cyclisation by nucleophilic attack of the 
electron rich methylene carbon. 
 
 
Scheme 118 Synthesis of 4-formylbenzo[b]furan 395 by lithium-halogen exchange followed by NFP quench 
 
The final step is to exchange the bromine at C4 with a formyl group. Hagihara et al.
16
 
performed this transformation by conducting a metal-halogen exchange with n-BuLi to form 
the organolithium intermediate which was then quenched by the fast addition of DMF 
at -90
o
C to form the aldehyde. This procedure is the general approach and can provide the 
aldehyde in high yields but the use of DMF in the formylation can lead to inconsistent results 
and has been known to only undergo nucelophilic attack at elevated temperatures.
20,21
 
However when N-formylpiperidine (NFP) is used as the electrophile the substitution occurs 
consistently at low temperatures with a range of substrates and the corresponding aldehydes 
are produced in high yields by isolation by recrystallisation without the need for 
chromatography.
22
 With these conditions in mind the formyl addition was executed by 
conducting the bromine-lithium exchange at -78
o
C with t-BuLi followed by the addition of 
anhydrous N-formylpiperidine between -78
o
C to -40
o
C and allowing the reaction mixture to 
slowly warm to room temperature overnight (Scheme 118). After some optimisation the 
crude product was recrystallised from PhMe to afford pure 395 in 70% yield.   
 
With the aldehyde precursor to the chalcone hybrid prepared the aldol condensation was the 
next step. The ketone building block chosen was 2-acetylbenzoic acid as it was the simplest, 
commercially available ketone that would form a chalcone with a carboxylic acid group, 
thereby mimicking the cinnamic acid structure in (+)-Salvianolic acid C. Aldol condensations 
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of this type have been achieved in the past by Batt et al.
23
 and Wang et al.
24
 where the 
standard procedure was to perform the reaction at room temperature with NaOH as the base 
catalyst in an aqueous EtOH solution. Surprisingly, when these conditions were used no 
reaction occurred after stirring at room temperature for twenty hours and pure starting 
material was recovered (Scheme 119). This was thought to be due to the low solubility of 
aldehyde 395 in aqueous EtOH at room temperature therefore a different reaction medium 
was required. In a more recent publication by Meng et al.
25
 aldol condensation of 4-
acetylbenzoic acid with a variety of heterocyclic benzaldehydes was achieved by using 
freshly prepared LiOMe in a solvent mixture of MeOH and DMF.  
 
 
Scheme 119 Preparation of chalcone 397 by the aldol condensation of 395 with 2-acetylbenzoic acid (396) 
 
The aldol condensation between 395 and 2-acetylbenzoic acid (396) was then attempted with 
LiOMe according to Meng et al.
25
 After twenty four hours at room temperature the 
condensation product was obtained as the major product by 
1
H NMR with a small proportion 
of unreacted 2-acetylbenzoic acid. The reaction was then repeated at 80
o
C and after the same 
period of time chalcone 397 was isolated from the crude product by trituration with Et2O in 
83% yield (Scheme 119). Chalone (397) was determined to have trans-configuration by 
1
H 
NMR with a coupling constant of 16.1 Hz for the alkene proton adjacent to the ketone. The 
peak for the other olefinic proton was obscured by over-lapping aromatic resonances.  
 
The final step in the preparation of this Salvianolic acid C – chalcone hybrid was to esterify 
the benzoic acid motif with the (R)-danshensu side chain (63). From the previous 
investigation into the esterification of the cinnamic acid scaffold of (+)-Salvianolic acid C it 
was known that the Steglich protocol was not a suitable for electron rich substrates as the 
imine intermediate requires acidity to be displaced by DMAP to catalyse the esterification 
(see Chapter 4). As the latter esterification was accomplished via acid chloride activation the 
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same procedure was attempted for the esterification of carboxylic acid 397 with 63. However, 
the microwave conditions used to prepare the first acid chloride were not compatible with 
chalcone 397 and the compound decomposed under the harsh conditions with an excess of 
SOCl2 (Scheme 120). It was attempted to prepare acid chloride 398 by the milder approach 
with oxalyl chloride ((COCl)2) catalysed by DMF but the acid chloride could not be isolated 
due to instability. As the acid chloride could not be prepared an attempt was made to prepare 
the corresponding acid fluoride using the optimised procedure from the previous 
investigation with cyanuric fluoride. Following the standard procedure a yellow solid was 
obtained but the 
1
H NMR of this product did not resemble either the acid fluoride or the 
starting material and was determined to be the result of decomposition.  
 
 
Scheme 120 Attempted syntheses of acid chloride 398 
 
One method that wasn‟t attempted in the previous investigation was the Mitsunobu reaction 
where a diazo reagent (either DEAD, diethylazodicarboxylate or DIAD 
diisopropyldicarboxylate) is combined with PPh3 to form a phosphonium intermediate which 
deprotonates the carboxylic acid to form a stabilised complex. The PPh3 then activates the 
alcohol component allowing the carboxylate anion to attack the alcohol causing the PPh3 to 
leave as O=PPh3. The downside to the Mitsunobu reaction is that, when a chiral alcohol is 
used, an inversion of chirality is generally observed and has been documented on many 
occasions.
26
 This was not a problem here though as both enantiomers of the danshensu 
derivative were prepared as a result of the kinetic resolution of the racemic precursor. This 
Mitsunobu reaction was attempted by adding a mixture of the chalcone-carboxylic acid 397 
and alcohol 325 to a chilled solution of DEAD and PPh3 in anhydrous THF (Scheme 121). 
After stirring at 40
o
C for three days the reaction was stopped and tested by TLC and ESI-MS 
but no trace of ester 399 was found. There was an ion in the MS corresponding to 
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triphenylphosphine oxide (O=PPh3) but the major product was unreacted carboxylic acid 
(397). 
 
 
Scheme 121 Attempted Mitsunobu esterification of chalcone 397 with (S)-danshensu derivative 325 
 
It became evident that, while this esterification required a high activation energy, the 
activation and condensation could only be performed under mild conditions. A technique that 
offers these attributes is the mixed anhydride approach were a sterically hindering acid 
chloride forms an anhydride with the carboxylic acid starting material, generally at or below 
room temperature. The most common mixed anhydride procedure is the Yamaguchi 
esterification
27
 where a solution of the mixed anhydride formed between the carboxylic acid 
moiety and 2,4,6-trichlorobenzoyl chloride (2,4,6-TCBC) is then added to a solution of the 
alcohol and DMAP where DMAP acts as an acyl transfer reagent, regioselectively attacking 
the less hindered side of the anhydride to form ionic intermediate. The alcohol then 
substitutes with DMAP at a fast rate due to nucelophilic strength of DMAP to form 
functionalised esters in high yields (Scheme 122). This procedure was originally designed by 
Yamaguchi and co-workers
27
 for the formation of macrocyclic lactones but has since then 
applied to many esterifications involving complex highly functionalised substrates.
28-33
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Scheme 122 Mechanism for the Yamaguchi esterification 
 
 
Scheme 123 First attempt at the Yamaguchi esterification of 397 with 63 
 
The Yamaguchi esterification is typically performed in PhMe (or PhH) but, due to the low 
solubility of the chalcone, the strategy was to perform the first step in THF, remove the THF 
and conduct the second step in PhMe. As it was noted from the previous investigation that a 
2:1 ratio of carboxylic acid to danshensu derivative 63 was required to achieve practical 
yields of the ester so the same approach was taken here where an excess amount of chalcone 
397 was treated with an excess of 2,4,6-TCBC in the presence of Et3N (Scheme 123). The 
THF was then removed and the crude anhydride was redissolved in PhMe before a solution 
of alcohol 63 and DMAP in PhMe was added at room temperature. Using this procedure ester 
399 was obtained in 7% yield with a significant amount of an unknown by-product. The 
Chapter 5 
Page | 307  
 
reaction was repeated using the same strategy but with the ratio of starting materials reversed 
unfortunately this resulted in lower yields of ester 399 with the major product being 
unreacted alcohol 63, as predicted.  
 
In the original publication by Yamaguchi and co-workers
27
 it was noted that if THF was used 
for the formation of the mixed anhydride it was important to remove it before the 
esterification and perform the second part of transformation in PhMe as small amounts THF 
were found to reduce the yield of esterification. Even though the solution was evaporated to 
dryness it was proposed that small amounts of THF could still be present as the anhydride 
was a foam making complete evaporation difficult. The entire reaction was then repeated in 
PhMe with a ratio of 5:1 for chalcone 397 to alcohol 63. Even though chalcone 397 formed a 
suspension in PhMe at room temperature it still reacted with 2,4,6-TCBC to form a yellow 
solution (Scheme 124). After eighteen hours of stirring at room temperature the reaction 
mixture was analysed by TLC and alcohol 63 was still present even with a heavy excess of 
the anhydride. The temperature of the reaction was then raised to reflux (130
o
C) and after an 
additional two hours a second TLC was taken and all of alcohol 63 had reacted but a complex 
mixture of products had formed. An attempt was made to isolate the target compound (Rf = 
0.34) by CC but, surprisingly it co-eluted with the unknown by-product to form a 1:1 mixture 
(by 
1
H NMR). The mixture was then subjected to preparative-TLC but ester 399 could not be 
completely separated and 399 was obtained with a purity of 83% by 
1
H NMR which equated 
to an isolated yield of 14%.  
 
 
Scheme 124 Second attempt at the Yamaguchi esterification of 397 with 63 
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With this by-product having an almost identical Rf value it was of great interest to elucidate 
its structure. From a previous experiment an almost pure sample was isolated by CC, 
presumably due to the lower yield of the ester and this provided an interpretable 
1
H NMR 
spectrum. Seeing as this by-product had an almost identical Rf it was assumed that it would 
have a similar structure. From the previous investigation an anhydride by-product formed 
during the esterification of alcohol 63 with the acid chloride. It was speculated that the same 
phenomenon could have occurred with this reaction, even though it seemed unlikely. In the 
1
H NMR spectrum there are three singlets between δH 3.9 – 4.1 which would correspond to 
the three methyl ethers present in the either the danshensu or 2-arylbenzo[b]furan moieties. 
The is no quartet between δH 5 – 5.3, which is characteristic for methine group from the 
danshensu moiety, or any other peaks that could correspond to an aliphatic proton and 
therefore the product is most likely completely aromatic. Since there are only three singlets 
between δH 3.9 – 4.1 compared to the six in the 
1
H NMR of ester 399 it is clear that the by-
product does not contain a mixture of the two starting materials and is therefore most likely a 
highly symmetrical compound made from two moles of either starting material. 
 
The aromatic region of the 
1
H NMR is simply too complex to arise from only one aromatic 
ring therefore it is very unlikely that this by-product is made up of the danshensu building 
block (Figure 23). Upon comparison of the aromatic region of the 
1
H NMR of ester 399 and 
the unknown it can be seen that both spectrums are very similar, with similar splitting 
patterns across the region. One of the major differences is the absence of the multiplet at δH 
6.74 in the spectrum for the unknown (Figure 23). When this peak is integrated with the 
adjacent doublet and compared to a peak known to correspond to one proton an integral ratio 
of 4:1 is found. It is thought that this multiplet is due to the three aromatic protons present in 
the danshensu motif as in the 
1
H NMR of the pure starting material the three aromatic protons 
appear as a multiplet and not separate peaks. This confirms that the danshensu motif is not 
present in this by-product.  
 
These observations are consistent with the hypothesis that this by-product could be an 
anhydride of the starting chalcone. Another key difference between the 
1
H NMR spectra is 
the absence of the doublets corresponding to the trans-double bond in the spectrum of the 
unknown which appear at δH 7.08 and δH 7.54 in the spectrum of ester 399. In place of these a 
pair of doublets appear at δH 6.32 and δH 5.97 in the spectrum for the unknown, however their 
coupling constants are significantly smaller being J = 9.1 Hz and J = 8.9 Hz, respectively.  
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Figure 22 Proposed structure of the cis-anhydride by-product (400) from Yamaguchi esterifcation 
 
This suggests that the stereochemistry about the double bond in the chalcone moiety has 
inverted from trans to cis. This data suggests that an unusual transformation has occurred and 
agrees with the hypothesis. The ESI-HRMS of ester 399 was then inspected for any ions or 
adducts that aligned with the predicted monoisotopic mass for the structure of the anhydride. 
Amazingly a small ion with a mass-to-charge value of 921.2520 was found which matches 
the predicted monoisotpic mass for the sodium adduct of the anhydride (calculated for 
C54H42O13Na = 921.2523 m/z). The size of the ion is proportional to the strength of ionisation 
and not the concentration. Overall the data strongly suggests that this unknown is an 
anhydride (400, Figure 22) as result of chalcone 397 reacting with itself during the 
Yamaguchi esterification conditions used here as there is no other possible way to achieve 
that mass with the other reagents used in the reaction. Further research is required to elucidate 
the mechanism.  
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Figure 23 1H NMR (300 MHz, CDCl3) of the aromatic region of ester 399 (Top) and the anhydride by-product 400 (Bottom) from the Yamaguchi esterification
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The reaction was attempted again with a shorter time at room temperature and longer time at 
reflux but the result could not be improved.  The maximum yield of only 14% most likely 
arising from a steric hindrance effect since the carboxylic acid in chalcone 397 is adjacent to 
the carbonyl group in the chalcone functionality. Hydrogen bonding between these two 
groups could also occur which would have a detrimental effect on the yield of esterification 
and anhydride formation. Overall chalcone hybrid 399 was obtained in a total of nine linear 
steps from o-vanillin with an overall yield of 2%, representing the adverse effect of the yield 
for the Yamaguchi esterification since the overall yield up to chalcone 397 was 16%. Clearly 
further development of the process is required to improve the overall yield of 399 and will be 
the subject of future work. 
 
During the literature search for a suitable synthesis of 4-formylbenzo[b]furan 395 an 
interesting publication by Schevenels et al.
34
 was found where 2-formylbenzo[b]furans could 
be prepared from salicylaldehydes and 1,1-dichloroethylene via a one-pot procedure in high 
yields (80 to 90%, Scheme 125). The procedure was to treat the dichloroethylene with a 
freshly prepared solution of LDA at -78
o
C to produce lithium acetylide 402 by 
dehydrohalogenation which could then react with the salicylaldehyde (403) to produce 
terminal chloro alkene 404 which is then hydrolysed with H2SO4 to form 2-
formylbenzo[b]furans (405). As having this compound would extend the scope of the 
chalcone project by allowing for the preparation of a library of 2-substituted chalcones the 
reaction was attempted. A possible mechanism is outlined in Figure 24. 
 
 
Scheme 125 Synthesis of 2-formylbenzo[b]furans by Schevenels et al. 
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Figure 24 Possible mechanism for the formation of 2-formylbenzofuran 405 
 
The lithium acetylide was prepared according to Schevenels et al.
34
 and yellow solution was 
allowed to warm to 0
o
C when a solution of o-vanillin (387) in THF was added (Scheme 126). 
After stirring at room temperature for three hours the first part of the reaction was finished 
and the crude product was analysed by 
1
H NMR and confirmed to be chloroalkene 406. This 
product was then hydrolysed according to the standard procedure and 2-formylbenzo[b]furan 
407 was obtained in 27% yield after chromatography. This yield wasn‟t consistent with that 
reported by Schevenels et al.
34
 but a sufficient quantity of 407 was isolated for the next 
reaction. This product was then subjected to an aldol condensation with 2-acetylbenzoic acid 
using the optimised procedure developed for the first chalcone. Amazingly the same 
conditions were suitable for this substrate and chalcone 408 was isolated in 70% yield.  
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Scheme 126 Synthesis of chalcone 408 
 
The esterification of this product with danshensu derivative 63 was not attempted due to the 
low yield obtained in the previous esterification. For this reason the primary products of this 
synthesis were the chalcones and samples of both compounds were sent for biological testing 
along with the methylated derivatives of Salvianolic acid C. 
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5.3 Experimental 
 
5.3.1 Model reaction studies towards the synthesis of the aryl acetic acid 
core of (+)-Salvianolic acid D 
 
5.3.1.1 Preparation of Ni(acac)2 
 
Ni(OH)2.H2O 
 
To a 1L beaker equipped with a mechanical stirrer was added Ni(NO3)2.6H2O (30.29 g, 
104 mmol) followed by deionised H2O (200 mL). The stirrer was started and the pH of the 
vibrant green solution was adjusted to 14 by the addition of dilute aqueous NaOH (2M, 
150 mL). The colour of the solution became lighter and a green precipitate formed. The 
precipitate was filtered off, washed with an additional portion of deionsed H2O and dried 
under house vacuum to afford Ni(OH)2.H2O (50.2 g) a moist green solid. As it was not 
necessary to form the anhydrous product the product was not completely dried and an 
accurate yield was not calculated. 
 
Ni(acac)2
35,36
 
 
To a 250 mL beaker was added moist Ni(OH)2.H2O (22 g) followed by acetylacetone 
(9.5 mL). The green suspension was then placed in an ultrasonic bath for 30 min. The 
reaction mixture was then suspended in CHCl3 and filtered to remove the unreacted Ni(OH)2. 
The combined filtrates were then evaporated to afford the monohydrate of Ni(acac)2. This 
product was then suspended in anhydrous PhMe and the heterogeneous mixture was set to 
reflux with vigorous stirring for 1 hour. The hot solution was then allowed to return to room 
temperature and evaporated to afford anhydrous Ni(acac)2 (6.2 g) as emerald green crystals.    
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5.3.1.2 Attempted preparation of 2-(3,4-Dimethoxyphenyl)acetonitrile (376) 
 
 
 
With formation of organozinc reagent by Rieke zinc
10
 
 
An oven dried 100 mL, three-necked RBF was assembled with a rubber septum, a reflux 
condenser attached to gas inlet adapter, a glass stopper and a Teflon coated, oval shaped 
magnetic stir while hot and then evacuated. The flask was then flame dried and allowed to 
cool under N2. Freshly cut Li metal (0.255 g, 36.74 mmol, 2 equiv to ZnCl2) was then added 
followed by anhydrous naphthalene (4.6885, 36.58 mmol, 2 equiv to ZnCl2). The flask was 
then sealed and evacuated and purged with N2 (3×). Anhydrous THF (18 mL) was then added 
and the lithium suspension was stirred at room temperature for 2 hours or until all of the 
lithium metal had reacted to form a dark green solution of lithium naphthalenide. In a second 
dry flask a solution of anhydrous ZnCl2 (2.457 g, 18 mmol, 3 equiv to 4-bromoveratrole) in 
THF (18 mL) was prepared. After stirring the dark solution of lithium naphthalenide for 
2 hours the ZnCl2 solution was added via cannula to the naphthalenide solution at rate of 
approximately 3 seconds per drop. Upon completion of the addition the fine black suspension 
of the active zinc was allowed to settle and the supernatant was decanted by syringe. The 
active zinc was then washed with an additional portion of anhydrous THF to remove the 
naphthalene. The active zinc was then finally suspended in anhydrous THF (20 mL) before 4-
bromoveratrole (374, 0.85 mL, 5.91 mmol, 1.03 equiv to BrCH2CN) was added via syringe. 
The black suspension was then heated to reflux and maintained at this temperature for 
4 hours. The reaction mixture was then allowed to cool undisturbed to settle the unreacted 
zinc suspension. 
 
An oven dried 100 mL, Schlenk flask was assembled with a rubber septum and Teflon 
coated, oval shaped magnetic stir bar while hot and then evacuated. The flask was then flame 
dried and allowed to cool under N2. Anhydrous Ni(acac)2 (65 mg, 0.25 mmol, 5 mol%) was 
then added followed by PPh3 (66 mg, 0.25 mmol, 5 mol%). The flask was then sealed and 
evacuated and purged with N2 (3×). Anhydrous THF (4 mL) was then added and the resulting 
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green solution was allowed to stir under N2 at room temperature for 5 minutes. Additional 
THF (5 mL) was then added followed by BrCH2CN (0.40 mL, 5.74 mmol). The still green 
solution was then cooled to 0
o
C (ice/H2O) and the resulting organozinc reagent was 
transferred via cannula to the green solution of the Ni(0) catalyst. The final reaction mixture 
was then allowed to stir at room temperature overnight during which time the colour of the 
solution changed from green to yellow. The reaction was then quenched by the addition of a 
chilled solution of dilute aqueous HCl (1M, 10 mL). The biphasic mixture and was then 
extracted with Et2O (3 × 50 mL) and the combined organic layers were washed with 
deionised H2O (50 mL), brine (50 mL), dried over MgSO4, filtered through a pad of SiO2 
(3-5 cm) and evaporated to yield the crude product (0.93g) which was analysed by GC/MS to 
determine a yield of 30% for 376.  
 
HRMS (EI) calculated for C10H11NO2 [M]
+
: 177.0790, found 177.7092 m/z. 
 
Via transmetalation with ZnCl2
11
 
 
An oven dried 100 mL, three-necked flask was assembled with a  rubber septum, gas inlet 
adapter, a Teflon coated, oval shaped magnetic stir bar and a glass stopper while hot then 
evacuated. The flask was then flame dried and allowed to cool under N2. 4-Bromoveratrole 
(0.90 mL, 6.26 mmol, 1.09 equiv to BrCH2CN) was then added to the dry flask followed by 
anhydrous Et2O (10 mL). The flask was then cooled to -78
o
C (dry ice/acetone) before a 
solution of n-BuLi (2.5 M, 3.0 mL, 7.5 mmol, 1.2 equiv to 4-bromoveratrole) was added. The 
resulting solution was at this temperature for 15 minutes to ensure complete formation of the 
organolithium. 
 
To a dry 100 mL, Schlenk flask equipped with a magnetic stir bar and rubber septum was 
added anhydrous ZnCl2 (0.89 g, 6.53 mmol, 1.04 equiv to 4-bromoveratrole) followed by 
anhydrous THF (5 mL). The chilled ethereal solution of the organolithium was then diluted 
with THF (10 mL) before being transferred via cannula to the ZnCl2 chloride solution at 
room temperature. After stirring for 1 hour a heavy white precipitate of the organozinc 
chloride formed.  
 
While the organozinc solution was left to stir, a second dry 100 mL Schenk was assembled 
with a magnetic stir bar and rubber septum. Anhydrous Ni(acac)2 (64 mg, 0.25 mmol, 
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4.4 mol%, to BrCH2CN) was then added followed by PPh3 (66 mg, 0.25 mmol, 4.4 mol%, 
BrCH2CN). The flask was then sealed and evacuated and purged with N2 (3×). Anhydrous 
THF (4 mL) was then added and the green solution was allowed to stir at room temperature 
for 5 min. Additional THF (5 mL) was then added before neat BrCH2CN (0.40 mL, 
5.74 mmol) was added via syringe. The white suspension of the organozinc was then cooled 
to 0
o
C (ice/H2O) before it was transferred via cannula to the green solution of the Ni(0) 
catalyst. Upon completion of the addition the final reaction mixture was allowed to stir at 
room temperature overnight. The reaction was then quenched by the addition of a chilled 
solution of dilute aqueous HCl (1M, 10 mL). The biphasic mixture was then extracted with 
Et2O (3 × 50 mL) and the combined organic layers were washed with deionised H2O 
(50 mL), brine (50 mL), dried over MgSO4, filtered through a pad of SiO2 (3 – 5 cm) and 
evaporated to afford the crude product which was analysed by GC/MS to determine a yield of 
40% for 376 and a large amount of a biaryl homocoupled product.  
 
HRMS (EI) calculated for C10H11NO2 [M]
+
: 177.0790, found 177.7092 m/z. 
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5.3.1.3 Attempted synthesis of 2,3-dihydro-1-benzofuran-2-one 383 via intramolecular 
Reformatsky cyclisation
8
 
 
2-Bromophenyl 2-bromoacetate (382) 
 
 
 
To an oven dried 250 mL, single necked RBF equipped with a Teflon coated, oval shaped 
magnetic stir bar was added 2-bromophenol (381, 5.20 g, 30 mmol) followed by anhydrous 
CH2Cl2 (50 mL) and pyridine (4.8 mL, 60 mmol, 2 equiv). The clear solution was then cooled 
to -10
o
C (ice/H2O) before bromoacetyl bromide (3.2 mL, 36.73 mmol, 1.2 equiv) was added 
in portions. Upon completion of the addition and air condenser attached to a gas inlet adapter 
was fitted and the flask was evacuated and purged with N2 (3×). The cooling bath was then 
removed and the reaction mixture was allowed to stir at room temperature under N2 for 4 
hours. The reaction mixture was then concentrated to afford a residual oil which was 
dissolved in Et2O (50 mL) and deionised H2O (50 mL). The layers were separated and the 
aqueous layer was extracted again with additional Et2O (2 × 50 mL). The combined ethereal 
layers were then washed with dilute aqueous HCl (2 M, 50 mL), brine (50 mL), dried over 
MgSO4, filtered through a pad of Celite (3-5 cm) and evaporated to afford 382 (8.8 g, > 99%) 
as a light brown oil. 
 
1
H NMR (300 MHz, CDCl3) δ 4.13 (2H, s, CH2), 7.17 (2H, m, ArH), 78.37 (1H, m, ArH), 
7.64 (1H, dd, J = 8.5, 1.7 Hz, ArH); 
13
C NMR (75 MHz, CDCl3) δ 25.06 (CH2Br), 115.70 
(ArCBr), 123.18, 127.77, 128.51, 133.39, 147.61 (ArCOR), 164.77 (CO2); HRMS (EI) 
calculated for C8H6Br2O2 [M]
+
: 291.8735, found : 291.8786 m/z. 
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Attempted preparation of 2,3-dihydro-1-benzofuran-2-one (383) 
 
 
 
An oven dried 100 mL, three necked RBF was assembled with a reflux condenser attached to 
a gas inlet adapter, a rubber septum, a Teflon coated, oval shaped magnetic stir bar and a 
glass stoper while hot and then evacuated. The flask was then flame dried and allowed to cool 
under N2. Granular zinc (0.46 g, 7 mmol, 2 equiv) was then added to the dry flask followed 
by anhydrous THF (10 mL). The zinc suspension was then warmed to 30
o
C and 5% of the 
total charge of 382 (62 mg) was added followed by a solution of DIBAL (20% (w/w), 10 
drops). The temperature of the suspension was then increased to 40
o
C and a solution of the 
remainder of 382 (0.9983 g, total 3.6 mmol) in THF (10 mL) was transferred to the flask via 
cannula. The zinc suspension was then stirred at 40
o
C for 1 hour before the reaction mixture 
was heated to reflux and maintained at this temperature for 3 hours. The THF solution was 
then decanted from the unreacted zinc and placed into a separatory funnel. Brine (50 mL) and 
EtOAc (50 mL) were then added and the layers were separated. The EtOAc phase was then 
washed with a dilute aqueous solution of citric acid (0.5 M, 30 mL). The aqueous phase was 
then re-extracted with EtOAc (2 × 50 mL) and the combined organic layers were washed 
with brine (50 mL), dried over MgSO4, filtered through a pad of Celite (3-5 cm) and 
evaporated to afford the crude product which was analysed by 
1
H NMR. 
 
A pure sample of 383 could not be obtained; therefore a full characterisation was not carried 
out. 
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5.3.1.4 Attempted synthesis of 2,3-dihydro-1-benzofuran-2-one 385 via addition of 
dimethyl malonate
14
 
 
 
 
An oven dried 250 mL, three necked RBF was equipped with a reflux condenser attached to a 
gas inlet adapter, a rubber septum, a Teflon coated oval shaped magnetic stir and a glass 
stopper while hot and then evacuated. The flask was then flame dried and allowed to cool 
under N2. NaH (60% dispersion in mineral oil, 2.33 g, 58.25 mmol, 2 equiv) was then added 
to the dry flask followed by freshly distilled dioxane (111 mL), dimethyl malonate (3.7 mL, 
32.32 mmol, 1.1 equiv) and 2-bromophenol (381, 3.35 mL, 28.89 mmol). The solution was 
then stirred at room temperature for 30 min to ensure complete formation of the sodium salt. 
Cu(I)Br (0.84 g, 5.86 mmol, 20 mol%) was then added and the flask was evacuated and 
purged with N2 (3×). The temperature of the reaction mixture was increased to 80
o
C and the 
heterogeneous mixture was stirred at this temperature under N2 for 6 days. After returning to 
room temperature the dioxane was evaporated to afford a brown residue. The residue was 
dissolved in CH2Cl2 and transferred to a 1L single necked RBF. Deionised H2O (290 mL) 
was then added followed by additional CH2Cl2 (360 mL) and a solution of NaCN (3.6 g) in a 
saturated aqueous NaHCO3 (75 mL). The biphasic mixture was then stirred at room 
temperature for 1 hour. The mixture was then filtered and the layers were separated. The 
organic phase was then dried over MgSO4 and evaporated to afford a dark yellow oil which 
was left at room temperature overnight. The next day, crystals appeared within the oil which 
were isolated by recrystallisation from Et2O. The product was then analysed by 
1
H NMR and 
GC/MS to determine that the compound was the homocoupled by-product 386 (266 mg, 5%). 
 
1
H NMR (300 MHz, CDCl3) δ 6.87 (8H, m, ArH); LRMS (EI) [M]
+
 184 m/z. 
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5.3.2 Synthesis of salvianolic acid C – chalcone hybrid 399 
 
5.3.2.1 2-Formyl-6-methoxyphenyl acetate (388)
18
 
 
 
 
To a 250 mL RBF equipped with an oval shaped, Teflon coated magnetic stirrer and glass 
stopper was added o-vanillin (387, 20.07 g, 132 mmol) followed by DMAP (1.62 g, 
13.2 mmol, 10 mol%) and anhydrous DIPEA (66 mL). Anhydrous CH2Cl2 (50 mL) was then 
added to the red suspension and the resulting homogenous solution was cooled to 0
o
C 
(ice/H2O). The chilled solution was stirred vigorously and freshly distilled Ac2O (16.5 mL, 
174 mmol, 1.3 equiv) was added in one portion. After approximately 2 to 5 minutes of 
stirring at 0-5
o
C the solution changed colour from red to yellow, the ice bath was removed 
and this solution was stirred at room temperature overnight. The progress of the reaction was 
monitored via TLC (30% EtOAc/Hexane) and upon completion (20 h) the reaction mixture 
was quenched with 2M HCl (250 mL). The biphasic mixture was transferred to a separatory 
funnel, with CH2Cl2 rinses and the layers were separated. The aqueous layer was then re-
extracted with CH2Cl2 (2 × 100 mL) and the combined organic layers were then dried over 
MgSO4, filtered through a thin pad of Celite and evaporated. The resulting yellow residue 
was then recrystallised from EtOH/H2O (1:1.7) to obtain 388 (20.70 g, 81%) as light yellow 
to colourless crystals. 
 
1
H NMR (300 MHz, CDCl3) δ 3.10 (3H, s, COCH3), 3.89 (3H, s, OCH3), 7.22 (1H, dd, J = 
8.1, 1.5 Hz, ArH), 7.35 (1H, tt, J = 16.1, 8.3, 0.6 Hz, ArH), 7.47 (1H, dd, J = 7.8, 1.5 Hz), 
10.14 (1H, d, J = 0.6 Hz, CHO); HRMS (EI) calculated for C10H10O4 [M]
+
: 194.0579, found: 
194.0604 m/z. 
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5.3.2.2 3-Bromo-2-formyl-6-methoxyphenyl acetate (389)
18
 
 
 
 
To a 1 L RBF equipped with a large oval shaped, Teflon coated magnetic stir bar and glass 
stopper was added KBr (69.22 g, 580 mmol, 3.2 equiv) followed by deionised H2O (435 mL) 
and Br2 (11.8 mL, 458 mmol, 2.5 equiv). A red solution was formed and 388 (34.97 g, 
180 mmol) was added in one portion. The resulting turbid orange solution was stirred 
overnight at room temperature. After 24 h of stirring the precipitated product was filtered off, 
washed with deionised H2O (3×) and allowed to air dry to provide 389 (49.0 g, >99%) in 
quantitative yield as a purple to pink powder. This product was determined to be relatively 
clean (via 
1
H NMR) and did not require further purification. A portion of this product was 
recrystallised from isopropanol for characterisation.  
 
1
H NMR (300 MHz, CDCl3) δ 2.39 (3H, s, COCH3), 3.86 (3H, s, OCH3), 7.06 (1H, d, J = 
8.9 Hz, ArH), 7.52 (1H, d, J = 8.9 Hz, ArH), 10.27 (1H, s, CHO); HRMS (EI) calculated for 
C10H9
79
BrO4 [M]
+
: 271.9684, found: 271.9672 m/z. 
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5.3.2.3 6-Bromo-2-hydroxy-3-methoxybenzaldehyde (390)
18
 
 
 
 
To a 1 L RBF equipped with a large oval shaped, Teflon coated magnetic stir bar and glass 
stopper was added 389 (69.4 g, 250 mmol) followed by reagent grade MeOH (490 mL), 
deionised H2O (50 mL) and anhydrous NaHCO3 (30.0 g, 357 mmol, 1.4 equiv). The resulting 
bright yellow suspension was stirred at room temperature for 2 h. Upon completion the 
reaction mixture was concentrated to form a dark residue. This residue was then re-dissolved 
in deionised H2O (200 mL) and the pH was adjusted to 1 with dilute aqueous HCl (6M). The 
acidic solution was then extracted with CH2Cl2 (3 × 200 mL). During the extraction a vibrant 
orange colour appeared in the organic layer. The combined organic layers were then dried 
over MgSO4, filtered through a pad of Celite and evaporated to form an orange solid. The 
crude solid was then recrystallised from isopropanol to yield 390 (33.6 g, 81%) as orange 
crystals.  
 
1
H NMR (300 MHz, CDCl3) δ 3.91 (3H, s, OCH3), 6.93 (1H, d, J = 8.3 Hz, ArH), 7.11 (1H, 
d, J = 8.6 Hz, ArH), 10.31 (1H, s, CHO), 12.29 (1H, d, J = 0.6 Hz, OH); HRMS (EI) 
calculated for C8H7
79
BrO3 [M]
+
: 229.9579, found: 229.9596 m/z. 
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5.3.2.4 3-Bromo-2-(hydroxymethyl)-6-methoxyphenol (391)
16
 
 
 
 
To a 2L RBF equipped with a large, oval shaped Teflon coated magnetic stir bar and glass 
stopper was added 390 (35.16 g, 152 mmol) followed by anhydrous MeOH (850 mL) and 
THF (340 mL). The orange solution was then cooled to 0
o
C (ice/H2O) and NaBH4 (5.83 g, 
154 mmol, 1.01 equiv) was added in portions, allowing the gas to evolve between each 
addition. Upon completion of the addition a white suspension formed which was stirred at 0 
to 5
o
C for 30 min and then at room temperature for 1 h. Upon completion the reaction 
mixture was concentrated to form an oily residue. This residue was treated with dilute 
aqueous HCl (1M). The acidic solution was then extracted with EtOAc (3 × 150 mL) and the 
combined organic layers were washed with brine (100 mL), dried over MgSO4, filtered 
through a pad of Celite and evaporated to provide 391 (34.8 g, 98%) as a yellow solid. This 
solid was analysed via GC/MS and 
1
H NMR and was determined to be >95% pure and was 
therefore deemed to be satisfactorily pure for the next step as the by-products (trace amounts 
of starting material and an over-reduced product) would not interfere in the following 
reaction.    
 
1
H NMR (300 MHz, CDCl3) δ 3.88 (3H, s, OCH3), 4.91 (2H, s, CH2OH), 6.70 (1H, d, J = 
8.7 Hz, ArH), 7.06 (1H, d, J = 8.7 Hz, ArH); HRMS (EI) calculated for C8H9
79
BrO3 [M]
+
: 
231.9735, found: 231.9724 m/z. 
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5.3.2.5 (6-Bromo-2-hydroxy-3-methoxybenzyl)triphenylphosphonium bromide (392)
16
 
 
 
 
To a 500 mL RBF equipped with an oval shaped, Teflon coated magnetic stir bar and reflux 
condenser was added 391 (34.04 g, 146 mmol) followed by analytical grade CH3CN 
(290 mL), recrystallised PPh3 (38.33 g, 146 mmol, 1 equiv) and aqueous HBr (47%, 25.17 g, 
146 mmol, 1 equiv). The resulting suspension was stirred vigorously and heated to reflux and 
held at this temperature for 3 h. During this time the PPh3 dissolved. The reaction mixture 
was then allowed to cool to room temperature before being concentrated to form a yellow 
residue. This residue was then re-dissolved in CH2Cl2 and a proportional amount of PhMe 
was added before being evaporated to dryness to form a second yellow-green residue. At this 
point the residue was triturated with anhydrous Et2O and washed with anhydrous THF to 
afford 392 (71.9 g, 88%) as a colourless crystalline solid.  
 
1
H NMR (300 MHz, CDCl3) δ 3.73 (3H, s, OCH3), 4.90 (2H, d, J = 13.2 Hz, CH2PPh3), 6.64 
(1H, dd, J = 8.9, 2.2 Hz, ArH), 6.89 (1H, dd, J = 8.7, 0.7 Hz, ArH), 7.59 (12H, m, o & mH 
PPh3), 7.76 (3H, m, pH PPh3); 
31
P NMR (121 MHz, CDCl3) δ 21.54; 
13
C NMR (75 MHz, 
CDCl3) δ 27.3 (d, JC-P = 49.5 Hz, CH2), 56.3 (OCH3), 113.7 (d, JC-P = 3.30 Hz, ArC), 115.4 
(d, JC-P = 6.1 Hz, ArC), 116.3 (d, JC-P = 8.8 Hz, ArC), 117.7 (ArC), 118.8 (ArC), 122.5 (d, JC-
P = 2.8 Hz, 3 × ArC from PPh3), 129.8 (d, JC-P = 12.7 Hz, 6 × m-ArC from PPh3), 133.8 (d, 
JC-P = 9.9 Hz, 6 × o-ArC from PPh3), 134.9 (d, JC-P = 2.2 Hz, 3 × p-ArC from PPh3), 146.4 (d, 
JC-P = 5.5 Hz, ArCOCH3), 147.1 (d, JC-P = 3.3 Hz, ArCOH); HRMS (ESI) calculated for 
C26H24
79
BrO2P [M-Br+H]
+
 478.0697, found 478.0653 m/z. 
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5.3.2.6 4-Bromo-2-(3,4-dimethoxyphenyl)-7-methoxybenzofuran (394)
16
 
 
 
 
An oven dried 1 L, three-neck RBF was assembled with a rubber septum, glass stopper, an 
oval shaped, Teflon coated magnetic stir bar and a reflux condenser equipped with a gas inlet 
adapter while hot and then evacuated. The flask was then flame dried and allowed to cool 
under N2. Dry 392 (22.34 g, 40 mmol) was added followed by anhydrous PhMe (500 mL) 
and 3,4-dimethoxybenzoyl chloride (393, 8.84 g, 44.06 mmol, 1.1 equiv). The apparatus was 
then evacuated and purged with N2 (3×) before anhydrous Et3N (19 mL, 136 mmol, 3.4 equv) 
was added via syringe to the stirred suspension. The reaction mixture was then stirred 
vigorously, heated to reflux and maintained at this temperature for 3 h. The reaction mixture 
was then allowed to cool to room temperature and diluted with EtOAc (200 mL). The 
EtOAc/PhMe solution was then transferred to a separatory funnel and washed with dilute 
aqueous HCl (2M, 400 mL). The aqueous layer was then re-extracted with EtOAc (2 × 
50 mL). The combined organic layers were then washed with brine (50 mL), dried over 
MgSO4 and filtered through a pad of SiO2 (3-5 cm). The SiO2 pad was then eluted with 50% 
EtOAc/PhMe (50 mL) and the combined filtrates were evaporated to form an oily residue. 
The residue was then evaporated from Et2O to form a solid which could be triturated with 
MeOH to afford 394 (6.7 g, 46%) as a tan solid. 
 
1
H NMR (300 MHz, CDCl3) δ 3.95 (3H, s, OCH3), 4.01 (3H, s, OCH3), 4.04 (3H, s, OCH3), 
6.69 (1H, d, J = 8.5 Hz, ArH), 6.92 (1H, s, ArH), 6.95 (1H, d, J = 8.6 Hz, ArH), 7.28 (1H, d, 
J = 8.5 Hz, ArH), 7.38 (1H, d, J = 1.9 Hz, ArH), 7.50 (1H, dd, J = 8.5, 2.1 Hz, ArH); 
13
C 
NMR (75 MHz, CDCl3) δ 55.9 (OCH3), 56.0 (OCH3), 56.2 (OCH3), 100.3, 104.2, 107.4, 
108.1, 111.2, 118.3, 122.7, 125.9, 132.0, 143.4, 144.6, 149.1, 149.7, 156.6; HRMS (EI) 
calculated for C17H15
79
BrO4 [M]
+
: 362.0154, found 362.0152 m/z. 
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5.3.2.7 2-(3,4-Dimethoxyphenyl)-7-methoxybenzofuran-4-carbaldehyde (395) 
 
 
 
An oven dried 500 mL, Schlenk flask was assembled with an oval shaped, Teflon coated 
magnetic stir bar and glass stopper and then evacuated. The flask was then flame dried and 
allowed to cool under N2. 394 (7.26 g, 20 mmol) was then added, the glass stopper was 
replaced with a rubber septum and the vessel was evacuated and purged with N2. Anhydrous 
THF (200 mL) was then added via syringe and the light yellow solution was cooled to -78
o
C 
(dry ice/acetone). t-BuLi (28 mL of a 1.7 M solution in pentane, 48 mmol, 2.4 equiv) was 
then added at -78
o
C, drop-wise via syringe over a period of 1 h. The resulting dark red 
solution was stirred at this temperature for 30 min. Anhydrous N-formylpiperidine (6.8 mL, 
66.6 mmol, 3.3 equiv) was then added quickly (< 10 s) and the dry ice bath was removed. 
The reaction mixture was then allowed to warm to room temperature and stirring was 
continued overnight (17 h). The reaction mixture was then cooled back down to 0
o
C 
(ice/H2O) and dilute aqueous HCl (6M, 100 mL) was added slowly (fuming). The biphasic 
mixture was then stirred vigorously at 0 to 10
o
C for 15 min to ensure efficient quenching of 
any unreacted lithium species and piperidine by-product. EtOAc (100 mL) was then added 
and the phases were separated. The aqueous solution was then re-extracted with EtOAc (2 × 
50 mL) and the combined organic layers were washed with saturated aqueous NaHCO3 (10% 
(w/w), 100 mL), brine (100 mL), dried over MgSO4, filtered through a thin pad of SiO2 (3 – 
5 cm) and evaporated. The resulting dark orange solid was then recrystallised from boiling 
PhMe to afford 395 (4.4 g, 70%) as orange crystals. 
 
1
H NMR (300 MHz, CDCl3) δ 3.96 (3H, s, OCH3), 4.01 (3H, s, OCH3), 4.15 (3H, s, OCH3), 
6.90 (1H, d, J = 8.3 Hz, ArH), 6.97 (1H, d, J = 8.5 Hz, ArH), 7.43 (1H, d, J = 2.1 Hz, ArH), 
7.57 (1H, dd, J = 8.5, 2.1 Hz, ArH), 7.67 (1H, d, J = 8.3 Hz, ArH), 7.71 (1H, s, ArH), 10.07 
(1H, s, CHO); 
13
C NMR (75 MHz, CDCl3) δ 55.7 (OCH3), 55.8 (OCH3), 56.1 (OCH3), 100.4, 
105.5, 108.0, 111.0, 118.3, 122.4, 122.4, 129.9, 131.7, 143.5, 149.0, 149.3, 149.9, 158.8, 
190.5 (CHO); HRMS (EI) calculated for C18H16O5 [M]
+
: 312.0998, found: 312.1045 m/z. 
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5.3.2.8 2-[(2E)-3-[2-(3,4-dimethoxyphenyl)-7-methoxybenzofuran-4-yl]prop-2-
enoyl]benzoic acid (397)
25
 
 
 
 
An oven dried 500 mL, three-necked RBF was assembled with a 250 mL pressure equalising 
funnel topped with a rubber septum, a glass stopper, an oval shaped, Teflon coated magnetic 
stir bar and a reflux condenser topped with a gas inlet adapter while hot and then evacuated. 
The flask and funnel were then flame dried and allowed to cool under N2. Anhydrous MeOH 
(75 mL) was then added via syringe through the pressure equalising funnel and the stirrer was 
started. Freshly cut and washed Li metal (0.144 g, 20.8 mmol, 4.2 equiv) was then added and 
the methanolic solution was stirred at room temperature until all of the Li metal had reacted. 
In a separate dry flask, 395 (1.56 g, 5 mmol) and 2-acetylbenzoic acid (396, 0.82 g, 5 mmol, 
1 equiv) were dissolved in anhydrous DMF (160 mL) and transferred via cannula to the 
pressure equalising funnel. The DMF solution was then added dropwise to the methanolic 
LiOMe solution at room temperature. The reaction was then heated to 80
o
C and stirred at this 
temperature overnight (18 h). The reaction mixture was then allowed to cool to room 
temperature before being quenched with deionised H2O (700 mL). The aqueous layer was 
then extracted with one portion of EtOAc (200 mL), which was discarded. The pH of the 
aqueous phase was then adjusted to 1 with dilute aqueous HCl (6M, 50 mL). The acidic layer 
was then extracted with EtOAc (3 × 100 mL) and the combined organic layers were washed 
with 2M HCl (3 × 50 mL), brine (3 × 50 mL), dried over MgSO4, filtered through a thin pad 
of SiO2 (3 – 5 cm) and evaporated to afford a bright yellow residue. This residue was then 
triturated with anhydrous Et2O to afford 397 (1.9 g, 83%) as an intense yellow solid. 
 
1
H NMR (300 MHz, d6-DMSO) δ 3.83 (3H, s, OCH3), 3.89 (3H, s, OCH3), 4.02 (3H, s, 
OCH3), 6.98 (1H, d, J = 8.5 Hz, ArH), 7.09 (1H, d, J = 9.1 Hz, ArH), 7.26 (1H, d, J = 
16.2 Hz, HC=CHCO), 7.55 (5H, m, ArCH=CH, ArH), 7.67 (2H, m, ArH), 7.76 (1H, s, ArH), 
7.91 (1H, J = 7.6, 1.3 Hz, ArH), 13.18 (1H, br s, CO2H); 
13
C NMR (75 MHz, d6-DMSO) δ 
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55.6 (OCH3), 55.8 (OCH3), 56.0 (OCH3), 100.0, 107.1, 108.6, 111.9, 118.0, 119.6, 122.1, 
125.2, 126.4, 127.7, 129.7, 129.9, 130.2, 130.9, 131.9, 141.8, 142.0, 143.0, 146.6, 149.2, 
150.0, 157.0, 168.0, 172.1 (CO2H), 195.2 (CO); HRMS (ESI) calculated for C27H21O7 [M-H]
-
: 457.1287, found 457.1298. 
 
5.3.2.9 Methyl (2R)-3-(3,4-dimethoxyphenyl)-2-(2-[(2E)-3-[2-(3,4-dimethoxyphenyl)-7-
methoxybenzofuran-4-yl]prop-2-enoyl]benzoyloxy)propanoate (399) 
 
 
 
An oven dried, 100 mL three-necked RBF was assembled while hot with a rubber septum, 
glass stopper, a Teflon coated oval shaped magnetic stir bar and gas inlet adapter and allowed 
to cool under N2. 397 (253 mg, 0.55 mmol, 5 equiv) was then added to the dry vessel 
followed by anhydrous Et3N (92 µL, 0.66 mmol, 6 equiv) and anhydrous PhMe (20 mL). A 
yellow suspension was obtained to which was added 2,4,6-trichlorobenzoyl chloride (2,4,6-
TCBC, 86 µL, 0.55 mmol, 5 equiv). A suspension was obtained and this was allowed to stir 
at room temperature for 1 h.  
 
Meanwhile, in a separate dry 25 mL RBF under N2 a solution of 63 (26.4 mg, 0.11 mmol, 
1 equiv) and DMAP (20.6 mg, 0.17 mmol, 1.5 equiv) in anhydrous PhMe (5 mL) was 
prepared. The PhMe solution of alcohol 63 and DMAP was then transferred via cannula to 
the yellow PhMe solution of the mixed anhydride with a PhMe rinse (1 mL). The final PhMe 
solution became cloudy after 2 min and was allowed to stir at room temperature overnight 
(18 h) before it was heated to reflux (130
o
C) and maintained at this temperature for 2 hours. 
The reaction mixture was then allowed to slowly cool to room temperature before being 
quenched by a saturated aqueous NaHCO3 (10% (w/w), 10 mL) and diluted with CHCl3 
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(10 mL). The layers were separated and the aqueous layer was re-extracted with CHCl3 (2 × 
20 mL). The combined organic layers were then dried over MgSO4, filtered through a plug of 
Celite and evaporated to afford a yellow residue. The yellow residue was then subjected to 
CC (SiO2, 0 – 10% Et2O/CH2Cl2). The fractions containing 399 were then further purified by 
preparative-TLC (SiO2, 7.5% Et2O/CH2Cl2) to obtain 399 (11 mg, 14%) as a bright yellow 
film. 
 
1
H NMR (300 MHz, CDCl3) δ 3.15 (2H, m, CH2), 3.60 (3H, s, CO2CH3), 3.808 (3H, s, 
OCH3), 3.812 (3H, s, OCH3), 3.96 (3H, s, OCH3), 4.02 (3H, s, OCH3), 4.09 (3H, s, OCH3), 
5.37 (1H, m, CH), 6.76 (4H, m, ArH), 6.95 (1H, d, J = 8.5 Hz, ArH), 7.08 (1H, d, J = 
16.2 Hz, HC=CHCO), 7.19 (1H, s, ArH), 7.33 (1H, d, J = 8.5 Hz, ArH), 7.42 (1H, d, J = 
2.1 Hz, ArH), 7.54 (4H, m, ArH), 7.67 (1H, tt, J = 14.9, 8.9, 1.3 Hz, ArH), 8.03 (1H, dd, J = 
7.6, 0.8 Hz, ArH); 
13
C NMR (75 MHz, CDCl3) δ 36.9 (CH2), 52.3 (CO2CH3), 55.7 (2 × 
OCH3), 56.0 (OCH3), 56.2 (OCH3), 56.2 (OCH3), 74.3 (CH), 106.5, 108.2, 111.1, 111.2, 
112.4, 118.5, 120.1, 121.4, 122.7, 125.4, 126.3, 127.8, 127.9, 128.0, 128.1, 128.2, 129.7, 
130.4, 130.6, 132.6, 132.8, 143.8\ (CO2CH3), 147.0, 148.0, 148.7, 149.2, 150.1, 155.2, 157.7, 
165.8, 169.7; HRMS (ESI) calculated for C39H36O11Na [M+Na]
+
: 703.2155, found 
703.2149 m/z. 
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5.3.3 Preparation of second salvianolic acid C – chalcone hybrid (408) 
 
5.3.3.1 7-Methoxybenzofuran-2-carbaldehyde (407)
34
 
 
 
 
An oven dried 250 mL, Schlenk flask was assembled with a Telfon coated, oval shaped 
magnetic stir bar and a rubber septum while hot and then evacuated. The flask was then flame 
dried and allowed to cool under N2. Anhydrous DIPA (14.8 mL, 106 mmol, 3.2 equiv) was 
then added via syringe followed by anhydrous THF (110 mL). The solution was then cooled 
to 0
o
C (ice/H2O) before n-BuLi (43 mL, 2.5 M solution in hexanes, 108 mmol, 3.3 equiv) 
was added via syringe. The solution was then stirred at 0-10
o
C for approximately 10-15 min 
and during this time the colour of the solution changed from clear to yellow to light green 
indicating the presence of LDA. The LDA solution was then cooled to -78
o
C (dry 
ice/acetone) and anhydrous 1,1-dichloroethylene (3.0 mL, 37.5 mmol, 1.1 equiv) was added 
via syringe. The solution was then allowed to warm to -10
o
C and during this time the colour 
of the solution changed from green to light orange. In a second dry flask under N2 a solution 
of o-vanillin (387, 5.0 g, 32.9 mmol) in anhydrous THF (12 mL) was prepared and once the 
LDA solution had reached -10
o
C the o-vanillin solution was transferred via cannula to the 
LDA solution. The cooling bath was then removed and the reaction mixture was allowed to 
stir at room temperature for 4 h. The reaction was then quenched with saturated aqueous 
NH4Cl (10% (w/w), 200 mL) and extracted with EtOAc (3 × 100 mL). The combined organic 
layers were then washed with brine (100 mL), dried over MgSO4, filtered through a plug of 
Celite and evaporated to form a yellow oil. This was determined to be the chloro intermediate 
(406, via 
1
H NMR) and was used immediately in the next step, without purification.  
 
In a 250 mL, single necked RBF equipped with a Teflon coated, oval shaped magnetic stir 
bar the yellow oil was then dissolved in distilled 1,2-DCE (100 mL) and dilute aqueous 
H2SO4 (1M, 5 mL) was added followed by deionised H2O (95 mL). The biphasic solution 
was then stirred vigorously, heated to reflux and maintained at this temperature overnight. 
The reaction mixture was then allowed to cool to room temperature and two layers were 
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formed. The layers were separated and the aqueous layer was extracted with CH2Cl2 (2 × 
100 mL). The combined organic layers were then dried over MgSO4, filtered through a plug 
of SiO2 (3 – 5 cm) and evaporated to form a dark brown residue. This residue was then 
subjected to DCVC (SiO2, 10% EtOAc/Hexane) to afford 407 (1.6 g, 27%) as a yellow 
crystalline solid. 
 
1
H NMR (300 MHz, CDCl3) δ 4.05 (3H, s, OCH3), 7.00 (1H, dd, J = 7.7, 1.3 Hz, ArH), 7.24-
7.35 (2H, m, ArH), 7.56 (1H, s, ArH), 9.93 (1H, s, CHO); 
13
C NMR (75 MHz, CDCl3) δ 55.9 
(OCH3), 109.9, 115.1, 116.6, 124.7, 128.1, 145.8, 145.9, 152.6, 179.7 (CHO); HRMS (EI) 
calculated for C10H8O3 [M]
+
: 176.0473, found: 176.0432 m/z. 
 
5.3.3.2 2-[(2E)-3-(7-methoxybenzofuran-2-yl)prop2-enoyl]benzoic acid (408) 
 
 
 
408 (1.1 g, 70%) was prepared using the same method for 397, but on a smaller scale 
(5 mmol). 
 
1
H NMR (300 MHz, d6-DMSO) δ 3.95 (3H, s, OCH3), 7.0 (2H, m, HC=CHCO, ArH), 7.21 
(3H, m, ArH), 7.40 (1H, s, ArH), 7.51 (1H, d, J = 7.6 Hz, ArH), 7.68 (2H, m , ArH), 7.94 
(1H, dd, J = 7.4, 0.9 Hz, ArH), 13.31 (1H, br s, CO2H); 
13
C NMR (75 MHz, d6-DMSO) δ 
55.9 (OCH3), 109.0, 113.1, 114.1, 124.4, 127.1, 127.6, 129.8, 130.0, 130.2, 130.4, 132.3, 
141.6, 144.4, 145.1, 152.3, 167.8 (CO2H), 195.0 (CO); HRMS (ESI) calculated for C19H13O5 
[M-H]
-
: 321.0763, found 321.0770 m/z. 
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6.0 Preliminary results of biological assays for antifungal 
activity and the inhibition of Aβ42 oligomerisation in yeast 
cells 
 
6.1 Introduction 
 
A selection of compounds prepared during this investigation was sent for biological testing to 
Assoc. Prof. Ian Macreadie‟s laboratory at the Bundoora campus of RMIT. After a discussion 
it was determined that compounds were suitable for testing as antifungal and potential 
inhibitors of Aβ42 aggregation as these compounds are reasonably non-polar thereby allowing 
them to pass through cell walls. 
 
The accumulation of β-amyloid peptide (Aβ42) is one of the major neurodegenerative 
processes occurring during the progression of pathogenesis in Alzheimer‟s disease (AD).1 
Thus, the development of therapeutic agents which target amyloid production, aggregation or 
clearance is an emerging area of research. 
 
6.2 Results and discussion 
 
6.2.1 Determination of minimum inhibitory concentration (MIC) against 
Candida albicans 
 
A selection of (+)-Salvianolic acid C derivatives and precursors (Figures 25-28) were tested 
for antifungal activity by the determination of their MIC values for the inhibition of C. 
albicans (WM1172). The positive control was C. albicans cells without inoculation of the 
sample compounds and the negative control was C. albicans with Fluconazole, a known 
antifungal drug. The antimicrobial effect of each compound was determined by measuring 
the optical density at 595 nm (OD595) at the start of the assay (0 h), to generate a baseline 
measurement and after twenty four hours of incubation at 30
o
C. The assay was conducted in 
this way since the sample compounds are highly coloured which adds to the level of optical 
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density. The MIC values for each compound was then determined by observing the difference 
in optical density between these two time points and are displayed in Table 33. 
 
Methyl (+)-pentamethylsalvianoate C (348) displayed a high level inhibition with an MIC of 
only 30 µM. However, the carboxylic acid analogue (359) was not as potent with a slightly 
higher MIC of 125 µM. Cinnamic acid 281 displayed the same level of efficacy (30 µM) as 
348 confirming that the danshensu moiety is not an essential part of the core structure of (+)-
Salvianolic acid C for activity as an antifungal agent. This hypothesis is supported by the fact 
that none of the danshensu derivatives (299, 300, 63 & 325) were particularly effective 
against C. albicans with MIC values ranging from 250 – 500 µM. The chalcone analogues 
(397 & 408, Figure 28) displayed the same level of potency as cinnamic acid 281 with MIC 
values of 30 µM. This is consistent with previous reports of other known chalcones acting as 
antifungal agents.
2
 
 
Table 33 MIC values for tested compounds against C. albicans (WM1172) 
Compound MIC (µM) 
395 500 
279 200 
281 30 
299 450 
300 450 
63 250 
325 500 
348 30 
359 125 
397 30 
408 30 
5 500 
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Figure 25 Benzo[b]furan candidates for antifungal and yeast spot assays 
 
 
Figure 26 Danshensu candidates for antifungal and yeast spot assays 
 
 
Figure 27 (+)-Salvianolic acid C analogues (348 & 359) and (+)-Rosmarinic acid (5) as candidates for antifungal and yeast 
spot assays 
 
 
Figure 28 Chalcone-Salvianolic acid C hybrids as candidates for antifungal and yeast spot assays 
 
It would have been interesting to subject the chalcone-danshensu ester to the same assay but 
as a sample of sufficient purity could not be generated this was not possible. Further 
optimisation of the reaction conditions is required to improve the process and will be the 
subject of future work.  
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6.2.2 Yeast spot assay for inhibition of Aβ42 aggregation 
 
The same selection of compounds was tested for their ability to prevent the accumulation of 
β-amyloid peptide (Aβ42) in vitro using yeast cells. The Aβ42 in the yeast cells was 
transformed with different plasmid encodings in selective media (YNB-u) including GFP-
Aβ42 (abbreviated to GA in Figures 30-42). The transformed yeast cells were then added to 
the plates containing 10 µM of each compound in YNB-u media with 10-fold serial dilution. 
The final plates were incubated at 30
o
C for two days to obtain varying degrees of yeast 
growth (Figures 30-42). As Aβ42 is toxic to yeast the inhibition of Aβ42 production by the 
sample compound is demonstrated by comparing the amount of yeast growth between the 
sample plates and the control, where the control yeast was not innoculated with the sample 
compound. (+)-Salvianolic acid B (23) was used as a standard (Figure 29). 
 
 
Figure 29 (+)-Salvianolic acid B (23) the standard compound 
 
 
Figure 30 Control compared to sample plate treated with 10 µM 63 
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Figure 31 Control compared to sample plate treated with 10 µM 299 
 
Figure 32 Control compared to sample plate treated with 10 µM 279 
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Figure 33 Control compared to sample plate treated with 10 µM 300 
 
Figure 34 Control compared to sample plate treated with 10 µM 325 
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Figure 35 Control compared to sample treated with 10 µM 281 
 
Figure 36 Control compared to sample plate treated with 10 µM 348 
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Figure 37 Control compared to sample plate treated with 10 µM 359 
 
Figure 38 Control compared to sample plate treated with 10 µM 395 
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Figure 39 Control compared to sample plate treated with 10 µM 397 
 
Figure 40 Control compared to sample plate treated with 10 µM 408 
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Figure 41 Control compared to sample plate treated with 10 µM 5 (Rosmarinic acid) 
 
Figure 42 Control compared to sample plate treated with 10 µM 23 (Salvianolic acid B) 
 
Upon comparison of each sample to the control it can be seen that there is very little 
difference between the size of the yeast spots in both plates. In fact the inhibitory effect of the 
synthetic compounds is similar to that observed for the natural products (+)-Salvianolic acid 
B and (+)-Rosmarinic acid (5 & 23, Figures 41 & 42, respectively). Therefore the conclusion 
is that all sample compounds show some inhibition of Aβ42 accumulation within the cells but 
as this assay is only qualitative the precise activity of each compound could not be 
determined. However these preliminary results show that there is potential for compounds of 
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this type to be used Aβ42 inhibitors but testing and structural activity studies is required to 
determine the minimum concentration required to prevent apoptosis. 
 
6.3 Methodology 
 
6.3.1 Summary of the protocol for the determination of MIC for C. albicans 
 
 Overnight growth of the C. albicans at 30oC 200rpm 
 Inoculating 100uL into 70 ml fresh media (YNB + glucose) next day to starting OD595: 
0.04 
 Macro broth dilution method of C. albicans WM1172  cell suspension in micro titer plate  
 Media used as blank  
 Various dilution of the compounds have been made from 1mM 
 Measure OD595 at 0 h and 24 h 
 Fluconazole as a negative control 
 DMSO as a vehicle control 
 Cell suspension alone as a positive control  
 
6.3.2 Summary of the protocol for the yeast spot assay 
1. Preparation of Bacterial CaCl2 competent cells (Escherichia coli DH5α; genotype (fhuA2 
Δ (argF-lacZ) U169 phoA glnV44 Φ80 Δ(lacZ)M15 gyrA96 recA1 relA1 endA1 thi- 1hsdR17)) 
2. Transformation of competent cells with plasmids and amplification 
3. Miniprep isolation of plasmids 
4. Transformation of yeast with the plasmids (Expression of GFP/Abeta 42) in plasmid 
vector of p416GPD with selective marker of URA3
3
 
5. Preparation of selective media 
6. Incorporation of the compound into selective media 
7. Preparation of the transformed yeast in water in a microtiter plate with 10 fold serial 
dilution 
8. Transfer of the inoculum onto the solid media using a sterile multi- pronged inoculator  
 
 Yeast cells transformed with plasmid encoding Flemish, Dutch, Iowa, Vari, GA, P4164 
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 Selective media (YNB-u) for the selection of transformant have been used. 
 Compound/s were added to YNB-u media in a 50ml tubes and mixed then immediately 
added to petridish 
 A microtitire plate have been used to make 10 fold serial dilution of the transformant in 
water 
 The dilutions were transferred onto appropriate YNB-u plates combined with the 
compounds 
 Plates were then incubated at 30oC for 2 days, untill growth of the cells became visible 
 Control plates of only YNB-U were used to compare the effect of compound on the 
growth of transformants 
 
Yeast Media: 
 YPD: contain 1% yeast extract, 2% peptone and 2% glucose dissolved in distilled water 
 YNB (minimal media): contain 0.67% yeast nitrogen base with ammonium sulfate and 
2% glucose dissolved in distilled water 
 Selective media: (YNB-U) which is YNB +2% glucose minus selective amino acid or 
base) 
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7.0 Conclusion & Future work 
 
7.1 Concluding statements 
 
As complete deprotection of the methylated derivative (348) could not be achieved, a 
metabolite mimic of the Danshen caffeic acid trimer (+)-Salvianolic acid C (13), (+)-
Pentamethysalvianolic acid C (359) has been prepared in a total of seven linear steps (total of 
thirteen steps) with an overall yield of 11% from isovanillin.  
 
The benzo[b]furan core (281) was prepared via a Sonogashira type coupling of cuprous 
acetylide (270) with ethyl bromocinnamate (273) with an overall yield of 22% from 
isovanillin (185). The (R)-danshensu motif (63) was prepared by the racemic approach as the 
yields obtained via selected asymmetric routes were low and not reproducible. The optimised 
procedure utilised the Darzens condensation to obtain trans-epoxide 314 in 49% yield from 
3,4-dimethoxybenzaldehyde (61) and methyl 2-chloroacetate (317). The epoxide was then 
hydrogenated at atmospheric pressure over 10% Pd/C to afford methyl (±)-
dimethyldanshensu (300) in 85% yield. Kinetic resolution of the racemic mixture with lipase 
Burkholderia cepacia afforded (S) (325) and (R)-trimethyldanshensu (63) in overall yields of 
14% and 20%, respectively after deacetylation of the (S)-enantiomer.  The enantiomeric 
excess (ee) of both enantiomers was determined to be 96% which is an improvement of more 
than 10% in optical purity compared to the kinetic resolution performed by Eicher et al. in 
the first asymmetric synthesis of (+)-Rosmarinic acid (5).  
 
The two building blocks were then esterified by acid chloride activation of the carboxylic 
acid motif.  The cinnamic acid-benzo[b]furan (281) precursor was converted to acid chloride 
(352) by a novel microwave activation protocol where tetrachloroethylene (C2Cl4) was 
employed as the reaction medium with SOCl2 to provide acid chloride 352, as a crystalline 
solid in quantitative yield. The acid chloride (352) was then esterified with (R)-danshensu 
derivative 63 using standard conditions to provide methyl (+)-pentamethylsalvianoate C 
(348) in 71% yield.  Selective saponification of 348 with Me3SnOH afforded (+)-
pentamethylsalvianolic acid C (359) in 71% yield. Many approaches were attempted to 
remove all five methyl ethers but after a lengthy investigation only four methyl ethers could 
be removed with BBr3. Due to a competing reaction the yield of the deprotected product was 
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too low for isolation and the highly hydrophilic product could not be unambiguously 
characterised. 
 
To adjust this synthesis for the preparation of natural (+)-Salvianolic acid C (13), it is 
recommended to use another protecting group as the conditions required for the complete 
removal of five methyl ethers proved detrimental to the fragile electron rich scaffold. To 
enable the esterification to be performed with the optimum conditions via acid chloride 
activation, the allyl ether is suggested as a suitable protecting group as it is not acid sensitive 
and can be catalytically removed. 
 
In the pursuit of the development of novel Danshen pharmaceuticals, a chalcone-salvianolic 
acid C hybrid (399) was prepared in a total of nine linear steps with an overall yield of 2%. 
The key step in the preparation of the benzo[b]furan moiety (395) was an intramolecular 
Wittig cyclisation between acid chloride 393 and phosphonium salt 392. The phosphonium 
salt (392) was obtained from o-vanillin (387) in a total of five steps with an excellent overall 
yield of 56%. However the cyclised product (394) could only be isolated in 51% yield, due to 
the electron donating effect of the methyl ethers present within the skeleton hindering the 
electrophilic cyclisation and ultimately the yield. This provided 4-bromobenzo[b]furan 394 
that was converted to the formyl analogue (395) by lithium-halogen exchange followed by 
substitution with N-formylpiperidine to present the formyl building block (395) in 70% yield. 
This aldehyde was then subjected to an aldol condensation with 2-acetylbenzoic acid (396) in 
the presence of LiOMe to afford chalcone 397 in 83% yield. As in the previous investigation, 
the esterification between the carboxylic acid in chalcone 397 with the danshensu counterpart 
(63) was problematic and could only be achieved in low yields (14%) via the Yamaguchi 
esterification. The low overall yield for hybrid 399 was therefore primarily due to the 
sterically hindered esterification as the overall yield up to chalcone 397 was 16%.  
 
In conclusion, two methylated analogues of (+)-Salvianolic acid C have been prepared. The 
lower polarity of these compounds will improve the bioavailability of the natural product and 
allow access to a wider range of medicinal applications that are currently under investigation. 
Globally methylated (+)-Salvianolic acid C (348) has already shown activity as an antifungal 
agent and potentially as an inhibitor of β-amyloid peptide (Aβ42) accumulation within yeast 
cells. Further biological evaluation of these derivatives could uncover other therapeutic 
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properties of these derivatives and stimulate further investigation into the synthesis of other 
Danshen secondary metabolites. 
 
7.2 Future work 
 
There are many elements of this investigation that could be subject of further investigation. 
Of key interest is the adjustment of the reaction scheme for the preparation of (+)-Salvianolic 
acid C by substituting a different protecting group for the phenolic hydroxyls and carboxylic 
acid motif. The first group that comes to mind is the allyl ether which has been used 
previously in the related total synthesis of (+)-Rosmarinic acid. As this group is not acid 
sensitive and can be catalytically cleaved it is the perfect protecting group for this electron 
rich substrate. Another topic of further research would be to elucidate the mechanism by 
which the anhydride by-product forms during the esterification. This product is itself an 
activated carboxylic acid and could be used to perform the esterification making the 
procedure highly versatile. This would increase the overall yield of the protected ester and 
therefore improve the overall yield. 
 
In the preparation of Salvinolic acid D further optimisation on either the production of 
arylacetontrile 376 or lactone 385 is required. In the nitrile route, coupling of 
bromoacetonitrile with the aryl bromide could be accomplished by Stille coupling of an 
oganotin reagent prepared from bromoacetonitrile and tributyltinchloride. In the lactone route 
further development could be initiated by optimising the coupling reaction between dimethyl 
malonate and the desired bromophenol by trying alternative nucleophilic bases for the 
generation of the salts by which the coupling proceeds. Sodium bases such as either NaOMe 
or NaOEt would be a good starting point as these have shown promise in related coupling 
reactions. The lactone route should take precedence as the lactone building block could be 
biologically active as compounds of this type are known therapeutic agents and therefore 
multiple drug candidates could be prepared by a single synthetic scheme.  
 
In the development of Aβ42 inhibitors for the treatment of Alzheimers disease (AD) the first 
modification to the developed hybrid compounds should be to reduce the double bond in the 
benzo[b]furan core as dihydrobenzo[b]furans of this type have shown this activity and are 
significantly more potent than the structurally strained aromatic derivatives. Another step that 
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requires further development is the esterification between the carboxylic acid of the chalcone 
precursor and the danshensu motif. It is suggested to use a different isomer of 2-
acetylbenzoic acid (possibly 4-acetylbenzoic acid) to reduce the chance of steric hindrance 
during the esterification and finally improve the overall yield of the hybrid compound. 
 
Finally, the last approach to the preparation of (R)-danshensu from L-serine requires further 
development, focusing on the Gilman addition of 4-bromoveratrole to ethyl (R)-glycidate. 
This scheme would allow for structure activity relationship studies of Danshensu derivatives 
through variation of the aryl bromide. 
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Appendix 
 
General experimental conditions 
 
Unless otherwise noted, all materials obtained from commercial suppliers were used as 
received. o-Vanillin and 3,4-dimethoxycinnamic acid were purchased from Alfa-Aesar. 3,4-
dimethoxybenzoyl chloride was obtained from Matrix Scientific. 2,4,6-Trichlorobenzoyl 
chloride was obtained from AK Scientific. Isovanillin and TBME were obtained from Merck. 
3,4-Dimethoxybenzaldehyde was purchased from Acros Organics. t-BuLi (1.7 M solution in 
pentane), n-BuLi (2.5 M solution in hexanes), DMAP, 2-acetylbenzoic acid, 2-Chloroacetic 
acid, (1S)-(+)-10-camphorsulfonic acid and Amano lipase PS from Burkholderia cepacia 
were obtained from Sigma – Aldrich. Me3SnOH was purchased from Strem chemicals. 
AcOH was dried and distilled over Ac2O and CrO3, ZnCl2 was recrystallised from THF and 
dried under high vacuum; Naphthalene was recrystallised from EtOH; Bromoacetyl bromide 
was distilled; DDQ was recrystallised from PhH; Ph2S was distilled; Ac2O was distilled; PPh3 
was recrystallised from CH2Cl2/MeOH; N-formylpiperidine was dried over activated 4Å 
molecular sieves; 1,1-dichloroethylene was passed through a short alumina column with 
positive N2 pressure and stored away from light; Pyridine, pyrrolidine, DIPEA, DIPA, 2,4,6-
Collidine were dried and distilled over KOH; MeOH was dried and distilled over Mg(OMe)2; 
EtOAc was dried over K2CO3; SOCl2 was freshly distilled before each use; K2CO3 was dried 
in an oven at 110
o
C overnight and stored in a desiccator; Et3N was dried and distilled over 
CaH2 and stored over KOH; TBME was dried over activated 4Å molecular sieves; DMSO 
was distilled under partial vacuum and dried over activated 4Å molecular sieves; CH3CN was 
dried and distilled over CaH2; THF and Dioxane were distilled from Na/benzophenone ketyl; 
CH2Cl2 was dried and distilled over CaH2; tetrachloroethylene (C2Cl4) was dried and distilled 
over CaH2 under partial vacuum and 1,2-DCE was dried and distilled over CaH2. Other high 
grade and anhydrous solvents including CH2Cl2, Et2O, PhMe and DMF were dried and 
dispensed from a Glass Contour cartridge solvent dispensing system. EtOAc and Hexane 
were distilled prior to use. 
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Thin – layer chromatography was performed on aluminium-backed, SiO2 gel TLC plates (60 
F254) obtained from Merck and were visualised with KMnO4 dip (KMnO4, K2CO3, NaOH, 
H2O), 20% (w/w) phosphomolybdic acid in EtOH, 2% (w/w) AlCl3 in MeOH, or UV (254 or 
350 nm). Column Chromatography (CC), Flash Column Chromatography (FCC) and 
Vacuum – Liquid Chromatography (VLC) were performed with Davisil LC60A SiO2 (40-
63 µm) which was obtained from Grace Davison Discovery Sciences.  
 
NMR spectra were obtained on the Bruker Avance III 300 MHz spectrometer where the 
residual solvent peaks from the deuterated solvents (CDCl3 
1
H δ 7.27, 13C δ 77.0; d6-DMSO 
1
H δ 2.50, 13C δ 39.51; d4-MeOH 
1
H δ 3.31, 13C δ 49.15) were used as the reference. HRMS 
spectra were recorded on either the Waters GCT Premier (HR-TOFMS) equipped with an 
Agilent 7890 GC or Agilent 6220 Accurate Mass LC-TOF system with Agilent 1200 Series 
HPLC. LRMS spectra were recorded on either the Varian Saturn 2200 MS/MS (ion trap) 
coupled to a Varian CP-3800 GC or a Micromass Platform II ESI-MS. FTIR spectra were 
obtained on a Perkin – Elmer Spectrum 100 spectrometer. Specific rotations ([α]) were 
measured on a Rudolph research analytical Autopol IV Polarimeter at the Sodium D line 
(589 nm), in a 200 mm glass cell and are recorded in degrees (
o
). Microwave reactions were 
performed in a CEM Discover Microwave reactor. Melting points were recorded on a Stuart 
SMP10 melting point apparatus and are uncorrected. 
 
NMR Spectra of novel compounds 
 
(From page 363 to 428) 
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Figure 43 1H NMR (300 MHz, CDCl3) 269 
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Figure 44 13C NMR (75 MHz, CDCl3) 269 
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Figure 45 1H NMR (300 MHz, d6-DMSO) 272 
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Figure 58 13C NMR (75MHz, CDCl3) 292 
Appendix 
Page | 370  
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Figure 63 1H NMR (300 MHz, d6-DMSO) 296 
Appendix 
Page | 375  
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Figure 77 1H NMR (300 MHz, CDCl3) 325 
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Figure 78 13C NMR (75 MHz, CDCl3) 325 
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Figure 86 1H NMR (300 MHz, CDCl3) 348 
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Figure 88 1H NMR (300 MHz, d6-DMSO) 353 
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Figure 91 13C NMR (75 MHz, d6-DMSO) 359 
Appendix 
Page | 403  
 
 
Figure 92 1H NMR (300 MHz, CDCl3) 382 
Appendix 
Page | 404  
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Figure 94 1H NMR (300 MHz, CDCl3) 386 
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Figure 98 13C NMR (75 MHz, CDCl3) 394 
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Figure 99 1H NMR (300 MHz, CDCl3) 395 
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Figure 100 13C NMR (75 MHz, CDCl3) 395 
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Figure 101 1H NMR (300 MHz, d6-DMSO) 397 
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Figure 102 13C NMR (75 MHz, d6-DMSO) 397 
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Figure 104 13C NMR (75 MHz, CDCl3) 399 
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Figure 105 1H NMR (300 MHz, CDCl3) 407 
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Figure 106 13C NMR (75 MHz, CDCl3) 407 
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Figure 107 1H NMR (300 MHz, d6-DMSO) 408 
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Figure 108 13C NMR (75 MHz, d6-DMSO) 40 
